Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A2M "CPAMD5, FWP007, S863-7" ENSG00000175899 Alpha-2-macroglobulin P01023 12 9067664-9116229 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 231.0;lung: 227.4" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 495.9;Hepatocytes: 596.0;Horizontal cells: 643.6;Ito cells: 555.5;Sertoli cells: 329.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.4" "Group enriched" "Detected in many" 7 "dendritic cells: 1.4;T-cells: 4.4" "Group enriched" "Detected in some" 5 "AF22: 113.6;ASC diff: 33.7;Hep G2: 91.5;SK-MEL-30: 32.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002265, CAB017621" Supported "Secreted to blood" NA NA 1630000000000 220000000000 "CAB017621: AB_1118894, HPA002265: AB_1078142" "unprognostic (1.73e-2)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (2.29e-2)" "unprognostic (7.36e-2)" "unprognostic (3.91e-2)" "unprognostic (7.95e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.19e-2)" "unprognostic (4.71e-2)" "unprognostic (2.06e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (2.32e-2)" "unprognostic (8.58e-2)" "unprognostic (9.03e-3)" 77.4 20.5 12.5 14.7 16.8 0.3 39.6 6.1 16.1 41.8 27.3 25.3 10.5 15.0 54.6 28.2 39.5 30.6 49.7 68.0 12.4 10.2 50.0 231.0 227.4 14.9 16.9 8.0 40.8 13.0 20.9 20.4 48.0 20.5 77.3 35.9 47.5 20.5 26.3 26.0 10.2 23.1 57.7 20.9 42.3 25.8 26.2 13.0 4.0 29.5 17.0 8.6 68.9 59.0 0.2 1.4 0.0 0.4 0.0 4.4 0.3 0.0 0.0 113.6 0.0 33.7 2.4 0.3 13.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 91.5 0.0 0.1 0.1 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 32.9 0.5 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.4 0.0 4.4 0.2 2.6 0.2 0.5 1.2 0.3 0.0 0.1 0.7 0.0 0.0 0.0 1.4 0.0 0.3 12.5 16.8 6.1 16.1 12.4 10.2 16.9 8.0 20.5 13.0 11.9 137.3 25.5 1.9 17.3 5.4 90.3 28.1 8.1 12.5 1.8 7.9 1.9 0.0 0.1 16.7 495.9 0.0 23.3 4.5 3.0 24.6 4.2 25.6 596.0 196.9 643.6 0.0 555.5 100.3 27.1 71.7 64.0 21.9 65.9 0.0 4.7 0.2 0.0 133.0 0.0 18.6 329.8 207.9 1.8 1.1 12.3 3.4 16.7 0.0 2.2 ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647496 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 64.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.7;LHCN-M2: 3.7;U-2 OS: 10.4;U-266/84: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063601 Approved Vesicles,Centrosome,Cytosol NA NA Vesicles "Centrosome, Cytosol" "HPA063601: AB_2685057" "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.3 0.2 0.1 0.3 1.0 35.4 0.7 0.0 1.1 1.2 0.3 0.4 0.0 0.3 0.3 1.1 10.3 1.8 0.5 3.5 1.8 0.2 1.1 0.7 15.7 0.2 0.1 0.0 0.4 1.2 0.1 8.7 1.2 0.4 0.2 0.4 0.0 1.7 0.4 0.8 1.3 0.3 0.2 0.9 1.3 0.2 4.2 0.0 4.6 7.1 5.4 14.4 0.5 0.3 0.6 0.6 3.2 0.7 1.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.3 1.0 0.0 0.3 0.0 0.0 0.0 2.2 0.0 1.9 0.6 1.2 2.1 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 1.0 0.8 0.0 0.3 0.0 0.1 3.7 0.0 0.0 0.1 0.1 0.0 2.1 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.0 0.6 10.4 0.4 1.5 3.1 4.2 0.0 1.3 0.4 0.4 3.2 0.7 0.6 0.3 0.4 0.3 0.4 0.2 0.2 0.1 0.6 0.4 0.4 1.6 1.0 0.3 0.6 0.1 0.2 0.1 1.0 0.0 1.1 1.8 0.2 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.0 64.3 9.1 1.8 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.2 0.0 0.0 0.0 0.3 0.1 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;lung: 75.8" "Cell type enriched" "Detected in many" 6 "Alveolar cells type 2: 382.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.3 6.2 12.9 3.4 15.3 1.6 7.0 21.9 30.8 3.0 3.8 13.1 1.8 2.7 3.2 4.2 3.6 4.9 3.3 5.6 14.6 13.8 3.9 1.5 75.8 3.9 11.4 13.1 3.2 9.6 14.8 6.0 4.7 18.3 5.3 2.1 4.9 8.5 5.0 5.0 4.2 2.5 5.0 11.3 3.7 3.0 7.2 6.1 5.6 16.2 0.5 6.4 3.0 1.3 0.2 0.5 0.0 0.6 2.0 1.5 0.4 0.3 9.7 1.8 15.1 0.4 0.0 0.1 2.6 0.6 1.0 1.1 1.3 1.5 0.1 3.8 1.2 0.9 0.2 8.7 0.1 0.3 15.2 5.8 1.0 1.1 0.2 1.3 0.1 1.6 0.1 0.2 0.1 0.5 6.2 14.7 0.1 10.4 0.0 0.0 12.9 0.0 1.0 2.0 2.3 4.7 2.4 0.3 1.7 8.7 0.3 21.2 15.3 1.8 10.7 0.2 0.8 34.9 0.9 4.2 0.1 0.5 4.1 4.3 2.8 1.2 0.0 2.1 5.2 0.1 0.0 0.1 0.0 1.5 0.1 0.8 0.2 0.6 1.4 0.5 0.1 0.6 1.5 0.0 2.0 0.6 0.0 0.3 0.4 12.9 15.3 21.9 30.8 14.6 13.8 11.4 13.1 18.3 6.1 65.5 382.0 0.0 0.4 0.6 16.5 5.1 2.5 4.0 17.0 17.4 11.8 0.0 0.0 4.6 7.7 4.2 0.2 0.0 3.3 0.0 1.4 1.9 27.8 0.9 0.9 17.5 5.2 2.5 2.7 2.7 1.7 1.6 1.7 2.8 0.7 6.9 2.4 0.0 3.2 1.5 9.5 6.5 3.1 1.9 14.0 1.4 0.0 2.5 0.6 0.1 AC009086.2 ENSG00000277669 16 29663279-29695144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 17.3;lymphoid tissue: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 4.0;intermediate monocyte: 4.5;myeloid DC: 5.3;non-classical monocyte: 7.2;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 9 "dendritic cells: 5.3;monocytes: 7.2" "Group enriched" "Detected in some" 5 "BEWO: 19.3;EFO-21: 51.2" HPA011887 Uncertain NA NA "HPA011887: AB_2668555" 3.4 0.4 0.3 8.5 1.3 1.9 0.4 0.0 0.5 0.4 9.5 1.2 0.0 6.8 0.4 0.4 0.7 0.4 1.4 2.2 0.1 0.4 0.5 17.3 12.5 2.0 0.0 0.4 0.5 0.4 0.0 0.4 1.0 0.4 0.4 0.5 3.1 0.4 0.4 0.4 2.5 0.4 2.7 8.3 1.5 0.4 0.7 55.9 0.4 0.6 11.7 0.4 0.0 0.0 5.3 0.0 7.2 0.1 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 3.7 0.0 0.0 2.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.7 0.0 0.4 0.0 0.0 4.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.0 0.0 0.1 7.2 2.8 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC078864.2 ENSG00000284791 12 52079696-52108239 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lung: 23.3;prostate: 18.7;testis: 15.3" "Group enriched" "Detected in some" 17 "Ciliated cells: 2.7;Distal tubular cells: 1.7" "Cell type enriched" "Detected in single" 87 "plasmacytoid DC: 8.7" "Lineage enriched" "Detected in single" 87 "dendritic cells: 8.7" "Cell line enhanced" "Detected in some" "HHSteC: 2.5;MOLT-4: 1.6;RPMI-8226: 1.9" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 1.2 1.1 1.9 0.0 0.0 0.8 0.2 0.1 3.0 0.0 1.4 2.2 0.0 0.0 0.1 23.3 0.6 0.9 0.0 4.1 0.3 0.0 0.0 0.8 0.0 18.7 1.4 0.0 0.0 0.6 0.1 0.0 1.4 4.3 0.6 9.1 1.1 15.3 0.0 0.0 0.0 0.2 2.5 4.8 1.5 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC119676.1 ENSG00000284895 1 41585306-41628816 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 16 "blood: 1.9;lung: 3.2;smooth muscle: 1.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 3.2;ASC diff: 11.5;U-266/70: 1.8;WM-115: 2.9" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACADL "ACAD4, LCAD" ENSG00000115361 "Acyl-CoA dehydrogenase long chain" P28330 2 210187939-210225491 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 29.5;thyroid gland: 29.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 49.8;Early spermatids: 59.0;Late spermatids: 54.8;Leydig cells: 43.4;Peritubular cells: 43.9" "Group enriched" "Detected in many" 8 "liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.0;HeLa: 7.0;RPTEC TERT1: 6.3;RT4: 2.4;SuSa: 6.5;U-2 OS: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011990 Enhanced Supported NA NA "HPA011990: AB_1844465" "unprognostic (6.29e-3)" "unprognostic (7.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (1.33e-2)" "unprognostic (7.66e-3)" "unprognostic (3.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" "unprognostic (1.99e-1)" "prognostic favorable (1.58e-11)" "unprognostic (4.22e-3)" "unprognostic (1.18e-4)" "unprognostic (8.81e-3)" "unprognostic (1.06e-1)" 9.6 1.1 2.0 1.0 1.8 0.0 10.7 1.4 1.8 3.2 0.8 1.5 4.5 0.1 0.7 6.8 1.3 2.3 2.1 2.2 2.4 1.0 17.3 23.0 29.5 0.0 1.6 2.3 12.2 19.3 11.6 5.8 1.2 3.4 14.5 0.2 3.2 9.9 4.8 7.0 2.2 0.3 1.5 3.1 0.0 3.3 4.2 0.9 0.7 29.7 3.7 0.0 0.7 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.3 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.4 0.0 0.0 2.3 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.6 0.0 0.0 0.0 6.3 2.4 0.1 0.9 0.0 0.1 0.0 6.5 0.0 0.0 0.0 0.0 3.5 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.8 1.4 1.8 2.4 1.0 1.6 2.3 3.4 0.9 26.8 49.8 0.0 1.1 0.6 0.2 0.8 10.2 1.4 12.5 21.0 2.0 5.8 13.3 3.4 59.0 0.0 0.0 0.0 10.5 0.4 1.3 4.7 2.3 20.7 0.5 0.0 0.0 1.3 0.3 54.8 43.4 0.8 0.0 0.0 0.0 0.0 5.3 0.0 43.9 25.4 0.1 0.0 1.0 0.6 0.5 0.9 5.3 0.0 0.0 0.6 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732573-111118222 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 29.7;lung: 20.8;placenta: 23.8" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 27.4" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 0.3 0.3 0.2 0.5 0.4 1.6 0.3 0.2 0.4 0.4 0.4 0.2 2.3 0.0 0.3 29.7 0.2 0.5 0.4 0.3 0.2 0.2 0.6 0.2 20.8 0.6 0.2 0.2 0.2 0.4 4.9 0.7 23.8 0.4 4.1 0.1 0.2 0.5 0.2 0.3 0.4 0.3 2.6 0.2 1.3 0.4 4.6 0.2 0.6 1.5 0.2 0.9 8.5 5.2 1.0 0.6 4.1 1.1 0.7 0.6 0.3 9.1 0.0 0.2 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.6 0.2 0.2 0.1 0.2 1.0 0.0 0.0 0.0 0.2 3.2 0.2 0.4 0.2 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.3 0.0 0.4 1.4 1.4 0.1 3.3 0.7 0.4 3.1 0.1 0.4 0.1 0.2 16.5 0.0 21.3 2.0 0.4 0.1 0.4 0.1 0.7 0.2 1.0 0.3 0.2 0.4 0.2 0.1 14.4 3.7 0.5 0.1 0.2 0.2 2.2 1.1 0.5 0.4 0.7 0.2 1.0 0.4 0.6 0.2 0.8 0.5 0.4 4.1 0.7 0.4 0.6 0.4 0.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.0 27.4 0.0 0.2 0.2 0.6 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 1.2 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.3 0.9 2.2 0.3 0.0 0.0 0.0 0.7 ACP5 "HPAP, TRAP" ENSG00000102575 "Acid phosphatase 5, tartrate resistant" P13686 19 11574660-11579008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 117.9;lung: 151.9" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 439.8;Ito cells: 434.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 51.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 14.6;BJ hTERT+: 9.8;K-562: 10.3;RPMI-8226: 13.9;SK-MEL-30: 41.4;U-138 MG: 38.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002584, HPA057655, HPA059463" Enhanced Uncertain Cytosol "Intracellular and membrane" NA NA 3700000 Cytosol "CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028" "unprognostic (4.27e-2)" "unprognostic (2.05e-2)" "unprognostic (2.93e-1)" "unprognostic (8.60e-3)" "unprognostic (2.96e-1)" "unprognostic (1.95e-2)" "unprognostic (5.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.13e-2)" "unprognostic (3.80e-1)" "unprognostic (3.66e-3)" "unprognostic (9.09e-2)" "unprognostic (1.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 117.9 2.8 0.9 21.1 1.1 1.4 7.7 0.7 1.0 11.9 10.2 1.2 2.1 7.7 7.7 6.5 12.1 3.5 9.1 6.8 0.9 0.4 28.0 16.3 151.9 30.8 1.0 1.0 13.2 8.7 0.2 1.6 9.2 1.2 6.4 8.7 19.1 8.6 2.8 3.0 10.4 15.6 3.3 1.9 20.7 15.0 3.5 0.7 9.2 2.2 8.2 18.4 11.4 10.1 51.4 13.9 16.8 9.4 2.6 16.0 8.1 3.3 0.4 0.0 0.0 0.2 0.0 14.6 0.4 9.8 0.0 0.0 0.0 0.1 0.5 0.6 2.9 2.4 0.1 0.0 1.5 0.0 3.7 0.3 0.1 0.0 1.8 0.6 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.7 0.3 0.5 0.3 0.1 0.3 0.1 0.7 13.9 0.0 0.1 0.2 0.3 0.0 0.0 41.4 0.4 0.0 0.1 0.3 38.9 0.4 0.7 0.1 0.2 1.8 0.2 8.0 0.0 1.2 0.0 9.4 16.8 4.1 9.1 2.1 51.4 6.4 4.7 1.7 23.5 8.3 4.7 2.6 2.6 8.7 13.9 16.0 8.1 0.9 1.1 0.7 1.0 0.9 0.4 1.0 1.0 1.2 0.7 8.9 8.5 68.7 8.2 9.2 6.0 1.1 22.9 2.7 2.3 7.0 17.7 29.7 8.3 1.6 0.1 2.9 5.9 0.0 9.9 23.7 12.1 16.2 65.4 6.4 439.8 1.6 2.9 434.6 101.6 0.0 1.7 100.7 13.5 131.7 4.5 43.7 4.7 21.0 11.3 91.3 31.7 0.0 3.2 0.0 0.1 9.7 21.9 25.4 8.3 4.3 ACVRL1 "ACVRLK1, ALK1, HHT, HHT2, ORW2" ENSG00000139567 "Activin A receptor like type 1" P37023 12 51906908-51923361 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 55.0" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 53.3;Enterocytes: 82.1;Ito cells: 40.5;Paneth cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 3.6;myeloid DC: 5.0" "Group enriched" "Detected in many" 12 "dendritic cells: 5.0;monocytes: 3.6" "Cell line enhanced" "Detected in some" "ASC diff: 18.5;ASC TERT1: 12.6;EFO-21: 16.4;HUVEC TERT2: 59.9;TIME: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007041 Approved "Intracellular and membrane" NA NA "HPA007041: AB_1078097" "unprognostic (2.50e-1)" "unprognostic (4.83e-1)" "unprognostic (3.79e-2)" "unprognostic (3.61e-2)" "unprognostic (4.98e-1)" "unprognostic (4.06e-3)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (5.80e-2)" "unprognostic (5.10e-2)" "unprognostic (4.60e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-3)" "unprognostic (1.39e-1)" "unprognostic (7.98e-3)" "unprognostic (2.79e-1)" "unprognostic (1.10e-1)" 25.5 5.1 3.2 9.3 4.3 0.2 15.6 1.6 3.6 15.1 20.1 3.7 13.1 4.9 12.7 11.0 12.1 13.9 11.0 15.4 3.7 3.2 13.6 3.4 55.0 19.1 4.9 3.6 5.9 6.1 21.6 2.7 44.1 5.3 12.3 14.7 12.3 6.9 10.6 14.2 8.0 11.1 8.2 3.7 14.8 8.1 3.5 3.6 1.7 12.9 6.8 5.4 9.3 11.2 0.1 5.0 0.3 3.6 0.0 0.1 0.7 0.0 0.2 0.1 0.0 18.5 12.6 0.0 0.8 1.6 0.0 0.0 0.1 0.1 0.0 16.4 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 2.7 0.0 0.4 5.2 0.0 0.1 0.0 0.0 59.9 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 46.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 3.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.7 3.2 4.3 1.6 3.6 3.7 3.2 4.9 3.6 5.3 3.6 3.0 12.2 0.0 0.2 4.6 0.0 3.9 0.0 4.0 2.3 0.0 0.0 0.5 0.0 2.5 0.0 53.3 82.1 0.0 1.2 36.2 20.2 0.5 0.0 0.0 10.2 0.0 5.2 40.5 25.4 0.7 10.9 5.6 5.0 15.4 26.0 2.3 0.0 50.9 3.2 0.0 0.2 38.8 15.3 0.1 0.7 4.6 2.2 0.0 26.4 0.4 ADAMTS8 "ADAM-TS8, FLJ41712, METH2" ENSG00000134917 "ADAM metallopeptidase with thrombospondin type 1 motif 8" Q9UP79 11 130404925-130428993 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 13.0;lung: 21.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 1.1;Bipolar cells: 1.1;Cardiomyocytes: 2.5;Ciliated cells: 4.0;Club cells: 2.3;Fibroblasts: 2.6;granulocytes: 1.1;Melanocytes: 1.7;Peritubular cells: 1.4;Smooth muscle cells: 3.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.0;HeLa: 1.8;HMC-1: 5.8;NTERA-2: 2.9;U-2 OS: 13.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 6.4;cerebral cortex: 7.6;hippocampal formation: 7.3;olfactory region: 5.2" HPA066349 Approved "Secreted to extracellular matrix" NA NA 2200000 "HPA066349: AB_2685662" "unprognostic (4.76e-6)" "unprognostic (3.92e-2)" "unprognostic (6.13e-2)" "prognostic favorable (1.38e-4)" "unprognostic (2.41e-1)" "unprognostic (7.81e-2)" "unprognostic (3.09e-2)" "unprognostic (9.83e-2)" "unprognostic (1.09e-4)" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (4.66e-3)" "unprognostic (4.03e-3)" "unprognostic (5.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.41e-1)" 2.1 0.1 1.5 10.2 2.5 0.0 0.5 0.6 4.4 1.3 5.3 0.5 0.2 1.1 2.6 1.5 3.1 1.7 13.0 3.9 1.6 0.6 2.1 0.2 21.0 0.2 0.7 0.2 1.0 0.7 0.0 0.8 2.7 0.9 2.9 0.5 0.7 0.3 5.7 0.4 0.1 1.6 7.4 0.8 0.9 5.6 0.2 0.4 0.2 0.4 0.2 0.4 3.8 3.4 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 2.5 0.6 3.2 1.6 0.6 0.7 0.2 0.9 0.4 0.0 1.1 0.0 0.2 0.3 1.1 2.5 0.0 4.0 2.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.4 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 3.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 ADGRE3 EMR3 ENSG00000131355 "Adhesion G protein-coupled receptor E3" Q9BY15 19 14619117-14690027 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 70.7;lung: 26.3" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 3.7;Ciliated cells: 1.4;granulocytes: 2.3;Macrophages: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7" "Lineage enriched" "Detected in many" 9 "granulocytes: 70.7" "Cell line enriched" "Detected in single" 38 "HMC-1: 32.5" "Not detected" "Not detected" HPA015638 Uncertain "Secreted to blood" NA NA "HPA015638: AB_1848039" "unprognostic (2.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (5.69e-2)" "unprognostic (5.63e-2)" "unprognostic (4.53e-2)" "unprognostic (1.14e-1)" "unprognostic (8.07e-2)" "unprognostic (9.61e-2)" "unprognostic (9.11e-4)" "unprognostic (4.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.13e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 1.7 0.2 0.3 8.5 0.8 4.0 0.3 0.2 0.7 0.2 0.4 0.3 0.1 2.1 0.2 0.7 0.4 0.6 1.2 0.6 0.3 0.3 0.4 1.1 26.3 5.9 0.4 0.1 0.5 0.3 0.0 0.3 1.7 0.7 0.6 0.5 0.7 6.2 0.1 0.9 0.2 3.2 0.7 0.6 8.1 0.4 0.8 0.3 0.8 0.5 0.9 3.4 2.6 0.4 0.0 0.7 70.7 8.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 3.2 69.6 0.0 7.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 70.7 0.0 8.0 0.0 0.0 0.9 0.3 0.8 0.2 0.7 0.3 0.3 0.4 0.1 0.7 0.3 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 4.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRF5 "DKFZp564O1923, GPR116, KIAA0758" ENSG00000069122 "Adhesion G protein-coupled receptor F5" Q8IZF2 6 46852512-46954943 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 54.6" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 271.0;Alveolar cells type 2: 421.7;Club cells: 164.9;Endothelial cells: 125.4;Ito cells: 281.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 13.5;TIME: 40.3" "Low region specificity" "Detected in all" NA NA 23000000 "unprognostic (8.45e-2)" "unprognostic (3.00e-3)" "unprognostic (1.13e-1)" "unprognostic (3.26e-1)" "unprognostic (6.51e-2)" "unprognostic (1.89e-2)" "unprognostic (5.76e-2)" "unprognostic (9.00e-3)" "unprognostic (7.80e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (4.56e-2)" "prognostic favorable (8.84e-5)" "unprognostic (1.43e-2)" "unprognostic (5.91e-2)" "unprognostic (2.82e-2)" "unprognostic (3.78e-2)" 32.6 11.9 5.0 3.4 7.1 0.2 27.5 2.1 5.8 6.6 5.3 4.2 7.0 2.9 10.4 8.9 5.9 6.7 8.5 34.3 6.4 4.9 33.6 8.7 54.6 6.1 7.3 4.7 6.5 3.3 7.0 5.2 25.1 5.9 5.5 3.1 7.5 3.5 5.0 19.4 3.8 4.0 11.1 6.1 26.2 3.8 3.1 3.0 0.1 16.1 8.8 1.7 8.1 13.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 7.1 2.1 5.8 6.4 4.9 7.3 4.7 5.9 3.0 271.0 421.7 5.7 0.3 0.0 0.0 8.4 12.7 88.3 164.9 1.8 0.0 0.2 10.0 0.2 8.1 125.4 0.0 0.0 0.0 1.0 0.0 0.4 11.6 1.5 0.2 0.0 0.0 281.1 20.0 3.0 2.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 97.0 1.5 0.1 0.4 0.0 0.2 0.0 0.0 0.5 AFP "FETA, HPAFP" ENSG00000081051 "Alpha fetoprotein" P02771 4 73431138-73456174 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "heart muscle: 4.3;liver: 9.6;lung: 2.9" "Group enriched" "Detected in some" 10 "Hepatocytes: 99.9;Proximal tubular cells: 38.7" "Group enriched" "Detected in some" 14 "liver cancer: 208.8;testis cancer: 49.4" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 190 "Hep G2: 219.7" "Region enhanced" "Detected in single" "cerebellum: 0.8" "Not detected" "Not detected" "HPA010607, HPA023600, CAB024283, CAB025339" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 3010000 930000 "Golgi apparatus" Cytosol "CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769" "unprognostic (4.69e-1)" "unprognostic (1.87e-1)" "unprognostic (3.34e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-3)" "unprognostic (2.95e-2)" "unprognostic (3.35e-1)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-6)" "unprognostic (1.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.14e-1)" 0.0 0.4 0.1 0.0 1.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.3 0.3 0.0 0.0 9.6 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 219.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.3 0.0 2.4 0.7 0.3 0.0 0.0 99.9 2.1 0.0 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 AGER "RAGE, SCARJ1" ENSG00000204305 "Advanced glycosylation end-product specific receptor" Q15109 6 32180968-32184324 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 178.6" "Cell type enriched" "Detected in many" 18 "Alveolar cells type 1: 2224.3" "Cancer enhanced" "Detected in all" "lung cancer: 27.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB011682, HPA064436, HPA069474" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cell Junctions" "Secreted in other tissues" NA NA 5360000 140000 "Plasma membrane, Cell Junctions" "Nucleoli fibrillar center" "CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: " "unprognostic (9.37e-2)" "unprognostic (3.70e-1)" "unprognostic (2.37e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-2)" "unprognostic (1.59e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (4.38e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.01e-7)" "unprognostic (3.57e-1)" "unprognostic (3.70e-2)" "unprognostic (4.44e-2)" "prognostic favorable (2.74e-6)" 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.6 0.4 0.4 0.2 0.2 0.2 0.0 0.5 0.2 178.6 0.2 0.2 0.2 0.5 0.3 0.1 0.7 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.0 0.2 0.2 0.2 0.2 22.6 0.2 0.2 0.2 0.3 0.7 0.7 1.0 0.3 0.1 0.5 0.1 0.2 0.2 0.0 0.6 0.2 1.9 2.7 0.1 0.2 0.1 0.2 0.1 0.4 0.2 2.1 0.5 0.0 2.2 0.2 1.1 0.3 0.4 4.9 1.3 0.1 0.0 0.0 0.6 2.2 0.3 0.3 0.1 0.2 0.3 0.3 8.1 0.0 0.8 0.2 4.2 0.3 1.5 0.0 0.2 0.0 0.1 0.2 0.3 5.1 0.1 0.1 0.5 0.1 0.0 1.9 0.1 1.2 0.1 0.2 0.0 1.5 1.5 0.1 6.1 3.2 2.2 2.2 0.5 0.5 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.3 0.2 0.0 0.7 0.4 0.3 1.0 0.1 0.2 0.7 0.0 0.1 0.2 0.2 0.9 0.2 0.2 0.0 0.2 0.2 0.4 0.2 2224.3 120.3 1.7 1.1 0.8 4.8 3.4 5.1 8.1 37.5 1.8 0.0 0.9 0.0 1.5 0.0 2.6 0.5 0.0 0.8 0.8 1.6 2.3 16.3 1.8 1.2 6.4 0.0 2.5 9.0 0.2 1.7 4.9 1.7 2.8 1.4 7.4 0.8 2.9 1.1 0.2 4.1 6.5 1.7 0.0 0.7 1.6 1.8 5.0 0.9 0.8 AGTR2 "AT2, MRX88" ENSG00000180772 "Angiotensin II receptor type 2" P50052 X 116170722-116174972 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6" "Cell type enriched" "Detected in some" 15 "Alveolar cells type 2: 17.8" "Group enriched" "Detected in some" 12 "endometrial cancer: 3.0;lung cancer: 1.9" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "HSkMC: 1.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 9 "cerebellum: 3.8" NA NA "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (3.22e-2)" "unprognostic (4.37e-2)" 0.3 1.6 0.1 0.8 0.1 0.0 0.1 1.0 0.1 5.3 0.4 0.1 0.1 0.0 20.8 3.3 0.2 3.6 0.4 1.7 0.1 0.0 0.4 0.1 26.7 0.8 0.1 0.1 1.1 1.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 13.6 0.1 0.1 0.6 0.2 0.1 0.4 0.1 1.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL132671.2 ENSG00000282218 6 117318211-117573571 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "epididymis: 3.7;lung: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 37 "U-138 MG: 14.5" HPA019477 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA019477: AB_1849890" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL645941.2 ENSG00000248993 6 32937364-32953122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 18.7;lymphoid tissue: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 1.3;intermediate monocyte: 1.5;memory B-cell: 2.6;myeloid DC: 1.7;naive B-cell: 1.0;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 8 "B-cells: 2.6;dendritic cells: 1.7;monocytes: 1.5" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;SK-MEL-30: 1.4;U-698: 1.3" HPA012298 Uncertain NA NA "HPA012298: AB_1853927" "unprognostic (1.33e-1)" "unprognostic (2.53e-1)" "unprognostic (4.98e-1)" "unprognostic (5.56e-4)" "unprognostic (3.24e-2)" "unprognostic (4.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.93e-1)" "unprognostic (3.25e-2)" "unprognostic (3.78e-1)" "unprognostic (1.60e-1)" "unprognostic (8.18e-2)" "unprognostic (4.73e-2)" 10.0 2.9 1.7 12.1 2.8 2.3 2.4 1.6 2.0 3.0 5.6 3.7 1.7 4.0 2.8 5.5 1.8 1.7 4.3 5.3 1.8 1.8 8.3 1.7 18.7 10.8 3.8 0.0 2.4 5.0 1.7 2.1 1.9 3.6 2.6 2.0 3.0 7.3 3.8 2.8 2.0 12.7 1.9 5.5 13.2 3.5 1.8 2.7 7.3 7.1 4.7 19.3 2.1 1.9 2.6 1.7 0.2 1.5 0.0 0.2 0.6 0.0 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 1.4 0.0 0.1 0.5 0.0 0.3 0.6 0.0 0.0 0.5 0.4 1.3 0.2 0.2 0.2 0.0 1.3 0.2 0.0 1.5 0.0 2.6 0.0 0.1 1.7 1.0 0.0 0.0 0.1 0.0 0.2 1.1 0.2 0.6 1.7 2.8 1.6 1.6 1.8 1.8 3.8 0.0 3.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALOX15 15-LOX-1 ENSG00000161905 "Arachidonate 15-lipoxygenase" P16050 17 4630902-4642294 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 27.9;blood: 89.8;lung: 24.4" "Cell type enriched" "Detected in some" 15 "Ciliated cells: 210.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 183 "eosinophil: 89.8" "Lineage enriched" "Detected in single" 183 "granulocytes: 89.8" "Group enriched" "Detected in some" 7 "HMC-1: 16.5;MCF7: 14.3;T-47d: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB004962, CAB004963, HPA013859" Approved NA NA "CAB004962: , CAB004963: , HPA013859: AB_1844758" "unprognostic (5.31e-4)" "unprognostic (1.43e-2)" "unprognostic (2.81e-2)" "unprognostic (8.36e-3)" "unprognostic (2.22e-1)" "unprognostic (8.60e-2)" "unprognostic (2.36e-1)" "unprognostic (2.66e-2)" "unprognostic (1.70e-2)" "unprognostic (1.84e-2)" "unprognostic (2.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.31e-3)" "unprognostic (1.88e-2)" "unprognostic (1.30e-1)" "unprognostic (2.78e-1)" "unprognostic (1.59e-1)" 27.9 0.1 0.2 4.5 1.1 0.2 4.2 0.2 0.3 0.5 2.8 0.2 0.2 1.9 0.2 8.1 0.4 14.4 1.5 2.7 0.3 0.4 0.2 1.7 24.4 1.7 0.5 0.2 3.0 0.2 0.0 6.3 1.5 0.4 0.3 0.9 0.2 1.0 0.2 0.2 2.2 3.7 0.5 0.7 1.1 1.0 1.4 0.4 2.0 0.2 0.2 0.4 1.9 0.2 0.0 0.4 89.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 14.3 0.0 0.3 1.2 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 89.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 1.1 0.2 0.3 0.3 0.4 0.5 0.2 0.4 0.4 0.0 0.6 0.0 0.0 1.3 0.0 0.4 0.0 210.1 5.7 0.0 0.0 1.6 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 1.1 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.6 6.2 0.0 0.0 0.2 ALOX15B 15-LOX-2 ENSG00000179593 "Arachidonate 15-lipoxygenase, type B" O15296 17 8039017-8049134 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9" "Cell type enhanced" "Detected in many" 26 "Alveolar cells type 2: 58.0;Kupffer cells: 33.3;monocytes: 149.7" "Cancer enhanced" "Detected in all" "prostate cancer: 91.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 6.1;myeloid DC: 6.8" "Group enriched" "Detected in many" 9 "dendritic cells: 6.8;monocytes: 6.1" "Cell line enhanced" "Detected in some" "HHSteC: 6.1;HSkMC: 13.0;hTCEpi: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA010562 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA010562: AB_2668305" "unprognostic (1.76e-2)" "unprognostic (6.47e-2)" "unprognostic (2.56e-1)" "unprognostic (2.28e-3)" "unprognostic (1.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.59e-1)" "unprognostic (1.59e-2)" "unprognostic (9.37e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.49e-2)" 8.9 0.6 0.4 0.7 0.6 0.3 57.4 0.1 0.4 7.6 4.6 0.1 0.0 0.2 0.3 0.7 30.6 0.8 0.5 0.2 1.3 0.0 2.9 0.7 44.0 7.1 1.8 0.3 0.8 0.8 0.2 0.9 0.7 1.3 35.9 0.3 0.1 3.6 0.2 0.3 15.4 1.9 0.2 4.1 3.1 1.6 1.0 2.0 0.5 0.8 6.6 4.1 1.1 12.9 0.0 6.8 0.2 6.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 13.0 26.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.7 0.0 0.2 0.0 1.7 0.4 0.6 0.1 0.4 1.3 0.0 1.8 0.3 1.3 2.0 0.0 58.0 0.0 0.5 2.7 0.0 0.3 2.5 2.7 2.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 16.8 1.1 0.0 4.1 0.0 0.0 1.3 33.3 0.0 0.0 1.9 5.0 149.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 1.0 0.7 0.0 0.0 1.8 ALPL "HOPS, TNSALP" ENSG00000162551 "Alkaline phosphatase, liver/bone/kidney" P05186 1 21509372-21578412 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Biomineralization Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 73.3;liver: 52.7;lung: 45.1" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 88.5;Hepatocytes: 25.3;Ito cells: 25.8;Proximal tubular cells: 44.8;Rod photoreceptor cells: 28.1" "Cancer enhanced" "Detected in all" "testis cancer: 199.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 91 "neutrophil: 73.3" "Lineage enriched" "Detected in single" 127 "granulocytes: 73.3" "Cell line enhanced" "Detected in some" "HSkMC: 53.1;hTEC/SVTERT24-B: 41.5;LHCN-M2: 30.2;SCLC-21H: 26.4;SuSa: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007105, HPA008765, CAB020829" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 7300000 Cytosol "CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138" "unprognostic (3.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.05e-3)" "unprognostic (6.50e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (7.08e-4)" "unprognostic (1.17e-2)" "unprognostic (2.48e-3)" "unprognostic (1.74e-1)" "unprognostic (7.28e-2)" "unprognostic (1.73e-2)" "unprognostic (2.27e-1)" "unprognostic (9.70e-3)" "unprognostic (2.58e-1)" 15.9 22.7 4.5 17.6 6.0 2.6 10.6 2.2 7.8 2.2 2.1 4.1 0.7 1.9 3.7 1.1 2.0 5.7 2.8 10.9 5.7 4.2 29.7 52.7 45.1 28.1 5.3 4.8 1.2 4.3 2.4 4.1 2.2 7.7 2.6 1.3 18.3 3.1 6.6 0.9 1.8 2.7 2.5 3.8 19.6 1.8 2.9 2.7 0.5 3.7 1.7 3.9 7.1 8.4 0.5 0.0 73.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 2.0 3.3 0.1 0.7 0.2 0.4 0.2 0.0 0.7 2.3 0.0 0.0 0.0 9.1 0.0 0.1 0.0 0.6 0.0 1.1 1.1 0.5 0.0 0.2 53.1 0.0 41.5 0.1 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 12.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 26.4 0.3 0.0 0.0 0.1 14.8 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 73.3 0.0 0.0 0.0 0.0 0.0 4.5 6.0 2.2 7.8 5.7 4.2 5.3 4.8 7.7 2.7 3.0 88.5 0.5 0.5 0.1 2.6 2.0 0.0 1.4 10.3 0.0 0.0 0.0 6.6 0.0 1.2 7.1 0.0 23.3 0.0 0.3 0.3 1.5 7.0 25.3 0.1 1.6 0.0 25.8 1.0 4.4 0.3 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 44.8 28.1 0.0 1.0 0.3 13.6 0.4 1.3 0.0 0.0 0.3 ALPPL2 ENSG00000163286 "Alkaline phosphatase, placental like 2" P10696 2 232406843-232410714 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.2;lung: 9.4" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 1: 6.0;Ciliated cells: 1.4;Club cells: 2.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 49.1;testis cancer: 64.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 21.4;HaCaT: 15.7;SuSa: 25.7" "CAB020698, HPA038764, HPA038765, HPA051699" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.39e-1)" "unprognostic (6.63e-3)" "unprognostic (1.27e-2)" "unprognostic (2.89e-1)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.67e-1)" "unprognostic (6.72e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.2 1.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 21.4 0.0 0.0 0.0 0.0 15.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 ANKRD20A3 ENSG00000276203 "Ankyrin repeat domain 20 family member A3" Q5VUR7 9 66106815-66153135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "esophagus: 1.1;lung: 1.3;testis: 2.0" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 5.3;Horizontal cells: 4.8;Spermatocytes: 16.4;Spermatogonia: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;HDLM-2: 5.2;RPTEC TERT1: 1.4;WM-115: 1.3" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.27e-2)" 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.5 0.0 0.1 0.1 0.0 5.2 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.2 0.8 1.8 0.0 5.3 0.0 0.0 3.9 0.0 0.0 0.0 2.0 0.0 1.0 0.0 0.9 0.0 0.0 0.6 3.5 0.0 0.1 4.8 0.0 0.6 1.3 1.8 0.3 0.0 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.1 16.4 6.5 0.1 0.0 0.0 0.2 1.0 ANKUB1 C3orf16 ENSG00000206199 "Ankyrin repeat and ubiquitin domain containing 1" A6NFN9 3 149761100-149968385 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 12.2;lung: 11.9;ovary: 10.4" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 100.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 5.2" "Cell type enriched" "Detected in single" 8 "neutrophil: 4.8" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.8" "Cell line enhanced" "Detected in some" "OE19: 4.6" "Low region specificity" "Detected in all" HPA053749 Uncertain NA NA "HPA053749: AB_2682248" "unprognostic (1.71e-2)" "unprognostic (1.89e-4)" "unprognostic (1.01e-1)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-1)" "unprognostic (2.42e-1)" "unprognostic (1.61e-2)" "unprognostic (1.48e-1)" "unprognostic (9.61e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (2.18e-9)" "unprognostic (3.06e-1)" "unprognostic (2.96e-1)" "unprognostic (3.17e-1)" "unprognostic (7.07e-4)" 0.0 0.0 0.8 0.2 1.2 0.6 0.0 0.0 0.3 2.1 0.0 1.8 0.0 0.2 0.9 0.1 0.0 12.2 0.1 0.0 1.5 1.7 0.0 0.0 11.9 0.1 0.0 0.0 10.4 0.1 0.0 1.1 0.1 5.2 0.1 0.0 0.0 0.5 0.0 0.1 0.6 0.1 0.0 0.3 0.2 0.3 2.2 0.8 0.0 0.0 0.6 0.1 0.1 0.0 0.4 0.3 4.8 0.4 0.2 0.3 0.0 0.4 0.6 0.6 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.9 0.9 0.8 0.2 0.0 0.2 1.4 0.4 0.4 0.2 0.5 0.3 0.8 1.9 0.4 0.0 0.4 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.4 0.8 0.0 0.3 0.5 0.8 0.4 4.6 0.5 0.9 0.6 0.5 0.0 0.8 0.5 0.1 0.4 0.4 0.0 0.3 0.7 0.2 0.0 0.6 0.5 0.2 0.3 0.5 0.4 0.8 0.4 0.7 0.2 0.5 0.4 0.5 0.2 0.1 0.1 0.3 0.1 0.2 0.0 0.4 0.1 0.3 4.8 0.2 0.1 0.3 0.1 0.0 0.8 1.2 0.0 0.3 1.5 1.7 0.0 0.0 5.2 0.8 0.0 1.7 0.0 0.6 0.5 0.0 0.3 0.0 100.4 20.5 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.6 3.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 ANOS1 "ADMLX, KAL, KAL1, KALIG-1, WFDC19" ENSG00000011201 "Anosmin 1" P23352 X 8528874-8732186 "Disease related genes, Predicted secreted proteins" "Cell adhesion, Chemotaxis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5;lung: 37.1;parathyroid gland: 27.7" "Cell type enriched" "Detected in many" 6 "Alveolar cells type 1: 223.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 25.9;NTERA-2: 23.4;U-2 OS: 11.3" "Secreted in brain" NA NA "unprognostic (2.93e-1)" "unprognostic (5.33e-2)" "unprognostic (9.54e-2)" "unprognostic (4.16e-3)" "unprognostic (7.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.55e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-2)" "unprognostic (6.43e-2)" "unprognostic (2.09e-2)" "unprognostic (6.24e-2)" "unprognostic (1.71e-2)" "unprognostic (9.38e-3)" "unprognostic (6.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.56e-2)" 5.4 4.0 13.8 1.3 14.0 0.6 3.6 1.3 18.0 4.5 1.0 7.3 1.3 0.7 0.9 3.2 1.6 1.4 1.9 4.6 11.1 7.9 1.1 1.1 37.1 1.8 5.7 6.0 0.9 0.8 27.7 1.0 1.4 19.3 4.1 1.3 6.0 2.8 4.5 10.9 3.0 0.9 1.1 25.5 1.1 1.1 5.0 8.5 1.3 8.5 1.0 1.2 1.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.5 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.4 2.6 0.1 3.5 0.3 3.8 0.0 0.0 0.0 1.0 0.0 1.9 0.2 0.1 25.9 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 23.4 0.0 0.0 0.0 0.0 0.0 1.3 0.4 1.3 0.0 1.1 0.3 0.0 3.2 0.0 0.6 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 14.0 1.3 7.6 11.1 7.9 5.7 6.0 19.3 8.5 223.4 9.3 0.0 4.2 0.0 6.4 6.2 0.0 6.7 36.4 0.0 3.9 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 1.5 2.9 1.1 0.0 5.2 0.0 0.0 2.5 2.2 0.0 0.6 1.4 0.0 0.0 0.0 21.4 0.8 0.0 1.1 0.0 1.5 0.0 0.3 0.3 0.7 0.0 0.1 0.0 0.1 0.8 AQP4 MIWC ENSG00000171885 "Aquaporin 4" P55087 18 26852038-26865818 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 185.1;lung: 53.5" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 1024.3" "Cancer enriched" "Detected in some" 22 "glioma: 223.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005079, HPA014784, CAB058689" Enhanced Supported Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967" "unprognostic (7.23e-5)" "unprognostic (1.55e-1)" "unprognostic (3.19e-8)" "unprognostic (3.68e-1)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.34e-1)" "unprognostic (5.38e-3)" "unprognostic (1.64e-3)" "unprognostic (8.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (1.35e-1)" "unprognostic (4.10e-2)" 1.7 1.7 60.7 1.6 57.1 1.6 1.8 21.8 185.1 1.9 1.6 41.3 0.0 1.6 1.6 2.0 1.9 2.1 1.6 2.7 64.3 27.1 2.7 2.0 53.5 1.7 39.8 36.4 2.8 1.7 2.9 0.8 1.6 39.1 1.8 1.6 0.0 1.8 1.7 25.4 1.6 1.6 1.6 67.2 1.8 6.1 1.7 42.2 0.0 8.4 0.1 1.6 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.9 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 57.1 21.8 31.7 64.3 27.1 39.8 36.4 39.1 42.2 1024.3 245.1 0.0 0.6 0.0 2.1 8.5 0.0 37.5 138.8 3.5 5.9 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 3.5 0.5 0.0 1.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 224.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 ARHGAP45 "HA-1, HMHA1, KIAA0223" ENSG00000180448 "Rho GTPase activating protein 45" Q92619 19 1065923-1086628 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 32.1;bone marrow: 35.2;intestine: 23.4;lung: 17.5;lymphoid tissue: 50.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 44.7;Cytotrophoblasts: 32.5;Extravillous trophoblasts: 44.4;Hofbauer cells: 34.5;monocytes: 126.2;Syncytiotrophoblasts: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 22.2;Karpas-707: 31.2;RPMI-8226: 22.1;THP-1: 27.8;U-266/70: 41.1;U-937: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019816, HPA079252" Enhanced NA NA 2200000 "HPA019816: AB_1853923, HPA079252: " "unprognostic (1.34e-1)" "unprognostic (5.13e-3)" "unprognostic (5.17e-3)" "prognostic favorable (6.02e-4)" "unprognostic (2.26e-1)" "prognostic favorable (7.82e-4)" "unprognostic (1.59e-2)" "unprognostic (2.17e-2)" "unprognostic (3.55e-1)" "unprognostic (4.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-2)" "unprognostic (1.00e-1)" "unprognostic (4.59e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (5.33e-2)" 4.9 2.8 2.8 28.3 3.8 35.2 4.3 0.9 2.2 2.1 4.8 3.8 0.6 4.4 2.1 2.6 3.2 3.3 5.4 2.7 3.0 2.2 4.6 3.5 17.5 42.2 5.4 1.2 1.2 1.5 0.5 2.5 5.8 3.9 3.2 1.7 3.2 6.7 1.5 1.2 2.0 23.4 2.0 4.9 50.4 6.1 1.7 4.6 45.0 4.3 1.8 38.4 4.3 4.3 9.3 9.4 15.7 9.2 11.3 32.1 21.0 3.3 0.6 0.0 3.7 0.0 0.0 8.7 0.0 0.0 0.0 0.0 8.8 4.3 22.2 0.9 0.0 0.1 2.9 0.6 0.2 0.0 16.3 0.3 3.0 6.1 1.0 0.1 14.4 17.6 0.0 0.9 0.0 0.0 0.0 0.0 14.4 2.0 31.2 0.0 0.2 16.0 12.9 2.3 0.5 1.6 15.5 0.1 22.1 0.0 0.0 0.1 0.0 5.1 0.0 1.3 0.2 1.1 27.8 1.4 0.0 0.6 0.0 0.0 41.1 17.6 17.8 0.1 21.8 1.6 2.7 9.2 9.8 20.4 9.0 17.8 7.3 23.2 24.2 9.4 9.3 32.1 23.3 15.7 11.3 8.4 5.6 18.2 21.0 2.8 3.8 0.9 2.2 3.0 2.2 5.4 1.2 3.9 4.6 44.7 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 10.4 0.0 32.5 0.0 2.7 0.0 0.0 0.0 0.0 3.3 44.4 0.0 0.0 3.5 0.0 34.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 126.2 0.0 0.0 6.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 63.2 0.0 0.0 0.0 BCL2A1 "ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1" ENSG00000140379 "BCL2 related protein A1" Q16548 15 79960889-79971446 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 72.7;bone marrow: 105.7;lung: 45.6" "Group enriched" "Detected in many" 4 "granulocytes: 217.9;Hofbauer cells: 208.5;Macrophages: 391.0;monocytes: 632.2" "Cancer enhanced" "Detected in all" "melanoma: 39.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "eosinophil: 37.1;intermediate monocyte: 25.3;neutrophil: 72.7;non-classical monocyte: 47.2" "Group enriched" "Detected in all" 6 "granulocytes: 72.7;monocytes: 47.2" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 96.8" NA NA "unprognostic (3.19e-3)" "unprognostic (2.61e-1)" "unprognostic (3.99e-2)" "unprognostic (3.54e-3)" "unprognostic (9.65e-3)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-2)" "unprognostic (4.01e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (4.61e-2)" "unprognostic (8.96e-2)" "unprognostic (2.78e-1)" "unprognostic (1.87e-1)" 21.6 0.9 1.9 22.6 4.0 105.7 1.8 0.5 1.8 1.0 2.0 0.4 0.0 1.0 0.7 1.0 3.0 4.9 3.6 9.8 2.2 1.3 1.8 5.2 45.6 24.9 11.8 0.0 3.7 1.0 0.2 2.2 3.8 3.8 1.6 1.3 0.8 2.3 0.3 1.4 0.6 4.4 2.7 8.2 32.8 1.9 4.6 4.0 4.3 2.3 1.4 11.1 4.8 7.1 9.3 3.4 72.7 47.2 2.8 5.7 5.8 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.7 0.3 0.0 0.0 0.0 0.2 0.4 0.5 20.6 0.3 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 96.8 0.0 0.0 1.0 0.0 10.5 0.9 0.0 0.2 0.1 0.0 0.7 0.4 6.6 4.9 3.3 5.6 37.1 3.6 25.3 2.0 9.3 4.7 4.7 3.4 5.9 5.7 5.3 72.7 2.8 47.2 0.6 1.0 5.8 1.9 4.0 0.5 1.8 2.2 1.3 11.8 0.0 3.8 4.0 20.8 84.6 34.0 0.8 9.7 0.0 2.5 0.0 16.0 17.0 1.8 0.0 1.6 1.7 1.9 0.9 3.7 0.0 0.0 1.3 2.1 4.1 1.0 217.9 0.2 208.5 0.0 0.0 2.5 63.4 0.8 0.0 391.0 32.1 632.2 0.0 0.1 4.1 0.0 0.0 0.6 0.0 0.0 7.6 0.1 0.2 8.9 3.8 29.4 0.0 1.4 BMP1 PCOLC ENSG00000168487 "Bone morphogenetic protein 1" P13497 8 22164736-22212326 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "lung: 72.2;placenta: 106.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014572 Enhanced "Secreted to extracellular matrix" NA NA 2100000 "HPA014572: AB_1845390" "unprognostic (1.24e-1)" "unprognostic (8.01e-2)" "unprognostic (3.75e-2)" "unprognostic (5.89e-2)" "unprognostic (1.34e-2)" "unprognostic (6.76e-2)" "unprognostic (9.53e-2)" "unprognostic (2.64e-3)" "unprognostic (1.66e-1)" "unprognostic (9.75e-3)" "unprognostic (7.05e-3)" "unprognostic (3.14e-2)" "prognostic unfavorable (3.37e-9)" "unprognostic (2.11e-2)" "unprognostic (6.57e-2)" "unprognostic (1.50e-3)" "unprognostic (3.34e-2)" 6.9 11.7 2.7 3.6 4.6 1.1 5.9 7.8 4.2 8.1 5.8 3.1 3.7 4.4 9.4 5.2 4.8 7.7 5.4 3.4 2.6 1.3 4.9 9.2 72.2 3.2 3.4 1.5 5.2 3.7 2.8 2.2 106.2 3.5 6.5 4.7 4.6 2.4 4.6 2.4 6.8 5.7 11.0 3.6 3.2 2.9 2.2 3.6 1.0 7.1 2.4 2.9 9.9 9.5 0.0 0.9 0.1 1.4 0.8 2.2 0.4 4.6 4.8 1.3 6.2 15.2 11.3 6.8 20.2 16.8 10.3 9.6 2.5 3.0 1.1 12.7 18.5 6.4 10.1 1.5 5.3 2.0 1.0 2.1 1.7 7.3 2.8 12.4 0.7 3.4 12.8 8.5 8.0 2.6 18.3 10.0 0.6 2.1 2.0 5.6 1.7 0.4 1.0 0.8 6.9 2.6 1.1 3.3 4.9 8.9 0.7 0.8 3.3 14.6 0.8 3.3 5.6 0.9 2.0 12.6 2.7 5.9 6.5 5.9 1.0 0.6 0.2 5.3 2.7 7.4 0.0 1.4 0.0 2.2 0.7 1.4 0.0 0.4 1.0 0.0 0.0 0.3 1.7 0.1 0.8 0.5 0.9 0.0 0.4 2.7 4.6 7.8 4.2 2.6 1.3 3.4 1.5 3.5 3.6 6.0 61.3 0.5 5.3 5.6 1.5 3.0 2.5 1.4 2.3 5.2 0.0 2.4 0.0 21.2 0.5 10.5 18.6 0.0 7.1 8.6 24.4 2.5 15.0 15.8 4.1 1.6 2.9 14.1 4.0 0.5 9.5 3.5 10.1 0.0 5.5 3.2 11.4 11.0 10.3 3.1 1.0 25.8 18.4 0.9 3.6 4.5 20.4 1.9 9.7 6.4 BMP3 ENSG00000152785 "Bone morphogenetic protein 3" P12645 4 81030965-81057531 "Plasma proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;lung: 21.0;urinary bladder: 18.7" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 25.1;Club cells: 20.5;Enterocytes: 20.2;Paneth cells: 23.7" "Cancer enhanced" "Detected in some" "urothelial cancer: 7.5" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 3.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AF22: 10.6;Daudi: 16.1;RT4: 13.5;SK-BR-3: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (5.21e-3)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (3.36e-2)" "unprognostic (2.73e-3)" "unprognostic (9.11e-2)" "unprognostic (2.35e-1)" "unprognostic (1.94e-1)" "unprognostic (1.16e-4)" "unprognostic (2.26e-2)" "unprognostic (3.86e-1)" "unprognostic (1.11e-1)" "unprognostic (4.22e-2)" 2.4 0.5 1.4 3.8 0.6 0.8 4.5 0.8 0.7 0.9 15.0 0.0 0.3 3.5 0.2 0.3 4.2 1.1 2.5 0.2 0.7 1.0 0.3 0.2 21.0 0.5 0.3 0.4 3.0 1.0 0.0 0.4 0.0 0.5 3.7 7.9 2.9 6.9 0.0 0.6 0.7 11.2 1.5 0.9 0.2 2.2 0.3 0.0 0.0 0.3 1.6 2.3 18.7 10.5 3.5 0.0 0.6 0.1 1.2 0.1 0.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 2.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 13.5 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.5 0.1 0.0 0.5 1.2 0.0 0.0 0.0 0.2 1.4 0.6 0.8 0.7 0.7 1.0 0.3 0.4 0.5 0.0 3.0 25.1 0.0 0.6 0.1 2.2 1.1 0.0 9.4 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.6 0.2 0.2 23.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 5.5 3.0 BPIFA1 "bA49G10.5, LUNX, PLUNC, SPLUNC1" ENSG00000198183 "BPI fold containing family A member 1" Q9NP55 20 33235995-33243311 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9" "Cell type enriched" "Detected in some" 26 "Ciliated cells: 116.4" "Cancer enriched" "Detected in many" 27 "lung cancer: 262.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6" "Not detected" "Not detected" CAB025669 Supported "Secreted in other tissues" NA NA 1200000 "CAB025669: " "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (3.65e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 11.9 25.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 116.4 4.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPIFB1 "bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP" ENSG00000125999 "BPI fold containing family B member 1" Q8TDL5 20 33273480-33309878 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9" "Group enriched" "Detected in some" 16 "Ciliated cells: 887.4;Club cells: 1261.4" "Cancer enhanced" "Detected in many" "stomach cancer: 75.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.0;OE19: 6.6;RT4: 3.9;SK-BR-3: 7.9" "Region enriched" "Detected in single" 7 "olfactory region: 6.2" "Not detected" "Not detected" HPA024256 Enhanced "Secreted in other tissues" NA NA 7500000 "HPA024256: AB_1845664" "unprognostic (2.42e-1)" "unprognostic (5.41e-2)" "unprognostic (3.67e-2)" "unprognostic (3.09e-1)" "unprognostic (6.72e-2)" "unprognostic (3.43e-2)" "unprognostic (9.37e-3)" "unprognostic (1.14e-1)" "unprognostic (2.82e-1)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (1.36e-7)" "unprognostic (3.30e-1)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" 0.1 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.2 100.1 0.1 0.3 0.1 3.7 0.5 0.2 23.3 0.0 0.3 0.3 0.2 0.0 0.1 0.1 101.0 0.1 0.1 0.1 0.1 0.1 0.0 4.7 0.1 0.1 0.9 0.0 0.1 38.8 0.8 1.0 0.0 0.1 0.1 0.1 0.1 76.9 1.1 0.1 0.2 0.2 29.6 115.1 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 6.6 0.0 0.7 0.0 0.3 0.0 3.9 0.0 0.0 0.0 7.9 0.0 0.1 0.6 0.0 0.6 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.1 8.9 17.7 0.0 0.4 1.1 0.0 0.4 5.1 887.4 1261.4 0.0 0.0 0.2 0.0 0.1 66.1 0.2 0.0 0.0 0.2 0.1 0.9 1.9 3.5 0.0 0.2 0.0 0.0 0.0 0.0 66.3 0.3 0.3 1.7 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.9 0.4 0.4 0.1 0.0 0.0 0.7 C12orf74 ENSG00000214215 "Chromosome 12 open reading frame 74" Q32Q52 12 92702843-92708549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "memory B-cell: 3.7;naive B-cell: 3.1" "Lineage enriched" "Detected in single" 21 "B-cells: 3.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.7;RT4: 2.5;SK-BR-3: 2.8" HPA062856 Approved "Nucleoplasm,Nuclear bodies,Aggresome" NA NA Nucleoplasm "Nuclear bodies, Aggresome" "HPA062856: " "unprognostic (2.75e-2)" "unprognostic (4.33e-2)" "unprognostic (2.28e-3)" "unprognostic (4.55e-3)" "unprognostic (7.95e-4)" "unprognostic (2.23e-1)" "unprognostic (2.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (5.84e-2)" "unprognostic (5.83e-4)" "unprognostic (3.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.42e-2)" 0.2 0.1 0.1 12.3 0.1 0.0 0.2 0.1 0.1 2.1 0.7 0.0 3.6 0.3 0.7 6.9 1.7 4.5 0.3 0.2 0.1 0.1 1.3 0.5 6.6 1.9 0.1 0.0 1.0 1.1 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.9 0.9 0.1 0.2 1.8 0.0 0.1 2.6 2.1 0.5 0.0 0.1 0.2 0.0 10.5 2.5 1.4 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 2.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C16orf89 MGC45438 ENSG00000153446 "Chromosome 16 open reading frame 89" Q6UX73 16 5044122-5066110 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 35.8;thyroid gland: 79.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 2: 191.8;Club cells: 122.8;Distal tubular cells: 96.2" "Group enriched" "Detected in many" 14 "lung cancer: 64.7;thyroid cancer: 145.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 4.9;Hep G2: 5.9;HHSteC: 3.1;NTERA-2: 3.6;U-2197: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013613, HPA016934" Enhanced "Secreted to blood" NA NA 1200000 "HPA013613: AB_1845584, HPA016934: AB_2732417" "unprognostic (1.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.97e-1)" "unprognostic (6.29e-2)" "unprognostic (3.79e-2)" "unprognostic (1.48e-1)" "unprognostic (2.67e-2)" "unprognostic (1.01e-2)" "unprognostic (9.23e-2)" "unprognostic (2.65e-1)" "unprognostic (6.39e-2)" "unprognostic (3.25e-2)" "unprognostic (6.64e-3)" "unprognostic (3.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (8.48e-3)" 6.0 1.7 7.7 4.4 9.3 0.3 4.7 5.1 8.6 7.3 2.3 5.2 0.3 5.9 1.4 30.3 2.5 4.6 15.3 7.1 6.1 3.0 5.6 0.3 35.8 0.5 6.2 7.4 1.9 8.2 0.3 1.9 0.5 5.3 4.0 1.9 5.0 11.5 0.6 0.2 0.4 2.8 6.2 7.4 0.4 28.0 1.4 2.9 0.0 79.3 2.7 1.4 4.3 1.8 1.1 0.9 3.3 0.5 1.3 0.6 0.2 0.1 0.2 0.0 0.4 4.9 0.1 0.8 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.4 0.6 1.4 5.9 3.1 0.2 0.5 1.4 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.3 0.0 0.3 1.6 0.7 3.6 0.0 0.1 0.5 0.1 0.3 0.0 0.5 0.6 0.4 0.3 0.7 1.1 0.7 0.4 0.0 0.2 0.6 0.3 5.0 0.3 0.4 0.2 0.1 0.4 0.2 0.1 3.3 0.5 0.7 0.4 0.4 0.3 0.7 0.4 0.4 0.2 1.1 0.5 0.6 1.9 1.3 0.2 0.9 0.3 0.2 7.7 9.3 5.1 8.6 6.1 3.0 6.2 7.4 5.3 2.9 41.7 191.8 0.0 1.8 0.3 0.2 2.6 0.0 29.4 122.8 0.0 0.0 0.1 96.2 0.0 1.4 0.0 0.0 0.0 7.2 0.1 7.0 3.7 4.7 0.0 4.6 0.0 0.0 0.0 0.0 1.2 8.6 0.6 0.0 0.0 0.3 0.1 0.7 0.0 13.8 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.8 C19orf85 ENSG00000283567 "Chromosome 19 open reading frame 85" 19 55463002-55464707 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lung: 1.7;seminal vesicle: 1.3;testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 15.4" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1orf116 "FLJ36507, MGC2742, MGC4309, SARG" ENSG00000182795 "Chromosome 1 open reading frame 116" Q9BW04 1 207018521-207032756 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 163.8;Alveolar cells type 2: 71.9;Club cells: 78.5;Urothelial cells: 120.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 18.2;CAPAN-2: 32.4;HaCaT: 40.0;HBEC3-KT: 38.4;hTCEpi: 20.4;RPTEC TERT1: 18.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA011888, HPA011889" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 7900 "Plasma membrane, Cytosol" "HPA011888: AB_1853872, HPA011889: AB_1853873" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.68e-1)" "unprognostic (2.35e-1)" "unprognostic (5.78e-2)" "unprognostic (3.27e-1)" "unprognostic (5.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.18e-2)" "unprognostic (2.87e-3)" "unprognostic (7.09e-3)" "prognostic favorable (1.01e-5)" "unprognostic (5.17e-1)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (1.19e-1)" 0.2 0.3 0.2 1.6 0.2 0.0 4.1 0.2 0.4 7.1 8.3 0.3 0.2 8.4 1.0 1.1 49.4 0.6 14.0 0.2 0.3 0.1 4.3 1.1 42.8 0.2 0.2 0.2 0.5 7.0 0.0 0.9 1.4 0.4 18.8 2.7 0.3 12.5 1.9 0.3 14.4 16.5 0.6 0.2 0.4 20.3 0.4 0.2 0.4 6.8 16.0 37.1 6.1 12.3 0.0 0.0 0.7 0.0 0.1 0.0 1.8 18.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 32.4 0.0 2.1 0.0 0.0 40.0 0.0 38.4 0.0 0.0 0.0 3.3 0.3 0.5 0.0 0.0 0.2 0.0 20.4 0.0 11.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 11.8 1.0 0.0 0.0 0.0 18.7 4.8 0.0 0.1 0.3 3.6 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.8 0.2 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.4 0.2 163.8 71.9 0.0 39.9 18.4 0.0 42.3 28.1 41.5 78.5 10.4 0.0 0.0 13.3 21.7 4.8 0.0 31.1 0.0 21.6 0.0 0.5 57.3 5.8 0.0 0.2 0.0 10.3 0.0 0.0 3.3 0.3 0.6 0.0 0.0 16.3 0.0 41.6 7.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 20.5 0.0 0.0 7.4 120.4 C2orf91 ENSG00000205086 "Chromosome 2 open reading frame 91" Q6ZV80 2 41935368-41954266 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;lung: 4.7" "Cell type enhanced" "Detected in single" 22 "Alveolar cells type 1: 3.0" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.8" "Region enhanced" "Detected in some" "midbrain: 5.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AN3-CA: 5.2;HDLM-2: 17.9" HPA042517 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "HPA042517: AB_10795508" "unprognostic (9.49e-3)" "unprognostic (2.24e-2)" "unprognostic (1.73e-1)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (8.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (3.92e-2)" "unprognostic (1.16e-1)" "unprognostic (4.79e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (7.61e-2)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" 0.3 2.1 0.3 0.3 1.3 1.5 0.3 0.3 0.8 0.4 0.3 0.8 0.2 0.0 0.4 1.0 0.3 0.3 0.3 0.5 0.3 0.4 0.9 0.3 4.7 0.9 5.1 0.2 0.4 0.4 0.4 0.5 0.2 1.9 0.8 0.2 0.8 3.5 0.2 0.2 1.3 0.3 0.2 2.2 0.6 1.3 1.1 0.2 0.2 0.2 0.2 0.6 0.2 0.3 1.2 1.4 2.8 1.2 1.2 0.9 0.3 0.2 0.4 0.7 5.2 0.2 0.1 0.3 0.1 0.1 0.0 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.0 0.1 0.1 17.9 0.3 0.2 0.4 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 1.8 0.1 0.3 0.1 0.1 0.3 0.4 0.1 0.0 0.6 0.1 0.1 0.3 0.2 1.8 0.0 0.0 0.2 0.9 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.2 1.3 1.2 1.4 0.6 0.9 0.5 0.6 0.7 0.5 1.4 1.2 0.7 0.9 2.8 1.2 1.0 1.3 0.4 0.3 0.3 1.3 0.3 0.8 0.3 0.4 5.1 0.2 1.9 0.2 3.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 C3orf36 FLJ22173 ENSG00000221972 "Chromosome 3 open reading frame 36" Q3SXR2 3 133928145-133929812 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "lung: 8.2;seminal vesicle: 14.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 6.6;HeLa: 1.7;TIME: 5.2" HPA046432 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA046432: AB_2679664" "unprognostic (3.56e-1)" "unprognostic (3.28e-2)" "unprognostic (1.87e-1)" "unprognostic (5.29e-3)" "unprognostic (4.64e-4)" "unprognostic (5.05e-3)" "unprognostic (8.18e-5)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.03e-2)" "unprognostic (1.15e-2)" "unprognostic (2.22e-1)" "unprognostic (7.85e-2)" "unprognostic (4.79e-3)" "unprognostic (2.08e-1)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" 1.1 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 1.3 0.0 0.6 1.1 0.8 0.7 0.0 0.0 1.9 0.0 8.2 0.1 0.0 0.0 0.7 1.6 0.2 0.1 2.3 0.3 0.4 14.7 0.0 0.1 1.4 1.0 0.0 1.5 0.8 0.0 2.7 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C6orf223 MGC45491 ENSG00000181577 "Chromosome 6 open reading frame 223" Q8N319 6 44000580-44005958 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 23.6;lung: 9.4" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 2.7;Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.9;JURKAT: 18.7;RPTEC TERT1: 22.6;THP-1: 9.4" "HPA035765, HPA046117" Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA035765: AB_2797225, HPA046117: AB_10964082" "unprognostic (2.94e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-2)" "unprognostic (4.31e-2)" "unprognostic (2.74e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.59e-4)" "unprognostic (7.06e-3)" "unprognostic (2.34e-4)" "unprognostic (1.39e-3)" "unprognostic (2.70e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (9.38e-5)" "unprognostic (2.95e-1)" "unprognostic (5.15e-2)" "unprognostic (2.62e-1)" "unprognostic (1.31e-1)" 0.1 0.4 1.1 1.3 0.9 0.5 23.6 0.2 3.0 0.7 1.4 0.0 0.0 1.8 0.8 4.7 0.1 0.2 6.9 2.9 1.1 0.8 4.9 1.4 9.4 2.8 0.1 1.2 0.1 2.4 0.1 0.8 0.2 0.9 0.2 0.7 3.4 3.1 0.1 0.3 0.5 3.1 0.2 0.0 0.7 0.2 0.3 0.0 1.0 2.1 1.1 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.3 0.0 18.7 0.0 0.3 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.2 0.3 0.0 0.1 1.9 3.4 1.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.2 3.0 1.1 0.8 0.1 1.2 0.9 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.6 0.5 1.4 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.4 C7orf77 ENSG00000275356 "Chromosome 7 open reading frame 77" A4D0Y5 7 124777292-124790689 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "liver: 2.1;lung: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HDLM-2: 9.6" NA NA "unprognostic (9.32e-2)" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CACNA2D2 KIAA0558 ENSG00000007402 "Calcium voltage-gated channel auxiliary subunit alpha2delta 2" Q9NY47 3 50362799-50504244 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 86.1" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 145.9" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034771, HPA071829" Enhanced Approved Vesicles NA NA 1000000 Vesicles "HPA034771: AB_10603555, HPA071829: AB_2686454" "unprognostic (2.06e-1)" "unprognostic (2.37e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (7.62e-5)" "unprognostic (6.59e-2)" "unprognostic (6.37e-2)" "unprognostic (6.91e-2)" "unprognostic (6.57e-3)" "unprognostic (4.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.21e-4)" "unprognostic (2.71e-2)" "unprognostic (1.57e-4)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (3.55e-1)" "unprognostic (4.22e-2)" 1.0 0.9 1.6 1.3 11.1 1.1 1.4 14.9 6.5 1.1 1.7 0.9 0.6 1.4 1.7 1.2 0.9 1.1 0.9 7.6 1.7 9.1 1.6 0.5 86.1 1.3 3.9 3.2 2.2 4.0 3.8 6.0 1.9 6.1 3.0 2.0 6.1 1.5 1.4 1.7 2.6 1.7 1.4 1.4 1.5 4.1 5.8 2.5 0.2 2.3 0.1 0.7 0.7 0.7 1.8 0.3 0.7 0.1 2.3 3.6 1.1 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 8.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 6.4 66.5 0.2 0.1 0.0 2.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.2 0.0 2.7 1.8 2.6 2.0 0.0 1.3 3.6 2.2 0.0 2.3 0.1 0.3 3.2 1.1 1.6 11.1 14.9 6.5 1.7 9.1 3.9 3.2 6.1 2.5 71.5 145.9 0.0 0.3 1.3 7.2 3.0 0.0 4.0 4.5 1.8 19.6 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.1 0.7 19.7 0.0 0.1 0.0 1.2 0.6 0.0 2.3 0.3 0.0 0.0 0.0 3.5 4.0 0.6 0.0 1.8 0.4 10.0 12.9 0.8 1.6 11.1 0.5 0.2 1.0 0.4 0.3 CALCRL "CGRPR, CRLR" ENSG00000064989 "Calcitonin receptor like receptor" Q16602 2 187343129-187448460 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 91.0" "Group enriched" "Detected in many" 9 "Endothelial cells: 183.3;Ito cells: 192.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3" "Group enriched" "Detected in many" 6 "dendritic cells: 11.2;monocytes: 3.3" "Cell line enriched" "Detected in some" 4 "HUVEC TERT2: 62.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008070, HPA046515" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA008070: AB_1845912, HPA046515: AB_2679681" "unprognostic (7.06e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (3.44e-3)" "unprognostic (7.60e-3)" "unprognostic (9.25e-3)" "unprognostic (4.14e-2)" "unprognostic (7.71e-3)" "unprognostic (3.32e-1)" "unprognostic (3.77e-1)" "unprognostic (3.44e-1)" "unprognostic (1.51e-3)" "unprognostic (1.90e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" 42.4 5.2 4.9 6.4 3.8 0.2 19.6 7.3 9.4 21.2 12.6 2.6 4.0 3.1 17.9 6.8 16.3 6.5 13.4 15.1 4.5 3.8 16.5 12.5 91.0 16.9 4.7 3.5 15.2 3.7 8.2 5.3 6.4 7.5 10.7 5.3 7.5 8.4 4.4 5.0 4.2 5.6 14.5 18.1 9.1 5.0 7.9 2.8 2.3 16.9 11.8 4.7 10.6 14.0 0.2 11.2 0.1 3.3 1.2 1.1 1.1 0.0 0.0 3.2 0.0 2.3 0.6 0.0 0.2 0.4 0.0 0.4 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.5 0.0 0.0 1.8 0.0 0.0 1.6 0.1 0.1 0.7 0.2 62.5 0.0 0.0 0.8 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.1 14.7 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.0 0.2 0.0 0.0 0.1 2.3 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 11.2 0.0 1.1 0.2 0.1 1.2 1.2 3.3 0.0 1.1 4.9 3.8 7.3 3.7 4.5 3.8 4.7 3.5 7.5 2.8 0.0 14.0 0.8 2.3 8.2 0.1 7.0 2.5 2.7 4.5 0.0 0.0 0.3 3.3 0.1 0.5 183.3 0.0 0.0 0.4 0.1 5.4 1.7 4.7 2.1 0.9 0.0 0.0 192.8 14.2 0.4 7.2 7.7 10.1 20.8 0.0 0.0 0.1 0.0 2.5 12.3 0.0 6.5 6.6 1.2 0.4 5.9 0.2 0.0 0.0 1.2 CAPN9 "GC36, nCL-4" ENSG00000135773 "Calpain 9" O14815 1 230747384-230802003 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.6;lung: 19.8;stomach 1: 35.8" "Group enriched" "Detected in many" 10 "Alveolar cells type 1: 23.8;Mucus-secreting cells: 67.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Group enriched" "Detected in some" 6 "OE19: 11.9;SCLC-21H: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020398, CAB033483, HPA062050" Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: " "unprognostic (2.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.60e-2)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.49e-2)" "unprognostic (3.36e-2)" "unprognostic (2.30e-2)" "unprognostic (4.61e-2)" "unprognostic (3.44e-2)" "unprognostic (9.10e-2)" "unprognostic (1.60e-1)" "unprognostic (5.97e-5)" "unprognostic (1.51e-1)" "unprognostic (2.08e-1)" "unprognostic (4.60e-2)" "unprognostic (2.16e-1)" 0.2 0.7 0.4 7.0 0.3 0.0 0.2 0.3 0.5 0.4 10.4 0.4 0.2 3.9 0.2 0.2 0.7 1.5 12.7 0.2 0.5 0.2 0.2 0.2 19.8 0.2 0.6 0.2 0.3 0.2 0.0 0.6 0.2 0.2 0.8 13.7 0.2 8.1 0.2 1.3 0.0 17.6 0.2 1.1 0.2 35.8 0.2 0.2 0.2 0.2 1.0 7.1 3.7 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.1 0.0 0.6 11.9 0.0 0.4 0.0 0.0 0.0 0.1 17.1 0.0 0.0 0.5 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.3 0.4 0.5 0.2 0.6 0.2 0.2 0.2 23.8 4.8 0.0 0.5 0.0 0.0 3.3 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.2 4.5 0.0 3.5 0.0 0.2 0.0 0.0 0.4 2.3 0.0 0.1 0.0 2.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 67.4 0.2 1.1 3.5 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 1.0 CASS4 "C20orf32, HEFL, HEPL" ENSG00000087589 "Cas scaffolding protein family member 4" Q9NQ75 20 56412112-56460387 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.8;lung: 16.7" "Cell type enhanced" "Detected in some" 15 "granulocytes: 13.9;Kupffer cells: 8.0;Macrophages: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 10.8;neutrophil: 33.8" "Lineage enriched" "Detected in many" 10 "granulocytes: 33.8" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 6.6;HEL: 10.7;HMC-1: 32.8;K-562: 13.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB034217 Approved NA NA 890000 "CAB034217: AB_2071598" "unprognostic (9.55e-3)" "unprognostic (2.53e-2)" "unprognostic (2.44e-2)" "unprognostic (8.51e-2)" "unprognostic (3.04e-1)" "unprognostic (1.56e-3)" "unprognostic (2.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-1)" "unprognostic (4.10e-2)" "unprognostic (5.28e-2)" "unprognostic (6.19e-2)" "unprognostic (7.27e-4)" "unprognostic (5.33e-2)" "unprognostic (3.65e-2)" "unprognostic (6.50e-2)" "unprognostic (8.16e-2)" 3.3 1.7 2.0 13.0 2.2 2.4 1.7 1.3 4.5 1.7 1.4 6.1 0.0 1.8 2.5 0.9 1.4 1.6 3.5 1.6 2.4 1.5 1.6 2.2 16.7 12.1 1.9 3.1 2.4 1.5 0.4 1.3 6.6 3.4 1.4 1.3 2.7 1.8 2.5 1.3 1.5 2.9 1.8 2.9 9.2 1.5 1.1 2.2 4.1 1.3 1.1 4.3 3.0 1.4 0.0 3.4 33.8 1.9 1.4 2.3 1.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.6 0.2 0.1 0.3 0.1 2.3 0.1 0.1 6.6 0.1 0.1 0.1 0.0 0.4 0.1 0.1 10.7 0.1 0.6 0.2 0.3 32.8 0.7 0.2 0.2 0.0 0.3 0.0 0.2 13.2 0.1 0.4 0.1 0.2 4.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.0 1.4 0.1 0.2 1.9 10.8 0.7 0.4 1.0 0.0 1.2 1.3 3.4 0.0 2.3 2.0 33.8 1.4 0.0 1.2 0.6 1.1 2.0 2.2 1.3 4.5 2.4 1.5 1.9 3.1 3.4 2.2 0.0 1.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 13.9 0.9 2.3 0.0 0.0 0.6 8.0 0.0 0.0 6.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 3.2 0.0 0.0 CCDC141 "CAMDI, FLJ39502" ENSG00000163492 "Coiled-coil domain containing 141" 2 178829757-179050086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 47.5;lung: 17.6" "Cell type enhanced" "Detected in many" 22 "Alveolar cells type 2: 19.8;Cardiomyocytes: 103.0;Early spermatids: 34.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 12.9" "Group enriched" "Detected in many" 9 "B-cells: 7.6;T-cells: 12.9" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Daudi: 4.1;HEL: 9.5;RH-30: 5.1;U-266/70: 6.1;U-698: 8.5" HPA012718 Approved Nucleoplasm NA NA Nucleoplasm "HPA012718: AB_2072055" "unprognostic (1.58e-1)" "unprognostic (1.85e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-1)" "unprognostic (8.62e-3)" "unprognostic (4.25e-2)" "unprognostic (2.98e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.33e-2)" "unprognostic (8.03e-3)" "unprognostic (7.71e-8)" "unprognostic (2.50e-2)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-1)" 1.6 0.6 0.5 7.5 0.6 0.9 4.9 0.5 0.5 0.7 1.2 0.1 0.5 0.2 0.8 2.2 2.5 0.6 6.3 47.5 0.6 0.6 0.5 0.5 17.6 4.4 0.6 0.0 0.8 3.8 0.2 0.5 0.8 1.1 1.0 0.3 1.8 0.6 0.3 9.3 0.5 0.7 1.7 0.7 1.8 0.6 1.6 0.0 11.0 0.7 2.1 7.4 1.4 1.2 7.6 0.0 0.4 0.0 1.1 12.9 0.4 0.2 0.0 0.1 0.3 0.0 0.1 2.0 0.0 0.1 0.0 0.2 6.4 0.5 4.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 3.5 0.2 9.5 0.3 0.0 0.0 1.7 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.6 0.1 0.1 0.1 0.3 3.4 0.6 0.7 0.2 5.1 1.6 0.0 0.1 0.2 0.2 0.1 0.3 0.1 1.1 0.3 0.4 0.1 0.3 0.2 0.3 0.0 6.1 0.1 8.5 0.3 0.5 0.6 0.3 0.0 0.2 0.3 0.0 0.2 6.6 2.1 1.4 0.0 7.6 6.4 4.8 0.4 1.1 0.0 0.0 12.9 0.4 0.5 0.6 0.5 0.5 0.6 0.6 0.6 0.0 1.1 0.0 6.0 19.8 0.5 0.0 0.1 1.4 103.0 10.2 2.7 1.2 0.0 0.0 0.0 0.0 2.5 34.6 3.6 0.0 0.0 1.2 0.2 0.4 0.0 5.8 0.0 0.0 6.4 0.0 0.0 0.3 12.9 1.1 0.8 1.7 0.0 0.0 3.8 0.2 0.0 1.8 0.0 0.6 6.5 1.4 0.0 0.2 0.1 0.0 5.0 0.0 0.1 CCDC17 FLJ33084 ENSG00000159588 "Coiled-coil domain containing 17" Q96LX7 1 45620044-45624057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6" "Cell type enriched" "Detected in many" 12 "Ciliated cells: 291.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Region enriched" "Detected in single" 4 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA028338 Enhanced NA NA "HPA028338: AB_10669641" "unprognostic (3.53e-5)" "unprognostic (7.40e-2)" "unprognostic (3.08e-3)" "unprognostic (3.55e-3)" "unprognostic (3.31e-1)" "unprognostic (9.21e-3)" "unprognostic (6.97e-2)" "unprognostic (1.30e-2)" "unprognostic (8.55e-2)" "unprognostic (1.07e-1)" "unprognostic (4.46e-3)" "unprognostic (2.91e-1)" "unprognostic (8.37e-7)" "unprognostic (1.20e-1)" "unprognostic (1.96e-1)" "unprognostic (2.92e-1)" "unprognostic (5.91e-3)" 0.0 0.0 0.1 0.1 0.2 0.4 0.0 0.0 0.0 3.2 0.1 0.4 0.0 0.2 0.5 24.5 0.0 31.0 0.0 0.0 0.2 0.1 0.0 0.1 23.0 0.1 0.0 0.0 9.6 0.1 0.0 1.6 0.2 1.4 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.1 1.1 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 2.3 0.1 0.4 1.0 1.3 0.3 0.0 0.1 0.0 0.4 0.3 2.3 1.1 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.3 1.8 0.1 1.0 0.2 0.0 0.1 0.0 3.0 1.1 0.0 0.2 0.4 0.0 0.0 0.2 0.3 0.9 0.0 0.0 2.0 1.2 0.7 0.0 0.0 0.4 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 1.4 0.3 3.0 2.6 0.0 0.2 1.0 0.0 1.6 0.0 291.7 25.0 0.0 0.0 0.3 5.0 0.4 0.0 0.7 3.2 0.0 0.8 0.1 0.4 0.4 1.1 0.9 0.6 0.0 1.2 0.6 0.8 0.2 1.1 1.4 0.0 1.0 1.6 0.3 0.9 1.9 2.1 0.6 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.0 1.5 0.3 CCDC190 "C1orf110, MGC48998" ENSG00000185860 "Coiled-coil domain containing 190" Q86UF4 1 162824458-162868815 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 8.3;lung: 7.2;tongue: 7.5" "Cell type enriched" "Detected in some" 27 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 4.1;hTERT-RPE1: 5.1;HUVEC TERT2: 5.0;LHCN-M2: 7.6;TIME: 17.3;U-2197: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028579, HPA028584, HPA028592" Uncertain Approved Vesicles NA NA Vesicles "HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001" "unprognostic (4.29e-1)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (8.33e-3)" "unprognostic (3.04e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (7.41e-5)" "unprognostic (2.64e-1)" "unprognostic (1.52e-1)" "unprognostic (5.26e-1)" "unprognostic (1.70e-1)" 0.2 0.1 1.1 0.2 1.7 0.0 0.2 0.2 0.9 0.3 0.2 0.2 0.2 0.0 0.2 0.8 8.3 1.1 1.3 1.0 1.2 0.7 0.2 0.2 7.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.5 0.0 0.2 0.2 0.3 0.2 0.1 0.7 0.2 0.6 0.2 7.5 2.4 0.3 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 4.1 2.6 5.1 5.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.4 0.0 9.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.2 0.6 1.2 0.7 0.4 0.2 0.2 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 48.2 0.0 1.8 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 CCDC78 "C16orf25, FLJ34512" ENSG00000162004 "Coiled-coil domain containing 78" A2IDD5 16 722582-726954 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.1;epididymis: 21.3;fallopian tube: 47.9;lung: 13.3" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 57.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.8;RPMI-8226: 10.3;SCLC-21H: 12.4;U-266/70: 10.2" NA NA "unprognostic (1.10e-1)" "unprognostic (6.48e-2)" "unprognostic (2.62e-4)" "unprognostic (1.02e-2)" "unprognostic (1.24e-1)" "unprognostic (2.58e-2)" "unprognostic (3.47e-2)" "unprognostic (2.06e-2)" "unprognostic (9.39e-2)" "unprognostic (1.48e-1)" "unprognostic (7.82e-3)" "unprognostic (6.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.45e-3)" "unprognostic (5.20e-1)" "unprognostic (1.44e-1)" "unprognostic (7.22e-3)" 0.3 1.1 3.6 1.1 11.3 1.2 0.5 2.0 1.2 2.5 0.4 6.4 1.3 0.3 1.1 21.3 0.3 47.9 0.6 0.4 4.3 4.7 0.4 0.4 13.3 1.1 1.9 0.1 5.7 0.3 0.7 2.3 0.6 20.1 0.6 0.5 0.3 0.7 1.0 0.4 0.4 0.6 0.4 2.6 0.9 0.9 1.1 1.7 0.2 0.5 0.1 1.6 1.0 0.1 0.4 1.2 1.3 0.0 1.2 3.2 0.1 0.5 1.0 1.2 2.9 1.3 1.2 1.4 1.1 2.5 0.6 0.4 0.4 4.8 1.0 1.1 0.6 0.8 0.8 2.7 1.5 0.1 8.8 0.0 2.4 1.4 0.0 1.5 0.8 1.6 3.8 0.9 0.4 4.4 3.1 0.4 2.9 0.3 3.3 0.9 6.1 0.0 2.1 1.8 2.2 0.3 2.1 0.9 10.3 4.2 1.8 12.4 1.2 1.1 7.3 0.6 0.6 4.7 1.6 1.0 1.0 0.4 0.0 0.1 10.2 0.2 2.7 1.0 1.2 2.8 0.0 0.0 1.3 0.2 0.0 3.2 0.4 0.1 1.9 0.0 0.1 0.0 0.0 0.0 1.2 0.0 1.2 0.1 0.1 3.6 11.3 2.0 1.2 4.3 4.7 1.9 0.1 20.1 1.7 0.0 0.0 0.5 0.1 0.0 3.2 0.4 0.0 57.6 5.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.4 0.0 0.0 0.8 3.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.1 0.0 1.3 0.0 0.0 CCL18 "AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18" ENSG00000275385 "C-C motif chemokine ligand 18" P55774 17 36064280-36072032 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.4;lung: 77.9;lymphoid tissue: 61.9" "Cell type enriched" "Detected in some" 5 "Hofbauer cells: 197.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.5" "Secreted to blood" NA NA 55500000 940000 "unprognostic (8.91e-2)" "unprognostic (2.96e-2)" "unprognostic (5.71e-2)" "unprognostic (9.64e-2)" "unprognostic (1.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.96e-1)" "unprognostic (2.50e-1)" "unprognostic (3.11e-2)" "unprognostic (1.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.68e-1)" "unprognostic (3.63e-1)" "unprognostic (4.87e-2)" 18.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.2 0.0 3.1 0.0 0.0 1.6 0.0 5.8 3.2 0.0 0.4 41.4 0.0 0.0 1.3 77.9 61.9 0.0 0.0 3.7 0.3 0.0 0.0 5.9 0.0 0.2 2.5 0.0 0.2 0.0 0.0 0.3 3.4 4.1 0.0 3.7 0.3 1.6 0.0 43.8 2.2 4.3 16.7 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 8.5 0.0 0.2 0.0 9.4 25.0 0.0 0.0 0.4 0.0 0.0 24.7 0.3 0.0 0.0 0.0 0.3 2.1 0.0 4.7 0.0 197.4 0.0 0.0 0.0 2.2 3.6 0.0 40.3 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 3.0 1.4 0.0 0.0 0.0 CCL20 "CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38" ENSG00000115009 "C-C motif chemokine ligand 20" P78556 2 227805739-227817564 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Antibiotic, Antimicrobial, Cytokine" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.5;lung: 36.8;lymphoid tissue: 50.9" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 266.2;Glandular cells: 185.4;Paneth cells: 292.5;Urothelial cells: 548.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "MAIT T-cell: 6.6" "Lineage enriched" "Detected in single" 10 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "GAMG: 36.0;Hep G2: 19.3;NB-4: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 28000 "unprognostic (2.40e-1)" "unprognostic (1.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (7.06e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.53e-3)" "unprognostic (1.37e-1)" "unprognostic (5.21e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.19e-8)" "unprognostic (1.39e-1)" "unprognostic (2.75e-1)" "unprognostic (1.63e-1)" "unprognostic (1.82e-1)" 5.6 0.1 0.4 23.3 0.9 1.5 0.4 0.3 0.4 7.1 5.5 0.3 0.3 4.4 3.9 1.5 11.8 2.0 48.5 1.5 0.4 0.2 7.1 17.2 36.8 16.3 0.4 0.3 1.5 1.9 0.0 0.3 0.9 1.3 2.0 7.8 0.4 4.0 0.3 0.5 4.3 18.2 1.0 1.3 0.5 2.8 1.6 0.4 1.8 0.5 18.3 50.9 19.6 2.5 0.3 0.6 0.0 0.3 0.0 6.6 0.3 0.2 0.8 0.4 0.4 1.8 3.7 0.5 0.2 1.1 0.1 0.4 2.1 0.3 0.7 2.5 0.0 36.0 0.4 0.1 4.8 0.8 0.5 0.8 0.1 1.6 19.3 1.4 2.7 0.2 5.8 1.0 1.1 1.3 0.5 0.0 0.6 0.1 3.0 0.3 0.2 0.2 14.0 0.9 2.8 0.4 0.3 5.0 0.5 0.1 8.5 0.3 0.2 0.2 0.8 0.5 0.4 0.7 2.8 1.4 1.8 2.4 4.1 0.4 0.5 1.6 1.1 2.9 1.9 3.8 0.0 0.3 0.0 0.1 0.1 6.6 0.2 2.7 1.4 0.3 0.3 0.4 0.3 0.0 0.0 0.2 0.6 1.0 0.3 0.4 0.9 0.3 0.4 0.4 0.2 0.4 0.3 1.3 0.4 44.7 86.3 5.0 266.2 105.6 0.2 0.8 30.6 20.1 105.8 17.4 0.0 0.1 0.0 133.7 2.4 0.2 119.7 0.0 2.5 0.3 3.3 185.4 5.7 1.0 30.6 1.6 55.7 0.0 2.2 0.0 0.0 33.0 1.7 16.2 60.3 0.0 31.3 292.5 0.0 2.4 0.1 0.0 3.8 0.0 0.9 56.7 0.7 16.0 52.5 548.3 CCL24 "Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24" ENSG00000106178 "C-C motif chemokine ligand 24" O00175 7 75811665-75823356 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 33.1;lung: 23.3;lymphoid tissue: 63.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "colorectal cancer: 67.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 3.3" "Lineage enriched" "Detected in single" 5 "monocytes: 3.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.8;EFO-21: 2.7;HMC-1: 2.7;OE19: 4.1;RH-30: 3.4;U-2 OS: 9.4" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 276000 "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "prognostic favorable (5.41e-4)" "unprognostic (1.26e-2)" "unprognostic (1.44e-2)" "unprognostic (5.56e-2)" "unprognostic (1.73e-1)" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (3.15e-1)" "unprognostic (2.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" 8.2 0.5 0.3 5.7 0.3 0.0 0.8 0.3 0.3 0.6 12.2 0.3 0.2 9.4 0.4 0.6 1.0 0.4 1.1 0.5 0.3 0.3 0.6 3.8 23.3 21.2 0.3 0.2 0.6 0.4 0.0 0.4 0.3 0.3 0.5 33.1 0.6 0.6 0.5 0.4 0.7 26.8 0.5 0.3 63.3 1.0 1.0 0.2 1.2 0.5 0.9 2.8 13.4 0.7 0.0 0.6 0.0 3.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 8.8 0.2 2.7 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.4 0.7 0.2 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 4.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 9.4 0.0 0.5 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL4 "Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4" ENSG00000275302 "C-C motif chemokine ligand 4" P13236 17 36103590-36105621 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 69.3;lung: 23.1;lymphoid tissue: 20.8" "Cell type enhanced" "Detected in many" 16 "Hofbauer cells: 716.7;Macrophages: 396.6;T-cells: 809.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 69.3;MAIT T-cell: 21.8;memory CD8 T-cell: 40.6;naive CD8 T-cell: 30.5" "Lineage enriched" "Detected in many" 17 "T-cells: 69.3" "Group enriched" "Detected in some" 23 "Karpas-707: 5.2;U-266/70: 11.5;U-266/84: 5.5" CAB007805 Approved "Secreted to blood" NA NA 144000 "CAB007805: AB_598177" "unprognostic (6.03e-2)" "unprognostic (2.48e-2)" "prognostic favorable (3.54e-4)" "prognostic favorable (1.97e-5)" "unprognostic (2.06e-1)" "unprognostic (7.02e-2)" "unprognostic (9.08e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-1)" "unprognostic (8.57e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (3.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-2)" 2.3 2.6 0.0 3.7 0.4 9.3 5.7 0.1 3.6 0.9 2.9 1.4 0.5 0.2 1.6 0.8 1.7 1.6 4.4 3.8 0.0 1.3 5.7 23.1 20.8 1.1 0.0 3.4 0.9 0.0 0.2 4.3 0.9 1.1 1.0 3.9 1.6 1.6 0.5 0.0 0.9 1.4 1.5 10.4 2.3 0.3 0.0 1.0 1.6 2.0 4.3 1.9 0.8 1.8 0.4 4.0 0.6 3.0 69.3 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 5.5 0.3 0.0 0.0 0.0 1.7 0.2 4.0 69.3 0.0 21.8 0.9 7.7 40.6 0.1 1.8 2.3 30.5 1.6 3.0 0.6 0.4 0.0 11.6 0.0 85.1 30.1 1.1 13.9 1.0 10.2 5.1 10.7 12.5 0.0 0.0 7.8 0.0 0.4 21.7 11.3 0.4 0.0 0.3 9.8 13.1 1.2 58.9 4.3 716.7 1.6 1.2 14.7 198.1 23.7 0.9 396.6 49.0 1.8 0.1 1.2 0.1 0.0 0.4 1.8 5.1 0.0 11.3 0.4 0.2 12.7 21.6 809.7 0.0 1.6 CCL4L2 ENSG00000276070 "C-C motif chemokine ligand 4 like 2" Q8NHW4 17 36210924-36212878 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.8;bone marrow: 18.7;lung: 15.2" "Cell type enriched" "Detected in many" 4 "Hofbauer cells: 323.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "eosinophil: 41.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 41.8" "Group enriched" "Detected in some" 4 "Daudi: 5.7;HMC-1: 8.2;U-266/70: 12.7" "Secreted to blood" NA NA "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" "unprognostic (2.46e-2)" "unprognostic (1.44e-2)" "unprognostic (1.16e-1)" "unprognostic (6.07e-2)" "unprognostic (3.82e-1)" "unprognostic (3.19e-1)" "unprognostic (1.53e-2)" "unprognostic (1.14e-1)" "unprognostic (3.62e-2)" "unprognostic (1.93e-1)" "unprognostic (1.27e-2)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" "unprognostic (8.51e-2)" "unprognostic (1.99e-3)" 0.8 2.4 0.0 4.5 0.6 18.7 8.0 0.3 4.6 0.9 0.4 2.3 0.0 0.6 0.3 0.3 0.1 0.0 4.5 2.1 0.0 0.7 5.0 15.2 8.1 0.6 0.3 0.1 0.1 1.0 0.0 1.0 0.5 0.7 0.8 1.0 1.6 0.0 0.0 0.0 0.5 0.5 0.0 2.6 0.0 0.4 0.4 0.3 0.0 0.9 1.8 1.9 0.0 0.0 0.0 41.8 0.1 0.3 5.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 1.9 1.0 0.0 0.1 0.0 0.2 0.1 41.8 5.6 0.0 1.3 0.0 0.2 3.2 0.0 0.0 0.0 3.3 6.3 0.3 0.0 0.0 0.0 1.5 0.0 10.6 0.0 0.2 0.3 0.4 6.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.6 0.0 0.0 0.0 5.4 3.1 0.5 4.7 0.2 323.5 1.6 0.0 4.3 51.8 0.4 0.0 52.5 1.7 0.0 0.0 0.7 0.1 0.0 0.0 0.0 2.3 12.9 0.4 0.0 0.1 0.4 8.0 78.4 0.0 1.5 CD101 "IGSF2, V7" ENSG00000134256 "CD101 molecule" Q93033 1 117001750-117036476 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;lung: 17.5" "Cell type enhanced" "Detected in some" 9 "Kupffer cells: 6.2;Macrophages: 7.2;Sertoli cells: 6.5;T-cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.7" "Group enriched" "Detected in many" 17 "dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4" "Cell line enriched" "Detected in some" 9 "HMC-1: 25.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA049527, HPA057763" Approved Uncertain Mitochondria NA NA 42000 Mitochondria "HPA049527: , HPA057763: AB_2683519" "unprognostic (1.25e-1)" "unprognostic (7.95e-3)" "unprognostic (5.40e-3)" "unprognostic (4.10e-3)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (7.29e-3)" "unprognostic (3.15e-1)" "unprognostic (4.54e-2)" "unprognostic (7.15e-6)" "unprognostic (7.00e-2)" "unprognostic (8.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.28e-2)" 0.9 1.7 0.8 11.3 1.1 5.7 0.8 0.2 1.1 1.3 5.0 0.6 1.2 4.6 1.7 0.4 1.8 1.5 1.4 2.6 1.1 0.5 1.3 0.8 17.5 4.0 1.3 0.2 1.0 2.3 0.0 0.8 0.5 1.1 1.6 3.2 0.7 2.1 1.3 0.5 1.8 10.9 1.6 2.0 7.8 1.8 0.9 1.2 6.4 0.9 2.4 7.4 2.4 1.8 0.1 12.2 33.7 17.4 0.0 1.2 2.5 0.4 0.0 0.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 1.2 1.9 0.1 0.0 0.0 1.1 0.1 0.8 0.0 0.0 0.1 25.3 0.3 1.3 0.0 0.1 0.2 0.2 0.5 0.1 0.6 0.1 1.5 0.0 2.9 0.8 0.0 0.0 0.0 0.5 0.0 0.6 0.7 0.4 0.6 0.4 0.5 0.3 0.6 0.9 0.6 0.5 0.1 0.4 0.5 0.2 0.2 0.1 0.0 0.7 1.9 1.5 0.0 7.6 33.7 0.1 10.0 0.7 0.1 0.2 1.2 12.2 0.0 0.3 1.2 0.3 0.0 17.4 0.0 1.1 2.5 0.8 1.1 0.2 1.1 1.1 0.5 1.3 0.2 1.1 1.2 0.0 1.4 0.5 0.1 1.1 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.5 0.0 0.2 0.1 1.1 0.4 0.7 0.0 1.7 0.0 6.2 1.3 0.3 7.2 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.2 0.0 0.0 1.4 0.0 4.6 0.1 0.1 CD274 "B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1" ENSG00000120217 "CD274 molecule" Q9NZQ7 9 5450503-5470566 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 23.9;placenta: 56.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 26.7;monocytes: 73.9;Syncytiotrophoblasts: 37.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.4" "Group enriched" "Detected in many" 6 "granulocytes: 8.4;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HDLM-2: 34.2;HHSteC: 22.8;U-251 MG: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003528, CAB076385" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB076385: AB_2687655, HPA003528: " "prognostic favorable (8.89e-4)" "unprognostic (4.54e-2)" "prognostic favorable (1.64e-5)" "unprognostic (1.27e-2)" "unprognostic (2.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (5.67e-4)" "unprognostic (7.39e-3)" "unprognostic (1.69e-2)" "unprognostic (1.24e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-2)" "unprognostic (2.67e-1)" "unprognostic (9.02e-2)" 3.4 2.1 1.7 10.8 3.2 1.4 2.2 2.5 3.3 2.0 2.3 2.5 2.8 2.6 1.7 2.4 3.0 1.9 4.3 9.5 1.4 3.7 3.0 3.6 23.9 6.4 2.3 0.7 1.7 2.7 3.8 7.4 56.0 3.2 2.9 2.2 3.3 1.7 1.6 4.3 1.3 2.7 2.3 2.4 12.8 1.9 1.2 1.0 11.6 3.7 2.1 5.8 3.1 1.9 0.9 0.0 8.4 0.1 0.4 2.4 0.7 5.9 0.1 0.0 0.2 0.0 0.0 0.0 11.9 10.1 3.0 4.2 0.0 1.9 0.0 0.2 0.3 1.5 0.2 0.0 5.2 9.9 34.2 0.0 3.4 0.1 0.0 22.8 0.0 0.0 0.2 0.0 6.3 9.3 3.1 5.9 0.3 0.0 1.1 9.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.3 0.6 0.1 0.0 0.1 0.1 0.9 0.7 0.9 0.0 0.1 10.9 6.5 2.0 0.2 37.9 0.2 0.1 0.1 2.1 0.1 0.0 8.4 0.1 0.3 1.2 0.1 2.1 0.9 2.4 1.8 0.0 0.2 1.3 0.7 5.7 0.4 0.0 0.0 1.1 0.7 1.7 3.2 2.5 3.3 1.4 3.7 2.3 0.7 3.2 1.0 11.9 10.7 0.5 1.2 4.0 1.4 6.5 0.0 4.0 3.4 0.0 0.0 4.9 0.0 6.4 0.2 6.3 0.8 0.0 3.7 20.2 1.9 0.9 26.7 1.0 4.9 0.0 0.0 10.4 1.9 0.0 0.3 7.7 3.3 73.9 0.1 0.6 12.0 0.0 0.4 0.4 0.1 0.0 0.9 0.5 0.7 2.3 37.2 1.3 0.2 2.2 CD300LF "CD300f, CLM1, IGSF13, IREM1, NKIR" ENSG00000186074 "CD300 molecule like family member f" Q8TDQ1 17 74694311-74712978 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 47.8;bone marrow: 18.2;lung: 24.1;lymphoid tissue: 29.1" "Cell type enhanced" "Detected in some" 13 "granulocytes: 22.0;Hofbauer cells: 21.0;Kupffer cells: 28.8;Macrophages: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 47.8" "Group enriched" "Detected in many" 46 "dendritic cells: 13.5;granulocytes: 47.8;monocytes: 38.1" "Group enriched" "Detected in some" 6 "THP-1: 16.0;U-937: 30.9" HPA013712 Supported NA NA "HPA013712: AB_2668874" "unprognostic (6.51e-2)" "unprognostic (1.49e-3)" "unprognostic (3.81e-2)" "unprognostic (4.00e-2)" "unprognostic (8.51e-2)" "unprognostic (6.74e-2)" "unprognostic (1.79e-1)" "unprognostic (3.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (9.60e-2)" "unprognostic (4.14e-2)" "unprognostic (7.75e-2)" "unprognostic (4.79e-2)" 3.3 1.0 1.2 9.8 3.1 18.2 0.9 1.5 1.3 0.8 2.3 3.1 0.0 2.7 0.7 0.7 0.9 1.1 1.9 2.4 1.3 1.2 1.1 1.5 24.1 15.6 3.8 0.5 0.9 0.9 0.0 1.0 2.1 2.6 1.4 2.6 0.8 1.9 0.3 0.5 0.5 3.4 2.3 5.8 29.1 1.0 0.7 2.4 1.1 0.8 0.0 4.2 2.8 0.8 0.0 13.5 47.8 38.1 0.7 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 30.9 0.0 8.4 20.2 47.8 0.0 34.4 0.1 0.0 0.0 0.0 13.5 0.0 0.0 0.0 15.9 0.7 38.1 1.4 0.0 8.2 1.2 3.1 1.5 1.3 1.3 1.2 3.8 0.5 2.6 2.4 0.0 8.3 0.0 0.0 0.1 0.2 0.1 2.5 0.0 5.7 0.0 2.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.0 0.0 21.0 0.0 0.0 1.3 28.8 0.0 0.0 32.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CDC20B FLJ37927 ENSG00000164287 "Cell division cycle 20B" Q86Y33 5 55112995-55173175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 33.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.5;T-47d: 3.3;U-87 MG: 1.3" "Region enriched" "Detected in single" 4 "hypothalamus: 0.4" HPA053900 Uncertain NA NA "HPA053900: AB_2682299" "unprognostic (7.39e-3)" "unprognostic (1.02e-1)" "unprognostic (8.19e-2)" "unprognostic (1.78e-3)" "unprognostic (9.94e-2)" "unprognostic (1.59e-2)" "unprognostic (3.12e-1)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (7.84e-3)" "unprognostic (2.83e-2)" "unprognostic (3.06e-1)" "unprognostic (5.15e-4)" "unprognostic (1.99e-2)" "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (1.29e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.8 0.1 0.1 5.5 0.1 0.1 0.1 0.1 2.9 0.1 4.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 6.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.1 0.0 0.4 0.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.3 0.0 3.3 0.0 0.4 0.0 0.2 0.8 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.4 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.7 0.5 0.1 0.1 0.0 0.2 0.1 CDHR3 "CDH28, FLJ23834, FLJ44366" ENSG00000128536 "Cadherin related family member 3" Q6ZTQ4 7 105876796-106033773 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 51.9;lung: 28.9;ovary: 22.3" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 341.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 15.9" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 6.9;granulocytes: 1.8" "Cell line enhanced" "Detected in some" "AF22: 7.9;Daudi: 10.1;WM-115: 6.8" "Low region specificity" "Detected in many" HPA011218 Supported Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA011218: AB_1078886" "unprognostic (4.38e-4)" "unprognostic (9.18e-2)" "unprognostic (8.16e-3)" "unprognostic (8.08e-3)" "unprognostic (5.23e-2)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.18e-1)" "unprognostic (2.77e-2)" "unprognostic (3.70e-3)" "unprognostic (3.51e-3)" 0.4 0.6 2.2 0.6 3.3 0.5 2.5 4.4 1.4 2.4 7.6 4.9 1.1 1.1 2.4 14.9 5.9 51.9 0.2 3.3 3.1 2.1 0.7 0.6 28.9 0.4 1.1 0.3 22.3 0.3 0.1 1.4 0.1 15.9 0.3 0.9 0.1 0.3 0.6 0.5 0.4 12.0 1.7 0.6 0.2 4.6 2.2 1.2 0.1 1.4 0.4 0.7 0.3 0.1 6.9 0.2 1.8 0.2 0.3 0.7 0.1 0.1 0.4 7.9 1.4 2.8 2.7 0.2 0.7 0.6 0.3 0.2 0.0 0.1 10.1 0.0 0.5 1.1 0.1 1.9 0.0 0.3 0.9 1.2 0.0 0.2 0.7 0.0 0.2 0.4 1.0 0.3 0.5 0.0 0.2 0.0 0.0 0.1 0.3 0.3 0.0 0.2 0.1 1.8 2.8 0.6 0.0 0.0 0.4 0.1 0.1 0.6 2.9 0.0 0.8 0.5 1.4 0.0 0.0 0.4 1.4 0.5 1.5 0.0 0.0 0.0 3.3 0.2 0.3 6.8 0.1 0.1 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 6.9 0.3 0.1 1.8 0.3 0.2 0.2 0.7 0.1 2.2 3.3 4.4 1.4 3.1 2.1 1.1 0.3 15.9 1.2 3.0 7.2 0.0 1.6 2.4 4.5 1.2 2.5 341.3 55.7 0.0 0.0 0.5 5.0 0.5 5.4 1.0 2.8 0.0 0.5 0.2 1.5 0.5 3.5 1.7 0.1 0.0 28.7 0.0 0.0 2.5 2.6 0.6 8.5 0.0 3.6 9.5 0.2 2.9 1.4 4.4 1.0 6.5 1.7 1.4 3.1 1.8 0.2 0.7 2.9 0.4 CEACAM6 "CD66c, NCA" ENSG00000086548 "Carcinoembryonic antigen related cell adhesion molecule 6" P40199 19 41750977-41772208 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 81.4;gallbladder: 75.7;lung: 129.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 875.4;Club cells: 255.9;Paneth cells: 283.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Group enriched" "Detected in many" 6 "granulocytes: 2.6;monocytes: 1.3" "Cell line enriched" "Detected in some" 11 "OE19: 196.2" "CAB008370, HPA011041" Enhanced NA NA 79000000 "CAB008370: AB_592067, HPA011041: AB_1078481" "unprognostic (1.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.62e-2)" "unprognostic (8.22e-2)" "unprognostic (1.39e-1)" "unprognostic (9.06e-3)" "unprognostic (2.32e-2)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "unprognostic (5.22e-2)" "unprognostic (3.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.42e-4)" "unprognostic (4.08e-1)" "unprognostic (8.71e-3)" "unprognostic (2.85e-1)" "unprognostic (7.68e-2)" 0.3 0.3 0.3 7.4 0.3 29.7 0.3 0.3 0.3 16.8 35.3 0.2 0.1 5.8 0.9 0.2 81.4 1.1 75.7 2.3 0.3 0.3 0.3 0.8 129.1 0.1 0.3 0.1 0.3 1.7 0.0 0.3 32.1 0.2 0.9 43.1 0.2 50.1 0.1 0.3 2.1 12.8 0.9 0.3 0.8 2.6 0.3 0.1 1.0 0.3 25.3 58.1 2.3 21.0 0.1 0.3 2.6 1.3 0.1 0.3 5.2 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 196.2 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.6 0.1 0.5 0.3 0.0 5.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 875.4 62.6 0.0 2.8 0.0 0.0 0.0 81.5 95.0 255.9 0.0 0.0 0.0 0.0 44.8 0.0 0.0 46.4 0.0 13.9 0.0 0.0 19.2 6.9 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.1 0.0 93.7 283.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.8 105.5 CLDN18 SFTPJ ENSG00000066405 "Claudin 18" P56856 3 137998735-138033655 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "gallbladder: 37.4;lung: 91.9;stomach 1: 126.9" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 1488.8" "Group enriched" "Detected in some" 11 "pancreatic cancer: 113.7;stomach cancer: 186.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "OE19: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013010, CAB013243, HPA018446" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (2.93e-1)" "unprognostic (1.04e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (5.14e-4)" "unprognostic (2.00e-1)" "unprognostic (1.29e-1)" "unprognostic (2.60e-1)" "unprognostic (9.54e-2)" "unprognostic (1.38e-2)" "unprognostic (4.42e-5)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (8.26e-2)" "unprognostic (2.95e-1)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 0.1 0.1 0.3 0.1 37.4 2.0 0.1 0.0 0.1 0.1 91.9 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 126.9 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.9 0.3 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.6 18.9 0.1 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.5 0.3 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.1 1488.8 318.5 0.0 0.0 0.0 0.8 18.9 0.0 1.4 20.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 9.9 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 257.5 0.0 0.0 0.0 1.4 0.0 0.0 6.6 3.8 0.0 0.0 0.0 0.0 0.0 CLEC12A "CD371, CLL-1, DCAL-2, MICL" ENSG00000172322 "C-type lectin domain family 12 member A" Q5QGZ9 12 9951316-9995694 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 46.5;bone marrow: 35.4;lung: 36.2;lymphoid tissue: 22.4" "Cell type enhanced" "Detected in some" 18 "granulocytes: 27.9;Kupffer cells: 91.2;Macrophages: 86.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 46.5" "Group enriched" "Detected in many" 38 "dendritic cells: 17.1;granulocytes: 46.5;monocytes: 32.8" "Group enriched" "Detected in some" 6 "HL-60: 12.1;U-937: 37.8" HPA048515 Enhanced NA NA "HPA048515: AB_2680425" "unprognostic (4.74e-2)" "unprognostic (6.06e-3)" "unprognostic (7.76e-2)" "unprognostic (6.88e-2)" "unprognostic (2.00e-2)" "unprognostic (6.66e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (3.29e-1)" "unprognostic (1.44e-2)" "unprognostic (1.70e-1)" "unprognostic (2.74e-2)" "unprognostic (1.10e-3)" "unprognostic (9.67e-3)" "unprognostic (7.43e-2)" "unprognostic (3.78e-2)" "prognostic favorable (9.33e-4)" 4.2 1.2 0.3 6.4 1.2 35.4 1.2 0.6 1.1 0.9 1.5 0.3 0.1 0.2 1.9 3.7 0.9 1.3 2.8 3.5 0.3 0.3 1.9 3.4 36.2 9.6 0.5 0.8 1.0 1.4 0.0 0.6 3.4 1.2 1.3 1.3 1.4 1.5 0.1 0.7 1.1 1.9 3.5 1.5 22.4 1.3 0.9 0.3 2.8 0.7 0.1 1.2 2.1 1.0 0.0 17.1 46.5 32.8 0.8 0.1 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 12.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 37.8 0.0 4.1 32.8 46.5 0.0 26.4 0.1 0.0 0.0 0.0 17.1 0.0 0.0 0.1 10.2 0.8 28.4 1.5 0.0 12.5 0.3 1.2 0.6 1.1 0.3 0.3 0.5 0.8 1.2 0.3 3.0 5.3 4.2 0.0 0.3 0.0 0.4 0.0 2.7 5.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 27.9 0.8 20.0 0.0 0.0 1.3 91.2 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.5 1.1 3.2 0.0 0.0 CLEC14A C14orf27 ENSG00000176435 "C-type lectin domain containing 14A" Q86T13 14 38254103-38256369 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 63.2" "Group enriched" "Detected in some" 45 "Endothelial cells: 217.3;Ito cells: 286.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 17.4;HUVEC TERT2: 94.4;TIME: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039468, HPA048119" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 3600000 "Endoplasmic reticulum, Golgi apparatus" "HPA039468: AB_2676524, HPA048119: AB_2680270" "unprognostic (4.02e-1)" "unprognostic (4.26e-2)" "unprognostic (4.20e-3)" "unprognostic (9.44e-2)" "unprognostic (1.35e-1)" "prognostic favorable (4.13e-6)" "unprognostic (2.55e-3)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (6.90e-2)" "unprognostic (5.41e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-2)" "unprognostic (1.75e-2)" "unprognostic (1.55e-1)" "unprognostic (4.97e-2)" "unprognostic (5.28e-2)" 32.2 3.9 3.2 6.8 4.3 0.0 47.8 2.3 3.9 14.5 9.3 3.4 5.9 5.9 18.4 13.3 9.3 9.9 13.6 23.7 3.8 3.4 6.8 11.4 63.2 7.9 4.9 2.2 7.6 3.3 5.0 2.8 15.0 4.4 11.8 4.4 10.8 5.5 6.5 36.5 6.5 7.4 12.1 3.9 9.0 5.9 6.8 2.2 1.4 14.0 21.1 3.8 9.4 14.8 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 4.3 2.3 3.9 3.8 3.4 4.9 2.2 4.4 2.2 0.0 5.6 2.9 0.3 3.1 0.0 5.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.0 217.3 0.0 0.0 0.2 0.1 2.7 0.2 1.1 0.8 0.3 0.0 0.0 286.7 5.6 1.0 0.6 0.7 5.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.0 4.1 0.6 0.2 2.8 0.1 0.0 0.0 0.0 CLEC3B "TN, TNA" ENSG00000163815 "C-type lectin domain family 3 member B" P05452 3 45001548-45036071 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 185.2;lung: 216.5" "Cell type enhanced" "Detected in some" 15 "Fibroblasts: 14.4;Ito cells: 43.0;Late spermatids: 15.2;Leydig cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 51.1;ASC TERT1: 101.9;U-2197: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002582, HPA034794" Approved "Secreted to blood" NA NA 6540000000 46000000000 "CAB002582: AB_564027, HPA034794: AB_2674332" "unprognostic (2.04e-1)" "unprognostic (1.80e-3)" "unprognostic (2.58e-1)" "unprognostic (4.57e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.53e-4)" "prognostic favorable (9.99e-9)" "unprognostic (1.75e-2)" "unprognostic (2.25e-1)" "unprognostic (4.02e-1)" "prognostic favorable (5.68e-4)" "unprognostic (9.33e-2)" "unprognostic (2.39e-2)" "unprognostic (7.46e-2)" "unprognostic (1.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.21e-2)" 70.8 11.5 6.6 16.9 8.9 0.5 185.2 5.9 10.2 17.4 20.3 4.8 39.0 8.4 15.7 54.2 17.2 6.9 38.8 72.8 8.1 6.8 20.6 7.0 216.5 8.3 8.8 7.4 5.1 6.1 2.1 5.0 37.7 13.2 7.4 10.1 17.7 9.7 19.2 26.5 27.6 16.3 90.3 10.0 65.5 8.3 24.9 1.5 2.3 15.8 40.8 5.4 28.0 24.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 51.1 101.9 0.0 6.7 10.5 0.2 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 20.5 0.0 0.2 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.6 8.9 5.9 10.2 8.1 6.8 8.8 7.4 13.2 1.5 0.0 0.0 0.0 0.0 3.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 2.8 10.5 0.0 0.0 0.2 0.0 14.4 0.0 0.0 0.0 0.8 0.0 0.0 43.0 1.2 15.2 27.9 0.8 3.3 1.0 0.0 0.0 0.1 0.0 6.0 0.0 0.1 0.0 4.2 0.0 0.0 3.3 0.1 0.0 0.0 0.0 CLEC4A "CD367, CLECSF6, DCIR, DDB27" ENSG00000111729 "C-type lectin domain family 4 member A" Q9UMR7 12 8123632-8138607 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.6;lung: 30.0" "Cell type enhanced" "Detected in many" 18 "Hofbauer cells: 22.3;Kupffer cells: 81.7;Macrophages: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 29.2;classical monocyte: 54.6;intermediate monocyte: 31.2;myeloid DC: 53.2;neutrophil: 48.8;non-classical monocyte: 19.6" "Group enriched" "Detected in many" 12 "dendritic cells: 53.2;granulocytes: 48.8;monocytes: 54.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.4" HPA007842 Uncertain NA NA "HPA007842: AB_1078534" "unprognostic (9.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.41e-2)" "unprognostic (3.13e-2)" "unprognostic (2.69e-1)" "unprognostic (9.34e-2)" "unprognostic (5.49e-2)" "unprognostic (8.22e-2)" "unprognostic (1.62e-1)" "unprognostic (7.84e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.42e-3)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (3.05e-1)" "unprognostic (9.79e-2)" 8.3 2.0 2.7 20.1 4.0 14.6 3.3 2.2 2.6 3.7 3.1 3.5 0.6 3.6 2.7 5.2 2.1 2.9 5.6 3.4 2.5 2.5 5.4 4.1 30.0 25.1 2.8 2.4 5.5 2.5 0.5 3.3 6.0 3.2 4.1 4.6 4.0 2.6 2.2 2.2 3.8 4.7 3.3 8.1 16.3 2.0 2.8 3.7 5.7 2.8 3.2 7.4 6.0 3.1 4.5 53.2 48.8 54.6 0.5 0.2 23.7 0.3 0.0 0.7 1.8 3.3 8.4 1.1 2.2 0.9 1.8 2.5 3.0 1.4 1.3 0.3 1.2 0.7 0.4 1.9 0.4 1.1 2.2 2.2 1.4 1.5 0.8 4.1 4.2 5.6 4.2 1.9 0.7 2.3 5.2 0.4 3.0 0.7 1.2 2.3 1.0 1.2 3.1 1.3 1.1 0.8 0.8 1.4 2.1 1.2 2.0 0.3 0.7 0.5 1.6 0.0 2.9 0.2 0.3 0.5 3.1 1.9 1.2 1.4 1.4 0.2 1.7 0.4 1.6 0.1 29.2 54.6 0.1 0.1 31.2 0.1 2.0 0.1 0.2 53.2 4.5 0.1 0.1 48.8 0.5 19.6 7.3 0.1 23.7 2.7 4.0 2.2 2.6 2.5 2.5 2.8 2.4 3.2 3.7 0.0 5.8 5.0 0.6 3.8 0.5 0.8 0.0 4.0 3.4 0.0 3.9 0.2 1.7 0.1 4.1 1.4 0.0 0.0 0.4 0.2 2.2 0.8 2.3 0.9 22.3 0.0 1.7 1.3 81.7 0.9 2.3 93.5 6.8 1.0 0.0 0.4 0.5 0.3 1.4 0.2 0.6 0.0 1.2 0.2 0.5 2.9 0.2 0.5 0.0 0.7 CLEC6A "CLECSF10, dectin-2" ENSG00000205846 "C-type lectin domain containing 6A" Q6EIG7 12 8455926-8478330 "Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.4;heart muscle: 2.3;lung: 6.2;lymphoid tissue: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 8.4;myeloid DC: 3.5" "Group enriched" "Detected in many" 11 "dendritic cells: 3.5;monocytes: 8.4" "Cell line enriched" "Detected in some" 4 "NTERA-2: 8.6" "Low region specificity" "Detected in many" NA NA "unprognostic (1.44e-1)" "unprognostic (9.07e-3)" "unprognostic (5.32e-3)" "unprognostic (1.27e-2)" "unprognostic (2.54e-1)" "unprognostic (4.27e-4)" "unprognostic (6.06e-2)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (7.30e-4)" "unprognostic (8.89e-2)" "unprognostic (3.29e-1)" "unprognostic (2.43e-1)" "unprognostic (2.60e-2)" 0.2 0.2 0.1 4.9 0.2 0.5 0.2 0.1 0.1 0.8 0.2 0.0 0.0 0.0 0.2 0.8 0.2 0.3 0.2 2.3 0.5 0.2 0.4 0.8 6.2 5.0 0.2 0.0 0.1 0.3 0.0 0.2 0.9 0.4 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.4 0.9 0.1 0.5 0.0 0.7 0.2 0.0 1.7 1.1 0.2 0.0 3.5 0.5 8.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.2 0.1 0.1 0.5 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC7A "CD369, CLECSF12, dectin-1, hDectin-1, SCARE2" ENSG00000172243 "C-type lectin domain containing 7A" Q9BXN2 12 10116777-10130258 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 53.9;bone marrow: 43.9;brain: 18.7;lung: 32.8;lymphoid tissue: 28.8" "Group enriched" "Detected in many" 11 "Hofbauer cells: 84.0;Kupffer cells: 334.2;Macrophages: 240.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 53.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "Karpas-707: 60.8;U-266/84: 47.3" "Low region specificity" "Detected in many" NA NA "unprognostic (1.79e-1)" "unprognostic (1.88e-2)" "unprognostic (2.98e-2)" "unprognostic (3.64e-1)" "unprognostic (3.03e-2)" "unprognostic (5.49e-2)" "unprognostic (5.19e-2)" "unprognostic (5.88e-3)" "unprognostic (2.10e-1)" "unprognostic (9.87e-2)" "unprognostic (7.46e-2)" "unprognostic (4.40e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.83e-2)" "unprognostic (3.89e-2)" "unprognostic (5.13e-2)" "unprognostic (1.14e-1)" 7.1 5.0 6.3 27.7 7.4 43.9 3.7 0.9 3.4 3.9 4.5 9.5 0.5 3.7 3.2 8.9 8.7 5.3 7.4 5.2 6.2 4.2 8.7 6.9 32.8 24.2 8.9 4.3 2.4 2.8 1.6 2.6 7.8 8.6 2.7 5.0 6.4 6.5 2.4 1.2 3.2 6.5 5.7 18.7 28.8 3.1 1.6 7.3 5.1 2.3 3.2 9.1 5.5 3.8 0.1 13.1 53.9 30.1 0.1 0.1 7.4 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 0.1 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.4 47.3 0.0 0.1 0.3 0.0 0.2 26.4 0.4 0.0 29.5 0.1 0.0 0.0 0.0 13.1 0.1 0.0 0.0 53.9 0.1 30.1 0.2 0.0 7.4 6.3 7.4 0.9 3.4 6.2 4.2 8.9 4.3 8.6 7.3 11.9 20.4 11.3 0.2 3.3 0.0 0.6 0.0 4.0 13.6 0.0 0.0 1.2 0.0 0.0 1.4 3.1 0.0 0.0 0.0 10.7 2.6 0.1 5.8 2.1 84.0 0.0 0.0 8.0 334.2 1.5 0.3 240.6 3.3 8.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 12.9 0.1 0.0 0.5 2.6 4.5 1.3 0.0 0.4 COL6A5 "COL29A1, FLJ35880, VWA4" ENSG00000172752 "Collagen type VI alpha 5 chain" 3 130345516-130484844 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lung: 9.6;skin 1: 11.1" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 3.1;Club cells: 1.2;Early spermatids: 4.1;Late spermatids: 2.4;Suprabasal keratinocytes: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 63 "HDLM-2: 18.8" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Not detected" "Not detected" HPA043138 Uncertain "Secreted in other tissues" NA NA "HPA043138: AB_10796687" "unprognostic (3.45e-2)" "unprognostic (4.08e-2)" "unprognostic (6.01e-3)" "unprognostic (2.32e-1)" "unprognostic (3.42e-2)" "unprognostic (1.46e-6)" "unprognostic (8.44e-2)" "unprognostic (2.07e-3)" "unprognostic (2.47e-1)" "unprognostic (1.71e-1)" "unprognostic (7.58e-8)" "unprognostic (3.85e-2)" "unprognostic (4.51e-1)" "unprognostic (1.54e-1)" "unprognostic (2.79e-2)" 0.2 0.0 0.2 0.2 0.5 0.1 1.0 0.2 0.2 0.2 0.4 0.2 0.2 1.5 0.2 0.2 2.1 0.0 0.2 0.2 0.2 0.2 0.2 0.2 9.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 11.1 1.8 0.2 0.2 0.2 1.5 1.1 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.0 0.0 0.0 0.0 0.0 COL6A6 ENSG00000206384 "Collagen type VI alpha 6 chain" A6NMZ7 3 130560334-130678155 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 5.6;lung: 11.1;pituitary gland: 5.7" "Cell type enriched" "Detected in some" 4 "Fibroblasts: 7.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "SuSa: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA045239 Uncertain "Secreted to extracellular matrix" NA NA 490000 "HPA045239: AB_2679268" "unprognostic (4.86e-3)" "unprognostic (2.16e-2)" "unprognostic (9.91e-2)" "unprognostic (2.08e-4)" "unprognostic (2.79e-1)" "unprognostic (1.11e-5)" "unprognostic (3.74e-3)" "unprognostic (5.59e-2)" "unprognostic (1.42e-1)" "unprognostic (3.50e-2)" "unprognostic (8.90e-2)" "unprognostic (2.70e-1)" "unprognostic (2.96e-4)" "unprognostic (5.82e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-2)" "unprognostic (1.07e-1)" 2.3 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.7 0.3 1.2 0.3 0.0 5.6 0.0 0.0 0.0 0.9 11.1 0.0 0.0 0.2 0.0 0.0 5.7 0.8 0.0 0.0 2.2 0.0 0.0 0.4 0.0 0.5 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 5.5 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.8 1.2 1.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.4 0.6 0.1 0.0 0.0 0.0 CRTAC1 "ASPIC1, CEP-68, FLJ10320" ENSG00000095713 "Cartilage acidic protein 1" Q9NQ79 10 97865000-98030828 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 34.0;lung: 42.1;retina: 31.6;seminal vesicle: 31.1" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 90.9;Club cells: 66.0" "Cancer enhanced" "Detected in many" "melanoma: 43.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 3.6;HMC-1: 3.3;HUVEC TERT2: 8.9;SCLC-21H: 5.9;SK-MEL-30: 9.8;TIME: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008175 Enhanced "Secreted to extracellular matrix" NA NA 360000000 "HPA008175: AB_1847254" "unprognostic (2.55e-1)" "unprognostic (6.41e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (5.01e-6)" "unprognostic (2.54e-1)" "unprognostic (6.96e-3)" "unprognostic (9.30e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (7.66e-2)" "unprognostic (1.69e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.70e-4)" "unprognostic (1.05e-2)" "unprognostic (3.29e-3)" "prognostic favorable (1.51e-4)" 4.5 1.4 6.2 1.6 7.2 0.8 2.0 7.2 27.3 3.9 6.0 3.8 4.5 1.2 1.2 4.8 7.9 34.0 1.1 6.2 5.5 7.0 3.1 1.1 42.1 1.1 9.2 5.8 2.2 1.8 1.4 3.2 0.8 27.5 3.3 1.1 31.6 3.4 31.1 1.4 2.9 1.2 3.6 6.8 0.8 1.0 4.0 2.7 0.0 4.4 0.7 1.0 25.5 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.8 0.0 3.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 5.9 1.3 0.7 0.0 9.8 0.4 0.1 0.0 11.9 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 7.2 7.2 18.7 5.5 7.0 9.2 5.8 27.5 2.7 20.8 90.9 0.0 2.0 1.3 5.7 3.9 2.5 1.4 66.0 8.7 0.0 0.0 0.0 4.3 0.0 1.6 0.0 0.0 0.6 0.0 1.7 0.4 4.7 0.0 0.0 0.0 1.7 5.5 0.3 0.2 0.0 0.3 8.5 0.0 0.0 14.5 0.8 0.0 0.4 0.0 3.6 0.0 0.5 0.9 1.7 0.4 0.0 0.0 0.0 1.1 CSF2 "GM-CSF, GMCSF" ENSG00000164400 "Colony stimulating factor 2" P04141 5 132073790-132076170 "Cancer-related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.5;lung: 6.8;pancreas: 4.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 10.7;Ductal cells: 12.3;granulocytes: 5.7;Pancreatic endocrine cells: 14.6;T-cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "NK-cell: 9.5" "Lineage enriched" "Detected in single" 11 "NK-cells: 9.5" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 45.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA057404, HPA062006" Enhanced Vesicles "Secreted to blood" NA NA 23900 Vesicles "HPA057404: AB_2683428, HPA062006: AB_2684654" "unprognostic (7.29e-2)" "unprognostic (2.49e-3)" "unprognostic (8.77e-2)" "unprognostic (2.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-1)" "unprognostic (1.47e-2)" "unprognostic (2.64e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-8)" "unprognostic (4.81e-2)" "unprognostic (1.22e-1)" "unprognostic (9.07e-2)" "unprognostic (2.06e-2)" 0.2 0.1 0.1 3.9 0.1 1.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.7 0.0 1.5 0.1 1.1 0.2 0.1 0.1 0.3 0.9 6.8 0.3 0.1 0.0 0.1 4.5 0.0 0.1 0.5 0.0 0.2 0.7 0.0 1.9 0.0 0.1 0.4 1.0 0.6 0.1 1.0 0.2 0.2 0.0 0.4 0.2 0.0 1.8 2.3 0.1 0.0 0.0 0.0 0.0 9.5 0.8 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 0.0 2.6 0.0 3.6 0.0 0.7 0.0 2.7 0.1 0.0 3.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 10.4 7.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 1.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 10.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.5 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 4.9 0.0 1.3 CSF3 "C17orf33, G-CSF, GCSF, MGC45931" ENSG00000108342 "Colony stimulating factor 3" P09919 17 40015361-40017813 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 27.9;lung: 60.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 122.0;Basal keratinocytes: 30.7;Club cells: 33.0;Melanocytes: 37.1;Suprabasal keratinocytes: 29.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 19.9;U-87 MG: 78.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 6170 "unprognostic (3.59e-3)" "unprognostic (1.57e-2)" "unprognostic (1.73e-1)" "prognostic favorable (8.45e-4)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (1.10e-1)" "unprognostic (1.16e-2)" "unprognostic (1.74e-1)" "unprognostic (2.26e-1)" "unprognostic (2.82e-2)" "unprognostic (7.40e-4)" "unprognostic (1.21e-1)" "unprognostic (1.96e-1)" "unprognostic (4.10e-2)" "unprognostic (4.80e-3)" 12.4 1.5 1.0 13.8 1.3 3.0 2.8 0.8 1.6 27.9 3.0 1.4 0.0 0.2 2.3 2.2 5.9 2.9 2.1 6.9 1.1 1.0 0.2 0.5 60.9 0.5 1.2 0.1 3.3 4.1 0.2 3.8 2.6 7.4 4.3 0.7 1.6 0.6 0.3 20.6 0.4 1.4 1.6 2.6 1.0 2.0 1.1 1.2 0.1 0.7 8.8 7.0 7.2 1.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 3.2 0.0 2.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.3 0.8 1.6 1.1 1.0 1.2 0.1 7.4 1.2 20.8 122.0 0.0 4.6 30.7 0.0 0.1 0.0 14.7 33.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.0 8.9 8.7 7.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 37.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.7 29.4 0.0 0.0 0.1 5.4 CTSH "ACC-4, ACC-5, ACC4, ACC5, CPSB" ENSG00000103811 "Cathepsin H" P09668 15 78921058-78949574 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 82.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 1152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 42.8" "Group enriched" "Detected in all" 5 "B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.1;HaCaT: 31.5;OE19: 31.0;RT4: 119.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000458, HPA003524" Enhanced Supported "Vesicles,Cytosol,Cytoplasmic bodies" "Intracellular and membrane" NA NA 10000000 "Vesicles, Cytosol, Cytoplasmic bodies" "CAB000458: , HPA003524: AB_1846075" "unprognostic (6.47e-2)" "unprognostic (4.65e-3)" "unprognostic (1.05e-1)" "prognostic favorable (6.90e-4)" "unprognostic (4.37e-2)" "unprognostic (1.93e-1)" "unprognostic (7.18e-2)" "unprognostic (3.30e-3)" "unprognostic (2.22e-1)" "unprognostic (5.96e-2)" "unprognostic (4.10e-2)" "unprognostic (3.89e-2)" "unprognostic (6.63e-3)" "unprognostic (3.83e-1)" "unprognostic (4.42e-2)" "unprognostic (2.70e-3)" "unprognostic (1.79e-3)" 16.7 10.6 9.5 24.2 7.0 5.4 23.9 4.5 9.8 25.1 11.4 17.7 14.7 10.6 10.3 17.1 7.8 13.1 29.2 16.5 14.8 6.7 66.7 18.7 82.6 65.4 12.1 11.6 14.6 25.8 12.3 6.5 7.7 9.4 18.6 6.6 6.7 15.4 15.9 7.0 13.5 16.6 9.8 10.8 20.3 15.6 6.7 15.7 6.6 8.5 4.8 34.8 39.6 13.5 20.6 41.2 1.4 42.8 1.3 7.6 27.3 16.2 1.1 0.4 4.8 1.1 0.0 5.3 1.6 0.6 2.8 1.5 7.1 43.1 5.7 1.8 0.1 3.1 31.5 2.0 7.8 2.3 24.0 0.1 0.1 0.2 16.5 1.7 0.0 1.1 0.8 2.2 0.0 0.0 11.8 0.2 0.7 11.6 0.0 3.9 1.7 3.7 10.0 1.2 31.0 0.3 0.0 0.3 0.9 9.9 119.7 0.5 1.2 7.0 3.9 9.7 2.3 1.6 5.4 2.2 0.0 1.0 0.0 0.7 0.1 12.4 3.1 0.0 10.5 1.7 0.0 42.8 0.4 1.4 28.3 7.6 20.6 4.1 2.1 41.2 12.0 0.4 0.7 1.4 1.3 17.0 4.2 3.1 27.3 9.5 7.0 4.5 9.8 14.8 6.7 12.1 11.6 9.4 15.7 220.3 1152.3 144.6 210.0 21.5 0.8 25.2 351.6 270.4 197.9 349.0 3.9 16.6 71.3 153.3 17.1 109.7 15.8 0.0 128.8 33.6 30.0 89.1 30.2 82.9 261.0 0.0 8.7 15.4 160.1 15.9 67.6 392.5 75.9 476.1 19.5 21.1 69.6 11.5 5.6 352.9 5.6 19.4 17.8 5.0 52.9 16.3 19.6 25.4 37.0 308.4 CXCL10 "C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10" ENSG00000169245 "C-X-C motif chemokine ligand 10" P02778 4 76021117-76023497 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 9.7;Glandular cells: 10.1;Hofbauer cells: 18.2;Macrophages: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9" "Lineage enriched" "Detected in many" 15 "monocytes: 25.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 3.4;BJ hTERT+ SV40 Large T+ RasG12V: 3.4;GAMG: 7.9;RPMI-8226: 6.3;RT4: 3.6;THP-1: 4.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 253000 "unprognostic (1.94e-1)" "unprognostic (5.32e-2)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-1)" "unprognostic (7.59e-2)" "prognostic favorable (1.12e-5)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.75e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.03e-1)" "unprognostic (4.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-2)" 4.3 2.1 2.7 34.8 2.5 0.0 7.3 1.8 4.8 8.1 3.5 0.9 0.2 3.8 2.3 6.7 4.7 1.2 3.8 7.6 1.2 1.2 7.5 10.6 36.2 21.7 3.2 1.6 3.9 1.2 0.0 2.3 5.6 3.0 34.6 6.0 2.6 9.1 2.1 7.3 2.1 4.1 5.5 11.3 15.8 6.4 1.3 0.9 15.0 25.7 5.4 9.2 9.2 2.2 0.5 1.6 0.6 25.5 0.0 0.1 3.7 0.7 0.0 0.0 0.3 0.0 0.2 0.0 0.0 9.2 3.4 3.4 0.3 0.1 3.0 0.3 0.0 7.9 0.0 0.0 0.2 0.2 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 6.3 0.1 3.6 0.0 0.0 0.0 0.7 2.0 0.0 0.2 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.8 0.0 0.0 10.6 0.0 0.0 25.5 0.0 0.5 0.1 0.0 1.6 0.0 0.0 0.0 0.6 0.0 15.9 0.0 0.0 3.7 2.7 2.5 1.8 4.8 1.2 1.2 3.2 1.6 3.0 0.9 0.0 2.1 0.5 9.7 0.8 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 1.1 0.0 0.0 0.0 0.8 10.1 1.1 0.0 18.2 0.0 0.0 0.0 5.6 3.5 0.3 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 CXCL17 "Dcip1, DMC, UNQ473, VCC1" ENSG00000189377 "C-X-C motif chemokine ligand 17" Q6UXB2 19 42428288-42443048 "Predicted secreted proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 68.0;lung: 83.0;stomach 1: 79.9" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 380.6;Ciliated cells: 365.4;Club cells: 424.2;Pancreatic endocrine cells: 272.5;Urothelial cells: 1358.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Group enriched" "Detected in some" 7 "OE19: 13.0;RT4: 3.9" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.74e-1)" "unprognostic (3.96e-2)" "unprognostic (2.78e-1)" "unprognostic (1.03e-2)" "unprognostic (4.46e-3)" "unprognostic (3.77e-1)" "prognostic favorable (4.92e-5)" "unprognostic (6.68e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.70e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-1)" "unprognostic (1.88e-1)" "unprognostic (8.13e-3)" "unprognostic (2.29e-1)" 0.1 0.0 0.1 0.2 0.2 0.0 0.7 0.1 0.1 17.4 0.1 0.4 0.1 0.0 1.0 5.1 68.0 6.3 1.3 0.1 0.1 0.0 0.7 0.4 83.0 0.1 0.1 0.1 2.8 11.4 0.0 2.3 0.1 0.3 6.8 0.0 0.3 39.2 0.5 0.1 0.0 0.1 0.3 0.1 0.1 79.9 0.3 0.1 0.5 1.2 8.8 40.1 5.5 10.0 0.0 0.0 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.3 13.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 32.8 380.6 0.0 160.7 0.0 0.2 0.0 2.5 365.4 424.2 5.2 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 159.6 0.0 0.0 167.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.6 0.0 0.0 272.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1358.9 CXCL3 "CINC-2b, GRO3, GROg, MIP-2b, SCYB3" ENSG00000163734 "C-X-C motif chemokine ligand 3" P19876 4 74036589-74038807 "Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 28.5" "Cell type enhanced" "Detected in many" 12 "Macrophages: 757.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 23.2;hTEC/SVTERT24-B: 36.5;RPTEC TERT1: 21.0" "Secreted to blood" NA NA 28700 "unprognostic (2.12e-3)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.08e-3)" "unprognostic (6.97e-3)" "unprognostic (2.41e-2)" "unprognostic (2.74e-1)" "unprognostic (5.80e-4)" "unprognostic (2.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.81e-1)" "unprognostic (2.89e-6)" "unprognostic (2.61e-3)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (1.20e-1)" 18.8 0.6 1.7 16.5 1.2 10.3 4.3 0.2 1.2 19.6 3.3 1.0 0.4 0.5 0.7 2.2 1.3 1.7 9.2 7.2 1.3 0.8 1.7 3.2 28.5 1.8 2.0 1.0 4.9 3.1 0.0 0.6 1.5 3.0 2.3 7.9 0.8 4.4 0.9 2.3 0.6 2.8 1.2 2.2 5.3 10.3 1.6 0.6 2.7 0.8 2.7 1.9 11.7 0.5 0.0 0.5 0.4 1.0 0.0 0.4 2.4 0.2 1.7 0.7 0.0 0.4 0.7 0.0 2.5 23.2 0.6 1.4 0.0 2.8 0.0 2.5 0.0 8.6 0.1 0.1 0.8 5.1 0.0 0.0 1.9 0.2 0.0 2.8 0.2 0.0 0.5 0.6 36.5 3.6 0.6 0.5 0.4 0.4 0.0 1.0 0.0 0.5 0.1 0.3 3.3 0.7 0.0 0.8 0.0 21.0 0.6 0.0 0.0 0.2 0.0 0.5 0.3 0.1 0.0 0.9 5.2 0.2 2.6 6.4 0.0 0.0 0.0 5.8 0.1 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 1.0 0.5 0.0 2.4 1.7 1.2 0.2 1.2 1.3 0.8 2.0 1.0 3.0 0.6 92.3 203.1 5.1 105.8 203.0 0.0 6.1 33.1 87.0 40.9 5.2 0.0 0.5 0.0 138.2 0.4 32.1 49.7 0.0 85.9 1.0 32.9 154.6 26.5 1.1 74.4 0.0 50.8 10.4 119.3 0.9 13.0 757.6 178.8 48.7 41.4 0.0 148.4 28.8 0.4 0.0 0.0 38.8 169.7 0.7 3.1 129.9 6.8 2.5 59.8 50.3 CXCL5 "ENA-78, SCYB5" ENSG00000163735 "C-X-C motif chemokine ligand 5" P42830 4 73995642-73998779 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2" "Group enriched" "Detected in some" 8 "Ductal cells: 71.4;Pancreatic endocrine cells: 163.7" "Cancer enhanced" "Detected in many" "stomach cancer: 74.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "A549: 34.5;EFO-21: 29.1;HSkMC: 20.9;hTEC/SVTERT24-B: 15.0;RPTEC TERT1: 111.3" HPA065474 Approved "Secreted to blood" NA NA 1110000 "HPA065474: AB_2685494" "unprognostic (5.56e-3)" "prognostic unfavorable (3.43e-4)" "unprognostic (1.80e-2)" "unprognostic (1.43e-2)" "unprognostic (2.04e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.06e-2)" "unprognostic (3.04e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (7.99e-2)" "prognostic unfavorable (2.45e-5)" "unprognostic (3.72e-1)" "unprognostic (3.07e-1)" "unprognostic (2.72e-2)" "unprognostic (9.30e-2)" 1.7 0.3 1.6 28.0 6.0 0.7 2.4 0.4 1.4 10.5 0.7 1.5 0.2 0.6 0.3 0.0 0.6 0.4 3.9 1.4 4.3 2.8 0.4 2.1 20.0 13.6 1.2 0.1 0.3 0.8 0.0 0.3 1.5 7.4 1.5 0.2 0.0 31.2 0.5 0.3 0.3 1.8 0.1 2.6 5.2 6.4 5.4 0.2 1.0 0.3 10.8 0.8 10.9 0.3 0.0 0.0 1.1 0.1 0.0 0.2 5.5 0.0 34.5 0.1 0.0 0.0 1.3 0.0 0.6 0.5 0.2 0.5 0.1 0.3 0.0 29.1 0.0 6.3 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 20.9 0.0 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 5.5 1.6 6.0 0.4 1.0 4.3 2.8 1.2 0.1 7.4 0.2 3.0 0.0 0.0 0.8 0.8 0.0 1.3 15.3 1.4 3.4 0.0 0.0 0.0 0.0 71.4 0.2 0.7 0.0 0.0 1.2 0.0 0.5 2.8 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 9.3 0.0 2.8 0.0 0.0 163.7 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.3 CXCL8 "3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1" ENSG00000169429 "C-X-C motif chemokine ligand 8" P10145 4 73740506-73743716 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 79.4;bone marrow: 300.7;lung: 106.1" "Group enriched" "Detected in many" 4 "Basal glandular cells: 9866.5;Glandular cells: 5032.8;Urothelial cells: 12569.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 428 "neutrophil: 79.4" "Lineage enriched" "Detected in single" 794 "granulocytes: 79.4" "Group enriched" "Detected in many" 4 "BJ hTERT+: 291.3;GAMG: 80.6" "Not detected" "Not detected" HPA057179 Supported "Secreted to blood" NA NA 7260 "HPA057179: AB_2683362" "unprognostic (3.42e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (3.91e-3)" "unprognostic (8.49e-2)" "unprognostic (3.29e-2)" "unprognostic (3.03e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.37e-3)" "unprognostic (3.19e-1)" "unprognostic (4.46e-1)" "unprognostic (7.19e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.13e-6)" "unprognostic (4.73e-2)" "unprognostic (8.57e-2)" "unprognostic (1.64e-2)" "unprognostic (6.15e-2)" 13.4 1.6 1.8 21.9 1.9 300.7 1.7 0.4 1.5 6.5 1.4 0.8 0.0 0.5 4.5 0.9 6.7 3.9 18.9 17.7 1.3 1.1 2.4 8.4 106.1 2.3 2.4 0.9 4.4 4.3 0.3 1.1 9.6 7.8 4.3 1.0 1.9 7.4 0.3 2.9 0.5 1.6 1.4 5.5 1.6 2.8 13.5 1.1 1.0 1.1 9.3 7.7 27.9 1.5 0.0 0.0 79.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1.4 0.0 1.8 291.3 2.6 8.6 0.0 0.9 0.0 39.9 0.0 80.6 3.4 0.0 0.0 41.6 0.1 0.0 0.0 0.0 0.4 0.5 2.6 0.1 0.9 0.1 8.7 0.2 0.9 9.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.0 1.4 0.0 0.0 0.0 23.1 1.2 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.3 22.4 4.2 0.3 1.1 3.8 0.0 0.0 0.1 18.8 2.1 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.4 0.0 0.0 0.0 0.0 0.0 1.8 1.9 0.4 1.5 1.3 1.1 2.4 0.9 7.8 1.1 47.6 287.8 4.2 9866.5 0.0 0.2 22.2 150.3 327.9 783.7 0.0 0.0 3.4 0.0 1020.3 1.4 16.9 1.6 0.0 220.3 4.9 10.8 5032.8 48.7 2.5 332.1 0.0 18.3 23.9 507.0 0.5 0.6 391.0 0.0 2049.7 1.0 0.4 645.9 0.0 0.4 0.4 1.1 38.8 17.7 0.0 1.2 0.0 17.8 4.3 1.6 12569.9 CYBB "CGD, GP91-PHOX, NOX2" ENSG00000165168 "Cytochrome b-245 beta chain" P04839 X 37780011-37813461 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.3;lung: 49.4;lymphoid tissue: 74.5" "Group enriched" "Detected in many" 6 "Hofbauer cells: 133.2;Kupffer cells: 479.9;Macrophages: 227.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 50.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 16.5;NB-4: 19.8;REH: 16.9;RPMI-8226: 65.1" "Not detected" "Not detected" HPA051227 Enhanced NA NA 640000 "HPA051227: AB_2681395" "unprognostic (5.83e-2)" "unprognostic (1.77e-2)" "unprognostic (2.15e-3)" "unprognostic (1.48e-2)" "unprognostic (1.27e-1)" "unprognostic (5.65e-2)" "unprognostic (2.29e-2)" "unprognostic (4.45e-2)" "unprognostic (9.14e-2)" "unprognostic (2.32e-2)" "unprognostic (5.73e-2)" "unprognostic (5.18e-2)" "unprognostic (5.92e-2)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (1.32e-1)" "unprognostic (9.72e-2)" 16.4 11.0 9.7 44.2 13.2 42.6 8.1 2.5 6.7 3.7 6.0 10.4 0.2 5.2 3.4 6.3 3.2 6.0 7.5 10.1 6.8 6.5 6.2 11.8 49.4 74.5 12.6 2.9 5.3 4.5 1.4 4.9 16.1 10.3 4.8 8.9 4.5 6.0 2.7 2.5 2.2 16.1 15.3 20.3 49.9 4.9 2.3 10.3 5.4 3.4 3.5 20.2 13.9 3.1 8.1 17.5 20.0 50.3 0.1 0.1 22.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.1 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 19.8 0.0 0.0 0.1 16.9 0.0 65.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.0 0.0 2.8 0.0 0.3 45.5 20.0 0.0 50.3 0.1 8.1 0.0 0.0 12.1 7.2 0.0 0.0 3.7 0.1 42.7 17.5 0.1 22.0 9.7 13.2 2.5 6.7 6.8 6.5 12.6 2.9 10.3 10.3 23.8 33.4 47.7 0.1 0.9 0.0 9.6 2.5 13.4 23.9 1.8 0.0 0.9 0.0 0.0 0.1 1.6 0.9 0.0 0.3 0.9 4.3 0.0 7.0 2.1 133.2 1.6 0.0 7.4 479.9 0.4 0.6 227.9 1.7 3.6 0.7 0.1 0.2 0.0 0.0 0.5 0.5 12.9 0.9 0.0 0.3 1.1 1.5 2.5 1.2 0.0 CYP1A1 "CP11, CYP1, P1-450, P450-C, P450DX" ENSG00000140465 "Cytochrome P450 family 1 subfamily A member 1" P04798 15 74719542-74725610 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 38.3;lung: 144.1;urinary bladder: 40.0" "Cell type enhanced" "Detected in some" 21 "Glandular cells: 1.5;Hepatocytes: 6.0;Urothelial cells: 3.2" "Group enriched" "Detected in some" 24 "liver cancer: 18.6;urothelial cancer: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 22.0;hTCEpi: 12.0;HUVEC TERT2: 11.5;SK-BR-3: 9.0;SuSa: 23.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB018654 Uncertain NA NA "CAB018654: AB_2088699" "unprognostic (1.71e-2)" "unprognostic (7.86e-2)" "unprognostic (2.57e-2)" "unprognostic (2.89e-1)" "unprognostic (5.45e-3)" "unprognostic (6.34e-2)" "unprognostic (3.08e-1)" "unprognostic (6.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (4.21e-2)" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (4.77e-1)" "unprognostic (1.28e-1)" 9.3 0.4 0.1 0.4 0.2 0.2 7.7 0.2 0.5 2.3 0.7 0.4 3.9 0.5 3.8 4.4 1.2 0.2 11.3 3.0 0.1 0.0 0.7 38.3 144.1 0.2 0.1 0.1 0.5 0.5 0.2 0.1 3.5 0.3 0.2 0.2 0.8 2.1 0.5 1.5 8.1 10.7 5.9 0.2 0.2 0.4 0.3 0.1 0.1 0.8 0.8 8.0 40.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.3 0.1 0.0 0.3 0.0 7.2 0.0 0.0 0.4 0.2 22.0 0.9 0.2 5.9 0.0 5.4 6.9 0.4 4.4 0.2 0.0 0.6 0.3 1.5 3.2 0.1 0.2 7.1 0.0 12.0 0.1 0.9 0.2 11.5 0.2 1.3 0.2 0.0 0.4 0.0 0.2 0.1 7.2 1.8 0.7 0.0 0.2 0.0 1.4 0.3 0.1 1.0 9.0 2.3 23.3 0.3 0.1 0.6 1.0 0.3 3.2 0.0 0.4 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 3.2 CYP1B1 "CP1B, GLC3A" ENSG00000138061 "Cytochrome P450 family 1 subfamily B member 1" Q16678 2 38066973-38109902 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Disease mutation, Glaucoma, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.0;lung: 39.2" "Cell type enhanced" "Detected in many" 11 "Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 45.0" "Lineage enriched" "Detected in many" 22 "monocytes: 45.0" "Cell line enhanced" "Detected in many" "ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB011705, HPA026863" Approved Uncertain Mitochondria NA NA Mitochondria "CAB011705: AB_731810, HPA026863: AB_10600900" "unprognostic (7.25e-3)" "unprognostic (2.28e-1)" "unprognostic (1.24e-3)" "unprognostic (2.27e-1)" "unprognostic (2.04e-2)" "unprognostic (1.68e-1)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (9.69e-2)" "unprognostic (4.20e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.87e-3)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (2.76e-4)" 9.1 3.1 0.5 9.4 1.2 0.0 11.4 1.0 1.2 11.4 2.1 0.7 4.5 0.0 12.8 5.9 3.5 15.0 6.9 17.5 1.2 8.8 3.5 39.2 26.3 3.1 1.0 6.1 3.6 0.0 1.3 0.8 3.3 10.7 0.0 19.3 0.0 13.0 4.8 0.5 1.4 10.6 5.1 15.7 0.3 3.9 0.5 5.1 2.5 1.1 4.2 6.9 2.1 0.0 0.4 2.0 45.0 0.0 0.0 16.2 1.2 13.2 0.4 0.0 24.6 26.4 0.0 0.1 0.8 0.2 2.3 0.0 5.5 0.0 3.6 3.2 0.5 10.8 0.0 0.7 0.4 1.0 0.7 0.0 4.0 0.0 6.8 0.0 0.0 105.7 10.3 5.7 0.2 24.4 0.0 0.0 0.1 0.0 0.1 5.2 0.0 4.0 1.4 1.8 2.5 0.0 0.0 0.0 2.5 0.1 0.1 0.4 49.2 7.2 0.0 1.4 9.1 1.9 0.0 0.2 0.0 20.2 0.0 0.0 0.0 0.0 26.8 0.0 2.2 0.4 45.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 5.5 0.2 0.0 16.2 17.9 50.6 0.5 98.2 15.8 0.9 2.7 0.0 12.0 35.2 43.6 0.0 0.4 13.3 5.0 11.7 36.8 0.0 0.0 0.5 0.7 41.1 345.6 3.5 9.7 12.6 0.0 1.7 5.5 116.2 8.6 147.9 28.1 16.9 39.7 0.3 0.5 0.4 0.0 160.5 0.8 0.3 19.4 20.8 1.0 1.8 12.4 0.2 0.0 0.8 295.9 CYP2F1 CYP2F ENSG00000197446 "Cytochrome P450 family 2 subfamily F member 1" P24903 19 41114432-41128366 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 22.7;Club cells: 48.9;Spermatocytes: 9.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "basophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 7 "HMC-1: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (2.04e-1)" "unprognostic (8.79e-2)" "unprognostic (4.63e-1)" "unprognostic (4.60e-2)" "unprognostic (2.54e-1)" "unprognostic (7.29e-3)" "unprognostic (6.23e-3)" "unprognostic (2.87e-2)" "unprognostic (3.91e-2)" "unprognostic (1.58e-6)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (1.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 3.1 6.1 0.0 2.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 22.7 48.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 4.8 0.0 0.0 0.0 0.0 0.0 CYP4B1 ENSG00000142973 "Cytochrome P450 family 4 subfamily B member 1" P13584 1 46757838-46819413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 92.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 56.9" "Region enhanced" "Detected in single" "midbrain: 1.7" "Cell type enriched" "Detected in single" 11 "memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enriched" "Detected in some" 8 "RT4: 81.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA004331 Approved Supported Vesicles NA NA Vesicles "HPA004331: AB_1078616" "unprognostic (2.29e-2)" "prognostic favorable (5.99e-4)" "unprognostic (7.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.28e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (6.12e-2)" "unprognostic (5.46e-2)" "unprognostic (7.33e-2)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.22e-3)" "unprognostic (6.69e-3)" 41.6 2.2 0.0 0.6 0.1 0.3 45.5 0.1 0.3 9.5 6.7 0.1 7.2 0.7 2.1 2.8 17.9 18.5 0.8 13.5 0.0 0.0 1.4 0.2 92.0 1.5 1.7 0.1 3.3 0.9 0.5 4.8 0.9 0.8 15.4 0.5 2.8 5.0 6.9 14.4 10.4 3.4 6.8 3.5 0.5 3.0 1.7 0.1 0.7 12.7 4.5 5.7 36.5 18.9 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.5 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 1.7 0.1 0.8 0.1 1140.4 70.0 0.0 114.6 0.5 0.0 4.8 0.0 602.3 304.8 0.0 0.0 0.9 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.2 4.7 3.9 5.8 0.0 0.6 0.0 0.0 2.5 0.0 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.6 0.7 0.0 0.0 142.5 DCDC2B ENSG00000222046 "Doublecortin domain containing 2B" A2VCK2 1 32209094-32216196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 11.1;fallopian tube: 26.6;lung: 10.1" "Cell type enriched" "Detected in some" 13 "Ciliated cells: 115.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 1.6;hTERT-RPE1: 2.9;TIME: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045832 Uncertain NA NA "HPA045832: AB_10962048" "unprognostic (6.45e-3)" "unprognostic (3.71e-2)" "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (2.18e-1)" "unprognostic (1.87e-3)" "unprognostic (7.66e-3)" "unprognostic (6.35e-2)" "unprognostic (4.84e-2)" "unprognostic (3.33e-1)" "unprognostic (2.71e-3)" "unprognostic (8.73e-2)" "unprognostic (6.18e-4)" "unprognostic (8.53e-2)" "unprognostic (2.00e-1)" "unprognostic (4.76e-2)" "unprognostic (4.39e-3)" 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 11.1 0.0 26.6 0.2 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 5.5 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 1.0 0.6 0.1 0.2 0.3 0.0 0.1 0.8 1.6 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 2.9 0.0 0.9 0.1 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 1.2 0.4 0.0 0.0 0.6 0.2 0.5 0.8 0.1 3.6 0.1 0.7 1.0 0.7 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 1.0 0.1 0.0 0.0 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 115.1 9.1 1.8 3.9 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 3.2 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 DCSTAMP "DC-STAMP, FIND, TM7SF4" ENSG00000164935 "Dendrocyte expressed seven transmembrane protein" Q9H295 8 104339087-104356689 "Predicted membrane proteins, Transporters" "Differentiation, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adipose tissue: 28.8;lung: 18.2" "Group enriched" "Detected in some" 4 "Hofbauer cells: 7.5;Macrophages: 2.5" "Cancer enriched" "Detected in some" 46 "thyroid cancer: 45.3" "Region enriched" "Detected in single" 4 "amygdala: 3.5" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 1.5" "Lineage enriched" "Detected in single" 16 "monocytes: 1.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.1;RPMI-8226: 1.2;SuSa: 1.4;U-87 MG: 4.5;U-937: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.11e-2)" "unprognostic (1.22e-2)" "unprognostic (8.41e-2)" "unprognostic (2.96e-2)" "unprognostic (8.48e-4)" "unprognostic (2.14e-1)" "unprognostic (5.40e-2)" "unprognostic (1.51e-2)" "unprognostic (3.08e-2)" "unprognostic (1.18e-2)" "unprognostic (5.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.61e-3)" "unprognostic (8.84e-2)" "unprognostic (1.36e-1)" "unprognostic (8.05e-2)" "unprognostic (8.34e-3)" 28.8 0.1 3.5 0.3 0.2 0.4 1.2 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.3 0.0 0.8 0.2 0.1 1.0 18.2 0.8 0.2 0.0 0.8 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.5 1.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 3.5 0.2 0.0 0.6 0.8 0.2 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 7.5 0.0 0.0 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAH10 FLJ43808 ENSG00000197653 "Dynein axonemal heavy chain 10" Q8IVF4 12 123762188-123936206 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.0;epididymis: 10.1;fallopian tube: 9.5;lung: 11.8;testis: 16.4" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 104.4;Club cells: 20.5;Early spermatids: 27.9;Late spermatids: 49.5" "Cancer enhanced" "Detected in single" "testis cancer: 1.0" "Group enriched" "Detected in many" 4 "basal ganglia: 4.8;pons and medulla: 10.0" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 13 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;ASC diff: 3.9;SuSa: 2.4" HPA039066 Enhanced NA NA "HPA039066: AB_10673237" "unprognostic (1.37e-1)" "unprognostic (1.78e-1)" "unprognostic (6.08e-3)" "unprognostic (9.90e-3)" "unprognostic (2.16e-1)" "unprognostic (8.91e-2)" "unprognostic (3.39e-2)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" "unprognostic (1.08e-2)" "unprognostic (7.28e-3)" "unprognostic (5.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (7.23e-2)" "unprognostic (1.22e-2)" "unprognostic (9.11e-3)" 0.4 0.2 0.7 0.2 4.8 3.1 0.3 1.2 0.6 1.9 0.7 3.9 0.5 0.5 0.6 10.1 0.2 9.5 0.2 0.2 1.4 1.7 0.4 0.2 11.8 0.2 0.5 0.0 6.2 0.2 0.1 0.2 0.4 10.0 1.1 0.2 0.0 0.2 0.2 0.1 0.2 1.1 0.2 1.5 0.3 0.2 16.4 0.3 0.0 0.5 0.0 0.2 0.4 0.9 0.1 0.0 0.1 0.0 0.0 1.6 0.2 0.0 0.0 0.1 2.3 3.9 1.7 0.6 1.0 0.3 0.0 0.2 0.0 0.4 0.1 0.2 1.2 0.4 0.4 0.0 0.0 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 1.1 1.3 0.0 0.3 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.8 2.4 0.0 0.2 0.3 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 4.8 1.2 0.5 1.4 1.7 0.5 0.0 10.0 0.3 0.0 5.6 0.0 0.0 0.0 0.2 2.0 0.0 104.4 20.5 0.0 0.0 0.0 1.7 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 1.4 0.8 12.9 0.0 7.6 1.9 0.0 0.0 0.0 0.0 0.1 DNAH12 "DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19" ENSG00000174844 "Dynein axonemal heavy chain 12" Q6ZR08 3 57293699-57544344 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 439.0" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Region enriched" "Detected in many" 8 "pons and medulla: 23.0" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 3.1;GAMG: 1.9;LHCN-M2: 2.1" "HPA037493, HPA058203, HPA061365" Enhanced NA NA "HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493" "unprognostic (4.85e-2)" "unprognostic (1.29e-2)" "unprognostic (2.23e-1)" "unprognostic (2.18e-3)" "unprognostic (2.96e-2)" "unprognostic (2.17e-1)" "unprognostic (2.80e-2)" "unprognostic (1.51e-3)" "unprognostic (3.06e-2)" "unprognostic (3.21e-1)" "unprognostic (4.40e-2)" "unprognostic (5.90e-2)" "unprognostic (3.43e-5)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (2.53e-2)" "unprognostic (5.47e-2)" 0.2 0.3 0.6 0.1 3.0 0.1 0.4 0.2 0.5 1.3 0.2 5.3 0.0 0.1 1.4 11.6 0.2 16.7 0.5 0.1 2.9 0.8 0.2 0.3 17.5 0.2 0.4 0.0 7.6 3.1 0.1 8.9 0.1 23.0 0.2 0.2 0.0 0.3 0.2 0.2 0.3 0.2 0.2 0.4 0.2 0.2 17.6 1.0 0.0 0.3 0.0 0.1 0.2 0.2 0.5 0.5 0.0 0.0 1.2 0.9 0.1 0.3 0.7 0.0 0.0 0.9 0.3 0.1 0.0 0.2 0.3 0.0 3.1 0.3 0.1 0.0 0.4 1.9 0.4 0.0 0.3 0.2 0.7 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.6 0.1 0.4 0.4 0.2 0.6 0.2 0.1 2.1 0.0 0.0 0.4 0.0 0.4 0.5 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.9 0.1 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.5 0.2 0.0 0.0 1.2 0.0 0.5 0.0 0.1 0.6 3.0 0.2 0.3 2.9 0.8 0.4 0.0 23.0 1.0 3.0 1.4 0.0 0.2 0.0 0.2 0.8 0.0 439.0 70.5 0.0 0.0 0.1 0.0 0.1 38.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.0 0.1 0.0 1.7 0.0 0.0 5.6 0.9 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.4 0.4 0.0 0.0 0.0 24.4 2.6 0.0 0.0 0.0 0.0 0.0 DPPA3 "Pgc7, Stella" ENSG00000187569 "Developmental pluripotency associated 3" Q6W0C5 12 7711454-7717559 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.3;lung: 2.1;ovary: 1.8;testis: 3.6" "Cell type enhanced" "Detected in some" 14 "Extravillous trophoblasts: 1.1;Spermatocytes: 1.2;Spermatogonia: 1.6;Syncytiotrophoblasts: 1.1" "Cancer enriched" "Detected in single" 779 "testis cancer: 339.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.7;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 17 "dendritic cells: 2.3;granulocytes: 1.7" "Group enriched" "Detected in some" 5 "BEWO: 86.3;NTERA-2: 36.2" NA NA "unprognostic (2.52e-1)" "unprognostic (9.49e-2)" 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.4 3.6 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 2.3 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.0 1.1 0.0 0.0 0.0 DPPA5 Esg1 ENSG00000203909 "Developmental pluripotency associated 5" A6NC42 6 73353062-73354295 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lung: 2.0;testis: 6.8" "Cell type enhanced" "Detected in single" 35 "Spermatocytes: 1.4" "Cancer enriched" "Detected in single" 2209 "testis cancer: 347.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 49 "SuSa: 12.7" "Not detected" "Not detected" "HPA055016, HPA064505" Uncertain Approved "Cell Junctions" NA NA "Cell Junctions" "HPA055016: , HPA064505: AB_2685275" "unprognostic (1.85e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 6.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 DRAM1 "DRAM, FLJ11259" ENSG00000136048 "DNA damage regulated autophagy modulator 1" Q8N682 12 101877351-102012130 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 52.5;lung: 73.9" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 271.2;Early spermatids: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "BJ hTERT+: 103.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.82e-2)" "unprognostic (1.80e-1)" "unprognostic (7.19e-2)" "prognostic favorable (6.52e-8)" "unprognostic (1.15e-2)" "unprognostic (2.35e-3)" "unprognostic (1.29e-3)" "unprognostic (1.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (6.17e-3)" "unprognostic (5.02e-2)" "prognostic unfavorable (3.91e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-3)" "unprognostic (3.58e-2)" "unprognostic (2.07e-2)" 13.1 11.0 3.6 9.9 3.8 16.7 52.5 1.2 2.6 9.2 8.3 2.3 3.6 3.4 8.0 9.2 8.1 6.9 11.2 13.8 3.6 3.6 16.7 7.2 73.9 20.9 4.3 2.3 10.9 13.7 4.3 6.6 15.2 4.4 13.2 4.8 5.4 8.8 5.4 6.6 4.6 6.4 10.8 4.4 14.8 10.0 8.6 2.2 4.9 10.4 4.3 6.4 12.4 22.1 2.6 3.0 9.2 9.8 3.5 2.2 2.5 2.0 4.0 1.4 0.4 18.8 4.3 8.0 15.0 103.6 15.1 23.6 1.3 3.9 0.3 1.7 24.6 5.8 3.0 0.3 6.2 21.0 2.1 1.3 0.5 3.5 5.1 8.7 0.6 1.1 5.1 2.7 5.2 5.7 13.0 8.0 0.5 1.8 0.7 3.9 1.6 0.3 1.7 1.0 5.0 0.9 0.7 1.0 0.3 16.0 9.5 0.3 0.3 8.3 0.9 3.8 4.2 2.9 2.2 4.9 10.6 1.9 1.8 2.7 2.2 1.0 0.2 3.6 5.1 2.8 9.2 8.8 5.8 1.9 9.8 2.2 2.6 1.4 2.0 3.0 1.7 1.1 1.3 8.8 3.5 5.6 0.8 1.9 2.5 3.6 3.8 1.2 2.4 3.6 3.6 4.3 2.3 4.4 2.2 50.6 271.2 17.1 18.3 18.5 1.0 4.5 5.1 6.7 36.4 27.9 0.0 23.3 1.7 10.2 116.0 15.0 0.2 0.0 18.2 25.9 19.4 16.1 23.1 1.3 54.5 0.0 0.0 8.6 37.3 53.8 13.0 40.8 8.5 26.2 1.0 2.5 22.0 0.0 9.9 19.6 0.0 12.9 8.0 0.9 2.5 5.4 18.4 6.5 1.0 16.9 DTHD1 FLJ16686 ENSG00000197057 "Death domain containing 1" Q6ZMT9 4 36281622-36345756 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.6;fallopian tube: 20.6;lung: 18.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 286.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 6.8" "Lineage enriched" "Detected in many" 6 "T-cells: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (9.79e-6)" "unprognostic (4.04e-2)" "unprognostic (1.15e-2)" "unprognostic (5.54e-3)" "unprognostic (2.85e-1)" "unprognostic (5.45e-5)" "unprognostic (5.12e-3)" "unprognostic (9.11e-2)" "unprognostic (1.82e-2)" "unprognostic (7.59e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.05e-5)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.65e-2)" "unprognostic (7.12e-3)" 0.7 0.5 1.9 5.8 14.8 0.9 0.4 0.3 0.3 2.1 1.1 2.8 1.4 0.7 1.1 11.9 0.7 20.6 3.5 0.4 3.1 2.9 0.4 0.7 18.5 5.4 0.4 0.0 8.1 0.3 0.2 0.8 0.2 16.6 0.5 0.7 0.1 0.6 0.3 0.2 0.2 1.3 0.4 0.7 8.0 0.8 2.2 4.5 0.0 0.6 1.2 4.0 3.1 0.5 0.0 0.0 0.1 0.0 1.1 6.8 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.1 6.8 0.0 1.2 0.0 0.6 2.1 0.0 0.0 0.0 2.6 0.0 1.1 0.0 0.0 0.0 0.7 1.9 14.8 0.3 0.2 3.1 2.9 0.4 0.0 16.6 4.5 3.0 2.6 0.0 0.0 0.0 0.0 0.4 0.0 286.4 40.9 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.6 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 20.1 0.0 0.0 DUOX1 "LNOX1, NOXEF1, THOX1" ENSG00000137857 "Dual oxidase 1" Q9NRD9 15 45129933-45165576 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 48.7" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 77.4;Alveolar cells type 2: 116.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HaCaT: 34.6;hTCEpi: 16.8;RT4: 19.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.5" HPA023544 Approved NA NA "HPA023544: AB_1847878" "unprognostic (2.85e-2)" "prognostic favorable (4.31e-6)" "unprognostic (2.49e-2)" "unprognostic (8.84e-3)" "unprognostic (1.44e-2)" "unprognostic (3.27e-2)" "unprognostic (1.23e-1)" "unprognostic (2.57e-2)" "unprognostic (5.87e-2)" "unprognostic (6.02e-3)" "unprognostic (5.13e-2)" "unprognostic (1.19e-1)" "unprognostic (8.91e-3)" "unprognostic (2.23e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (3.03e-1)" 0.4 5.2 0.5 0.4 0.8 0.0 2.0 1.2 0.9 18.9 0.6 2.4 43.3 0.1 2.2 37.8 38.3 6.0 6.2 1.1 0.6 0.1 0.2 0.1 48.7 0.1 1.0 0.5 1.2 0.1 1.8 0.9 2.5 0.9 4.8 0.0 4.3 9.8 19.2 0.8 34.2 0.3 1.6 0.5 0.1 18.0 1.0 1.1 0.7 31.9 35.9 31.9 6.2 13.1 0.2 1.5 0.5 0.5 0.1 0.4 0.0 4.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.6 0.0 3.2 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 16.8 0.0 1.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 19.3 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.5 0.0 0.1 0.3 0.0 1.1 0.2 0.2 0.0 0.0 0.1 0.1 1.5 0.2 0.0 0.5 0.8 1.2 0.9 0.6 0.1 1.0 0.5 0.9 1.1 77.4 116.2 6.7 13.0 9.8 20.8 2.0 10.2 38.8 34.2 3.5 7.9 3.8 0.0 3.4 0.5 2.9 2.7 0.0 4.8 0.6 5.2 5.8 8.1 1.7 1.1 6.4 20.8 8.6 5.1 0.0 3.1 5.8 15.1 1.8 3.4 4.1 3.3 4.2 3.5 0.3 2.6 0.0 2.7 2.8 2.3 15.7 3.1 10.1 2.3 23.7 ECT2L "ARHGEF32, C6orf91, FBXO49, LFDH" ENSG00000203734 "Epithelial cell transforming 2 like" Q008S8 6 138795926-138904070 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 133.8" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "pons and medulla: 8.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 2.8;SCLC-21H: 2.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA035488 Uncertain NA NA "HPA035488: AB_10672865" "unprognostic (2.88e-2)" "unprognostic (7.88e-2)" "unprognostic (2.52e-2)" "unprognostic (5.53e-3)" "unprognostic (3.48e-2)" "unprognostic (8.45e-3)" "unprognostic (9.42e-2)" "unprognostic (2.44e-2)" "unprognostic (1.18e-1)" "unprognostic (7.03e-2)" "unprognostic (5.90e-4)" "unprognostic (2.32e-1)" "unprognostic (5.21e-2)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (7.07e-3)" "unprognostic (2.65e-3)" 0.5 0.3 0.7 0.2 1.1 0.5 0.4 0.8 0.7 1.1 0.3 4.2 0.0 0.2 0.6 7.7 1.0 18.5 1.7 2.7 1.1 1.1 0.1 0.2 12.2 0.2 0.3 0.0 9.4 0.1 0.3 1.8 0.2 8.1 0.3 0.1 0.8 0.6 0.2 0.5 0.7 0.6 1.6 0.3 0.3 0.3 1.2 0.8 0.0 0.4 0.0 0.1 0.8 0.3 0.6 0.3 1.7 0.6 0.7 0.8 0.0 0.2 0.1 0.2 0.8 0.0 0.5 1.2 0.0 0.0 0.1 0.1 0.8 0.8 0.8 0.3 0.0 0.3 0.3 0.0 0.0 0.9 0.2 0.5 2.8 0.2 0.0 0.1 0.9 0.4 1.3 1.0 0.0 0.0 0.6 0.0 0.2 0.2 0.9 0.0 0.3 0.6 1.0 0.6 0.2 0.6 0.5 0.3 0.2 0.0 0.7 2.9 0.7 0.2 0.8 0.4 0.5 0.3 1.2 0.0 0.6 0.3 0.8 0.3 0.4 0.2 0.3 0.4 0.8 0.2 1.7 0.3 0.6 0.3 0.3 0.4 0.3 0.2 0.7 0.1 0.6 0.7 0.8 0.6 0.7 0.6 0.3 0.2 0.0 0.7 1.1 0.8 0.7 1.1 1.1 0.3 0.0 8.1 0.8 0.0 0.6 0.0 0.5 0.5 2.2 1.2 0.0 133.8 21.6 0.0 2.0 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.3 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580698 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 118.7" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 3868.0;Suprabasal keratinocytes: 1026.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 59.5;RT4: 40.9;SK-BR-3: 58.8;T-47d: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014711, HPA070816" Approved Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA014711: AB_1848147, HPA070816: " "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 16.5 2.0 5.0 7.9 5.1 0.0 26.2 3.4 4.7 14.8 10.4 3.4 6.1 4.2 7.3 13.8 35.7 7.4 7.3 14.0 5.5 3.0 3.1 47.5 118.7 5.7 5.4 2.5 14.0 3.2 19.9 3.2 23.5 5.3 11.1 10.0 10.8 9.9 5.8 7.7 40.2 6.6 12.8 3.4 5.3 9.3 5.6 4.1 2.2 7.5 26.4 18.4 10.6 16.3 1.3 1.1 4.1 1.1 1.4 1.0 0.4 6.3 8.8 3.6 4.3 8.2 7.1 7.2 9.1 8.4 5.5 8.3 28.8 22.3 0.0 2.9 10.9 4.0 28.3 9.3 11.2 7.3 0.0 5.9 0.0 18.5 15.7 1.4 0.0 0.1 4.3 3.0 7.3 0.7 1.2 2.3 0.0 2.1 0.6 15.2 59.5 0.1 0.1 4.2 10.3 2.1 1.6 4.2 13.8 1.2 40.9 5.1 5.8 11.2 58.8 3.3 11.0 35.9 1.4 1.2 17.6 7.6 5.9 5.0 0.1 0.2 0.0 7.7 0.1 17.2 3.4 1.0 1.0 0.8 0.8 1.0 1.0 0.8 0.7 0.5 1.3 0.9 0.9 4.1 1.4 1.1 1.1 0.8 0.4 5.0 5.1 3.4 4.7 5.5 3.0 5.4 2.5 5.3 4.1 3868.0 343.3 4.5 123.1 317.0 1.8 48.0 109.5 153.9 326.4 40.1 0.0 59.0 0.0 2.5 4.2 191.2 51.9 0.0 60.2 16.3 121.0 91.1 34.8 181.1 8.8 0.0 100.6 112.3 14.0 5.0 176.6 42.0 82.7 58.7 141.3 5.2 27.3 172.1 259.6 0.0 1.1 51.8 141.5 2.3 13.2 1026.6 40.2 4.3 139.9 220.6 EPAS1 "bHLHe73, HIF2A, HLF, MOP2, PASD2" ENSG00000116016 "Endothelial PAS domain protein 1" Q99814 2 46293667-46386703 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Congenital erythrocytosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 200.8" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 341.0;Ito cells: 438.9;Smooth muscle cells: 281.4;Syncytiotrophoblasts: 292.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "basophil: 14.9;eosinophil: 7.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 14.9" "Cell line enhanced" "Detected in many" "BEWO: 46.9;BJ hTERT+: 46.2;HHSteC: 58.7;RT4: 58.1;TIME: 58.0;U-138 MG: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031200, HPA069697" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031200: AB_2673785, HPA069697: AB_2732139" "unprognostic (1.74e-1)" "unprognostic (9.47e-2)" "unprognostic (1.29e-2)" "unprognostic (2.74e-1)" "unprognostic (5.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.22e-2)" "unprognostic (8.67e-2)" "unprognostic (6.00e-2)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.29e-2)" "prognostic favorable (2.63e-4)" "unprognostic (6.66e-3)" "unprognostic (7.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-1)" 71.2 14.2 12.5 17.1 15.7 0.8 101.7 5.3 13.9 24.9 20.9 8.9 11.3 12.0 28.8 13.0 21.6 24.8 35.2 40.0 12.8 11.0 35.2 31.2 200.8 27.2 14.3 11.1 20.2 15.5 18.1 9.4 119.6 18.4 20.7 11.5 41.2 13.3 18.7 25.2 13.0 15.6 19.2 12.5 20.5 12.8 13.8 8.0 1.1 43.8 15.2 10.3 32.2 39.3 0.0 0.0 14.9 0.1 0.7 0.1 0.1 5.3 5.7 0.3 0.4 27.6 17.8 46.9 16.9 46.2 9.7 10.6 1.0 0.9 0.0 4.2 32.2 9.7 2.6 0.1 13.5 7.3 0.1 0.2 0.0 1.8 12.0 58.7 0.0 3.4 26.0 18.7 19.0 13.4 7.2 33.4 0.1 0.5 0.0 5.9 4.6 0.1 0.1 0.2 3.7 3.2 0.1 0.6 1.7 6.0 58.1 0.2 12.0 13.3 30.6 3.6 12.5 2.0 2.3 58.0 50.4 1.4 6.7 1.4 0.0 0.0 0.0 36.7 0.9 1.2 14.9 0.1 7.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 12.5 15.7 5.3 12.6 12.8 11.0 14.3 11.1 18.4 8.0 71.5 137.9 8.1 61.5 42.7 3.5 58.5 50.9 30.8 96.7 3.5 9.8 93.6 1.7 15.5 12.6 341.0 66.4 0.0 45.9 256.0 104.5 46.7 40.4 77.4 47.9 0.0 4.1 438.9 58.4 41.8 11.5 23.9 27.0 0.0 13.6 89.1 25.9 40.4 6.0 24.0 57.7 278.1 281.4 1.2 1.7 29.1 292.5 9.6 11.6 58.0 F2RL3 PAR4 ENSG00000127533 "F2R like thrombin or trypsin receptor 3" Q96RI0 19 16888860-16892606 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.4;breast: 30.7;lung: 33.0" "Group enriched" "Detected in some" 5 "Endothelial cells: 5.8;granulocytes: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HEL: 24.9;HMC-1: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031401, HPA042340" Supported "Plasma membrane" NA NA "Plasma membrane" "HPA031401: , HPA042340: " "unprognostic (6.17e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-2)" "unprognostic (3.83e-1)" "unprognostic (3.27e-1)" "unprognostic (8.31e-3)" "unprognostic (2.97e-1)" "unprognostic (3.28e-2)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (6.30e-2)" "unprognostic (3.00e-3)" "prognostic favorable (6.25e-4)" "unprognostic (2.37e-2)" "unprognostic (1.43e-1)" "unprognostic (3.53e-1)" "unprognostic (2.11e-2)" 69.4 3.3 0.2 2.6 0.4 1.3 30.7 0.2 0.6 1.3 16.9 0.4 0.5 1.9 1.3 1.9 4.3 1.0 4.5 9.7 0.5 0.2 5.0 0.8 33.0 2.6 0.2 0.3 3.9 12.3 0.5 2.3 1.1 1.4 1.4 1.5 1.3 1.0 0.8 6.5 2.2 4.4 1.1 0.2 3.0 5.4 2.5 0.2 0.3 27.1 2.3 1.5 3.4 1.9 5.3 4.3 5.8 2.5 3.9 3.3 3.2 0.2 0.2 0.7 0.3 0.1 0.2 0.7 0.4 0.1 0.2 0.1 0.4 0.7 0.5 0.5 0.2 0.3 0.7 0.1 0.2 0.2 0.3 0.4 24.9 0.9 0.4 0.2 0.3 10.0 0.0 0.1 0.3 0.2 0.3 0.8 0.5 2.0 1.0 0.1 0.3 0.3 2.4 0.3 0.3 0.2 0.2 0.2 0.8 0.2 0.5 0.4 0.2 0.2 0.2 0.1 0.6 0.5 1.7 1.0 0.6 0.5 0.3 0.3 0.5 0.3 0.5 0.2 0.4 0.4 5.8 2.5 1.6 2.2 1.4 2.1 3.9 2.4 1.9 0.8 5.3 3.3 3.1 5.3 3.9 1.8 4.3 1.7 3.2 0.2 0.4 0.2 0.6 0.5 0.2 0.2 0.3 1.4 0.2 0.0 0.6 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.5 0.0 0.5 0.3 6.9 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.3 FAM216B "C13orf30, FLJ40919" ENSG00000179813 "Family with sequence similarity 216 member B" Q8N7L0 13 42781550-42791549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 348.0" "Group enriched" "Detected in some" 10 "endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9" "Group enriched" "Detected in many" 5 "basal ganglia: 9.5;pons and medulla: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-87 MG: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040118 Uncertain NA NA "HPA040118: AB_10674429" "unprognostic (1.03e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.77e-4)" "unprognostic (4.35e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (2.54e-2)" "unprognostic (5.44e-3)" "unprognostic (1.32e-1)" "unprognostic (2.27e-1)" "unprognostic (8.14e-3)" "unprognostic (1.37e-1)" "unprognostic (1.30e-2)" 0.3 0.2 1.7 0.9 9.5 0.2 0.2 0.1 0.6 3.0 0.3 8.0 0.0 0.3 1.3 18.2 0.2 51.3 0.4 10.0 3.1 3.2 0.2 0.2 28.5 2.2 0.1 0.0 18.3 0.3 0.2 2.0 0.2 21.0 0.2 0.5 0.0 0.7 0.2 0.2 0.2 1.5 0.2 0.5 0.3 0.3 1.0 1.7 0.0 0.2 0.0 3.9 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 9.5 0.1 0.6 3.1 3.2 0.1 0.0 21.0 1.7 0.0 3.8 0.0 0.0 0.0 0.0 7.7 0.0 348.0 42.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.3 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FAM92B FLJ44299 ENSG00000153789 "Family with sequence similarity 92 member B" Q6ZTR7 16 85098358-85112508 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.2;fallopian tube: 50.7;lung: 13.8" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 281.1" "Group enriched" "Detected in some" 5 "endometrial cancer: 5.4;lung cancer: 1.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 7.6;TIME: 2.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA041022 Enhanced NA NA "HPA041022: AB_10795500" "unprognostic (1.77e-4)" "unprognostic (7.44e-3)" "unprognostic (1.61e-1)" "unprognostic (2.11e-3)" "unprognostic (5.09e-3)" "unprognostic (1.14e-3)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (9.81e-2)" "unprognostic (3.70e-1)" "unprognostic (3.84e-2)" "unprognostic (2.05e-1)" "unprognostic (5.10e-13)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "unprognostic (2.47e-1)" "unprognostic (1.29e-1)" 0.1 0.9 2.0 0.7 8.3 0.3 0.3 0.7 0.6 2.0 0.5 6.3 0.0 0.9 0.9 10.8 0.1 50.7 0.2 0.1 2.7 5.0 0.1 0.1 13.8 0.3 0.0 0.0 8.8 0.1 0.1 13.5 0.1 14.2 0.2 0.4 0.0 0.3 0.2 0.1 0.3 0.5 0.1 0.4 0.6 0.3 0.7 1.8 0.0 0.1 0.0 1.2 1.3 0.0 1.2 0.2 0.9 0.3 2.5 0.4 0.2 0.4 0.0 0.5 0.3 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.4 0.3 0.6 0.3 0.1 0.6 0.0 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.2 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.3 0.0 0.6 0.0 0.1 0.5 0.1 0.2 0.2 0.5 0.2 0.3 0.4 7.6 0.9 0.0 0.1 0.2 0.3 0.8 0.7 2.2 0.6 0.5 0.1 0.2 0.2 0.2 0.4 0.4 0.2 1.6 0.1 0.2 0.1 0.4 0.3 0.2 1.2 0.2 0.1 0.2 0.3 0.2 0.2 0.9 2.5 0.1 0.2 0.0 0.2 2.0 8.3 0.7 0.6 2.7 5.0 0.0 0.0 14.2 1.8 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 281.1 27.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.0 3.4 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FBN3 ENSG00000142449 "Fibrillin 3" Q75N90 19 8065402-8149846 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 5.2;salivary gland: 7.5" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.4;Cardiomyocytes: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 8.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 3.7;NTERA-2: 12.6;REH: 18.2;SuSa: 4.9" "Low region specificity" "Detected in many" HPA049482 Uncertain "Secreted to extracellular matrix" NA NA "HPA049482: AB_2680786" "unprognostic (9.66e-3)" "unprognostic (5.15e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (4.14e-2)" "unprognostic (5.14e-3)" "unprognostic (6.26e-2)" "unprognostic (4.10e-3)" "unprognostic (3.17e-2)" "unprognostic (8.94e-2)" "unprognostic (4.61e-2)" "unprognostic (1.53e-1)" "unprognostic (2.76e-2)" "unprognostic (1.34e-2)" "unprognostic (2.57e-1)" "unprognostic (1.17e-2)" "unprognostic (3.17e-1)" 0.2 0.0 1.0 0.2 1.2 0.0 0.5 0.2 2.4 0.2 0.2 2.8 0.2 0.0 0.7 0.2 0.5 1.8 0.2 0.2 1.0 1.1 3.6 0.5 5.2 0.2 2.4 0.2 0.8 0.2 0.0 1.9 0.2 2.1 1.7 0.3 0.2 7.5 0.2 0.9 0.6 0.3 0.3 2.0 0.2 0.1 1.1 1.7 0.8 3.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 12.6 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.2 2.4 1.0 1.1 2.4 0.2 2.1 1.7 6.0 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 FBP1 FBP ENSG00000165140 "Fructose-bisphosphatase 1" P09467 9 94603133-94640249 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 248.1;lung: 87.8" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 322.6;Proximal tubular cells: 631.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 73.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 20.5;MCF7: 64.2;RT4: 42.1;SK-BR-3: 12.3;U-698: 30.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005857, HPA012513, CAB033869" Enhanced Approved Mitochondria NA NA 23000000 Mitochondria "CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (1.40e-1)" "prognostic favorable (5.16e-4)" "unprognostic (1.13e-2)" "unprognostic (1.37e-1)" "prognostic favorable (1.79e-4)" "unprognostic (6.94e-3)" "unprognostic (4.52e-2)" "unprognostic (7.79e-2)" "unprognostic (7.59e-2)" "unprognostic (1.12e-1)" "prognostic favorable (6.86e-7)" "unprognostic (6.91e-2)" "unprognostic (3.22e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.64e-5)" 19.3 5.8 0.6 2.3 0.9 1.1 7.0 0.4 0.8 2.2 48.8 0.7 17.6 40.7 0.6 2.5 0.7 0.9 9.7 1.3 0.8 0.5 34.6 248.1 87.8 8.9 0.9 0.7 1.0 8.1 17.1 1.9 1.0 1.0 6.4 3.0 1.5 9.1 17.7 0.5 1.7 60.4 3.1 1.2 2.8 10.4 1.0 0.8 0.5 4.3 1.0 1.1 22.4 9.6 0.6 17.1 73.5 30.7 2.8 3.3 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.3 5.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 64.2 0.0 1.1 0.2 10.4 2.3 0.0 0.2 0.4 0.0 42.1 0.2 1.2 0.1 12.3 0.0 0.2 7.3 1.8 0.0 0.0 0.2 0.2 0.0 0.0 0.2 30.5 0.0 0.3 0.0 10.6 13.0 73.5 1.5 30.7 2.3 0.6 0.9 0.9 17.1 0.6 3.3 1.6 2.3 2.8 16.3 6.1 0.4 5.2 0.6 0.9 0.4 0.8 0.8 0.5 0.9 0.7 1.0 0.8 71.5 142.5 10.2 6.5 0.7 0.0 0.6 107.0 13.4 68.2 59.3 0.0 9.7 94.5 14.4 0.0 1.8 32.6 23.3 56.4 1.6 1.7 17.4 45.2 322.6 187.5 0.0 30.7 11.1 49.8 0.8 1.4 103.2 11.8 0.0 49.9 2.1 23.8 68.4 3.9 631.0 0.0 6.5 1.2 0.6 0.1 0.9 8.5 13.1 59.5 51.2 FCAR CD89 ENSG00000186431 "Fc fragment of IgA receptor" P24071 19 54874248-54890472 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "IgA-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 3.7;Cardiomyocytes: 1.4;Ciliated cells: 1.4;Kupffer cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.6;neutrophil: 6.1" "Group enriched" "Detected in many" 44 "granulocytes: 6.1;monocytes: 2.6" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Low region specificity" "Detected in all" HPA014050 Approved Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA014050: AB_1846338" "unprognostic (1.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.30e-1)" "unprognostic (4.71e-3)" "unprognostic (3.46e-1)" "unprognostic (2.02e-1)" "unprognostic (7.99e-2)" "unprognostic (1.54e-2)" "unprognostic (1.59e-2)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (7.05e-2)" "unprognostic (4.19e-6)" "unprognostic (9.23e-2)" "unprognostic (8.10e-3)" "unprognostic (8.04e-3)" "unprognostic (9.81e-2)" 4.0 0.6 0.4 1.5 4.4 28.1 0.8 0.1 1.0 0.6 0.6 0.7 0.0 0.6 0.6 0.6 0.6 3.8 0.6 8.2 2.0 0.4 0.6 1.8 19.5 15.9 1.2 0.0 2.2 0.6 0.6 0.3 1.5 4.3 0.6 0.6 0.9 0.6 0.6 0.6 0.6 0.6 0.7 2.7 14.9 0.9 2.1 0.0 1.0 0.6 0.3 0.6 4.4 4.8 0.0 0.0 6.1 2.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.7 0.4 4.4 0.1 1.0 2.0 0.4 1.2 0.0 4.3 0.0 0.0 3.7 0.0 0.2 0.1 0.1 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 1.1 0.0 1.0 0.0 0.0 0.0 5.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 FCN3 "FCNH, HAKA1" ENSG00000142748 "Ficolin 3" O75636 1 27369112-27374824 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 83.2;lung: 153.7" "Cell type enriched" "Detected in many" 14 "Ito cells: 3886.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.8;MCF7: 2.2;U-2197: 2.2" CAB025945 Approved "Secreted to blood" NA NA 22800000000 33000000000 "CAB025945: " "unprognostic (1.59e-1)" "unprognostic (5.25e-2)" "unprognostic (1.55e-2)" "unprognostic (8.27e-2)" "unprognostic (1.45e-3)" "unprognostic (1.27e-2)" "unprognostic (1.87e-3)" "unprognostic (1.21e-1)" "unprognostic (6.28e-4)" "unprognostic (7.07e-2)" "unprognostic (2.86e-2)" "unprognostic (3.23e-2)" "unprognostic (3.87e-3)" "unprognostic (4.14e-2)" "unprognostic (1.02e-1)" "unprognostic (6.97e-2)" "unprognostic (1.61e-2)" 7.2 5.0 0.1 1.7 0.2 0.0 21.2 0.1 0.3 0.3 0.6 0.4 0.1 0.2 0.3 0.1 1.0 0.5 0.5 25.0 0.4 0.0 13.0 83.2 153.7 1.0 0.1 0.1 0.3 2.3 0.7 2.1 6.7 1.1 0.5 0.2 0.8 0.4 0.2 1.0 0.3 0.7 0.6 0.2 2.7 0.8 0.5 0.2 0.1 9.1 0.3 0.3 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.2 0.8 0.0 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.8 0.4 0.6 0.0 1.0 1.1 0.0 0.4 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.3 0.2 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.6 0.0 0.0 0.4 0.3 2.2 0.2 0.3 0.1 0.5 0.4 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.4 0.0 0.1 0.1 1.1 0.2 0.0 15.2 66.2 0.3 0.7 0.0 2.0 81.5 4.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 99.1 0.0 93.5 0.0 0.0 0.2 0.4 3.5 6.8 0.3 0.0 0.0 3886.1 270.1 2.2 3.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.4 0.6 1.0 0.0 8.6 0.0 0.3 FFAR4 "GPR120, GPR129, O3FAR1, PGR4" ENSG00000186188 "Free fatty acid receptor 4" Q5NUL3 10 93566665-93604480 "G-protein coupled receptors, Predicted membrane proteins" "Differentiation, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 15.8;lung: 11.7;pituitary gland: 39.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 18.7;Intestinal endocrine cells: 20.1;Mucus-secreting cells: 63.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "OE19: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042563 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042563: AB_10794762" "unprognostic (1.96e-1)" "unprognostic (1.06e-2)" "unprognostic (1.14e-2)" "unprognostic (4.21e-2)" "unprognostic (2.12e-1)" "unprognostic (4.98e-4)" "unprognostic (1.41e-3)" "unprognostic (1.20e-2)" "unprognostic (2.34e-2)" "unprognostic (7.87e-2)" "unprognostic (9.51e-2)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (5.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" 5.2 0.6 1.8 2.8 1.7 0.2 1.9 0.1 2.6 0.2 11.3 1.1 0.0 0.7 0.1 0.1 0.4 1.4 2.6 1.2 0.9 1.6 0.3 0.6 11.7 1.3 0.6 1.0 0.3 1.1 0.1 39.2 0.4 0.8 0.2 15.8 0.3 0.9 0.1 0.5 1.3 1.0 0.3 2.6 0.2 0.7 2.0 0.9 0.7 0.2 0.0 0.6 0.3 0.2 0.5 3.4 1.3 3.0 0.7 0.3 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.4 0.1 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 16.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.2 0.3 0.6 0.2 0.4 0.2 0.2 3.4 0.5 0.2 0.3 1.3 0.7 0.4 0.4 0.1 0.8 1.8 1.7 0.1 2.6 0.9 1.6 0.6 1.0 0.8 0.9 0.0 0.3 0.0 0.4 0.0 0.0 0.3 12.7 0.0 1.2 0.0 0.0 0.1 0.0 0.6 18.7 0.1 6.5 0.0 0.0 0.5 0.2 0.3 0.0 0.0 7.8 0.0 20.1 0.0 3.2 12.2 0.6 3.8 1.7 0.0 63.6 0.0 1.4 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.2 FGR "c-fgr, p55c-fgr, SRC2" ENSG00000000938 "FGR proto-oncogene, Src family tyrosine kinase" P09769 1 27612064-27635277 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Daudi: 30.1;U-266/70: 55.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002024 Enhanced Approved "Plasma membrane,Aggresome" NA NA "Plasma membrane" Aggresome "HPA002024: AB_1078503" "unprognostic (2.66e-2)" "unprognostic (1.51e-2)" "unprognostic (6.32e-2)" "unprognostic (9.74e-3)" "unprognostic (6.66e-3)" "unprognostic (6.71e-2)" "unprognostic (5.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.81e-2)" "unprognostic (7.45e-2)" "unprognostic (2.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-2)" "unprognostic (6.26e-2)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "unprognostic (8.12e-3)" 20.8 2.6 2.2 23.6 4.5 73.6 5.6 1.1 4.2 2.9 2.8 1.5 4.2 1.6 4.0 2.3 2.2 6.3 5.3 8.5 2.6 2.3 3.0 4.2 30.9 34.1 6.6 1.7 1.9 2.4 0.4 1.2 3.3 4.2 2.5 1.8 2.1 2.9 2.6 4.4 1.7 3.7 6.4 4.8 54.3 2.5 2.6 4.1 1.9 2.9 2.5 7.8 5.1 6.1 13.3 28.9 40.8 68.0 36.3 29.6 55.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 55.9 0.7 2.3 0.0 6.8 0.0 3.1 52.4 32.3 29.6 68.0 1.7 7.7 2.6 13.6 28.9 13.3 1.3 12.8 40.8 36.3 55.6 1.3 0.1 55.0 2.2 4.5 1.1 4.2 2.6 2.3 6.6 1.7 4.2 4.1 6.0 30.7 12.5 0.5 2.5 0.0 1.6 2.5 2.7 10.3 1.8 0.0 0.4 0.0 0.0 0.2 11.5 0.0 0.0 0.2 0.5 1.4 0.3 12.7 0.9 58.9 0.0 0.0 4.3 187.9 0.4 0.3 86.1 1.7 7.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.2 0.5 1.0 0.8 45.8 0.0 0.9 FMO2 ENSG00000094963 "Flavin containing monooxygenase 2" Q99518 1 171185208-171211230 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.0;esophagus: 35.3;lung: 53.0" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 428.8;Club cells: 348.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 57 "ASC diff: 24.6;ASC TERT1: 11.2;HSkMC: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028261 Approved NA NA "HPA028261: AB_10601012" "unprognostic (1.85e-2)" "unprognostic (3.14e-2)" "unprognostic (7.44e-2)" "unprognostic (3.75e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-3)" "unprognostic (3.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.58e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (3.83e-2)" 40.0 11.8 1.2 1.7 4.4 0.0 22.5 1.5 0.6 7.6 5.0 0.6 2.9 0.3 1.9 3.5 35.3 6.7 2.0 17.4 1.8 1.2 9.4 1.8 53.0 5.7 3.9 1.2 6.1 2.1 1.8 7.0 0.0 2.4 6.0 0.7 8.3 14.0 1.3 7.6 1.7 1.5 2.5 1.9 0.4 2.4 3.3 1.3 0.4 5.8 6.8 5.5 5.0 10.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 29.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 4.4 1.5 0.6 1.8 1.2 3.9 1.2 2.4 1.3 428.8 20.8 0.0 5.3 0.3 0.2 6.9 0.0 62.9 348.1 1.8 0.0 0.0 0.0 0.0 2.7 5.3 0.0 0.0 0.0 0.0 0.6 3.0 3.5 0.0 0.0 0.0 0.0 4.3 0.0 2.3 0.9 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.4 0.2 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.0 1.1 FO681492.1 ENSG00000277758 10 47750864-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.2;brain: 6.7;lung: 10.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 37.0" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 0.5 0.0 0.1 0.0 0.0 6.7 0.3 0.0 0.0 0.1 0.0 2.4 1.1 0.4 0.4 0.0 0.0 10.6 2.3 0.3 1.4 0.0 1.1 0.0 0.0 1.4 0.4 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.9 0.7 2.5 0.4 5.2 0.9 1.1 0.4 0.5 4.2 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 0.0 2.7 3.0 0.0 0.2 1.2 0.8 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 3.3 37.0 0.1 0.2 3.2 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.3 2.3 0.3 0.7 2.8 1.1 0.7 1.1 0.8 2.5 0.3 0.5 0.7 0.4 0.9 5.2 1.0 0.7 0.4 3.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FREM2 DKFZp686J0811 ENSG00000150893 "FRAS1 related extracellular matrix protein 2" Q5SZK8 13 38687129-38887131 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 13.9;lung: 11.2;thyroid gland: 12.2" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 19.8;Cholangiocytes: 7.6;Proximal tubular cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.2;HAP1: 8.2;MCF7: 5.9;RT4: 5.5;SK-BR-3: 5.0;SuSa: 24.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028831 Uncertain Approved Cytosol NA NA 170000 Cytosol "HPA028831: AB_10603668" "unprognostic (1.71e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-1)" "unprognostic (6.24e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.25e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.23e-7)" "unprognostic (7.21e-2)" "unprognostic (1.40e-1)" "unprognostic (9.92e-2)" "unprognostic (3.14e-1)" 0.6 0.4 1.3 0.1 1.7 0.1 0.5 1.5 6.4 0.7 1.3 1.2 1.1 0.4 1.1 0.5 0.2 0.9 1.5 0.2 2.8 0.4 13.9 3.4 11.2 0.1 0.4 0.8 1.8 5.2 0.1 1.1 2.6 0.8 3.5 0.4 2.9 0.4 1.5 6.3 0.6 0.7 0.7 0.4 0.3 2.2 1.8 1.5 0.1 12.2 4.1 0.1 1.5 0.3 0.3 0.3 0.9 0.2 0.2 0.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.8 0.0 0.1 0.0 1.1 0.1 1.8 5.5 0.1 0.1 0.0 5.0 0.2 24.6 0.9 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.6 0.9 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.2 0.7 0.2 0.2 0.3 0.1 0.0 1.3 1.7 1.5 6.4 2.8 0.4 0.4 0.8 0.8 1.5 0.0 19.8 0.0 0.1 0.6 0.1 2.0 7.6 5.3 2.3 1.8 0.0 5.1 5.0 1.7 0.6 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.3 0.0 0.0 22.4 0.2 0.0 0.0 0.1 0.4 0.1 1.6 0.0 0.0 0.0 FREM3 ENSG00000183090 "FRAS1 related extracellular matrix 3" P0C091 4 143577302-143700675 "Predicted secreted proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "brain: 5.0;lung: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "TIME: 3.2" "Group enriched" "Detected in some" 5 "basal ganglia: 3.3;hypothalamus: 3.2;thalamus: 4.8" "Low region specificity" "Detected in some" HPA041641 Uncertain "Secreted to extracellular matrix" NA NA "HPA041641: AB_2677592" "unprognostic (1.19e-2)" "unprognostic (4.09e-9)" "unprognostic (3.09e-3)" "unprognostic (2.74e-1)" "unprognostic (1.66e-1)" "unprognostic (4.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-1)" "unprognostic (2.68e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (7.11e-3)" "unprognostic (3.24e-1)" 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 1.8 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GDF10 BMP-3b ENSG00000266524 "Growth differentiation factor 10" P55107 10 47300386-47313547 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.8;tongue: 14.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 17.8;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 34.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "AF22: 17.7;MOLT-4: 3.8;SH-SY5Y: 7.2" "Region enriched" "Detected in many" 8 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA015498 Uncertain Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA015498: AB_1849584" "unprognostic (4.34e-2)" "unprognostic (3.10e-1)" "unprognostic (1.41e-1)" "unprognostic (5.09e-1)" "unprognostic (3.17e-1)" "unprognostic (9.84e-3)" "unprognostic (1.37e-2)" "unprognostic (2.26e-2)" "unprognostic (1.55e-1)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-7)" "unprognostic (3.49e-2)" "unprognostic (1.48e-1)" "unprognostic (2.59e-3)" "unprognostic (2.63e-1)" 6.8 4.4 1.4 0.3 2.8 0.0 10.8 7.6 5.2 1.9 0.4 1.7 0.0 0.0 2.3 2.4 5.4 0.5 2.9 2.1 3.0 0.0 0.0 15.8 0.9 0.0 5.0 0.1 11.6 0.2 0.0 0.0 0.9 2.8 0.3 6.8 3.0 0.3 2.5 0.3 0.1 0.6 0.8 0.1 0.1 10.5 0.8 0.0 3.7 14.8 2.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.3 17.8 0.6 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 4.7 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.2 0.9 0.0 1.7 0.0 0.0 4.3 0.0 0.0 0.0 0.0 34.3 0.0 0.1 0.2 0.5 0.6 0.0 0.0 0.0 0.0 GGTLC1 "dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4" ENSG00000149435 "Gamma-glutamyltransferase light chain 1" Q9BX51 20 23985050-23988779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "lung: 24.2;testis: 11.1" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 128.1;Early spermatids: 37.6;Late spermatids: 92.1" "Cancer enriched" "Detected in some" 8 "lung cancer: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.3;SK-BR-3: 1.7;T-47d: 1.2;U-2197: 4.5" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (1.94e-2)" "unprognostic (5.32e-1)" "unprognostic (4.19e-1)" "unprognostic (1.00e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.1 0.0 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.1 4.5 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 128.1 14.9 0.0 0.0 0.0 0.0 0.0 5.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 37.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.0 0.0 GGTLC3 ENSG00000274252 "Gamma-glutamyltransferase light chain family member 3" B5MD39 22 18516344-18518161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 4.2;salivary gland: 3.0" "Group enriched" "Detected in some" 21 "Alveolar cells type 1: 3.0;Early spermatids: 4.1;Late spermatids: 10.4;Spermatocytes: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.9;SuSa: 5.3;U-2197: 3.6" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (1.37e-1)" "unprognostic (2.06e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 4.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 1.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.5 1.2 0.0 0.0 1.2 0.3 0.0 0.7 0.6 1.1 0.3 0.0 0.0 5.3 0.0 0.0 0.0 0.3 1.4 3.6 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12890782-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 155.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 872.5;Glandular cells: 325.5;Pancreatic endocrine cells: 368.5;Urothelial cells: 1048.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 3.1" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "A-431: 42.7;CAPAN-2: 164.8;HaCaT: 43.2;SiHa: 60.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" NA Yes "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: AB_2679685" "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavorable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 9.8 1.4 0.2 6.0 0.6 0.4 5.4 0.1 0.3 12.1 19.8 0.5 2.0 6.2 4.3 1.9 9.1 3.0 15.5 7.1 0.1 0.2 5.1 0.6 155.0 0.1 0.5 0.1 18.5 1.1 0.0 0.9 20.1 3.1 10.4 16.9 4.8 9.6 1.5 1.1 2.0 36.9 14.2 1.1 0.1 11.4 4.8 0.3 0.1 54.2 14.9 11.5 32.1 14.0 0.6 0.6 3.1 0.3 0.5 0.4 0.0 42.7 34.2 0.0 0.1 0.4 0.2 2.2 12.9 4.9 8.4 6.4 6.0 164.8 0.0 1.1 10.3 8.9 43.2 0.1 6.2 12.9 0.0 0.5 0.0 14.1 0.2 3.1 0.0 0.0 0.2 8.4 3.5 0.8 10.4 5.1 0.0 0.0 0.0 0.3 30.0 0.0 0.0 0.1 15.6 5.4 0.0 0.9 0.0 16.6 8.5 0.0 0.0 60.6 4.6 1.9 6.9 1.3 0.1 0.5 0.3 10.9 19.6 0.5 0.0 0.0 0.0 4.4 0.0 0.2 3.1 0.3 0.4 0.3 0.2 0.3 0.3 0.2 0.3 0.1 0.6 0.4 0.4 1.3 0.5 0.2 0.6 0.3 0.0 0.2 0.6 0.1 0.3 0.1 0.2 0.5 0.1 3.1 0.3 872.5 165.8 0.0 282.3 11.1 0.0 1.0 5.1 69.6 257.0 43.6 0.0 0.7 0.0 49.3 0.0 7.5 159.2 0.0 63.3 8.9 57.8 325.5 9.3 0.0 1.5 0.0 7.9 4.9 0.0 0.0 12.4 10.7 49.0 1.0 28.8 1.3 368.5 52.7 9.6 0.0 0.2 0.0 24.7 0.0 0.2 8.0 0.9 1.3 79.7 1048.5 GPRIN2 "KIAA0514, MGC15171" ENSG00000204175 "G protein regulated inducer of neurite outgrowth 2" O60269 10 46549044-46555530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 8.9;lung: 10.5;skin 1: 13.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 17.9;Exocrine glandular cells: 18.0;Mucus-secreting cells: 22.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.8;A549: 28.4;SiHa: 5.3;SK-BR-3: 15.7" "Low region specificity" "Detected in many" "HPA038129, HPA070760" Approved Approved "Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Plasma membrane, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA038129: AB_2675846, HPA070760: " "unprognostic (1.00e-2)" "unprognostic (1.91e-1)" "unprognostic (1.77e-2)" "prognostic unfavorable (8.60e-8)" "unprognostic (5.77e-2)" "prognostic favorable (3.47e-4)" "unprognostic (2.23e-1)" "unprognostic (2.67e-2)" "unprognostic (2.54e-1)" "unprognostic (1.27e-1)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.98e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.67e-3)" 0.0 0.0 0.0 0.6 0.2 0.0 1.1 6.5 0.0 0.2 5.7 6.6 0.0 0.0 2.8 0.1 0.0 0.0 0.0 5.2 1.7 0.0 10.5 0.0 1.2 0.0 4.1 0.0 3.0 0.0 1.6 4.0 4.2 1.5 0.0 13.8 8.9 0.0 0.2 0.0 5.1 1.3 2.3 0.3 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.3 0.0 1.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.2 0.0 0.0 0.0 0.0 1.5 0.4 0.7 0.1 5.3 15.7 0.0 1.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 3.0 0.0 2.4 1.4 0.4 0.1 5.1 2.7 1.2 3.5 0.0 0.0 0.0 11.6 7.9 0.0 12.8 0.0 18.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.3 0.0 0.0 12.9 0.3 0.0 0.0 0.0 22.0 0.0 9.1 10.5 0.4 2.4 0.0 0.0 0.0 0.5 0.4 5.4 0.0 0.0 6.3 1.1 GRP ENSG00000134443 "Gastrin releasing peptide" P07492 18 59220168-59230774 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.6;pituitary gland: 13.2;retina: 22.5" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 8.5;Glandular cells: 6.6;Late spermatids: 9.9;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BJ hTERT+: 8.6;fHDF/TERT166: 10.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 12.7;hippocampal formation: 34.7;midbrain: 24.8" "Secreted to blood" NA NA 340000 "unprognostic (3.91e-2)" "unprognostic (1.85e-1)" "unprognostic (2.30e-3)" "unprognostic (3.21e-2)" "unprognostic (7.86e-3)" "unprognostic (3.01e-3)" "unprognostic (1.14e-1)" "unprognostic (2.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (1.79e-1)" "unprognostic (5.86e-4)" "unprognostic (2.65e-4)" "unprognostic (9.94e-2)" "unprognostic (6.99e-2)" "unprognostic (5.16e-2)" 0.7 0.7 3.6 0.5 0.7 0.2 5.2 0.5 3.7 0.5 2.3 1.3 0.0 0.4 0.9 0.9 0.6 0.3 1.3 0.2 11.7 5.6 0.3 0.2 15.6 0.2 4.9 0.7 0.2 4.7 4.7 13.2 0.2 10.5 1.9 0.4 22.5 0.2 0.5 0.2 0.4 0.7 2.3 1.6 0.3 12.7 3.0 0.1 0.1 11.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 0.7 0.0 10.8 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 0.5 3.7 11.7 5.6 4.9 0.7 10.5 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 GSAP "LOC54103, PION" ENSG00000186088 "Gamma-secretase activating protein" A4D1B5 7 77310751-77416400 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 33.1" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 11.2;U-937: 14.7" "Low region specificity" "Detected in many" HPA023994 Approved Vesicles NA NA Vesicles "HPA023994: AB_1855386" "prognostic favorable (3.36e-4)" "unprognostic (3.70e-1)" "unprognostic (8.55e-3)" "unprognostic (4.53e-3)" "unprognostic (6.80e-3)" "unprognostic (3.52e-3)" "unprognostic (4.36e-2)" "unprognostic (7.18e-3)" "unprognostic (1.09e-1)" "unprognostic (9.98e-3)" "unprognostic (2.07e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (3.61e-1)" "unprognostic (1.82e-2)" "unprognostic (9.49e-2)" "prognostic favorable (4.15e-5)" 5.7 6.3 3.8 19.9 3.9 7.0 5.7 1.7 6.6 3.5 6.4 4.4 2.8 2.0 3.9 6.7 5.0 5.7 8.0 7.3 4.2 5.4 6.2 13.9 33.1 24.0 4.5 2.2 4.0 5.4 9.4 14.0 3.6 4.2 5.8 4.1 5.6 5.6 5.3 2.5 3.7 10.1 8.0 5.5 21.5 6.9 1.9 3.3 3.8 9.4 3.4 14.8 5.5 3.4 13.7 11.7 1.3 9.7 11.2 6.6 5.7 3.2 1.7 0.0 0.0 0.5 2.2 0.3 2.0 6.8 1.1 2.9 0.5 4.7 0.7 0.2 0.0 3.9 1.6 0.1 1.6 3.0 2.1 1.4 3.5 0.2 9.0 3.0 0.3 0.0 0.8 6.2 5.5 11.2 8.2 0.5 0.0 0.0 0.3 9.2 1.8 0.0 7.0 0.5 5.1 2.4 0.0 0.1 0.1 6.2 2.7 0.2 5.2 2.2 1.1 5.3 0.4 2.0 2.9 0.0 1.7 1.2 0.2 6.1 1.3 0.0 1.2 7.9 14.7 1.4 0.0 9.7 0.9 6.6 8.9 3.9 13.7 2.2 4.5 11.7 12.3 2.9 4.8 1.3 11.2 6.4 0.3 0.1 5.7 3.8 3.9 1.7 6.6 4.2 5.4 4.5 2.2 4.2 3.3 71.5 50.8 31.3 9.0 4.6 16.8 7.3 5.1 12.0 29.6 3.5 15.7 2.4 21.6 6.2 0.0 9.9 0.9 0.0 5.3 0.7 2.6 10.5 12.7 13.2 9.6 19.1 5.2 3.7 33.4 0.0 4.9 31.0 8.5 13.6 5.3 37.9 6.0 5.7 3.5 6.8 21.3 6.5 3.1 1.1 0.4 4.0 1.4 15.9 4.3 15.9 HELT "bHLHb44, HCM1228, HESL, MEGANE, Mgn" ENSG00000187821 "Helt bHLH transcription factor" A6NFD8 4 185018841-185020804 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 2.9;lung: 2.2;skin 1: 2.0" "Cell type enriched" "Detected in single" 9 "Distal tubular cells: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 5.2;HEK 293: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036188, HPA036189" Uncertain NA NA "HPA036188: AB_10672237, HPA036189: AB_2674997" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.2 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646021-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;lung: 29.7" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 69.8;TIME: 80.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 4.0 5.2 9.9 1.7 22.2 2.3 1.1 2.3 16.0 3.4 6.5 31.5 0.0 5.5 4.1 8.1 1.0 1.2 3.0 1.1 16.0 6.3 2.4 12.7 29.7 1.0 21.6 9.9 2.2 4.8 1.0 1.1 1.0 17.5 9.8 6.8 4.4 1.3 6.2 1.3 1.1 8.2 1.3 12.3 1.0 11.2 3.7 26.5 2.3 1.6 0.0 1.0 7.1 1.0 0.1 2.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 3.8 69.8 6.2 0.0 0.0 1.0 0.0 9.8 0.0 0.9 0.0 0.6 0.1 14.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.5 0.0 0.8 0.0 0.5 0.4 0.0 2.1 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.0 9.9 22.2 2.3 16.0 16.0 6.3 21.6 9.9 17.5 26.5 11.9 177.0 0.0 0.0 0.0 1.4 1.1 0.0 8.1 6.8 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.4 0.0 16.1 0.0 0.1 0.0 0.0 16.0 0.0 1.8 126.0 1.0 1.7 0.0 0.0 0.2 0.1 0.0 41.4 0.0 3.5 0.0 0.4 0.2 0.2 0.5 0.0 0.0 0.0 0.0 HIST1H4K "dJ160A22.1, H4/d, H4F2iii, H4FD" ENSG00000273542 "Histone cluster 1 H4 family member k" P62805 6 27831216-27831527 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4;lung: 2.9;lymphoid tissue: 3.1" "Group enriched" "Detected in some" 11 "Alveolar cells type 2: 1.1;Cardiomyocytes: 1.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HHSteC: 2.9;LHCN-M2: 2.9;RT4: 1.6;U-87 MG: 1.7" HPA042201 Supported NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (3.19e-1)" "unprognostic (9.09e-3)" "unprognostic (1.16e-1)" "unprognostic (4.84e-3)" "unprognostic (9.63e-2)" "unprognostic (9.13e-2)" "unprognostic (1.48e-1)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.79e-2)" "unprognostic (3.13e-2)" "unprognostic (2.79e-1)" "unprognostic (3.45e-1)" "unprognostic (4.16e-2)" "unprognostic (1.02e-1)" 0.7 0.0 1.0 3.1 3.4 0.0 0.0 0.7 2.0 0.4 0.6 0.3 0.0 0.0 0.0 0.5 2.1 0.0 1.3 0.0 0.3 0.1 0.0 2.9 2.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.7 1.1 0.0 0.9 0.0 2.1 0.5 2.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HLA-DQA2 HLA-DXA ENSG00000237541 "Major histocompatibility complex, class II, DQ alpha 2" P01906 6 32741342-32747215 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.7;lymphoid tissue: 51.1" "Cell type enhanced" "Detected in many" 22 "B-cells: 96.0;Hofbauer cells: 116.5;Kupffer cells: 86.7;Macrophages: 348.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.06e-3)" "unprognostic (2.46e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "unprognostic (2.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.64e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (4.40e-1)" "unprognostic (1.04e-1)" "unprognostic (7.67e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-2)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-2)" 6.1 2.7 0.5 1.5 0.5 1.5 3.6 0.0 1.5 6.3 1.8 2.1 0.0 1.5 3.8 1.5 2.5 1.9 27.2 16.5 1.0 0.9 12.5 3.5 37.7 43.6 1.3 0.6 1.5 1.5 1.5 1.5 1.9 3.0 7.9 1.5 6.5 19.9 2.5 1.5 4.7 11.7 1.5 5.9 35.5 2.3 1.5 0.0 40.5 3.5 6.7 51.1 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.2 1.0 0.9 1.3 0.6 3.0 0.0 3.0 2.2 96.0 0.2 20.8 0.0 0.4 0.0 5.3 5.7 3.5 0.0 0.2 0.0 0.0 0.5 8.7 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 116.5 0.0 2.4 3.1 86.7 0.5 1.1 348.8 23.6 35.1 0.0 0.0 0.3 0.0 0.0 1.5 0.0 6.5 0.2 0.0 0.0 20.5 0.3 21.5 0.0 0.7 HLA-DRB1 HLA-DR1B ENSG00000196126 "Major histocompatibility complex, class II, DR beta 1" "P01911, P04229, Q29974, Q9GIY3" 6 32578769-32589848 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.6;lung: 95.9" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 1496.4;Macrophages: 3257.5;monocytes: 4435.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 95.6" "Group enriched" "Detected in all" 10 "B-cells: 41.3;dendritic cells: 95.6;monocytes: 52.5" "Cell line enhanced" "Detected in some" "HDLM-2: 157.6;HMC-1: 22.4;THP-1: 18.9;U-266/70: 21.0;U-698: 27.1;U-87 MG: 43.5" "CAB015400, CAB034021, HPA043151" Enhanced NA NA "CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342" "unprognostic (3.69e-3)" "unprognostic (3.66e-3)" "unprognostic (1.80e-2)" "unprognostic (2.40e-3)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.22e-3)" "unprognostic (8.56e-2)" "unprognostic (3.00e-2)" "unprognostic (1.23e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-3)" "unprognostic (6.16e-2)" "unprognostic (1.19e-1)" "unprognostic (5.10e-2)" "unprognostic (1.53e-1)" 36.8 18.7 9.7 32.2 15.9 8.7 24.9 3.6 10.0 14.2 18.2 11.5 11.2 0.2 10.5 27.2 12.1 13.3 12.0 11.9 8.5 6.9 50.0 15.6 95.9 80.8 18.9 5.4 6.9 8.0 0.0 9.4 5.7 14.8 9.5 23.7 16.1 11.3 2.4 8.2 13.3 42.1 3.8 19.7 62.1 38.1 5.6 13.2 33.6 14.1 3.8 44.7 29.7 17.0 41.3 95.6 6.3 52.5 2.7 4.7 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.2 0.0 0.6 0.0 157.6 1.7 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.5 0.2 0.6 18.9 0.0 0.0 0.1 0.3 0.0 21.0 0.5 27.1 43.5 0.7 0.0 0.2 34.6 6.3 1.8 52.5 0.3 32.7 1.2 3.7 95.6 41.3 0.1 1.6 1.2 2.7 26.9 20.4 4.7 37.7 9.7 15.9 3.6 10.0 8.5 6.9 18.9 5.4 14.8 13.2 137.0 520.2 984.8 8.4 154.2 1.7 28.0 109.5 140.5 174.0 134.3 0.0 2.5 21.6 104.5 3.5 441.7 148.8 0.0 65.2 4.6 54.7 18.7 119.2 3.4 1496.4 0.0 34.5 186.6 1186.4 7.6 13.8 3257.5 205.8 4435.6 52.0 8.3 76.3 364.7 25.1 169.2 9.4 25.8 72.3 1.8 3.4 129.4 5.7 137.1 73.6 61.3 HLA-DRB5 ENSG00000198502 "Major histocompatibility complex, class II, DR beta 5" Q30154 6 32517343-32530287 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 71.8;lymphoid tissue: 64.8" "Cell type enhanced" "Detected in many" 11 "B-cells: 354.6;Hofbauer cells: 502.6;Kupffer cells: 564.1;Macrophages: 808.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 26.4" "Group enriched" "Detected in many" 10 "B-cells: 13.3;dendritic cells: 26.4;monocytes: 16.0" "Group enriched" "Detected in some" 5 "HDLM-2: 112.0;HMC-1: 28.3;U-698: 33.5;U-87 MG: 44.2" HPA043151 Supported NA NA "HPA043151: AB_2678342" "unprognostic (1.97e-3)" "unprognostic (4.74e-2)" "unprognostic (3.30e-2)" "prognostic favorable (7.89e-4)" "unprognostic (2.28e-2)" "unprognostic (4.68e-3)" "unprognostic (9.09e-3)" "unprognostic (2.08e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.87e-1)" "unprognostic (2.89e-2)" "unprognostic (1.45e-1)" "unprognostic (7.60e-3)" "unprognostic (9.72e-2)" "unprognostic (5.48e-2)" 21.8 14.2 2.9 22.1 3.9 3.7 16.2 2.0 3.2 16.7 21.7 7.0 6.4 2.3 8.7 22.1 9.5 12.6 6.6 9.1 4.3 4.0 32.2 9.3 71.8 60.4 7.3 0.8 4.9 4.9 0.0 6.0 4.9 5.4 9.5 10.2 11.2 9.0 2.7 7.4 8.8 34.7 4.7 12.2 64.8 40.3 4.6 4.5 15.3 9.5 11.2 27.6 21.8 6.5 13.3 26.4 1.5 16.0 0.9 1.8 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 112.0 1.1 0.0 0.0 0.0 0.0 0.1 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 9.9 0.0 0.6 0.1 0.3 0.0 7.6 0.1 33.5 44.2 0.3 0.0 0.0 10.1 1.5 0.4 16.0 0.0 10.5 0.4 1.1 26.4 13.3 0.0 0.5 0.3 0.9 8.1 5.9 1.8 15.4 2.9 3.9 2.0 3.2 4.3 4.0 7.3 0.8 5.4 4.5 14.9 139.1 354.6 2.3 92.6 0.6 6.9 137.6 5.3 7.9 14.0 3.9 1.1 1.7 1.1 2.3 236.0 13.4 0.0 6.9 2.7 11.4 6.5 57.8 3.4 502.6 0.0 1.7 114.2 564.1 3.7 14.7 808.2 114.7 129.0 14.9 0.0 18.4 51.8 32.2 19.6 1.4 19.4 37.4 0.7 0.2 79.3 2.6 71.0 3.5 18.2 HS3ST2 3OST2 ENSG00000122254 "Heparan sulfate-glucosamine 3-sulfotransferase 2" Q9Y278 16 22814177-22916338 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 12.7;brain: 38.2;lung: 13.4" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 3.2;Bipolar cells: 3.5;Hofbauer cells: 13.5;Peritubular cells: 5.3;Smooth muscle cells: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 10.5;SH-SY5Y: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017736 Approved NA NA "HPA017736: AB_1851095" "unprognostic (4.09e-2)" "unprognostic (2.90e-3)" "unprognostic (5.97e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (2.00e-1)" "unprognostic (1.05e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-1)" "unprognostic (2.75e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "prognostic favorable (1.35e-4)" "unprognostic (4.89e-2)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (3.00e-2)" 12.7 1.7 3.8 1.1 6.5 1.1 2.4 0.5 38.2 2.0 1.4 0.3 0.3 1.0 1.0 1.0 1.2 1.0 1.1 3.8 7.8 4.3 1.0 2.2 13.4 2.1 2.2 8.4 4.5 1.0 1.0 0.4 1.2 1.5 2.0 1.4 5.0 2.9 1.1 1.0 2.0 1.0 1.2 1.0 1.1 1.1 1.1 0.0 0.0 1.8 0.4 1.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 6.5 0.5 19.1 7.8 4.3 2.2 8.4 1.5 0.0 0.0 0.0 0.0 0.1 3.2 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 13.5 0.0 0.0 0.6 0.6 0.7 1.1 0.4 0.0 0.0 0.0 0.0 0.6 0.0 5.3 0.0 0.6 0.0 4.1 0.0 0.0 1.8 0.2 0.0 0.0 0.7 HTR3C ENSG00000178084 "5-hydroxytryptamine receptor 3C" Q8WXA8 3 184053047-184060671 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 6.8" "Cell type enriched" "Detected in single" 7 "Intestinal endocrine cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "GAMG: 3.8" "Not detected" "Not detected" NA NA "unprognostic (4.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (1.61e-1)" "unprognostic (2.88e-2)" "unprognostic (1.68e-2)" "unprognostic (8.72e-2)" "unprognostic (1.75e-1)" "unprognostic (3.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.3 0.0 0.1 0.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 ICAM1 "BB2, CD54" ENSG00000090339 "Intercellular adhesion molecule 1" P05362 19 10270835-10286615 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 68.3;lung: 91.3" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 568.7;Alveolar cells type 2: 522.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 31.6;Karpas-707: 90.1;RPMI-8226: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002126, CAB002142, HPA004877" Enhanced Approved "Plasma membrane,Cytosol" NA NA 87900000 3100000000 "Plasma membrane, Cytosol" "CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317" "prognostic favorable (7.09e-4)" "unprognostic (1.88e-1)" "unprognostic (1.94e-1)" "unprognostic (2.63e-2)" "unprognostic (3.25e-3)" "unprognostic (3.05e-1)" "unprognostic (1.45e-2)" "unprognostic (3.48e-1)" "unprognostic (3.18e-2)" "unprognostic (1.09e-2)" "unprognostic (1.49e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.32e-6)" "unprognostic (2.77e-1)" "unprognostic (2.16e-2)" "unprognostic (2.25e-1)" "unprognostic (3.70e-3)" 26.1 8.6 4.0 41.0 4.1 36.5 15.0 1.0 4.5 5.6 10.0 2.7 1.6 6.1 8.5 7.7 7.9 10.7 19.8 16.3 2.6 2.1 10.9 68.3 91.3 32.8 5.4 1.7 12.4 7.2 2.5 4.0 9.3 6.8 10.4 6.6 10.6 7.2 3.6 13.9 6.9 7.9 8.0 7.8 42.2 7.3 6.5 3.6 8.3 11.6 13.7 13.4 14.8 17.1 2.2 13.3 22.2 14.2 7.9 5.6 8.9 8.4 0.1 1.5 0.0 0.4 0.9 2.1 1.7 18.8 4.2 12.7 2.8 9.5 7.7 26.2 0.7 19.3 1.7 0.3 0.0 8.9 23.1 0.0 0.7 0.2 11.5 31.6 0.2 4.5 11.1 0.7 2.6 4.1 0.4 2.1 0.9 2.9 90.1 0.3 0.6 0.1 6.5 0.5 0.1 4.8 0.2 0.0 28.6 7.2 0.0 0.0 0.2 11.6 0.6 18.4 0.7 1.4 0.5 6.5 4.3 0.4 2.4 0.1 27.5 28.3 4.8 7.0 4.9 6.3 2.2 13.9 2.6 3.0 14.2 5.6 2.2 2.4 3.6 13.3 0.9 1.0 2.2 22.2 7.9 7.9 7.5 3.4 8.9 4.0 4.1 1.0 4.5 2.6 2.1 5.4 1.7 6.8 3.6 568.7 522.3 12.0 22.9 75.8 0.0 0.8 20.4 80.3 159.3 3.5 0.0 1.0 0.0 152.6 1.9 139.3 0.5 0.0 84.4 2.5 171.6 19.1 133.1 12.9 75.0 0.0 2.4 56.4 41.3 1.1 4.4 160.6 72.6 168.7 0.3 2.3 107.4 0.0 1.4 9.4 0.3 6.5 95.4 0.5 1.7 60.6 1.0 12.7 0.5 10.0 ICAM4 "CD242, LW" ENSG00000105371 "Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)" Q14773 19 10286967-10288522 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 53.1;bone marrow: 13.7;lung: 13.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 62.5;Alveolar cells type 2: 75.3;Club cells: 34.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.0;pons and medulla: 2.4" "Cell type enriched" "Detected in many" 5 "non-classical monocyte: 53.1" "Lineage enriched" "Detected in many" 6 "monocytes: 53.1" "Cell line enhanced" "Detected in some" "HEL: 36.1;HMC-1: 9.1;K-562: 18.6;NB-4: 15.5;U-937: 8.7" "Intracellular and membrane" NA NA 1.9 0.4 0.4 1.6 0.4 13.7 0.6 0.2 2.0 1.0 2.9 0.2 0.0 1.1 1.1 2.9 2.3 1.1 1.1 1.1 0.5 0.3 1.6 1.7 13.5 3.3 0.4 0.0 1.2 0.4 0.1 0.4 1.9 2.4 2.4 0.5 0.9 2.5 2.7 1.7 0.8 1.4 0.2 0.9 2.8 1.6 0.6 0.3 1.5 0.9 0.0 4.5 3.3 0.7 0.5 8.4 4.5 53.1 0.1 0.6 2.4 0.1 0.1 0.1 0.2 0.0 0.0 3.1 0.3 0.1 0.0 0.0 4.0 0.2 0.4 0.4 0.0 0.2 0.3 0.1 0.0 0.0 0.3 0.2 36.1 0.2 5.4 1.0 0.6 9.1 0.2 0.0 0.1 0.1 0.0 0.0 5.8 18.6 1.6 0.0 0.1 1.0 15.5 0.1 0.0 0.1 2.6 1.5 6.8 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.4 0.1 1.0 0.3 0.1 0.0 0.3 0.0 0.5 1.0 0.1 0.3 8.7 0.2 4.5 2.6 2.6 0.2 9.7 0.5 0.5 0.3 0.2 8.4 0.4 0.3 0.1 0.7 0.1 53.1 2.7 0.6 2.4 0.4 0.4 0.2 2.0 0.5 0.3 0.4 0.0 2.4 0.3 62.5 75.3 0.8 0.9 0.9 0.0 0.0 0.0 4.0 34.2 0.0 0.0 0.3 0.0 0.5 0.0 6.7 0.0 0.0 1.8 0.7 11.2 1.4 20.9 0.0 5.2 0.0 0.0 1.8 3.5 0.0 0.0 8.1 5.0 19.8 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.1 1.1 0.7 0.0 0.0 1.6 IFNG ENSG00000111537 "Interferon gamma" P01579 12 68154768-68159747 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Antiviral defense, Growth regulation" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.4;lung: 14.5" "Cell type enriched" "Detected in some" 14 "T-cells: 93.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "gdT-cell: 7.3;memory CD4 T-cell: 3.3;memory CD8 T-cell: 8.6;naive CD8 T-cell: 5.2" "Lineage enriched" "Detected in many" 7 "T-cells: 8.6" "Cell line enhanced" "Detected in some" "Karpas-707: 2.3;U-266/70: 2.3;U-698: 1.2" "Low region specificity" "Detected in some" CAB010344 Approved "Secreted to blood" NA NA 1470 "CAB010344: AB_2123447" "unprognostic (2.16e-4)" "unprognostic (1.93e-3)" "unprognostic (9.21e-2)" "unprognostic (1.04e-4)" "unprognostic (5.14e-1)" "unprognostic (3.96e-3)" "unprognostic (1.33e-1)" "unprognostic (3.17e-4)" "unprognostic (7.79e-2)" "unprognostic (7.97e-3)" "unprognostic (1.63e-2)" "unprognostic (5.36e-2)" "unprognostic (7.62e-9)" "unprognostic (3.54e-2)" "unprognostic (5.36e-1)" "unprognostic (6.32e-2)" "unprognostic (7.38e-3)" 2.4 0.9 0.3 4.5 0.3 14.4 0.5 0.1 1.0 1.4 0.9 0.5 0.0 0.2 0.6 1.4 1.3 0.2 0.6 1.0 0.3 0.3 0.7 4.1 14.5 8.5 1.5 0.4 0.4 0.2 0.0 0.5 0.8 0.6 1.2 0.4 1.1 1.4 0.2 1.7 0.3 0.7 0.7 1.3 4.1 0.8 0.2 0.0 0.8 1.3 3.1 4.7 2.2 0.6 0.5 0.0 0.2 0.0 1.2 8.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 3.3 8.6 0.0 0.5 0.8 5.2 0.2 1.2 0.0 0.0 0.2 1.1 0.3 0.3 0.1 1.0 0.3 0.3 1.5 0.4 0.6 0.0 0.0 0.0 0.5 0.4 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.8 0.1 0.0 0.0 1.3 3.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 93.0 0.1 0.1 IL18R1 "CD218a, IL-1Rrp, IL1RRP" ENSG00000115604 "Interleukin 18 receptor 1" Q13478 2 102311529-102398775 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.3" "Cell type enriched" "Detected in many" 5 "granulocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 26.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 13.8;HHSteC: 29.8;HMC-1: 20.0;U-937: 32.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA007615 Approved Approved Mitochondria "Intracellular and membrane" Yes No Mitochondria "HPA007615: AB_1851675" "unprognostic (3.60e-3)" "unprognostic (9.75e-3)" "unprognostic (1.12e-3)" "unprognostic (3.01e-2)" "unprognostic (2.34e-3)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.74e-2)" "unprognostic (3.59e-1)" "unprognostic (7.86e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.62e-1)" "unprognostic (1.62e-2)" "unprognostic (5.71e-2)" "unprognostic (2.48e-2)" 17.8 2.6 1.4 8.3 1.7 12.5 11.2 0.8 1.3 8.2 8.1 0.7 6.6 5.1 4.2 5.7 4.5 4.5 14.1 10.5 1.7 1.9 7.4 8.8 39.3 29.6 2.0 0.1 3.3 2.6 0.8 4.6 10.7 1.6 6.3 3.4 5.0 3.0 28.4 2.8 3.2 10.7 7.9 1.9 19.5 4.6 2.4 0.4 2.5 3.2 3.2 6.6 8.2 12.9 0.1 6.8 5.5 0.1 26.8 10.6 1.1 0.9 0.3 0.0 0.0 0.7 0.7 1.6 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.5 0.0 1.9 0.0 13.8 0.8 2.5 0.6 0.1 29.8 5.2 20.0 6.8 1.1 2.2 3.6 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.7 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.4 0.6 0.4 2.4 0.4 0.0 0.0 0.0 0.1 32.0 2.3 5.5 0.0 2.4 4.2 0.1 10.6 0.1 2.4 3.0 2.0 0.1 0.4 0.8 4.1 26.8 0.0 6.8 2.4 1.1 1.4 1.7 0.8 1.3 1.7 1.9 2.0 0.1 1.6 0.4 0.0 13.3 0.0 1.0 0.7 0.0 1.5 0.0 5.3 3.4 1.8 0.0 0.0 1.7 0.8 0.0 7.1 0.0 0.0 0.5 0.7 2.2 0.8 104.4 6.2 0.1 0.0 0.0 13.5 3.1 0.0 0.3 19.4 3.3 0.0 0.0 0.3 0.7 0.0 0.0 0.8 0.0 6.5 0.9 0.2 0.4 0.9 0.0 22.4 0.0 0.7 IL1RL1 "DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1" ENSG00000115602 "Interleukin 1 receptor like 1" Q01638 2 102311502-102352037 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 49.7;lung: 77.2;placenta: 95.0" "Cell type enriched" "Detected in many" 11 "granulocytes: 477.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.9" "Group enriched" "Detected in many" 5 "basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6" "Group enriched" "Detected in some" 59 "basophil: 17.1;eosinophil: 17.0" "Lineage enriched" "Detected in single" 59 "granulocytes: 17.1" "Group enriched" "Detected in some" 6 "HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007406, HPA007917" Uncertain Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 19100000 1700000 "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA007406: AB_1079128, HPA007917: AB_1079129" "unprognostic (7.25e-2)" "unprognostic (9.72e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (5.28e-2)" "unprognostic (1.98e-2)" "unprognostic (3.25e-3)" "unprognostic (2.07e-1)" "unprognostic (2.77e-1)" "unprognostic (4.50e-2)" "unprognostic (8.58e-2)" "unprognostic (9.74e-2)" "unprognostic (1.44e-1)" "unprognostic (1.32e-2)" "unprognostic (1.60e-2)" "unprognostic (1.17e-1)" "unprognostic (4.60e-3)" 10.7 7.5 1.4 2.0 11.4 0.9 6.9 0.5 6.6 2.6 3.1 0.1 0.1 1.3 1.7 0.9 2.7 0.8 7.8 16.6 5.6 1.8 49.7 6.2 77.2 1.4 3.8 0.0 0.7 2.8 0.8 1.8 95.0 14.6 1.9 2.3 1.0 0.7 5.7 2.8 1.1 2.0 3.3 5.0 1.0 6.7 0.8 0.3 0.0 5.6 0.7 0.9 6.0 2.6 0.0 0.0 17.1 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 3.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 1.3 0.1 0.0 0.0 9.7 0.1 0.1 55.4 0.4 82.4 1.1 0.3 1.3 8.9 0.1 40.2 0.0 0.2 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.1 17.1 0.0 17.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 11.4 0.5 6.6 5.6 1.8 3.8 0.0 14.6 0.3 8.9 22.8 0.0 15.1 7.6 0.0 1.8 0.0 12.0 13.6 1.8 0.0 0.0 0.0 0.0 0.2 29.2 0.0 0.0 0.4 0.1 4.2 8.9 477.2 0.0 0.0 0.0 0.0 44.2 0.3 0.9 0.9 11.2 3.3 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.2 38.8 5.2 0.0 0.0 4.4 0.0 4.3 0.0 11.1 IL7R CD127 ENSG00000168685 "Interleukin 7 receptor" P16871 5 35852695-35879603 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1" "Group enriched" "Detected in many" 5 "monocytes: 441.0;T-cells: 326.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1" "Group enriched" "Detected in many" 33 "NK-cells: 19.1;T-cells: 70.3" "Cell line enhanced" "Detected in many" "BJ: 22.2;BJ hTERT+ SV40 Large T+: 20.1;fHDF/TERT166: 41.6;HBF TERT88: 38.3;REH: 86.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB010215, HPA067550" Supported "Plasma membrane" "Intracellular and membrane" NA NA 180000 "Plasma membrane" "CAB010215: AB_673727, HPA067550: " "unprognostic (2.93e-3)" "unprognostic (3.38e-2)" "unprognostic (3.82e-3)" "unprognostic (5.58e-3)" "unprognostic (3.06e-2)" "unprognostic (1.74e-1)" "unprognostic (2.51e-3)" "unprognostic (5.53e-2)" "unprognostic (1.12e-1)" "unprognostic (9.29e-3)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (1.76e-2)" "unprognostic (5.64e-2)" "unprognostic (3.27e-3)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" 6.7 3.6 0.7 34.0 0.7 3.1 4.8 0.5 0.6 4.8 20.6 0.3 0.9 3.5 1.8 2.9 6.6 3.7 8.5 1.9 0.7 0.7 7.0 2.7 52.6 133.1 0.8 0.1 2.5 1.7 0.0 1.5 1.2 0.8 3.3 5.4 1.7 13.2 1.8 0.9 1.8 34.0 1.2 1.5 32.3 7.8 3.0 0.4 130.9 5.1 5.3 42.9 12.6 4.6 0.4 0.3 1.3 0.2 19.1 70.3 12.7 0.1 0.0 0.1 0.1 0.1 0.1 0.2 22.2 11.2 20.1 11.9 0.1 0.1 2.1 0.0 41.6 3.7 3.5 0.0 1.3 38.3 1.8 0.2 0.6 2.4 0.0 0.3 0.2 1.6 0.3 0.0 4.3 0.9 0.5 0.5 0.1 0.1 0.3 15.7 0.0 0.5 0.2 0.1 0.0 1.0 86.5 1.2 0.1 0.0 1.2 0.0 0.0 3.7 0.3 0.0 0.1 0.1 0.0 1.5 7.9 13.4 3.4 2.9 0.2 0.0 2.5 4.0 2.1 6.1 0.5 0.2 0.1 19.2 0.2 70.3 0.2 39.9 28.0 0.1 0.4 34.5 22.5 1.3 19.1 0.2 0.3 6.7 12.7 0.7 0.7 0.5 0.6 0.7 0.7 0.8 0.1 0.8 0.4 14.9 19.4 10.9 1.9 10.3 0.0 3.2 0.0 10.7 4.5 0.0 0.0 0.1 0.0 0.9 0.1 3.6 0.0 23.3 1.6 0.1 7.1 1.1 18.5 4.5 10.4 0.0 0.0 17.8 12.7 0.0 0.0 79.7 20.3 441.0 0.0 0.0 0.2 0.9 0.0 0.6 0.0 0.0 9.0 0.0 0.0 9.2 0.2 326.6 0.0 3.8 INMT ENSG00000241644 "Indolethylamine N-methyltransferase" O95050 7 30697985-30757602 "Enzymes, Predicted intracellular proteins" Detoxification "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 73.5" "Group enriched" "Detected in many" 10 "Ito cells: 257.8;Leydig cells: 264.1;Peritubular cells: 428.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "CACO-2: 18.7;HHSteC: 8.0" HPA061343 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA061343: AB_2684483" "unprognostic (1.70e-1)" "unprognostic (4.36e-2)" "unprognostic (5.26e-2)" "unprognostic (6.78e-3)" "unprognostic (1.59e-1)" "unprognostic (3.39e-4)" "prognostic favorable (5.72e-4)" "unprognostic (3.08e-2)" "unprognostic (3.94e-2)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (9.07e-2)" "unprognostic (4.97e-2)" "unprognostic (1.62e-2)" "unprognostic (1.43e-2)" "unprognostic (9.71e-2)" "unprognostic (1.58e-2)" 19.7 18.0 0.3 3.0 0.7 0.0 5.9 0.3 0.6 4.9 3.7 1.3 14.0 0.8 9.8 18.9 12.4 16.3 14.7 24.6 0.6 0.4 11.8 24.3 73.5 12.1 1.1 0.8 20.2 4.0 0.7 3.2 12.9 2.5 10.1 1.6 13.0 6.1 19.9 4.7 1.5 3.9 11.3 1.3 6.5 5.0 28.2 0.2 0.5 9.4 3.8 2.8 9.6 6.4 1.7 1.1 4.2 1.0 2.2 1.0 0.6 0.0 0.1 0.1 0.1 1.8 2.6 0.4 0.2 2.4 0.0 0.0 18.7 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 8.0 0.1 0.3 0.9 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.3 0.3 0.1 0.0 0.4 0.9 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.6 0.1 0.8 0.0 0.8 0.2 0.1 1.1 0.1 0.8 0.3 0.1 0.8 0.3 0.1 0.2 0.1 0.3 4.2 1.0 0.8 0.7 0.4 0.7 1.2 0.7 0.6 0.4 1.7 1.0 0.8 3.0 2.2 0.4 1.1 0.6 0.6 0.3 0.7 0.3 0.6 0.6 0.4 1.1 0.8 2.5 0.2 0.0 5.1 0.0 0.2 1.9 0.0 7.8 2.5 1.4 4.5 0.0 0.0 0.5 0.0 0.0 1.3 9.7 0.0 0.0 0.0 0.2 21.8 0.2 0.0 3.0 0.7 0.0 1.2 257.8 19.4 8.5 264.1 0.5 3.3 0.0 0.0 0.0 0.0 0.0 428.2 0.0 0.0 32.3 16.0 1.4 1.4 1.9 1.5 0.0 0.0 0.3 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751662 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 101.3;Alveolar cells type 2: 59.1;Basal keratinocytes: 179.6;Suprabasal keratinocytes: 114.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.5;BEWO: 24.3;HaCaT: 13.8;hTCEpi: 26.6;SK-BR-3: 16.3" "Group enriched" "Detected in many" 5 "midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3" "Low region specificity" "Detected in all" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: AB_2682566" "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favorable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 2.4 0.1 0.8 0.1 2.8 0.1 27.9 8.4 1.7 0.4 0.7 0.7 4.4 0.1 0.1 2.5 3.1 0.2 0.1 2.1 1.9 1.7 14.3 0.1 32.8 0.3 3.9 0.2 0.1 1.9 2.7 1.4 9.0 36.9 3.9 0.3 1.8 26.6 1.4 0.3 17.7 0.1 0.1 4.8 0.1 8.7 3.1 2.2 0.0 1.4 3.1 3.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 40.5 0.0 2.2 1.6 24.3 2.4 1.3 2.0 1.6 4.8 0.0 0.0 0.0 4.5 0.0 13.8 0.0 9.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 26.6 0.9 8.2 0.0 0.0 0.0 0.0 0.0 1.4 7.8 0.0 0.0 4.5 10.5 0.0 0.0 2.5 0.0 9.0 0.0 1.5 0.0 7.9 16.3 0.0 6.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 8.4 0.5 1.9 1.7 3.9 0.2 36.9 2.2 101.3 59.1 0.0 14.0 179.6 0.5 2.4 0.0 10.7 30.7 7.0 0.0 23.0 23.2 0.1 3.9 0.5 0.5 0.0 0.0 17.1 12.8 15.9 1.1 0.0 2.8 0.0 0.0 0.0 0.0 8.9 0.0 1.3 18.6 0.0 1.5 0.2 0.5 1.9 0.0 0.5 2.4 0.0 16.9 0.7 3.8 114.7 12.7 0.0 1.9 9.2 ITGAE "CD103, HUMINAE" ENSG00000083457 "Integrin subunit alpha E" P38570 17 3714628-3801243 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.2;lung: 25.9;lymphoid tissue: 13.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.1;memory CD8 T-cell: 7.4;T-reg: 1.9" "Lineage enriched" "Detected in many" 7 "T-cells: 7.4" "Cell line enriched" "Detected in single" 21 "MOLT-4: 16.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036313, HPA052147" Enhanced NA NA 13000 "HPA036313: AB_10795355, HPA052147: " "unprognostic (9.81e-2)" "unprognostic (1.78e-3)" "unprognostic (7.86e-2)" "prognostic favorable (1.04e-4)" "unprognostic (2.17e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-1)" "unprognostic (8.02e-2)" "unprognostic (2.92e-2)" "unprognostic (1.10e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.34e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (8.40e-3)" "unprognostic (1.15e-1)" "unprognostic (1.82e-2)" "prognostic favorable (3.56e-4)" 3.6 0.2 0.3 13.0 0.6 8.0 0.9 0.2 0.2 0.6 9.6 0.2 0.0 4.9 0.4 0.4 2.0 1.5 2.7 0.2 0.5 0.4 0.3 0.3 25.9 8.1 0.3 0.0 0.9 1.2 0.5 0.4 0.1 0.2 1.2 2.0 0.2 1.8 3.9 0.3 0.6 20.2 2.0 0.7 1.4 3.6 1.6 0.1 3.1 1.0 1.5 5.3 1.9 2.5 0.2 0.1 0.0 1.0 0.0 7.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.7 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 1.0 3.1 0.2 1.0 7.4 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.9 0.9 0.3 0.6 0.2 0.2 0.5 0.4 0.3 0.0 0.2 0.1 6.0 25.5 50.2 35.5 26.7 15.9 58.6 43.3 28.1 21.6 14.0 7.9 24.2 77.9 33.2 38.9 29.2 23.6 0.0 57.0 49.7 37.3 38.0 67.9 39.4 49.2 6.4 27.1 40.5 43.7 30.3 24.7 54.5 55.6 41.5 24.9 35.9 42.9 21.0 28.0 67.5 13.0 25.8 38.1 61.9 29.7 36.1 11.0 55.3 34.6 29.8 ITGAX CD11c ENSG00000140678 "Integrin subunit alpha X" P20702 16 31355134-31382997 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.9;blood: 31.7;lung: 33.2;lymphoid tissue: 46.3" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 80.7;granulocytes: 70.6;Hofbauer cells: 46.3;Kupffer cells: 28.3;Macrophages: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 10.1;eosinophil: 9.2;intermediate monocyte: 18.1;myeloid DC: 12.4;neutrophil: 31.7;NK-cell: 14.9;non-classical monocyte: 20.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HMC-1: 49.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004458, HPA004723, CAB072871" Enhanced NA NA "CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231" "unprognostic (9.75e-3)" "unprognostic (2.49e-2)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (1.89e-1)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (9.59e-2)" "unprognostic (8.06e-3)" "unprognostic (3.20e-1)" "unprognostic (7.75e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.82e-1)" "unprognostic (2.95e-2)" 47.9 1.9 4.4 28.1 5.7 28.6 2.9 1.4 4.4 1.8 2.1 17.1 0.6 1.7 2.1 2.5 1.9 4.3 7.7 2.5 5.3 4.6 2.3 4.6 33.2 24.4 13.6 3.8 3.0 2.1 0.8 2.4 3.3 8.1 2.5 3.2 2.5 4.3 1.3 1.1 1.6 3.8 3.3 15.6 46.3 3.3 0.9 7.5 3.8 2.2 0.9 9.7 5.1 1.9 0.8 12.4 31.7 20.3 14.9 1.8 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.1 0.0 0.0 0.1 0.0 8.3 0.0 0.0 0.1 0.1 0.0 0.5 49.2 0.0 0.0 0.8 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.5 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.8 0.1 3.9 10.1 9.2 1.8 18.1 0.1 0.8 0.0 0.3 12.4 0.4 0.0 0.2 31.7 14.9 20.3 0.2 0.0 3.2 4.4 5.7 1.4 4.4 5.3 4.6 13.6 3.8 8.1 7.5 11.9 80.7 2.9 0.2 2.5 0.0 1.4 0.0 2.7 19.4 0.0 0.0 0.3 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.2 2.1 0.2 70.6 0.0 46.3 0.0 0.0 0.0 28.3 0.0 0.0 71.4 1.7 2.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.1 1.0 0.3 5.0 0.0 0.0 KHDC3L "C6orf221, ECAT1" ENSG00000203908 "KH domain containing 3 like, subcortical maternal complex member" Q587J8 6 73362677-73364171 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 4.1;epididymis: 1.5;lung: 3.0;lymphoid tissue: 4.4;testis: 4.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 3155 "testis cancer: 254.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;NTERA-2: 2.1;SuSa: 1.1" HPA043699 Uncertain NA NA "HPA043699: AB_10960564" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (4.36e-1)" 0.2 0.5 1.2 0.2 2.1 0.0 0.2 4.1 0.9 0.2 0.2 0.2 0.2 0.1 0.2 1.5 0.3 0.1 0.2 0.2 2.1 0.6 0.2 0.2 3.0 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.6 0.3 4.9 0.2 4.4 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.5 0.5 0.2 2.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.8 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 4.1 0.9 2.1 0.6 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 KIR2DL1 "47.11, CD158A, cl-42, nkat1, p58.1" ENSG00000125498 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1" P43626 19 54769811-54784322 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.8;lung: 4.0;lymphoid tissue: 4.5" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 2: 4.5;granulocytes: 2.3;T-cells: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Cell line enriched" "Detected in single" 26 "U-266/84: 2.5" NA NA "unprognostic (2.14e-1)" "unprognostic (9.82e-2)" "unprognostic (8.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.93e-1)" "unprognostic (1.55e-2)" "unprognostic (3.19e-4)" "unprognostic (4.11e-2)" "unprognostic (6.87e-2)" "unprognostic (1.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.84e-2)" "unprognostic (3.61e-2)" 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.0 0.1 2.8 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 2.2 4.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.8 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.8 4.5 0.4 1.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 KIR2DL3 "CD158B2, cl-6, nkat2, nkat2a, nkat2b, p58" ENSG00000243772 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3" P43628 19 54738515-54753052 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 3.0;lymphoid tissue: 5.6" "Group enriched" "Detected in some" 42 "Alveolar cells type 2: 2.2;T-cells: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.37e-2)" "unprognostic (2.35e-2)" "unprognostic (2.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.92e-1)" "unprognostic (7.76e-3)" "unprognostic (1.55e-2)" "unprognostic (1.99e-1)" "unprognostic (1.41e-2)" "unprognostic (2.41e-4)" "unprognostic (1.19e-1)" "unprognostic (1.91e-1)" "unprognostic (1.62e-2)" "unprognostic (1.59e-2)" 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.1 2.1 0.1 0.1 0.2 0.1 2.2 0.0 0.0 0.1 0.4 3.0 2.4 0.0 0.0 1.0 0.1 0.1 0.0 0.8 0.1 1.3 0.1 1.1 1.9 0.1 0.1 0.1 0.1 0.1 0.0 5.6 0.1 0.1 0.8 0.6 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 0.0 0.0 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122213-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 123.9" "Group enriched" "Detected in many" 7 "Alveolar cells type 2: 374.8;monocytes: 592.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Group enriched" "Detected in many" 8 "granulocytes: 7.6;T-cells: 6.6" "Cell line enhanced" "Detected in some" "EFO-21: 57.7;HDLM-2: 14.6;HHSteC: 21.4;hTCEpi: 19.5;JURKAT: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB025133, HPA051467" Enhanced Enhanced Vesicles NA NA 47000 Vesicles "CAB025133: , HPA051467: AB_2681495" "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favorable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavorable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.5 0.7 0.4 14.1 0.4 0.0 0.5 0.3 0.4 1.0 0.6 0.1 0.6 0.4 0.4 1.0 2.5 0.5 0.8 0.4 0.4 0.4 0.8 0.6 123.9 11.2 0.4 0.1 0.4 8.3 0.0 0.6 1.0 0.6 1.0 1.7 0.2 6.8 1.9 0.4 1.9 1.4 0.8 0.5 2.0 0.8 8.4 0.0 21.3 8.3 3.1 11.3 3.3 0.9 0.4 0.0 7.6 0.1 0.8 6.6 1.1 3.5 0.1 0.0 0.5 0.0 0.0 2.8 0.0 0.9 0.6 0.1 0.8 1.8 0.0 57.7 0.3 6.5 0.5 1.2 2.2 0.1 14.6 1.7 0.0 0.1 0.1 21.4 0.0 0.5 0.3 19.5 0.0 2.6 0.0 2.6 17.7 0.1 3.4 0.1 0.0 0.8 0.1 0.1 0.3 0.8 0.0 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.1 1.5 0.7 1.1 0.1 2.7 0.0 1.0 0.1 0.0 1.2 4.3 0.1 0.0 0.0 0.0 0.4 0.1 7.6 0.4 0.0 3.2 0.1 2.7 1.7 0.0 0.4 3.5 2.0 1.9 0.8 0.1 0.0 6.6 1.1 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.6 0.0 59.6 374.8 0.5 3.2 5.4 0.0 1.2 2.5 9.4 15.9 1.8 0.0 1.9 0.0 0.6 26.0 0.5 0.0 0.0 5.3 0.2 0.2 1.2 17.4 0.0 1.3 0.0 0.0 0.0 0.0 69.6 0.6 3.1 1.7 592.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 5.0 1.0 0.5 0.3 2.0 LANCL3 FLJ42925 ENSG00000147036 "LanC like 3" Q6ZV70 X 37571569-37684463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.1;lung: 6.8" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 7.8;Suprabasal keratinocytes: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 7.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 17.2;HMC-1: 5.6;K-562: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005470, HPA076575" Approved Approved Mitochondria NA NA Mitochondria "HPA005470: AB_2134886, HPA076575: AB_2732315" "unprognostic (6.76e-2)" "unprognostic (4.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.85e-1)" "unprognostic (5.20e-2)" "unprognostic (5.26e-2)" "unprognostic (3.60e-1)" "unprognostic (1.21e-3)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.81e-2)" "unprognostic (2.88e-1)" "unprognostic (7.90e-5)" "unprognostic (4.01e-3)" "unprognostic (7.93e-3)" "unprognostic (1.11e-2)" "unprognostic (2.08e-2)" 1.2 0.8 0.7 0.3 2.3 0.9 0.4 2.5 2.4 1.2 3.8 0.7 0.2 0.6 0.5 0.3 4.6 0.2 0.9 0.7 1.1 2.8 0.4 0.2 6.8 0.4 1.3 1.3 1.3 0.2 0.1 1.7 0.2 2.2 0.6 2.8 2.5 1.1 0.9 1.0 2.6 1.1 1.9 1.8 0.2 2.2 1.8 0.9 0.2 1.2 1.7 1.2 1.8 2.9 0.3 0.2 7.1 0.2 1.1 1.8 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 1.1 2.5 0.3 0.0 0.0 0.3 17.2 1.8 0.0 0.0 0.0 5.6 0.0 0.5 0.0 0.1 0.0 0.3 0.0 3.9 0.0 1.2 0.0 0.2 0.3 0.4 0.2 1.7 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 1.2 0.0 0.0 1.6 0.7 0.0 0.0 2.9 0.0 0.4 7.1 0.2 0.9 1.0 0.2 0.8 0.2 0.4 1.8 0.1 0.3 0.1 1.0 1.1 1.1 0.2 0.2 0.6 0.7 0.7 2.3 2.5 2.4 1.1 2.8 1.3 1.3 2.2 0.9 3.0 2.6 0.0 1.1 7.8 0.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 0.2 0.1 0.4 0.5 1.1 0.0 0.1 3.2 1.7 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.5 1.3 0.9 1.4 0.0 1.4 0.0 1.7 0.2 1.7 3.9 0.1 1.0 0.6 2.2 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007299-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 64.2;lung: 16.1;ovary: 20.5" "Cell type enriched" "Detected in some" 15 "Ciliated cells: 499.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 3.7;Hep G2: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA052489: AB_2681850" "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.1 0.1 0.0 0.0 0.6 2.1 0.4 64.2 1.1 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 20.5 0.1 0.0 1.5 0.1 0.2 0.5 0.0 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.8 4.8 0.0 0.0 0.7 0.5 2.1 0.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 3.7 0.0 1.9 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 0.3 0.8 15.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.6 0.3 0.0 0.1 1.0 0.0 0.1 0.8 0.1 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.2 2.1 0.4 0.3 0.4 0.2 0.3 0.5 0.3 0.4 0.1 0.7 0.4 0.5 2.1 0.4 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.0 7.4 0.0 0.2 0.0 0.0 0.0 0.0 499.2 34.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 4.7 0.0 0.1 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 LGI3 ENSG00000168481 "Leucine rich repeat LGI family member 3" Q8N145 8 22146825-22157084 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 20.3;Melanocytes: 38.8" "Cancer enhanced" "Detected in many" "melanoma: 14.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.2;GAMG: 2.1;SCLC-21H: 4.6;SK-MEL-30: 4.6;U-2 OS: 2.6;WM-115: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024826 Approved Cytosol "Secreted in brain" NA NA Cytosol "HPA024826: AB_10601131" "unprognostic (4.41e-2)" "unprognostic (1.78e-1)" "unprognostic (3.28e-1)" "unprognostic (8.11e-3)" "unprognostic (1.14e-1)" "unprognostic (7.45e-2)" "unprognostic (3.38e-1)" "unprognostic (2.43e-2)" "unprognostic (9.64e-2)" "unprognostic (1.64e-2)" "unprognostic (6.25e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-5)" "unprognostic (1.36e-2)" "unprognostic (9.41e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 1.2 4.8 13.1 1.1 26.4 1.1 1.2 7.7 52.2 2.6 1.2 35.5 0.0 1.4 1.5 1.3 6.1 2.0 1.1 1.5 20.7 15.7 1.1 1.0 17.7 1.0 24.2 10.4 1.1 1.5 0.9 0.7 1.0 24.9 2.3 1.1 4.6 1.2 4.2 1.0 16.3 1.4 1.7 29.8 1.1 1.3 1.4 14.8 0.0 14.9 0.0 1.3 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.0 2.1 1.1 0.8 0.3 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.3 0.0 4.6 0.6 0.0 0.0 4.6 0.0 0.5 0.0 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 26.4 7.7 32.1 20.7 15.7 24.2 10.4 24.9 14.8 0.0 20.3 0.0 0.0 2.1 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 38.8 0.0 0.0 1.0 0.1 0.0 6.7 0.0 2.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 LIPH "LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B" ENSG00000163898 "Lipase H" Q8WWY8 3 185506262-185552613 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.8;lung: 28.5;stomach 1: 27.0" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 134.0;Enterocytes: 247.9;Mucus-secreting cells: 115.8;Urothelial cells: 130.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 37.9;OE19: 8.6;RPTEC TERT1: 19.2;T-47d: 9.1;U-266/84: 9.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA049079 Approved "Secreted to blood" NA NA "HPA049079: AB_2680623" "unprognostic (4.50e-3)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (9.40e-4)" "unprognostic (3.38e-1)" "unprognostic (1.01e-1)" "unprognostic (8.59e-2)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (7.88e-2)" "prognostic favorable (9.20e-5)" "unprognostic (1.84e-1)" "unprognostic (1.97e-1)" "prognostic favorable (4.21e-4)" "unprognostic (1.15e-1)" 0.3 0.5 0.5 5.1 1.2 0.0 2.1 0.3 1.4 2.5 20.4 0.6 3.1 6.2 0.2 5.1 12.9 0.5 16.5 0.6 0.4 0.7 8.5 0.5 28.5 0.0 0.3 0.0 0.7 13.6 0.0 2.1 0.9 1.8 10.7 21.9 2.1 15.7 3.0 0.3 6.1 28.8 1.6 0.3 0.5 27.0 6.2 0.0 0.2 0.4 4.1 14.9 8.8 5.0 0.9 0.4 2.4 0.9 0.6 0.7 1.7 5.1 6.8 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.1 0.1 0.6 37.9 0.0 3.9 0.1 1.5 1.8 2.8 0.0 0.2 0.0 0.8 0.9 0.9 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 0.3 8.6 0.5 0.0 0.0 0.5 19.2 4.6 0.0 0.0 0.5 6.3 0.1 0.3 9.1 0.1 0.0 0.0 0.5 0.0 0.1 0.6 9.0 0.0 0.0 0.0 0.0 2.2 0.9 0.4 0.5 0.2 0.3 0.4 0.5 0.4 0.2 0.9 0.7 0.6 2.4 0.6 0.4 0.4 0.3 1.7 0.5 1.2 0.3 1.4 0.4 0.7 0.3 0.0 1.8 0.0 134.0 29.7 0.0 12.6 0.7 0.4 0.4 68.8 45.5 54.6 64.6 0.0 0.2 1.7 42.3 0.0 0.2 247.9 0.0 22.4 0.1 0.4 71.5 6.9 0.0 0.0 0.0 21.4 1.3 0.0 0.0 0.0 0.1 15.1 1.0 115.8 0.3 39.8 89.6 0.0 1.6 0.7 0.0 0.2 0.5 0.0 1.8 0.2 0.0 61.8 130.6 LPCAT1 "AGPAT10, AGPAT9, AYTL2, FLJ12443" ENSG00000153395 "Lysophosphatidylcholine acyltransferase 1" Q8NF37 5 1456480-1523977 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 35.6" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 286.5;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 34.9;EFO-21: 33.5;PC-3: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012501, HPA022268" Enhanced Supported "Endoplasmic reticulum,Lipid droplets" NA NA "Endoplasmic reticulum" "Lipid droplets" "HPA012501: AB_1845224, HPA022268: AB_1845225" "unprognostic (5.33e-3)" "prognostic unfavorable (7.11e-5)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (3.13e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.88e-8)" "unprognostic (5.90e-2)" "unprognostic (6.37e-2)" "unprognostic (2.08e-2)" "prognostic favorable (4.90e-5)" "unprognostic (4.89e-2)" "prognostic unfavorable (2.64e-7)" "unprognostic (2.60e-1)" "unprognostic (3.13e-1)" "unprognostic (1.52e-1)" "unprognostic (4.03e-1)" 9.8 5.6 5.2 9.0 5.7 5.1 7.4 9.2 9.5 5.4 7.5 2.9 4.5 3.9 7.0 3.2 3.2 5.9 5.8 4.3 5.3 5.2 4.9 3.1 35.6 8.5 3.2 3.7 5.0 5.4 3.1 5.6 10.0 4.6 5.2 2.3 13.6 4.5 4.4 3.5 3.2 5.9 5.5 3.3 28.8 9.4 3.0 2.9 5.8 4.7 1.4 8.1 6.6 10.6 0.9 0.7 2.4 1.7 1.7 3.6 0.6 2.0 3.0 0.5 3.3 0.3 0.5 34.9 7.8 0.4 0.4 0.3 1.1 0.9 6.8 33.5 0.2 1.4 5.8 0.6 0.2 0.2 16.5 14.2 1.6 4.9 2.0 0.6 1.7 4.6 0.6 0.1 0.3 0.1 0.5 0.4 2.3 3.7 1.3 0.0 4.3 6.4 2.6 12.3 0.1 23.3 12.3 0.6 4.9 1.4 2.8 4.4 4.3 6.2 5.7 1.8 0.3 2.6 2.7 3.9 0.6 7.7 2.3 2.8 4.4 4.2 1.6 1.4 2.8 2.1 0.0 0.6 0.8 3.6 1.7 3.6 0.9 0.8 1.8 0.7 0.7 0.1 1.0 2.4 1.7 1.2 0.2 0.8 0.6 5.2 5.7 9.2 8.0 5.3 5.2 3.2 3.7 4.6 2.9 80.4 286.5 25.1 1.9 5.6 52.2 3.2 7.6 5.3 21.6 14.0 137.4 5.1 0.0 16.9 1.5 10.3 2.6 0.0 11.7 67.8 9.3 5.6 8.1 4.0 21.8 22.3 14.3 18.4 26.3 1.5 10.0 16.2 6.8 10.8 9.0 28.2 22.2 0.0 14.5 4.4 124.0 0.0 12.3 1.7 9.8 3.4 26.5 26.7 2.5 1.6 LRRK2 "DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2" ENSG00000188906 "Leucine rich repeat kinase 2" Q5S007 12 40196744-40369285 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Differentiation" "GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 40.4;lung: 50.4" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 391.0" "Group enriched" "Detected in many" 7 "lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 40.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 40.4" "Cell line enhanced" "Detected in some" "A549: 9.9;ASC TERT1: 10.2;BJ hTERT+: 5.7;RPTEC TERT1: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014293, CAB037160" Approved Supported Vesicles NA NA Vesicles "CAB037160: AB_1840989, HPA014293: AB_1853353" "unprognostic (2.67e-1)" "unprognostic (1.75e-1)" "unprognostic (6.45e-3)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-3)" "unprognostic (2.71e-1)" "unprognostic (3.14e-1)" "unprognostic (2.25e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "prognostic favorable (3.02e-6)" "unprognostic (2.55e-2)" "unprognostic (3.43e-2)" "unprognostic (2.01e-3)" "unprognostic (5.21e-3)" 3.7 3.4 2.3 7.0 3.9 8.6 3.0 1.7 5.0 5.1 4.5 1.7 2.6 0.7 5.3 2.9 5.3 3.8 4.5 4.0 1.8 1.4 10.6 4.5 50.4 6.8 2.2 3.6 5.8 3.3 10.9 2.5 1.0 1.9 3.6 1.6 3.3 4.2 2.0 5.6 2.6 3.4 6.7 4.9 8.6 2.7 1.2 2.4 0.5 3.9 2.7 4.9 4.6 6.8 0.9 1.5 40.4 5.8 0.0 0.0 0.8 0.0 9.9 0.1 0.0 3.9 10.2 0.1 2.1 5.7 0.4 0.3 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.3 0.0 0.4 0.0 0.8 0.3 0.2 0.0 0.7 0.5 0.1 2.5 0.7 0.0 0.2 3.8 0.6 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.2 0.0 0.1 0.0 0.0 0.0 10.9 0.0 0.1 0.6 0.0 0.2 2.8 0.3 2.8 2.2 1.4 1.2 1.1 1.2 0.7 0.0 0.0 0.0 2.4 0.0 0.5 0.0 5.8 1.2 0.0 3.1 0.0 0.9 0.0 0.0 1.5 0.9 0.0 0.0 40.4 0.0 3.0 0.2 0.0 0.8 2.3 3.9 1.7 5.0 1.8 1.4 2.2 3.6 1.9 2.4 29.8 391.0 17.5 1.5 2.2 7.5 6.9 5.1 5.3 30.7 26.2 0.0 0.0 1.7 0.8 0.4 4.5 0.0 0.0 2.3 0.1 9.4 0.6 12.8 7.8 4.6 44.5 0.0 9.2 74.8 0.0 17.5 19.9 11.8 10.8 0.0 11.0 1.1 0.0 11.3 15.2 0.9 0.0 3.9 0.2 0.4 2.8 0.3 0.8 0.0 0.5 LRRN4 "C20orf75, dJ1056H1.1, NLRR4" ENSG00000125872 "Leucine rich repeat neuronal 4" Q8WUT4 20 6040778-6054049 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 9.5;kidney: 13.0;lung: 36.4" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.8;Ductal cells: 3.6;Proximal tubular cells: 2.2" "Group enriched" "Detected in many" 7 "lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "RPTEC TERT1: 40.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA075974 Uncertain "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 32000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA075974: AB_2686770" "unprognostic (6.16e-2)" "unprognostic (1.69e-3)" "unprognostic (2.40e-3)" "unprognostic (9.04e-3)" "unprognostic (5.95e-2)" "unprognostic (1.32e-2)" "unprognostic (2.59e-1)" "unprognostic (8.94e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-2)" "unprognostic (2.79e-2)" "unprognostic (4.83e-3)" "unprognostic (1.15e-3)" "unprognostic (2.33e-2)" "unprognostic (6.88e-2)" "unprognostic (2.31e-1)" "unprognostic (9.84e-3)" 9.5 0.1 0.0 2.4 1.1 0.1 0.1 0.0 0.2 0.7 2.2 0.0 0.0 0.1 0.1 2.8 0.1 1.5 0.1 1.1 0.0 0.2 13.0 0.4 36.4 0.1 0.0 0.0 1.6 2.6 0.1 0.0 3.4 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 40.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.4 0.2 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.9 3.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.8 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LTK TYK1 ENSG00000062524 "Leukocyte receptor tyrosine kinase" P29376 15 41503638-41513887 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 13.4;Ito cells: 14.7;Mucus-secreting cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "MAIT T-cell: 8.3;plasmacytoid DC: 7.0" "Group enriched" "Detected in many" 10 "dendritic cells: 7.0;T-cells: 8.3" "Cell line enhanced" "Detected in some" "HEL: 5.4;NB-4: 10.5;RH-30: 5.1;THP-1: 16.1" "Low region specificity" "Detected in many" HPA059545 Approved Vesicles NA NA Vesicles "HPA059545: AB_2684057" "unprognostic (9.47e-4)" "unprognostic (5.52e-4)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (4.12e-1)" "unprognostic (5.65e-3)" "unprognostic (1.74e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.81e-3)" "unprognostic (9.36e-3)" "unprognostic (5.36e-2)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" 1.0 0.5 0.5 5.1 1.6 3.1 0.5 2.0 3.2 0.6 8.2 0.5 1.9 10.6 1.3 1.1 1.2 0.3 2.0 2.2 0.5 0.1 3.5 4.3 15.1 0.6 0.5 0.5 1.0 0.5 1.0 0.7 8.9 0.5 0.7 4.8 4.3 11.7 0.5 2.0 0.9 10.7 0.5 0.5 5.5 8.3 2.4 0.8 0.5 0.7 0.5 2.2 0.6 0.7 0.7 7.0 0.0 0.0 0.0 8.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.6 1.0 1.3 2.4 0.0 0.0 0.1 0.7 0.0 0.0 2.9 0.0 0.4 0.2 1.4 5.4 0.0 0.0 2.4 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 2.0 0.0 2.1 0.0 0.0 10.5 0.4 2.0 0.2 0.2 5.1 0.2 0.0 0.0 0.5 3.4 0.1 0.2 0.0 3.0 0.2 16.1 0.0 0.0 0.2 0.2 0.1 0.4 0.2 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.6 0.0 8.3 0.7 0.5 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.2 0.5 1.6 2.0 3.2 0.5 0.1 0.5 0.5 0.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 5.1 4.0 1.2 0.0 0.0 0.2 0.0 0.0 2.1 0.1 13.4 0.0 0.2 1.1 0.2 0.0 0.0 0.2 0.1 0.0 1.7 14.7 3.2 1.7 0.0 0.0 3.3 0.0 7.8 0.0 0.5 3.5 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.1 0.3 1.3 2.8 0.0 LY6G6E "C6orf22, G6e" ENSG00000255552 "Lymphocyte antigen 6 family member G6E" 6 31711771-31714065 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 111 "HEL: 23.1" HPA056234 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056234: AB_2732601" "unprognostic (1.77e-1)" "unprognostic (1.58e-2)" "unprognostic (2.25e-1)" "unprognostic (6.88e-2)" 0.3 0.0 2.9 0.0 0.5 4.3 0.0 0.0 5.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.3 0.2 1.7 0.1 0.0 0.3 3.9 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.6 0.7 0.2 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.6 2.2 0.0 0.1 0.2 0.4 0.4 0.8 1.1 0.4 0.1 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.4 0.4 0.4 0.7 0.4 0.0 0.2 0.3 0.4 1.1 0.1 0.3 0.8 0.7 1.0 2.9 0.5 0.0 5.2 1.7 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6G6F "C6orf21, G6f, LY6G6D, NG32" ENSG00000204424 "Lymphocyte antigen 6 family member G6F" Q5SQ64 6 31706885-31710595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enriched" "Detected in single" 141 "HEL: 14.0" HPA008053 Uncertain NA NA 12000000 "HPA008053: AB_1840160" "unprognostic (3.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.66e-3)" 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 1.1 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 4.3 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGI3 MAGI-3 ENSG00000081026 "Membrane associated guanylate kinase, WW and PDZ domain containing 3" Q5TCQ9 1 113390749-113685923 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 50.7" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 247.1;Bipolar cells: 91.7;Club cells: 97.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008444 Supported "Cell Junctions" NA NA "Cell Junctions" "HPA008444: AB_2668069" "unprognostic (4.07e-1)" "unprognostic (3.59e-2)" "unprognostic (1.54e-3)" "unprognostic (2.32e-2)" "unprognostic (2.31e-2)" "unprognostic (5.21e-3)" "unprognostic (2.23e-1)" "unprognostic (7.06e-2)" "unprognostic (2.80e-2)" "prognostic favorable (4.29e-4)" "unprognostic (1.09e-2)" "unprognostic (1.03e-1)" "prognostic favorable (2.60e-8)" "unprognostic (1.71e-2)" "unprognostic (7.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-2)" 4.4 4.3 9.5 9.0 6.2 0.4 11.6 11.3 11.9 4.9 15.3 1.3 1.7 7.4 6.2 8.7 10.0 4.8 6.3 4.2 6.6 9.5 9.6 8.0 50.7 2.6 8.0 7.9 8.0 13.3 7.1 8.2 9.2 5.2 5.5 10.5 5.9 7.8 3.6 2.4 3.1 25.1 5.9 5.4 3.6 14.6 4.9 3.9 3.9 16.5 9.1 9.0 4.5 9.8 0.1 0.7 1.1 0.2 0.8 1.8 0.2 8.1 9.4 9.0 4.0 4.2 6.1 2.7 5.8 2.7 4.4 5.0 8.3 2.4 0.3 4.3 5.1 3.7 3.6 8.1 4.3 5.5 8.8 8.7 3.5 8.2 3.8 1.0 2.8 5.3 3.2 2.2 4.6 10.3 5.3 6.0 3.7 4.4 7.8 5.9 5.3 4.6 0.7 3.3 13.8 5.9 6.6 14.4 1.0 5.2 3.6 8.3 8.6 6.7 11.3 2.0 11.9 5.8 1.5 10.6 7.3 9.2 6.6 7.9 3.1 2.5 0.0 3.8 1.4 5.8 0.4 0.2 0.0 0.5 0.0 0.5 0.0 1.3 0.2 0.7 0.1 1.8 0.1 1.1 0.8 0.2 0.2 0.0 0.2 9.5 6.2 11.3 11.9 6.6 9.5 8.0 7.9 5.2 3.9 247.1 72.0 0.0 7.8 9.6 91.7 7.5 15.3 21.4 97.8 12.2 47.1 12.8 6.6 8.8 20.1 12.0 41.6 0.0 9.3 1.7 11.3 11.7 5.8 12.2 3.3 38.1 13.2 9.8 1.8 21.6 9.5 2.8 11.8 0.0 19.0 36.6 11.9 26.6 10.6 4.3 46.3 12.9 6.9 15.9 10.1 6.6 4.6 1.8 25.9 8.9 MALL BENE ENSG00000144063 "Mal, T cell differentiation protein like" Q13021 2 110083870-110116566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 107.7;intestine: 142.1;lung: 72.9" "Cell type enhanced" "Detected in many" 14 "Ductal cells: 224.3;Enterocytes: 724.1;Pancreatic endocrine cells: 223.5;Urothelial cells: 444.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 9.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.3" "Cell line enhanced" "Detected in some" "A-431: 40.7;A549: 39.9;CAPAN-2: 55.2;fHDF/TERT166: 60.6;HaCaT: 43.0;PC-3: 24.4" "Low region specificity" "Detected in single" HPA051410 Uncertain NA NA "HPA051410: AB_2681474" "unprognostic (5.17e-1)" "unprognostic (4.15e-2)" "unprognostic (2.92e-1)" "unprognostic (3.53e-1)" "unprognostic (1.92e-2)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (4.46e-2)" "unprognostic (6.50e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (2.37e-1)" "unprognostic (7.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.84e-1)" "unprognostic (2.80e-1)" "unprognostic (6.50e-3)" 5.5 1.0 0.9 11.1 2.1 0.1 7.7 0.4 1.1 22.5 46.4 0.2 1.3 41.2 6.0 2.7 107.7 2.8 6.7 10.8 1.7 1.0 1.9 1.1 72.9 3.7 1.1 0.2 1.6 2.9 49.8 1.0 3.7 3.6 5.5 19.0 1.6 11.2 1.5 2.1 11.1 142.1 5.1 4.2 2.0 1.8 2.2 0.4 0.6 5.6 45.8 63.8 7.8 35.4 0.9 0.7 9.3 0.7 2.1 1.0 0.5 40.7 39.9 0.0 0.1 0.0 0.0 0.1 7.9 0.4 0.0 0.0 6.6 55.2 0.1 20.1 60.6 0.0 43.0 0.0 2.3 0.0 0.1 0.0 0.3 1.1 0.0 0.3 0.0 0.1 0.9 2.2 0.1 0.0 0.0 19.8 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 19.1 24.4 0.0 0.0 0.1 5.2 2.3 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.2 20.3 0.0 0.1 0.1 0.1 0.0 0.0 4.7 0.0 0.0 0.0 9.3 0.7 1.0 0.4 0.4 0.4 0.7 0.8 0.7 0.3 0.9 0.5 1.0 4.4 2.1 0.2 0.7 0.6 0.5 0.9 2.1 0.4 1.1 1.7 1.0 1.1 0.2 3.6 0.4 38.7 157.7 0.0 55.9 14.5 0.0 2.8 5.1 10.7 42.1 1.8 0.0 0.1 0.0 224.3 19.6 50.2 724.1 0.0 57.6 0.1 7.4 142.5 6.9 0.6 6.2 0.0 16.8 27.6 1.2 5.6 2.3 1.8 13.5 1.8 39.1 0.0 223.5 112.2 1.1 11.3 0.0 0.0 5.0 7.7 0.9 11.5 0.5 1.3 52.5 444.9 MARCO "SCARA2, SR-A6" ENSG00000019169 "Macrophage receptor with collagenous structure" Q9UEW3 2 118942166-118994660 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 66.3;lung: 65.6;lymphoid tissue: 58.7" "Cell type enriched" "Detected in some" 6 "Kupffer cells: 829.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 15.8;intermediate monocyte: 26.7" "Lineage enriched" "Detected in many" 5 "monocytes: 26.7" "Cell line enhanced" "Detected in some" "HaCaT: 4.0;THP-1: 5.7;U-2 OS: 6.2;U-266/70: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063793 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 24000000 "Golgi apparatus" Vesicles "HPA063793: AB_2685123" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (5.96e-3)" "unprognostic (3.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.58e-2)" "unprognostic (3.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (6.27e-3)" "unprognostic (5.13e-2)" "unprognostic (2.24e-3)" "unprognostic (1.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (6.55e-2)" 22.8 11.7 0.8 29.6 1.1 0.9 3.3 2.3 1.3 0.3 2.8 0.9 0.0 0.6 0.3 12.9 5.2 13.8 0.8 10.8 0.6 0.4 1.6 66.3 65.6 29.3 1.3 3.1 4.7 0.4 0.2 0.8 2.3 2.7 4.5 0.7 1.0 2.9 0.8 6.8 1.1 1.3 9.6 1.7 58.7 2.2 2.8 0.6 0.0 3.0 0.5 0.4 8.8 1.1 0.0 5.0 0.3 26.7 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.9 4.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.7 0.0 0.0 6.2 0.9 0.0 3.6 0.0 0.2 0.0 1.3 0.0 0.0 15.8 0.0 0.0 26.7 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.3 0.0 3.2 0.4 0.0 3.4 0.8 1.1 2.3 1.3 0.6 0.4 1.3 3.1 2.7 0.6 23.8 42.6 0.0 0.0 1.0 0.0 0.4 0.0 24.1 30.7 3.5 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.7 1.5 0.1 11.6 0.8 145.4 0.0 0.0 13.5 829.9 0.0 0.0 63.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.6 1.3 0.0 0.0 MATN1 "CMP, CRTM" ENSG00000162510 "Matrilin 1, cartilage matrix protein" P21941 1 30711277-30723587 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 6.6" "Cell type enhanced" "Detected in some" 14 "B-cells: 2.7;Club cells: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 3.0" "Group enriched" "Detected in many" 10 "B-cells: 3.0;T-cells: 2.3" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;Karpas-707: 3.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA028580 Supported "Secreted to extracellular matrix" NA NA "HPA028580: AB_10601913" "unprognostic (4.71e-2)" "unprognostic (6.92e-2)" "unprognostic (1.73e-2)" "unprognostic (3.75e-6)" "unprognostic (9.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.31e-3)" "unprognostic (2.63e-1)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (7.31e-2)" "unprognostic (5.22e-2)" "unprognostic (4.01e-13)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (3.42e-2)" 0.4 0.4 1.1 1.0 0.7 2.6 0.4 0.4 1.7 2.0 0.4 0.4 0.4 0.3 1.7 0.6 0.4 0.9 0.7 0.4 1.2 1.1 0.4 0.4 6.6 2.0 1.1 0.4 2.9 0.6 0.0 1.1 1.1 0.4 0.5 0.0 0.4 1.4 0.4 0.4 0.9 0.5 0.4 1.4 1.4 0.5 1.0 0.4 0.4 1.4 0.4 0.4 0.5 1.2 3.0 0.1 0.2 0.1 0.0 2.3 0.6 0.9 0.5 0.2 1.0 0.2 0.0 0.3 0.5 0.2 0.1 0.0 0.1 1.5 0.7 3.5 0.1 0.7 1.3 0.2 0.1 0.2 1.5 0.4 1.3 1.0 0.1 0.0 0.4 1.0 0.0 0.0 0.0 0.9 0.6 0.0 0.4 2.0 3.5 0.0 1.4 0.1 0.2 0.2 0.3 1.0 0.5 1.4 0.5 0.0 0.4 0.4 0.6 0.5 0.4 0.8 0.6 0.4 1.2 0.6 0.3 0.8 0.2 0.8 0.9 0.1 0.3 0.0 0.6 2.1 0.0 0.1 0.0 0.5 0.0 0.9 0.9 0.6 0.5 0.0 3.0 2.3 1.2 0.2 0.0 0.0 0.1 0.8 0.6 1.1 0.7 0.4 1.7 1.2 1.1 1.1 0.4 0.4 0.4 0.0 0.3 2.7 0.5 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 0.5 0.1 0.2 0.0 0.0 0.1 MATN3 "EDM5, HOA" ENSG00000132031 "Matrilin 3" O15232 2 19992111-20012694 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 19.5;placenta: 16.6" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 35.7;Sertoli cells: 25.8;Smooth muscle cells: 11.4" "Cancer enhanced" "Detected in all" "pancreatic cancer: 13.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "Hep G2: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA051250 Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" NA NA "Endoplasmic reticulum, Golgi apparatus" "HPA051250: AB_2681406" "unprognostic (3.47e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (7.57e-2)" "unprognostic (2.75e-2)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.62e-5)" "unprognostic (1.27e-1)" "unprognostic (4.84e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.54e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.51e-1)" "unprognostic (7.04e-2)" "unprognostic (3.15e-2)" 2.4 1.3 6.6 1.0 5.1 0.3 3.4 1.8 7.9 4.1 1.0 2.4 2.6 0.9 2.7 1.8 1.4 2.6 3.4 0.9 6.2 4.9 4.1 0.4 19.5 0.7 8.6 3.7 1.1 1.3 0.4 0.3 16.6 7.4 2.7 1.0 1.9 0.8 7.2 0.5 0.9 0.8 2.8 7.9 0.7 2.8 1.6 6.0 0.0 1.7 0.0 0.7 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 1.9 6.5 0.0 1.9 4.1 0.4 0.8 0.4 2.6 3.4 1.8 1.1 0.0 0.3 0.6 2.5 0.4 0.1 5.0 3.8 0.0 0.1 0.0 0.4 56.1 0.4 0.0 0.0 8.8 0.3 2.9 0.7 1.8 3.5 0.0 0.0 0.0 5.5 0.9 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 7.9 1.7 0.0 0.8 4.2 0.7 2.4 11.6 7.7 0.0 1.9 3.9 4.8 0.1 0.4 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 5.1 1.8 7.9 6.2 4.9 8.6 3.7 7.4 6.0 35.7 2.1 0.0 0.3 0.2 0.0 0.2 0.0 2.7 2.3 1.8 0.0 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.2 1.6 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.7 0.0 4.2 0.3 0.0 25.8 11.4 0.0 1.5 0.1 0.1 0.0 0.0 0.1 MCEMP1 "C19orf59, MGC132456" ENSG00000183019 "Mast cell expressed membrane protein 1" Q8IX19 19 7676628-7679826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 34.6;Club cells: 20.5;Hofbauer cells: 30.0;Kupffer cells: 41.3;Macrophages: 51.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 2.9" "Group enriched" "Detected in some" 5 "classical monocyte: 36.5;neutrophil: 16.6" "Group enriched" "Detected in many" 5 "granulocytes: 16.6;monocytes: 36.5" "Group enriched" "Detected in some" 6 "THP-1: 19.2;U-937: 59.8" HPA014731 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014731: AB_1845619" "unprognostic (4.84e-2)" "unprognostic (9.81e-4)" "unprognostic (2.41e-1)" "unprognostic (4.36e-2)" "unprognostic (8.85e-3)" "unprognostic (2.62e-3)" "unprognostic (5.57e-3)" "unprognostic (1.42e-1)" "unprognostic (2.19e-1)" "unprognostic (4.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.69e-5)" "unprognostic (1.15e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" 2.2 0.3 0.3 10.0 0.5 30.9 0.5 0.4 0.9 0.1 0.3 0.0 0.0 0.1 0.1 0.2 0.3 1.2 0.2 4.8 0.2 0.2 0.6 1.3 66.4 11.8 2.9 0.0 0.4 0.4 0.0 0.1 0.8 0.6 0.4 0.0 0.1 0.6 0.0 0.2 0.1 0.3 2.4 0.9 24.2 0.6 0.7 0.3 0.3 0.7 0.0 0.1 0.5 2.9 0.0 5.3 16.6 36.5 0.2 0.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.8 0.0 0.0 36.5 0.9 0.1 2.1 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.1 16.6 0.2 0.1 0.3 0.1 11.6 0.3 0.5 0.4 0.9 0.2 0.2 2.9 0.0 0.6 0.3 17.9 34.6 1.4 0.0 0.0 0.0 0.3 0.0 9.4 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 7.0 0.0 30.0 0.0 0.0 0.0 41.3 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 MMP13 CLG3 ENSG00000137745 "Matrix metallopeptidase 13" P45452 11 102942995-102955734 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 12.6;vagina: 10.8" "Group enriched" "Detected in some" 8 "Club cells: 30.7;Urothelial cells: 14.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 70.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HaCaT: 19.5;PC-3: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB002742 Supported "Secreted to extracellular matrix" NA NA "CAB002742: " "unprognostic (8.98e-3)" "unprognostic (1.54e-1)" "unprognostic (4.75e-2)" "unprognostic (4.57e-2)" "unprognostic (3.05e-2)" "unprognostic (1.59e-3)" "unprognostic (1.32e-1)" "unprognostic (6.35e-3)" "unprognostic (1.69e-1)" "unprognostic (7.55e-3)" "unprognostic (2.24e-1)" "unprognostic (1.73e-8)" "unprognostic (2.12e-2)" "unprognostic (3.14e-1)" "unprognostic (4.14e-2)" "unprognostic (4.33e-2)" 0.5 0.1 0.0 0.8 0.0 1.3 0.4 0.0 0.2 1.3 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 12.6 0.1 0.0 0.0 0.1 0.0 0.0 3.1 0.1 0.1 1.2 0.0 0.0 0.6 0.0 0.0 1.0 0.5 0.0 0.0 0.1 0.1 1.9 0.0 1.4 0.0 0.0 0.1 4.6 10.8 1.0 0.7 2.7 0.5 1.9 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 19.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.6 1.3 0.4 1.0 0.5 0.7 0.8 0.3 1.0 0.6 1.1 1.9 1.9 0.3 0.7 0.4 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 2.7 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 MRC1 "bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1" ENSG00000260314 "Mannose receptor C-type 1" P22897 10 17809344-17911170 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 44.8;lymphoid tissue: 37.8" "Group enriched" "Detected in many" 6 "Hofbauer cells: 135.5;Ito cells: 511.3;Kupffer cells: 324.4;Macrophages: 182.8" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "myeloid DC: 8.2" "Lineage enriched" "Detected in single" 15 "dendritic cells: 8.2" "Group enriched" "Detected in some" 19 "MOLT-4: 17.7;TIME: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004114, HPA045134, CAB068203" Enhanced NA NA 130000000 "CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228" "unprognostic (2.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.03e-2)" "unprognostic (2.58e-1)" "unprognostic (5.62e-2)" "unprognostic (4.30e-1)" "unprognostic (6.36e-3)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (6.05e-2)" "unprognostic (5.61e-2)" "unprognostic (4.12e-1)" "unprognostic (2.94e-2)" "unprognostic (4.97e-2)" "unprognostic (3.05e-2)" "unprognostic (1.74e-2)" "unprognostic (7.02e-2)" 34.8 8.3 0.3 6.2 1.2 0.0 19.8 0.7 0.6 5.2 11.2 0.6 0.9 2.2 4.5 10.4 4.2 1.3 7.9 13.4 0.9 12.4 16.4 44.8 37.8 1.0 0.0 3.6 5.1 1.8 2.4 15.4 3.1 5.5 5.1 7.0 0.7 1.9 5.1 0.0 6.5 8.2 1.4 30.6 2.2 7.1 0.8 0.8 6.5 3.5 0.7 7.5 5.1 0.0 8.2 0.1 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.7 0.0 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.2 29.8 47.4 11.5 0.0 0.3 0.0 3.6 5.1 10.7 13.6 0.0 0.0 0.8 0.0 0.0 26.7 4.8 1.3 0.0 0.3 1.1 1.0 0.0 12.8 2.5 135.5 0.0 0.0 511.3 324.4 7.9 1.4 182.8 0.0 0.0 0.4 0.0 0.1 1.1 0.0 0.0 0.0 32.3 0.0 0.3 1.2 0.4 1.7 4.9 0.8 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756953-60776732 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 9.9;lung: 32.4" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 1: 89.3" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 9.9" "Lineage enriched" "Detected in single" 15 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7" "Region enriched" "Detected in single" 28 "olfactory region: 205.0" "Region enriched" "Detected in single" 30 "olfactory region: 39.1" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.3 0.3 0.0 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 1.8 0.3 0.4 1.0 0.3 0.3 0.3 0.2 0.3 0.3 32.4 0.3 0.3 0.3 2.4 0.3 0.0 0.3 1.1 0.3 0.3 0.5 0.3 0.3 1.9 0.3 0.2 1.4 1.7 0.3 0.3 0.2 0.6 0.3 0.3 0.3 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 9.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.4 1.6 3.8 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 13.5 5.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.9 0.5 0.0 0.0 1.8 0.7 0.0 0.6 0.0 0.0 9.9 0.7 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 89.3 4.8 0.0 0.0 0.0 0.0 0.2 0.0 2.7 11.4 0.0 0.0 0.7 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.0 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760762-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 85.5;lung: 88.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 175.7;Alveolar cells type 2: 67.0;Club cells: 66.0;Paneth cells: 190.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 9.0" "Group enriched" "Detected in many" 59 "dendritic cells: 9.0;monocytes: 2.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 104.2;EFO-21: 16.1;HeLa: 31.8;hTCEpi: 23.1;OE19: 19.3" "Low region specificity" "Detected in many" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 14000000 Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favorable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 36.5 0.0 0.4 6.7 0.5 0.7 0.3 0.1 0.4 5.4 5.4 0.8 26.8 2.1 4.8 18.9 3.1 85.5 9.6 4.3 0.4 0.3 2.6 0.2 88.5 0.4 0.6 0.0 22.3 0.4 0.0 0.6 13.7 0.9 1.9 1.2 0.2 14.4 33.1 0.0 0.5 0.7 1.0 0.8 0.1 3.7 2.1 0.0 0.1 0.1 0.6 7.8 1.4 1.3 0.0 9.0 0.0 2.6 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.5 1.8 0.4 1.5 104.2 0.0 16.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 31.8 1.2 0.9 0.0 0.0 0.0 23.1 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 19.3 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.4 0.4 0.5 0.1 0.4 0.4 0.3 0.6 0.0 0.9 0.0 175.7 67.0 0.0 1.3 0.2 1.3 1.2 50.9 25.4 66.0 24.4 0.0 0.1 0.0 1.6 1.1 0.0 1.9 0.0 0.7 0.0 0.6 1.2 0.0 0.0 2.9 0.0 2.9 0.0 0.6 4.5 4.4 2.6 1.7 7.2 1.3 0.0 19.2 190.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.1 0.1 0.0 2.5 37.2 MSR1 "CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII" ENSG00000038945 "Macrophage scavenger receptor 1" P21757 8 16107878-16567490 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 88.1;lung: 70.4" "Group enriched" "Detected in many" 4 "Hofbauer cells: 144.7;Kupffer cells: 246.5;Macrophages: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 16.0" "Lineage enriched" "Detected in many" 5 "monocytes: 16.0" "Group enriched" "Detected in many" 7 "BJ hTERT+: 48.2;REH: 18.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000272, CAB032491" Enhanced NA NA 25000 "CAB032491: AB_672722, HPA000272: AB_1846269" "unprognostic (8.19e-3)" "unprognostic (4.87e-2)" "unprognostic (1.93e-2)" "unprognostic (2.10e-1)" "unprognostic (9.24e-2)" "unprognostic (1.32e-2)" "unprognostic (5.85e-3)" "unprognostic (2.89e-1)" "unprognostic (9.70e-2)" "unprognostic (1.62e-2)" "unprognostic (7.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.76e-2)" "unprognostic (9.16e-2)" "unprognostic (7.39e-2)" "unprognostic (6.85e-2)" "unprognostic (4.69e-2)" 88.1 9.0 2.2 6.1 4.5 3.7 6.9 10.4 3.3 4.5 3.1 1.8 1.0 2.1 3.1 6.2 2.4 4.5 11.4 8.0 3.8 3.1 9.5 13.6 70.4 6.9 4.3 0.8 6.7 3.8 1.2 2.6 10.4 7.7 3.2 3.9 4.5 6.2 2.3 3.2 1.6 4.0 6.5 11.9 10.9 2.5 4.9 3.1 1.5 2.2 1.7 0.7 10.8 1.8 1.5 1.0 3.0 16.0 0.3 1.3 0.5 0.6 0.9 1.3 0.6 0.6 0.6 0.6 0.3 48.2 0.1 0.2 1.6 0.1 1.5 2.4 0.4 0.3 0.3 0.3 0.4 0.9 0.2 2.0 2.0 1.8 1.9 0.4 1.0 1.1 0.3 0.4 0.4 0.7 0.8 0.0 0.8 0.7 1.4 0.9 1.9 0.6 0.6 0.2 0.7 0.6 18.3 1.0 0.4 0.9 2.8 1.0 0.5 0.4 1.3 0.1 2.4 0.2 0.5 1.1 1.3 0.5 5.0 1.3 4.9 3.8 3.3 0.5 0.7 1.0 1.1 3.1 0.5 0.9 16.0 0.4 0.9 0.7 0.7 1.0 1.5 1.3 0.9 3.0 0.3 7.8 0.5 0.6 0.5 2.2 4.5 10.4 2.7 3.8 3.1 4.3 0.8 7.7 3.1 20.8 40.5 8.2 0.0 2.4 0.0 1.7 5.1 12.0 14.8 3.5 23.6 0.5 1.7 0.0 2.2 1.3 0.0 0.0 0.0 0.4 0.9 0.0 16.3 0.9 144.7 0.0 0.0 7.4 246.5 2.1 1.7 103.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 19.4 0.9 3.3 1.4 1.8 0.7 1.3 0.0 0.1 MUC1 "ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM" ENSG00000185499 "Mucin 1, cell surface associated" P15941 1 155185824-155192916 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 168.1;kidney: 158.5;lung: 143.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Group enriched" "Detected in many" 10 "granulocytes: 1.3;T-cells: 4.0" "Group enriched" "Detected in many" 6 "CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0" "CAB000036, CAB001986, HPA004179, HPA007235, HPA008855" Enhanced Supported "Plasma membrane" "Secreted in other tissues" NA NA 4900000 "Plasma membrane" "CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283" "unprognostic (4.74e-2)" "unprognostic (2.84e-2)" "unprognostic (2.19e-1)" "unprognostic (8.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.70e-1)" "unprognostic (2.61e-3)" "unprognostic (6.34e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.75e-1)" "unprognostic (2.05e-2)" "unprognostic (1.13e-1)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (1.21e-1)" 1.5 0.7 0.8 12.6 1.2 0.9 12.6 0.4 0.7 31.6 15.9 1.2 2.4 2.9 10.5 9.8 51.8 18.7 168.1 0.8 0.5 0.3 158.5 2.0 143.5 0.3 0.5 0.3 14.9 74.2 0.0 4.7 15.5 2.1 6.1 16.1 0.8 17.0 5.9 0.8 1.8 3.6 2.8 0.7 0.6 105.0 4.3 0.5 0.7 15.7 10.5 47.8 12.3 5.2 0.0 0.2 1.3 0.1 0.0 4.0 0.2 1.8 0.9 0.6 0.5 0.4 0.5 0.2 0.6 1.4 0.7 1.9 0.0 139.4 0.0 10.1 1.1 0.3 2.8 0.1 0.0 0.2 1.2 0.1 0.2 11.8 0.0 0.3 0.0 4.4 1.2 0.2 0.3 0.2 1.5 0.2 0.2 1.0 1.9 0.5 14.2 0.1 0.1 0.4 65.3 0.2 0.2 0.0 3.4 107.0 0.1 0.6 0.2 3.3 5.9 0.1 0.5 47.0 0.6 0.2 0.4 0.8 1.3 0.1 2.1 1.1 0.0 0.7 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.8 0.0 2.3 0.4 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.0 4.0 0.2 0.8 1.2 0.4 0.7 0.5 0.3 0.5 0.3 2.1 0.5 402.0 1308.2 0.9 16.1 0.6 1.0 0.4 384.7 92.3 252.5 465.9 3.9 0.1 29.9 144.7 27.3 3.5 49.2 0.0 994.6 1.2 3.1 11.6 45.2 0.5 0.2 1.6 29.4 1.3 3.4 68.9 2.3 2.6 5.0 42.3 249.7 1.1 807.2 66.2 1.4 0.9 0.2 0.0 1.9 6.2 0.8 1.0 0.2 0.0 132.5 164.3 MUC5AC MUC5 ENSG00000215182 "Mucin 5AC, oligomeric mucus/gel-forming" P98088 11 1157953-1201138 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "gallbladder: 70.3;lung: 87.0;stomach 1: 68.3" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 6.7;Club cells: 25.0;Pancreatic endocrine cells: 5.3" "Cancer enhanced" "Detected in many" "stomach cancer: 61.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "A549: 19.5;OE19: 13.0" "CAB002774, CAB009395, HPA040615" Enhanced "Secreted to digestive system" NA NA "CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042" "unprognostic (2.10e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.51e-2)" "unprognostic (4.56e-2)" "unprognostic (6.49e-2)" "unprognostic (2.44e-2)" "unprognostic (1.30e-3)" "unprognostic (8.46e-2)" "unprognostic (5.83e-4)" "unprognostic (1.84e-1)" "unprognostic (9.21e-3)" "unprognostic (4.07e-1)" "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 70.3 0.0 0.0 0.0 0.0 87.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 68.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 13.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.2 0.0 6.7 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 MYO1F ENSG00000142347 "Myosin IF" O00160 19 8520790-8577577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 69.4;Kupffer cells: 191.9;Macrophages: 117.9;T-cells: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 15.5;HL-60: 15.3;HMC-1: 27.2;NB-4: 60.4;THP-1: 45.0;U-937: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055242, HPA056036" Enhanced Enhanced Cytosol NA NA 8800 Cytosol "HPA055242: AB_2682754, HPA056036: " "unprognostic (4.86e-2)" "unprognostic (5.86e-3)" "unprognostic (1.39e-2)" "unprognostic (1.04e-3)" "unprognostic (1.76e-2)" "unprognostic (2.12e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (7.47e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.57e-1)" "unprognostic (9.35e-2)" 7.6 3.7 4.8 22.9 9.1 50.6 3.6 1.0 4.6 2.2 4.3 7.5 0.4 4.6 2.1 4.7 2.7 5.4 6.5 4.0 5.2 3.1 3.7 6.2 17.1 24.8 9.0 1.7 2.5 2.3 0.6 2.3 4.8 6.9 3.3 2.3 3.5 3.3 1.3 1.2 1.8 8.5 3.9 9.9 56.1 3.9 1.3 7.0 4.2 2.7 1.8 11.1 6.8 2.5 1.5 15.4 64.9 23.7 7.5 14.9 18.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 15.5 0.0 11.2 0.0 0.0 0.0 15.3 27.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 60.4 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 45.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 24.8 0.0 14.4 23.7 24.5 14.9 19.6 11.6 1.5 5.9 10.2 15.4 0.7 0.4 4.6 64.9 7.5 22.4 1.9 8.1 18.6 4.8 9.1 1.0 4.6 5.2 3.1 9.0 1.7 6.9 7.0 3.0 20.1 25.2 1.9 3.0 0.7 2.1 7.6 0.0 4.5 1.8 2.0 4.1 1.7 1.2 5.2 2.7 2.1 23.3 0.8 6.0 3.1 1.2 30.1 5.6 69.4 6.4 1.2 14.1 191.9 3.6 2.3 117.9 6.8 53.3 1.7 1.4 1.7 1.9 1.1 2.1 0.3 0.0 2.8 2.7 2.1 4.6 4.2 142.2 2.4 1.4 NAPSA "KAP, Kdap, NAP1, NAPA" ENSG00000131400 "Napsin A aspartic peptidase" O96009 19 50358477-50365830 "Enzymes, Plasma proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 47.5;lung: 153.3" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 2552.8" "Cancer enriched" "Detected in many" 18 "lung cancer: 249.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.5" "Group enriched" "Detected in many" 9 "B-cells: 5.1;dendritic cells: 10.5" "Cell line enriched" "Detected in some" 24 "U-698: 29.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB009591, HPA045280, HPA047236, HPA047744" Enhanced "Secreted in other tissues" NA NA 380000 "CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143" "unprognostic (5.36e-2)" "unprognostic (4.77e-2)" "unprognostic (1.64e-3)" "unprognostic (1.78e-1)" "unprognostic (1.93e-1)" "unprognostic (4.65e-2)" "unprognostic (1.02e-1)" "unprognostic (8.30e-3)" "unprognostic (2.29e-1)" "unprognostic (2.23e-2)" "unprognostic (1.76e-3)" "unprognostic (7.67e-3)" "prognostic favorable (1.21e-4)" "unprognostic (4.08e-4)" "unprognostic (3.29e-1)" "unprognostic (9.83e-3)" "unprognostic (7.26e-5)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 5.0 0.1 0.1 0.1 0.1 0.1 0.0 47.5 0.1 153.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 5.1 10.5 0.5 0.9 0.5 0.6 1.1 0.2 0.4 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.2 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.3 1.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.6 0.1 0.3 0.2 0.3 0.3 0.6 0.0 0.1 0.9 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.8 0.0 0.2 0.4 29.8 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.9 0.0 5.1 0.2 0.4 3.0 1.9 0.6 0.5 0.5 0.5 0.9 10.5 0.0 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 485.3 2552.8 8.0 0.4 0.1 1.3 0.4 0.0 29.4 84.2 43.6 3.9 0.4 8.3 0.4 34.9 0.1 0.9 0.0 0.7 0.2 0.2 0.6 64.0 0.0 0.3 0.0 0.0 0.0 0.3 4.5 0.9 4.0 0.0 0.0 0.9 1.3 0.1 2.8 0.4 230.9 0.7 0.0 0.3 0.5 0.7 0.5 0.1 0.0 0.8 0.0 NCF2 "NOXA2, p67phox" ENSG00000116701 "Neutrophil cytosolic factor 2" P19878 1 183555563-183590876 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4" "Group enriched" "Detected in many" 6 "Ductal cells: 59.6;Hofbauer cells: 199.3;Kupffer cells: 138.6;Macrophages: 192.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 125.2;neutrophil: 80.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 13.4;HMC-1: 11.7;hTERT-HME1: 28.0;U-2 OS: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002327, HPA006040, CAB022160" Enhanced Supported Cytosol NA NA Cytosol "CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906" "unprognostic (4.97e-2)" "unprognostic (3.48e-2)" "unprognostic (2.40e-2)" "unprognostic (1.22e-3)" "unprognostic (5.83e-3)" "unprognostic (4.04e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.29e-1)" "unprognostic (2.45e-1)" "unprognostic (2.33e-1)" "unprognostic (5.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-2)" "unprognostic (8.24e-2)" "unprognostic (2.36e-2)" 15.3 3.1 2.0 23.0 4.5 53.0 3.9 0.7 2.8 2.9 2.8 3.7 0.2 2.3 1.8 6.1 4.1 5.2 7.2 6.4 2.0 1.8 2.9 5.4 39.5 42.7 6.8 0.4 3.5 4.2 0.6 1.9 11.5 3.8 3.4 3.7 4.2 4.4 0.8 3.5 7.1 3.8 5.8 5.5 45.4 2.6 3.9 3.2 4.2 2.0 5.6 5.5 7.3 3.5 1.4 24.3 125.2 45.7 0.2 1.0 22.7 13.4 0.4 0.0 0.0 0.0 0.0 0.1 1.0 1.2 1.8 0.8 0.1 0.4 1.6 2.3 0.4 0.3 7.6 0.0 9.9 1.6 8.4 0.0 0.0 3.4 3.1 0.0 1.0 11.7 0.0 2.2 1.8 28.0 1.1 0.0 0.0 0.0 3.0 3.1 0.1 0.1 0.5 0.2 0.8 0.8 3.6 1.2 10.1 0.4 0.1 0.0 0.0 0.1 0.0 0.4 1.0 1.5 4.7 0.6 0.0 27.2 0.0 2.5 0.5 0.7 0.3 0.2 5.4 0.0 15.5 45.7 125.2 0.1 34.4 0.1 1.4 0.4 0.1 24.3 0.8 0.2 0.1 80.6 0.2 29.7 1.3 1.0 22.7 2.0 4.5 0.7 2.8 2.0 1.8 6.8 0.4 3.8 3.2 8.9 17.8 4.8 0.1 4.8 0.4 1.1 10.2 26.8 13.6 0.0 0.0 0.8 3.3 59.6 1.0 0.7 0.0 0.0 3.3 0.8 2.1 0.3 7.0 0.4 199.3 0.0 0.0 4.3 138.6 2.1 0.6 192.4 6.8 20.8 0.0 0.0 18.4 1.1 0.0 0.1 0.6 12.9 3.4 0.0 0.2 3.8 1.6 1.3 0.0 0.8 NCKAP5 "ERIH1, ERIH2, NAP5" ENSG00000176771 "NCK associated protein 5" O14513 2 132671799-133568463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.3;lung: 19.2" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 244.2;Bipolar cells: 119.6;Muller glia cells: 83.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 3.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 6 "AF22: 32.3" "Low region specificity" "Detected in all" "HPA034639, HPA044859" Uncertain Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoli "Golgi apparatus, Plasma membrane, Cytosol" "HPA034639: AB_10669678, HPA044859: AB_2679114" "unprognostic (2.54e-1)" "unprognostic (1.95e-2)" "unprognostic (2.30e-2)" "unprognostic (2.58e-2)" "unprognostic (2.49e-2)" "unprognostic (3.13e-1)" "unprognostic (7.07e-2)" "unprognostic (1.90e-1)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.46e-1)" "unprognostic (2.93e-1)" "unprognostic (1.06e-11)" "unprognostic (4.56e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.03e-1)" 3.6 2.0 6.6 1.5 6.3 0.2 5.4 5.2 5.6 3.1 5.8 6.2 0.9 3.8 3.6 6.2 6.9 1.0 1.5 4.6 6.0 3.9 16.3 6.7 19.2 2.2 6.6 4.7 4.5 1.8 2.2 1.3 4.6 4.2 1.6 1.9 7.5 7.8 1.0 1.1 3.7 18.3 1.0 6.3 2.9 3.0 2.1 6.6 0.3 2.1 5.4 2.3 1.3 3.1 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 1.5 32.3 0.0 0.0 0.3 0.1 0.5 5.7 0.5 0.6 0.0 0.0 2.4 0.0 0.3 0.3 0.1 0.2 0.4 1.8 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.3 2.7 3.1 0.4 5.3 0.5 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.7 0.2 1.0 0.3 0.0 1.3 0.7 0.7 0.1 1.0 0.0 1.2 1.6 0.3 0.5 0.0 1.6 0.2 0.2 4.7 0.0 0.1 0.0 0.9 0.3 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 6.3 5.2 5.6 6.0 3.9 6.6 4.7 4.2 6.6 244.2 14.1 0.0 0.4 7.9 119.6 16.1 0.0 1.4 51.2 1.8 39.3 0.0 3.3 0.4 5.4 0.8 11.0 0.0 0.2 0.1 5.2 0.9 1.1 5.3 0.5 31.8 3.5 0.6 5.1 2.7 24.5 6.8 1.7 6.4 3.3 83.1 0.9 4.9 7.1 9.0 5.6 6.5 8.1 0.1 0.7 2.5 0.0 0.0 0.9 1.6 NCR1 "CD335, LY94, NK-p46, NKP46" ENSG00000189430 "Natural cytotoxicity triggering receptor 1" O76036 19 54906150-54916140 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 5.5;lymphoid tissue: 13.9" "Cell type enriched" "Detected in some" 9 "T-cells: 10.9" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049311 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049311: AB_2680707" "unprognostic (3.92e-2)" "unprognostic (2.21e-3)" "unprognostic (1.67e-1)" "unprognostic (2.87e-4)" "unprognostic (2.89e-1)" "unprognostic (6.32e-4)" "unprognostic (2.22e-2)" "unprognostic (3.29e-1)" "unprognostic (1.07e-1)" "unprognostic (1.89e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-5)" "unprognostic (1.82e-2)" "unprognostic (5.92e-2)" "unprognostic (3.81e-3)" "unprognostic (6.05e-3)" 1.4 0.2 0.1 3.7 0.4 2.1 0.3 0.1 0.3 0.3 2.1 0.0 0.5 0.1 1.2 1.3 0.3 0.2 2.1 1.9 0.2 0.2 0.3 2.5 5.5 3.8 0.2 0.0 0.2 0.1 0.1 0.2 0.4 0.0 0.6 0.2 1.0 0.4 0.1 0.3 0.5 3.4 1.2 0.2 13.9 0.3 0.4 0.0 2.0 0.3 0.1 2.6 0.7 0.3 0.2 0.2 1.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.2 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.4 0.1 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.1 NDNF "C4orf31, FLJ23191" ENSG00000173376 "Neuron derived neurotrophic factor" Q8TB73 4 121035613-121073021 "Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 91.6;retina: 41.0" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 229.3;Early spermatids: 225.6;Late spermatids: 164.5" "Cancer enhanced" "Detected in many" "lung cancer: 12.6" "Region enriched" "Detected in many" 4 "pons and medulla: 7.6" "Cell type enriched" "Detected in single" 11 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 23.2;U-266/70: 10.3;U-266/84: 39.6" "Group enriched" "Detected in many" 4 "basal ganglia: 11.4;olfactory region: 41.7" "Low region specificity" "Detected in all" HPA048881 Supported Vesicles "Secreted in other tissues" NA NA Vesicles "HPA048881: " "unprognostic (2.84e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (3.94e-1)" "unprognostic (6.26e-2)" "unprognostic (2.22e-1)" "unprognostic (2.93e-2)" "unprognostic (6.65e-4)" "unprognostic (2.18e-3)" "unprognostic (6.27e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.38e-3)" "unprognostic (1.20e-1)" "unprognostic (1.18e-4)" "unprognostic (1.74e-1)" 3.8 1.3 1.2 0.4 1.0 0.0 14.2 0.6 1.5 7.2 3.5 1.2 1.7 1.3 3.1 2.2 5.7 10.0 6.9 4.9 1.2 1.5 12.5 0.5 91.6 0.1 1.8 1.2 21.3 0.6 0.4 8.2 28.0 7.6 26.1 4.0 41.0 2.1 2.2 7.5 1.8 3.9 2.6 5.5 0.4 2.2 8.0 0.8 7.0 1.6 9.0 1.4 8.9 11.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 5.2 0.0 7.0 5.7 0.1 0.1 0.2 0.1 0.2 0.7 0.0 0.0 0.0 23.2 0.4 0.0 0.0 0.0 0.5 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 6.9 0.4 0.0 0.0 0.0 0.4 3.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.3 0.1 0.0 0.0 5.7 0.0 0.1 0.2 10.3 39.6 0.0 1.9 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.6 1.5 1.2 1.5 1.8 1.2 7.6 0.8 229.3 38.7 0.0 0.0 1.0 69.0 1.6 15.3 22.7 52.4 12.2 17.7 0.2 0.0 0.0 225.6 11.7 0.0 0.0 0.2 0.0 3.1 0.0 2.3 0.0 0.1 1.6 1.7 4.3 0.0 164.5 3.1 0.4 5.0 0.0 0.2 15.1 0.1 0.0 0.7 0.0 18.7 0.0 3.3 7.5 4.7 0.6 0.5 0.0 1.2 0.0 NKD2 Naked2 ENSG00000145506 "Naked cuticle homolog 2" Q969F2 5 1008829-1038943 "Predicted intracellular proteins" "Exocytosis, Transport, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 25.1" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 5.5;Fibroblasts: 6.6;Melanocytes: 6.8;Muller glia cells: 5.6;Spermatogonia: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.5;HEK 293: 5.5;NB-4: 11.6;RPMI-8226: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049463 Uncertain NA NA "HPA049463: AB_2680777" "unprognostic (6.23e-3)" "unprognostic (2.82e-1)" "unprognostic (4.38e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (6.24e-3)" "unprognostic (5.87e-3)" "unprognostic (4.43e-1)" "prognostic unfavorable (9.97e-4)" "unprognostic (3.35e-2)" "unprognostic (6.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (2.66e-5)" "unprognostic (2.36e-1)" "unprognostic (1.48e-1)" "unprognostic (2.81e-2)" "unprognostic (1.52e-1)" 2.6 3.0 1.6 1.7 2.3 0.8 2.6 0.3 5.2 1.5 2.2 0.8 1.9 1.5 0.9 1.2 5.1 2.3 4.4 5.7 2.7 1.0 3.7 1.9 25.1 9.8 0.9 2.0 2.2 3.6 0.7 1.2 3.1 3.4 3.9 0.9 1.6 4.4 1.6 0.9 10.4 2.4 2.8 1.2 9.8 1.3 4.7 0.6 13.3 1.3 0.9 3.7 1.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.5 0.0 0.0 12.5 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.5 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 1.0 3.7 11.6 0.5 2.9 0.0 4.2 0.0 28.2 0.0 2.3 0.4 0.2 0.1 0.0 0.7 0.2 0.1 5.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.3 0.3 5.2 2.7 1.0 0.9 2.0 3.4 0.6 0.0 0.0 0.0 2.3 5.5 0.0 2.2 5.1 0.0 0.0 0.0 2.0 0.1 0.0 2.7 0.4 2.1 0.0 0.0 0.0 0.0 6.6 1.3 0.0 0.0 0.2 1.6 0.0 0.6 0.0 0.8 0.3 0.4 6.8 0.0 0.0 5.6 0.1 0.0 0.4 1.0 0.0 0.0 1.9 0.4 10.7 5.0 0.0 0.0 0.0 0.9 NKX2-1 "BCH, NKX2A, TITF1, TTF-1, TTF1" ENSG00000136352 "NK2 homeobox 1" P43699 14 36516392-36521149 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "lung: 51.5;thyroid gland: 122.8" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 128.1;Alveolar cells type 2: 108.1;Club cells: 46.6" "Group enriched" "Detected in some" 39 "lung cancer: 30.9;thyroid cancer: 103.2" "Group enriched" "Detected in some" 6 "basal ganglia: 2.4;hypothalamus: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 48.7" "Group enriched" "Detected in some" 5 "basal ganglia: 3.4;hypothalamus: 12.0" "Group enriched" "Detected in some" 13 "basal ganglia: 6.4;hypothalamus: 16.1" "CAB000078, CAB053633, HPA074316" Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "CAB000078: , CAB053633: AB_442138, HPA074316: " "unprognostic (3.79e-1)" "unprognostic (4.25e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" "unprognostic (1.26e-2)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.83e-2)" "unprognostic (4.18e-1)" 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.5 0.0 0.0 51.5 0.1 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 122.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 48.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.1 0.2 2.5 0.0 0.1 0.1 0.4 128.1 108.1 0.0 0.0 0.0 0.0 0.6 0.0 14.7 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580579-36582607 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6;lung: 7.7;testis: 22.9" "Cell type enhanced" "Detected in single" 18 "Basal glandular cells: 2.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;HaCaT: 10.0;HEK 293: 2.4;PC-3: 5.8;SiHa: 2.3" "Region enhanced" "Detected in single" "pons and medulla: 2.3" "Low region specificity" "Detected in many" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA062879: AB_2684892" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.3 0.3 0.2 0.4 0.7 0.3 0.3 0.0 1.2 0.3 0.3 2.0 0.0 0.3 0.3 0.3 5.3 0.3 0.3 0.3 0.3 2.0 0.3 0.3 7.7 0.3 2.0 0.0 0.3 0.3 1.5 2.1 0.3 5.7 0.4 0.3 0.0 2.0 0.3 0.3 1.1 0.3 0.3 9.6 0.3 0.3 22.9 0.5 0.0 4.2 1.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.5 10.0 0.0 0.5 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.3 0.4 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.2 0.3 2.0 2.0 0.0 5.7 0.5 0.0 0.0 0.0 2.3 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.3 NLRP12 "CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2" ENSG00000142405 "NLR family pyrin domain containing 12" P59046 19 53793603-53824394 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.0;Club cells: 6.8;granulocytes: 7.0;Kupffer cells: 12.3;Macrophages: 6.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 22.8;neutrophil: 15.0" "Group enriched" "Detected in many" 4 "granulocytes: 22.8;monocytes: 8.7" "Group enriched" "Detected in some" 4 "HMC-1: 7.7;THP-1: 6.7;U-87 MG: 7.3;U-937: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042099, HPA042981" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA042099: , HPA042981: AB_10795712" "unprognostic (6.92e-2)" "unprognostic (3.11e-1)" "unprognostic (6.66e-3)" "unprognostic (9.82e-2)" "unprognostic (1.81e-4)" "unprognostic (3.90e-2)" "unprognostic (5.79e-2)" "unprognostic (6.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-5)" "unprognostic (1.63e-1)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (4.48e-1)" 1.9 0.3 0.2 4.2 0.6 11.0 0.4 0.2 0.2 0.9 0.3 0.1 0.9 0.3 0.7 0.7 0.6 1.0 0.5 3.3 0.2 0.2 0.5 0.5 6.5 13.5 0.6 0.3 1.0 0.3 0.1 0.2 1.1 0.8 0.3 0.1 0.5 1.7 0.0 0.2 0.2 0.3 1.4 0.5 10.2 0.4 1.0 0.6 0.3 0.3 0.4 0.2 1.1 1.4 0.0 3.6 22.8 8.7 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.6 7.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 6.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 7.3 6.1 0.0 22.8 8.7 11.0 0.0 2.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 15.0 0.0 1.5 0.0 0.0 2.1 0.2 0.6 0.2 0.2 0.2 0.2 0.6 0.3 0.8 0.6 6.0 9.0 0.0 0.7 0.3 0.8 0.4 0.0 4.0 6.8 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.4 0.7 7.0 0.0 2.4 0.0 0.0 0.0 12.3 0.0 0.3 6.1 1.7 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.6 NOTCH4 INT3 ENSG00000204301 "Notch 4" Q99466 6 32194843-32224067 "Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 31.3;lung: 26.2" "Cell type enhanced" "Detected in many" 17 "Endothelial cells: 65.0;Ito cells: 155.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "EFO-21: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 820000 "unprognostic (2.27e-1)" "unprognostic (2.27e-1)" "unprognostic (6.80e-3)" "unprognostic (9.50e-2)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.88e-2)" "unprognostic (3.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.67e-1)" "unprognostic (1.93e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.56e-1)" "unprognostic (3.13e-1)" 31.3 3.5 3.6 2.9 6.3 1.5 16.7 2.5 8.2 3.4 5.9 1.3 3.3 3.2 5.8 12.1 3.7 4.0 2.7 10.5 4.2 2.1 6.1 5.0 26.2 2.6 4.9 1.1 2.5 3.4 1.5 2.9 6.0 5.5 4.6 2.0 3.7 1.9 4.3 8.5 4.1 2.7 1.5 4.8 3.4 3.6 2.0 5.1 0.0 9.3 4.3 2.0 3.3 12.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.6 6.3 2.5 8.2 4.2 2.1 4.9 1.1 5.5 5.1 0.0 9.6 11.8 23.5 4.6 2.8 6.4 0.0 4.0 6.8 5.2 3.9 0.3 0.0 1.8 31.8 65.0 0.0 0.0 1.0 0.2 3.1 3.1 0.0 0.8 1.6 6.4 5.8 155.3 11.0 26.3 6.6 4.9 3.3 1.0 0.6 19.5 0.3 0.0 4.9 0.8 3.5 0.0 5.9 4.2 1.6 1.4 0.2 2.5 1.0 4.7 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2" "Low region specificity" "Detected in all" HPA050798 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1060000 "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.5 3.1 0.5 2.0 0.7 32.7 0.0 0.4 0.0 4.2 0.1 17.2 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 34.6 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 65.9 26.2 0.0 4.9 7.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 26.8 30.9 0.0 0.2 1.3 0.4 0.0 2.5 12.0 7.9 0.0 0.0 386.0 0.0 0.0 9.4 1.2 0.0 0.0 0.0 8.5 1.3 0.0 14.0 0.8 209.3 0.0 0.0 0.0 21.9 7.6 0.3 102.1 0.0 36.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 387.3 0.0 0.0 0.0 OR8G5 "OR8G5P, OR8G6" ENSG00000255298 "Olfactory receptor family 8 subfamily G member 5" Q8NG78 11 124256376-124266218 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 5.2;lung: 4.0;testis: 7.8" "Group enriched" "Detected in some" 23 "Early spermatids: 12.8;Late spermatids: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 5.1;PC-3: 3.2;T-47d: 5.4" NA NA "unprognostic (1.48e-1)" 5.2 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.1 0.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 17.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 OSCAR ENSG00000170909 "Osteoclast associated, immunoglobulin-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 36.7;Kupffer cells: 33.7;Macrophages: 28.2;monocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 34 "classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2" "Group enriched" "Detected in many" 75 "dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6" "Cell line enhanced" "Detected in some" "EFO-21: 13.6;HHSteC: 9.3;hTERT-HME1: 4.9;NB-4: 5.4;U-937: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 72000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 4.5 1.0 1.4 3.8 2.8 18.9 1.4 0.4 1.5 1.3 0.9 3.5 0.0 0.4 0.7 1.3 1.2 2.2 2.3 1.1 3.8 1.9 1.0 1.7 40.4 4.7 3.5 0.4 1.2 0.7 0.3 0.5 2.2 4.0 0.8 0.7 1.0 1.3 0.8 0.7 1.9 1.0 2.8 5.6 20.2 1.3 0.6 2.4 1.7 1.0 0.0 1.2 1.7 3.1 0.0 9.4 18.3 20.6 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.4 0.0 13.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.3 0.7 0.0 0.0 0.2 0.6 4.9 0.8 0.0 0.1 0.0 0.4 0.1 0.1 0.0 5.4 0.3 0.2 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.6 0.5 16.8 0.0 0.0 20.6 11.7 0.1 12.8 0.0 0.0 0.1 0.2 9.4 0.0 0.0 0.0 18.3 0.0 11.2 0.4 0.1 7.0 1.4 2.8 0.4 1.4 3.8 1.9 3.5 0.4 4.0 2.4 3.0 5.1 0.0 0.5 0.7 0.0 0.3 2.5 6.7 3.4 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.2 1.1 0.0 36.7 0.0 0.0 0.0 33.7 0.0 0.0 28.2 0.0 39.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.6 0.1 0.2 0.0 0.0 0.3 OVCH1 OVCH ENSG00000187950 "Ovochymase 1" Q7RTY7 12 29412474-29497686 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 9.5;testis: 4.6" "Group enriched" "Detected in some" 6 "Early spermatids: 2.4;Late spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "Daudi: 11.0" "Low region specificity" "Detected in many" "Secreted in female reproductive system" NA NA "unprognostic (3.32e-1)" "unprognostic (2.20e-1)" "unprognostic (2.03e-1)" "unprognostic (1.56e-5)" "unprognostic (1.68e-1)" "unprognostic (1.58e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.36e-1)" "unprognostic (5.48e-2)" "unprognostic (5.59e-3)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" 0.6 0.4 0.0 0.4 0.3 0.1 0.5 0.0 0.1 0.4 0.2 0.0 0.2 0.0 0.1 0.2 0.4 0.2 0.1 0.2 0.2 0.3 9.5 0.2 0.1 0.3 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.3 0.5 0.1 0.0 0.2 1.9 0.2 4.6 2.1 0.0 0.1 0.2 0.5 0.2 1.3 0.5 0.0 0.6 0.3 0.0 0.0 0.6 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.3 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.8 0.0 0.5 0.8 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.5 0.0 0.6 1.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCSK9 "FH3, HCHOLA3, NARC-1" ENSG00000169174 "Proprotein convertase subtilisin/kexin type 9" Q8NBP7 1 55039548-55064852 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 47.1;lung: 14.6" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 15.3;Hepatocytes: 17.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 9 "cerebellum: 6.9;pons and medulla: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 29.1;CACO-2: 13.5;HaCaT: 38.9;HeLa: 33.9;RPTEC TERT1: 19.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 143000000 300000000 "unprognostic (1.28e-3)" "unprognostic (6.93e-2)" "unprognostic (4.02e-1)" "unprognostic (2.19e-2)" "unprognostic (7.30e-2)" "unprognostic (1.82e-1)" "unprognostic (1.20e-3)" "unprognostic (1.14e-2)" "unprognostic (5.44e-3)" "unprognostic (1.22e-2)" "unprognostic (2.09e-3)" "unprognostic (3.70e-2)" "unprognostic (2.45e-4)" "unprognostic (1.49e-1)" "unprognostic (1.86e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.40e-4)" 0.2 0.1 0.0 6.1 0.5 0.4 0.0 6.9 0.2 0.6 4.4 0.0 0.0 3.9 0.2 0.7 5.2 0.4 2.6 0.0 0.0 0.0 0.1 47.1 14.6 0.0 0.1 0.0 0.1 11.0 0.0 0.0 0.0 2.6 0.0 1.9 0.1 0.3 0.3 0.0 0.8 5.1 0.8 0.1 0.2 1.0 0.4 0.0 0.0 0.0 6.1 0.9 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 6.5 0.9 0.0 2.1 1.5 0.1 0.0 0.0 0.0 0.0 13.5 4.6 0.0 5.3 2.5 0.1 38.9 1.1 11.8 0.0 0.0 0.0 0.0 33.9 9.4 0.7 0.0 0.0 2.3 8.8 8.5 6.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 5.5 0.5 0.7 0.0 0.0 0.3 19.2 0.0 0.5 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.9 0.2 0.0 0.0 0.1 0.0 2.6 0.0 14.9 15.3 0.0 0.0 0.5 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.5 0.0 1.3 0.0 0.4 0.1 0.0 17.0 0.1 0.0 4.1 1.8 1.6 0.2 0.0 0.0 1.7 0.0 2.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 2.9 0.2 PHEX "HPDR, HPDR1, HYP, HYP1, PEX, XLH" ENSG00000102174 "Phosphate regulating endopeptidase homolog X-linked" P78562 X 22032441-22251310 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Biomineralization "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 8.3;lung: 6.7" "Cell type enhanced" "Detected in some" 21 "Basal glandular cells: 5.2;Horizontal cells: 15.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 37 "plasmacytoid DC: 8.3" "Lineage enriched" "Detected in single" 37 "dendritic cells: 8.3" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.8;HUVEC TERT2: 4.4;PC-3: 4.8;TIME: 4.9;U-87 MG: 10.6;WM-115: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (2.01e-2)" "unprognostic (2.69e-1)" "unprognostic (2.43e-1)" "unprognostic (1.05e-3)" "unprognostic (1.22e-1)" "unprognostic (3.04e-2)" "unprognostic (2.25e-3)" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-2)" "unprognostic (7.53e-2)" "unprognostic (7.45e-2)" "unprognostic (9.84e-8)" "unprognostic (1.18e-1)" "unprognostic (1.58e-1)" "prognostic favorable (2.51e-4)" "unprognostic (7.68e-2)" 0.3 0.0 1.8 1.9 1.1 0.0 1.7 0.9 1.1 0.8 0.9 0.8 0.3 1.2 5.0 0.3 0.4 0.1 2.0 0.3 1.5 1.8 0.3 0.3 6.7 3.4 2.0 0.3 3.9 0.3 0.0 0.3 0.3 5.0 1.3 0.0 0.3 2.8 0.9 0.3 0.1 1.4 3.9 3.8 3.4 0.0 0.3 0.3 1.3 4.8 0.3 4.3 0.5 0.6 0.1 8.3 0.0 0.0 0.0 0.2 0.0 0.3 0.8 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.1 0.3 1.3 0.1 0.1 1.3 0.1 0.2 0.1 0.0 5.8 0.3 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.2 2.2 1.1 1.1 3.4 0.2 4.4 0.4 0.0 0.5 0.5 0.0 0.0 0.2 0.0 0.0 4.8 0.0 1.0 0.0 0.6 0.2 0.1 0.2 0.4 2.5 0.8 0.6 2.9 0.0 4.9 1.0 0.2 0.6 0.8 0.0 0.1 0.0 10.6 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 8.3 0.0 0.0 1.8 1.1 0.9 1.1 1.5 1.8 2.0 0.3 5.0 0.3 0.0 0.0 0.0 5.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.4 0.2 1.7 0.0 1.0 0.1 0.5 1.6 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.8 0.7 0.0 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.1 0.7 0.0 0.0 2.7 PIH1D3 "CXorf41, MGC35261, NYSAR97" ENSG00000080572 "PIH1 domain containing 3" Q9NQM4 X 107206632-107244243 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.0;fallopian tube: 16.2;lung: 7.0;testis: 13.9" "Group enriched" "Detected in some" 11 "Ciliated cells: 148.5;Early spermatids: 139.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Region enhanced" "Detected in many" "pons and medulla: 8.0" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "WM-115: 1.7" "Region enhanced" "Detected in many" "midbrain: 4.6" HPA072496 Enhanced NA NA "HPA072496: AB_2732202" "unprognostic (8.66e-2)" "unprognostic (2.75e-3)" "unprognostic (7.73e-4)" "unprognostic (3.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.77e-2)" 0.0 0.1 0.9 0.0 4.0 0.2 0.0 0.0 0.1 1.3 0.0 1.9 1.0 0.1 0.5 4.5 0.1 16.2 0.1 0.1 1.6 1.5 0.2 0.0 7.0 0.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 13.9 1.3 0.1 0.4 0.0 0.1 0.0 0.0 0.5 0.3 2.1 0.3 0.6 0.2 0.2 0.3 0.9 0.1 0.0 0.5 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.8 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.5 0.5 0.6 0.3 0.3 0.2 1.0 0.0 0.2 0.0 0.8 0.4 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.3 1.7 2.1 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.5 0.1 0.2 1.2 0.6 0.2 0.3 0.1 0.2 0.9 4.0 0.0 0.0 1.6 1.5 0.0 0.0 8.0 1.3 3.0 1.0 0.0 0.2 0.1 0.0 0.0 0.0 148.5 12.5 0.0 0.0 0.0 1.7 0.0 139.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.5 8.8 0.0 0.0 0.0 0.0 0.0 PKD1L1 PRO19563 ENSG00000158683 "Polycystin 1 like 1, transient receptor potential channel interacting" Q8TDX9 7 47774652-47948491 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 13.4;tongue: 16.7" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 3.1;Early spermatids: 11.4;Ito cells: 2.5;Late spermatids: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "T-47d: 6.5;U-266/70: 17.1;U-266/84: 6.1" "Not detected" "Not detected" "HPA020422, HPA022424" Uncertain NA NA "HPA020422: AB_1855434, HPA022424: AB_1855435" "unprognostic (5.47e-2)" "unprognostic (5.33e-3)" "unprognostic (1.49e-2)" "unprognostic (9.74e-2)" "unprognostic (4.03e-2)" "unprognostic (6.31e-2)" "unprognostic (2.52e-2)" "unprognostic (1.11e-1)" "unprognostic (9.63e-3)" "unprognostic (7.96e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (1.88e-4)" "unprognostic (1.88e-3)" "unprognostic (2.56e-1)" "unprognostic (2.50e-1)" "unprognostic (1.90e-1)" 5.4 0.2 1.0 2.3 1.8 0.2 1.6 1.3 1.1 1.2 0.8 0.7 0.1 2.0 2.5 1.6 0.9 0.6 1.0 7.4 0.8 1.5 0.5 1.1 13.4 1.2 0.9 0.1 0.6 0.3 0.1 1.2 2.0 1.0 0.3 0.9 10.0 2.6 0.1 6.4 0.7 0.7 1.7 1.0 0.8 0.4 3.8 0.1 0.9 1.2 16.7 1.4 2.2 1.4 0.0 0.2 0.0 0.8 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.1 6.5 0.0 0.0 0.0 0.9 0.0 0.0 17.1 6.1 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.8 1.3 1.1 0.8 1.5 0.9 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.1 3.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.0 1.6 0.0 2.5 0.0 2.5 0.3 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 30.4;skin 1: 48.1" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 14.1;RT4: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: AB_2683226" "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.1 0.1 0.0 2.5 0.3 0.3 1.8 0.0 0.1 4.5 11.0 0.0 4.7 4.2 0.4 9.7 10.4 0.2 3.1 1.0 0.0 0.0 10.8 0.2 30.4 0.1 0.0 0.0 0.1 0.1 0.7 4.1 0.3 0.0 3.3 2.5 0.0 5.3 2.8 8.6 48.1 12.3 1.1 0.1 0.2 1.6 0.1 0.0 6.2 1.6 14.9 3.4 2.2 6.3 0.6 0.3 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.4 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.1 0.0 14.1 0.1 0.0 0.0 0.1 0.0 10.6 0.6 0.1 0.0 1.1 0.0 0.1 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 54.9 0.0 3.3 4.8 0.0 3.2 0.0 0.0 0.0 5.2 0.0 1.5 3.3 0.2 0.0 0.0 12.0 0.0 1.2 0.7 0.2 2.7 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 4.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 1.0 0.0 4.3 1.6 PRRT1B IFITMD8 ENSG00000283526 "Proline rich transmembrane protein 1B" 9 131545514-131558620 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "fallopian tube: 9.0;lung: 16.0;pancreas: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 16.0;BEWO: 10.7;MCF7: 4.2;T-47d: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.5 4.7 0.0 0.0 0.3 0.6 1.0 0.0 9.0 3.9 0.0 0.0 1.3 6.1 16.0 0.0 0.0 0.0 1.7 7.6 1.7 0.0 0.1 0.1 3.4 2.0 0.0 0.0 1.7 0.0 0.0 2.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 16.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393768-40413366 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 42.1;lung: 31.7;retina: 20.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 10.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "midbrain: 42.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in single" 21 "midbrain: 24.7" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 3.4 4.4 4.8 1.0 4.1 1.1 2.7 2.2 5.4 3.0 2.3 1.8 2.8 1.2 3.8 2.0 2.2 3.2 2.4 2.9 4.0 2.2 4.3 0.6 31.7 1.3 42.1 3.7 7.5 5.4 7.3 1.1 6.0 10.3 3.2 0.8 20.6 3.9 4.4 5.4 2.2 1.5 3.3 11.0 1.7 2.4 1.6 3.6 0.0 7.2 6.7 0.9 3.1 2.0 0.3 0.4 0.0 0.3 0.1 1.2 0.2 2.5 2.7 3.3 4.3 2.7 7.0 4.1 2.0 2.3 2.9 2.1 2.3 2.7 0.8 2.6 1.9 1.5 1.3 1.1 1.0 1.0 1.2 1.4 0.5 0.9 0.7 3.2 0.2 3.6 5.0 4.9 1.9 1.6 3.3 1.5 4.5 3.0 0.8 1.5 3.2 1.1 0.8 0.7 5.6 2.5 4.8 2.8 2.4 0.5 1.3 0.3 1.5 3.9 3.4 3.0 1.5 4.9 1.2 2.2 5.9 4.6 2.3 1.2 8.4 7.3 1.1 1.8 1.3 1.3 0.0 0.3 0.0 0.6 0.2 0.2 0.0 0.4 0.6 0.0 0.3 0.3 1.2 0.0 0.1 0.0 0.4 0.3 0.2 4.8 4.1 2.2 5.4 4.0 2.2 42.1 3.7 10.3 3.6 3.0 5.1 0.0 1.0 5.6 0.0 10.8 5.1 0.0 1.2 1.8 0.0 0.8 0.0 0.3 0.0 4.4 0.5 0.0 0.5 0.6 2.5 2.1 0.0 1.0 0.9 0.0 0.0 4.9 1.8 0.0 3.1 1.2 3.3 0.0 0.3 2.7 0.5 0.9 4.2 1.3 0.0 0.0 2.6 0.2 0.7 3.6 2.3 1.3 1.4 0.9 PTGIR IP ENSG00000160013 "Prostaglandin I2 receptor" P43119 19 46620468-46625118 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.7;lung: 35.1" "Cell type enriched" "Detected in many" 4 "monocytes: 249.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 10 "classical monocyte: 12.6;intermediate monocyte: 27.7;myeloid DC: 9.1;non-classical monocyte: 15.5" "Group enriched" "Detected in many" 12 "dendritic cells: 9.1;monocytes: 27.7" "Cell line enhanced" "Detected in some" "BJ: 8.5;BJ hTERT+: 9.7;fHDF/TERT166: 12.0;HDLM-2: 5.9;HEL: 22.0;HHSteC: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (3.49e-3)" "unprognostic (4.22e-2)" "unprognostic (6.09e-2)" "unprognostic (2.12e-1)" "unprognostic (7.45e-2)" "unprognostic (4.47e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.09e-8)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (1.16e-1)" "unprognostic (5.66e-2)" 7.8 6.3 0.4 8.0 0.6 3.8 3.0 0.1 0.6 6.5 6.0 1.2 1.4 2.7 5.0 2.7 4.5 2.7 6.4 16.0 0.6 0.3 9.0 9.6 35.1 6.5 0.8 0.7 6.9 3.5 0.1 1.2 6.3 1.1 3.2 1.4 3.3 2.5 1.3 12.2 3.0 3.7 4.1 0.5 11.3 4.5 1.6 0.8 3.5 14.5 3.4 4.3 10.2 6.5 0.5 9.1 0.5 27.7 0.0 1.5 7.2 0.0 0.0 0.0 0.0 0.1 4.6 0.0 8.5 9.7 1.2 3.5 0.0 0.0 0.0 0.7 12.0 0.1 0.0 0.0 0.0 0.7 5.9 0.0 22.0 0.0 0.0 5.9 0.0 0.0 1.4 0.0 3.1 0.2 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.4 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.0 12.6 0.0 0.0 27.7 0.2 0.5 0.1 0.0 9.1 0.3 1.5 0.0 0.5 0.0 15.5 0.8 1.4 7.2 0.4 0.6 0.1 0.6 0.6 0.3 0.8 0.7 1.1 0.8 0.0 1.1 4.5 0.9 3.8 0.5 0.8 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.1 0.1 2.6 0.0 0.0 0.3 0.1 8.9 0.8 3.5 0.0 2.6 0.0 0.0 5.5 6.0 0.0 2.0 14.1 6.8 249.7 0.0 0.0 0.5 0.0 0.0 0.0 0.6 6.5 58.0 0.1 0.4 3.9 0.2 0.9 0.0 0.3 RASGRF1 "CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187" ENSG00000058335 "Ras protein specific guanine nucleotide releasing factor 1" Q13972 15 78959947-79090773 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 34.3;lung: 13.0" "Group enriched" "Detected in some" 11 "Alveolar cells type 2: 58.8;Horizontal cells: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Cell line enhanced" "Detected in some" "A-431: 7.9;BEWO: 7.7;Karpas-707: 10.2;RPMI-8226: 12.3;U-2 OS: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010413, HPA041965" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB010413: AB_2238127, HPA041965: AB_10793939" "unprognostic (2.57e-3)" "unprognostic (3.08e-2)" "unprognostic (3.14e-2)" "prognostic favorable (6.14e-6)" "unprognostic (1.90e-1)" "unprognostic (1.15e-3)" "unprognostic (5.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.03e-1)" "unprognostic (4.02e-6)" "unprognostic (2.35e-1)" "unprognostic (8.02e-2)" "unprognostic (3.81e-2)" "unprognostic (8.81e-2)" 1.0 1.1 7.6 2.3 12.2 0.8 1.1 34.3 33.0 1.9 1.1 11.5 0.0 1.1 1.6 1.1 1.0 1.5 1.0 0.9 12.8 8.6 1.3 0.9 13.0 2.8 8.9 12.0 2.3 4.5 0.9 0.8 1.2 19.2 1.7 1.2 0.4 0.9 1.2 0.8 0.9 1.2 1.0 16.9 1.8 1.1 1.2 5.8 0.0 0.8 0.0 3.1 1.7 0.3 1.9 0.2 0.0 0.0 0.0 0.6 0.1 7.9 0.1 0.1 0.0 0.0 0.0 7.7 0.0 0.4 0.4 1.1 0.0 1.5 0.4 0.2 0.0 0.6 0.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 10.2 1.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.8 12.3 0.0 0.3 0.8 0.0 0.0 0.1 1.6 0.7 0.0 1.6 0.0 0.0 15.0 0.0 0.2 0.0 3.5 2.8 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 7.6 12.2 34.3 33.0 12.8 8.6 8.9 12.0 19.2 5.8 3.0 58.8 2.7 0.5 0.6 3.7 0.9 0.0 2.7 3.4 0.0 0.0 0.7 0.0 0.1 0.1 0.6 0.0 0.0 0.0 1.7 0.2 0.1 0.0 0.0 1.6 23.8 0.0 0.0 0.0 0.0 0.0 2.4 3.3 1.0 0.0 1.0 0.4 0.0 0.4 3.9 1.8 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.2 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457559-41470882 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.9;lung: 120.1" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 621.5;Erythroid cells: 303.7;Glandular cells: 288.4;Hofbauer cells: 320.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 46.2" "Lineage enriched" "Detected in many" 26 "T-cells: 46.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.4;BJ hTERT+: 80.7;Daudi: 26.2;U-698: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" No No 390000 Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: AB_2685096" "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 58.6 6.7 26.7 8.8 33.1 109.9 27.7 21.6 22.7 12.8 5.6 36.1 4.2 5.7 8.7 3.1 5.4 7.6 14.3 15.1 32.1 16.8 11.0 8.3 120.1 10.8 41.7 15.2 1.8 13.4 8.7 7.1 70.6 21.1 10.7 3.6 16.1 33.2 6.8 12.7 10.8 4.9 11.3 22.2 7.3 8.0 7.1 34.8 15.2 26.9 5.8 6.9 9.5 8.7 1.7 1.7 0.2 0.2 0.1 46.2 2.8 0.2 0.1 9.0 0.0 1.7 15.4 0.3 0.2 80.7 0.0 0.3 11.2 0.1 26.2 0.2 1.0 0.0 0.2 0.3 0.5 0.1 2.7 1.3 0.0 1.9 0.8 0.9 0.9 0.3 1.2 1.7 0.3 11.2 0.1 9.2 6.1 2.0 0.0 0.2 0.0 5.8 0.5 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.8 0.2 5.0 6.2 0.0 1.0 0.5 0.1 0.0 0.0 27.6 0.0 0.6 0.2 0.0 0.2 0.0 1.6 0.1 1.6 1.2 13.8 4.4 1.7 1.7 46.2 10.5 0.2 0.1 0.0 0.5 23.1 2.8 26.7 33.1 21.6 21.7 32.1 16.8 41.7 15.2 21.1 34.8 229.3 54.7 23.2 621.5 76.8 0.8 12.0 0.0 38.8 47.8 3.5 2.0 3.9 29.9 0.6 7.3 237.2 0.3 303.7 0.0 5.3 88.9 288.4 49.5 0.8 320.9 0.0 81.3 31.9 23.8 7.0 7.5 180.3 183.9 0.0 7.4 1.4 0.3 3.4 2.1 0.5 1.4 122.9 80.2 14.1 4.1 57.0 9.3 44.5 6.6 105.6 ROS1 "c-ros-1, MCF3, ROS" ENSG00000047936 "ROS proto-oncogene 1, receptor tyrosine kinase" P08922 6 117288300-117425855 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 38.6;lung: 20.2" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 56.7" "Cancer enriched" "Detected in some" 13 "lung cancer: 6.9" "Group enriched" "Detected in some" 10 "cerebral cortex: 7.4;olfactory region: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "GAMG: 16.3;HSkMC: 8.7;hTCEpi: 18.1;LHCN-M2: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049098, HPA072424" Uncertain Approved Vesicles NA NA Vesicles "HPA049098: AB_2680628, HPA072424: AB_2686519" "unprognostic (8.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (7.57e-2)" "unprognostic (2.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (2.79e-2)" "unprognostic (1.00e-2)" "unprognostic (2.42e-1)" "unprognostic (5.20e-2)" "unprognostic (1.56e-12)" "unprognostic (1.09e-2)" "unprognostic (2.81e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" 0.3 0.2 0.2 0.0 0.4 0.0 0.2 0.2 7.4 0.2 0.4 0.0 7.9 0.0 0.2 38.6 0.2 0.2 0.0 0.2 0.2 0.2 0.4 0.2 20.2 0.0 0.2 2.5 0.2 0.2 0.0 0.3 0.7 0.0 0.2 0.3 0.0 0.2 2.3 0.2 0.7 0.3 0.0 0.2 0.2 0.3 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 8.7 18.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.6 0.0 2.2 1.4 0.1 1.7 0.0 0.0 0.0 1.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 7.4 0.2 0.2 0.2 2.5 0.0 0.0 14.9 56.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RP1 "DCDC4A, ORP1" ENSG00000104237 "RP1, axonemal microtubule associated" P56715 8 54509422-54871720 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 15.4;lung: 28.7;retina: 49.2" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 212.8;Cone photoreceptor cells: 314.2;Rod photoreceptor cells: 1078.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.3;HDLM-2: 7.1;hTERT-RPE1: 2.8;RPTEC TERT1: 14.5;U-2197: 3.3" "Not detected" "Not detected" HPA042257 Enhanced NA NA "HPA042257: AB_10797385" "unprognostic (3.19e-3)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (1.58e-2)" "unprognostic (1.70e-1)" "unprognostic (9.16e-3)" "unprognostic (6.24e-2)" "unprognostic (4.56e-2)" "unprognostic (4.13e-5)" "unprognostic (2.48e-1)" "unprognostic (2.16e-5)" "unprognostic (8.92e-2)" "unprognostic (6.18e-2)" "unprognostic (1.89e-2)" "unprognostic (8.96e-2)" 0.2 0.1 0.1 0.0 0.1 0.0 0.9 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.4 0.3 0.1 15.4 0.0 0.1 0.1 0.1 3.6 0.1 28.7 0.0 0.1 0.0 3.9 0.1 0.0 0.6 0.3 0.1 0.1 0.0 49.2 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.3 0.6 1.7 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 2.3 0.0 0.2 0.0 1.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 14.9 3.7 0.0 0.0 0.0 59.5 0.4 0.0 212.8 55.7 5.2 314.2 0.0 3.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 83.8 0.2 0.0 0.0 0.2 1078.1 0.0 0.0 3.4 1.6 0.0 0.0 0.0 0.0 0.1 RSPO4 "C20orf182, dJ824F16.3" ENSG00000101282 "R-spondin 4" Q2I0M5 20 958452-1002264 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.5;lung: 12.0" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 6.3;Fibroblasts: 1.8;Late spermatids: 4.5;Melanocytes: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.4;EFO-21: 3.3;fHDF/TERT166: 3.5;NTERA-2: 9.1;SK-BR-3: 6.3;U-2 OS: 10.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA048887 Uncertain "Secreted in other tissues" NA NA "HPA048887: AB_2680545" "unprognostic (2.36e-1)" "unprognostic (3.60e-3)" "unprognostic (2.88e-2)" "prognostic unfavorable (2.98e-6)" "unprognostic (8.93e-2)" "unprognostic (1.14e-3)" "unprognostic (1.05e-2)" "unprognostic (1.47e-1)" "unprognostic (6.50e-2)" "unprognostic (2.02e-2)" "unprognostic (5.26e-3)" "unprognostic (2.96e-1)" "unprognostic (5.68e-9)" "unprognostic (6.65e-3)" "unprognostic (4.41e-2)" "unprognostic (6.18e-3)" "unprognostic (2.22e-2)" 1.0 0.8 2.0 1.7 6.2 0.2 1.7 0.5 2.4 2.0 0.3 1.6 0.0 0.7 0.3 4.2 2.3 3.1 1.5 1.1 2.8 9.0 0.3 0.5 12.0 0.4 4.5 0.8 0.4 0.4 0.4 1.7 0.9 17.5 0.6 0.3 3.7 0.3 0.9 0.2 3.1 0.4 1.8 2.0 0.3 0.5 3.4 1.4 0.0 5.4 0.6 1.3 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.7 0.0 0.1 0.0 0.0 0.0 1.2 3.3 3.5 0.4 0.1 0.0 0.2 0.5 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.3 0.0 0.0 0.1 0.1 0.0 0.0 10.8 0.0 0.0 2.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.5 1.6 2.8 9.0 4.5 0.8 17.5 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 1.1 0.4 0.2 0.0 0.0 0.0 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 67.6" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 1: 1628.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "T-reg: 15.4" "Lineage enriched" "Detected in single" 47 "T-cells: 15.4" "Cell line enhanced" "Detected in many" "A-431: 25.5;HaCaT: 20.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.3 0.1 0.7 1.8 0.8 0.5 0.7 0.1 1.6 1.5 1.1 0.0 0.1 0.7 0.6 0.1 7.1 0.2 0.4 0.2 0.5 0.2 0.5 0.2 67.6 2.3 0.2 0.5 0.3 0.2 0.2 0.8 0.7 0.1 0.7 1.2 0.1 1.6 0.1 0.1 0.7 1.1 0.3 0.2 0.8 0.7 5.3 0.1 6.9 0.8 1.3 4.1 0.7 3.0 0.3 0.2 0.3 0.1 0.2 15.4 0.2 25.5 1.4 13.7 6.3 0.0 0.1 3.3 3.7 4.3 4.2 6.7 10.6 5.1 0.1 1.6 1.4 4.3 20.5 7.6 0.6 4.4 3.6 5.2 4.2 3.1 4.4 0.0 5.7 3.3 0.2 0.3 5.2 0.5 2.3 0.6 6.8 0.2 0.2 5.6 3.2 11.0 7.3 5.8 3.8 5.2 9.5 14.6 0.0 2.7 11.1 7.5 8.6 2.4 8.6 3.5 4.2 7.8 3.1 0.0 1.9 12.5 0.1 9.3 0.1 0.0 9.8 2.5 0.0 3.0 0.1 0.1 0.1 1.3 0.0 0.1 0.1 2.1 0.4 0.0 0.3 0.8 0.3 0.3 0.2 0.1 0.2 15.4 0.2 0.7 0.8 0.1 1.6 0.5 0.2 0.2 0.5 0.1 0.1 1628.8 44.5 0.9 8.3 4.1 0.6 0.4 0.0 4.0 15.9 0.0 0.0 3.0 0.0 1.4 376.8 0.1 0.4 0.0 1.4 4.9 2.5 7.0 3.5 0.0 2.1 0.0 1.7 1.8 0.6 65.6 2.0 2.2 1.7 0.0 5.9 0.4 9.1 0.0 1.8 1.4 0.5 0.0 1.9 21.3 23.6 1.6 1.7 12.7 3.3 87.2 RUFY4 "FLJ46536, ZFYVE31" ENSG00000188282 "RUN and FYVE domain containing 4" Q6ZNE9 2 218034960-218090581 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 6.6;lymphoid tissue: 5.1" "Cell type enhanced" "Detected in some" 20 "Kupffer cells: 2.2;Macrophages: 1.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 13 "Karpas-707: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037980 Uncertain NA NA "HPA037980: AB_10672501" "unprognostic (1.27e-3)" "unprognostic (4.60e-3)" "unprognostic (9.39e-3)" "unprognostic (6.79e-2)" "unprognostic (5.92e-2)" "unprognostic (6.57e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-2)" "unprognostic (1.31e-3)" "unprognostic (1.50e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-1)" "unprognostic (2.41e-14)" "unprognostic (1.36e-2)" "unprognostic (1.13e-3)" "unprognostic (3.45e-1)" "unprognostic (1.43e-5)" 0.3 0.4 0.6 2.2 1.9 1.8 0.3 0.3 1.0 0.3 0.4 0.3 0.3 1.9 0.3 0.3 0.9 0.4 1.2 0.3 3.1 0.3 0.5 0.3 6.6 2.8 0.4 0.3 0.3 0.3 0.0 0.4 0.3 0.3 2.6 1.5 0.3 1.4 0.3 0.3 0.7 1.8 0.3 0.3 5.1 1.5 0.3 0.3 1.1 0.3 0.3 2.2 0.6 0.6 0.0 1.9 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.6 0.6 0.0 0.0 0.6 1.9 0.3 1.0 3.1 0.3 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 1.4 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 SCGB1A1 "CC10, CC16, CCSP, UGB" ENSG00000149021 "Secretoglobin family 1A member 1" P11684 11 62405103-62423195 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Phospholipase A2 inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "lung: 508.4" "Group enriched" "Detected in some" 11 "Ciliated cells: 14233.6;Club cells: 50441.2" "Cancer enriched" "Detected in many" 8 "lung cancer: 215.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 69 "HaCaT: 212.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025686, HPA031828" Enhanced "Secreted in other tissues" NA NA 17000000 "CAB025686: , HPA031828: AB_2674061" "unprognostic (2.40e-3)" "unprognostic (1.55e-2)" "unprognostic (5.46e-2)" "unprognostic (2.70e-2)" "unprognostic (4.69e-3)" "unprognostic (2.12e-2)" "unprognostic (1.23e-2)" "unprognostic (2.31e-2)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (2.40e-2)" 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 28.7 0.0 0.1 0.0 0.1 0.0 0.0 508.4 0.0 0.1 0.0 9.4 0.2 0.0 7.4 0.0 0.1 7.6 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.3 4.8 0.1 0.1 0.0 0.8 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 1045.2 3052.9 0.0 40.1 0.0 0.0 0.0 0.0 14233.6 50441.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 57.7 637.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 571.9 SCGB3A1 "HIN-1, HIN1, LU105, PnSP-2, UGRP2" ENSG00000161055 "Secretoglobin family 3A member 1" Q96QR1 5 180590103-180591540 "Plasma proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 56.1;gallbladder: 113.1;lung: 176.2;salivary gland: 196.6" "Group enriched" "Detected in many" 8 "Ciliated cells: 4434.1;Club cells: 12751.6" "Group enriched" "Detected in many" 7 "endometrial cancer: 114.2;lung cancer: 288.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 25.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 6.4;T-47d: 2.3;U-2197: 2.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted to blood" NA NA 8000000 "unprognostic (7.70e-3)" "unprognostic (4.90e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-2)" "unprognostic (3.03e-1)" "unprognostic (1.36e-2)" "unprognostic (7.87e-3)" "unprognostic (2.00e-2)" "unprognostic (3.20e-1)" "unprognostic (4.88e-2)" "unprognostic (3.55e-2)" "unprognostic (7.19e-2)" "unprognostic (8.74e-3)" "unprognostic (5.43e-2)" "unprognostic (4.62e-1)" "unprognostic (4.50e-1)" "unprognostic (1.50e-2)" 0.2 0.1 0.1 0.1 0.3 0.1 23.5 0.1 0.2 56.1 0.1 0.1 0.1 0.1 2.3 1.6 12.1 5.7 113.1 0.3 0.1 0.6 0.1 0.5 176.2 0.1 0.1 0.1 1.5 2.9 0.0 1.6 0.1 0.2 4.5 0.0 0.3 196.6 0.6 0.2 0.4 0.1 0.1 0.1 1.6 9.6 0.3 0.1 0.2 0.2 8.4 19.9 3.9 0.1 0.7 5.3 10.3 25.1 0.0 7.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 6.4 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.4 2.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.3 1.5 8.2 7.2 0.7 1.9 2.5 5.3 0.0 3.3 2.6 0.0 0.0 25.1 0.1 2.2 1.2 0.1 0.3 0.1 0.2 0.1 0.6 0.1 0.1 0.2 0.1 160.8 1144.5 0.0 27.2 0.5 0.0 0.3 677.7 4434.1 12751.6 0.0 0.0 0.0 0.0 2.1 0.1 5.5 0.0 0.0 1.4 0.2 0.3 164.9 32.5 0.0 0.3 0.0 0.0 35.6 0.0 0.0 0.6 6.2 5.0 0.0 0.0 0.0 85.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.0 4.3 0.0 398.4 SCGB3A2 "LU103, PNSP1, UGRP1" ENSG00000164265 "Secretoglobin family 3A member 2" Q96PL1 5 147870682-147882191 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 248.0" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 3186.5;Club cells: 12064.6" "Cancer enriched" "Detected in some" 10 "lung cancer: 211.2" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" "Cell type enriched" "Detected in single" 40 "basophil: 30.1" "Lineage enriched" "Detected in single" 40 "granulocytes: 30.1" "Cell line enhanced" "Detected in some" "A-431: 22.2;EFO-21: 13.9;NTERA-2: 15.9;PC-3: 78.6;SuSa: 33.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (3.85e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (3.51e-2)" "unprognostic (1.84e-2)" "unprognostic (3.17e-2)" "unprognostic (1.05e-2)" "unprognostic (1.90e-8)" "unprognostic (9.31e-3)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (9.11e-2)" 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 248.0 0.1 0.1 0.1 0.1 0.3 0.0 0.6 0.1 1.0 0.1 0.0 0.1 1.7 0.4 0.1 0.4 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.2 0.3 30.1 0.5 0.7 0.2 0.0 22.2 0.3 0.3 0.5 0.3 0.1 0.6 0.3 0.0 0.0 0.0 0.1 0.3 0.1 13.9 0.0 0.2 0.2 0.6 0.3 0.1 0.0 0.4 0.8 2.4 0.0 0.0 0.1 0.8 0.3 0.2 0.1 0.0 0.5 0.0 0.0 0.6 0.3 0.0 0.4 0.2 0.2 15.9 0.0 78.6 0.0 0.2 0.0 0.3 0.1 1.1 0.3 3.1 0.3 0.0 33.3 0.3 0.1 0.4 0.3 9.3 0.4 0.3 0.4 0.3 0.1 0.1 0.3 1.0 30.1 0.5 0.1 0.2 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.7 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.1 574.7 3186.5 0.0 0.0 0.0 0.0 0.0 0.0 1145.6 12064.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 97.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 SCN7A "NaG, Nav2.1, Nav2.2, SCN6A" ENSG00000136546 "Sodium voltage-gated channel alpha subunit 7" Q01118 2 166403573-166494326 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 51.9" "Group enriched" "Detected in many" 8 "Leydig cells: 93.5;Peritubular cells: 150.3;Sertoli cells: 148.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "MOLT-4: 2.9;SH-SY5Y: 1.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA072715 Approved NA NA "HPA072715: " "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (9.72e-2)" "unprognostic (7.43e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-1)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (5.21e-2)" "unprognostic (6.84e-3)" "unprognostic (6.88e-2)" "unprognostic (1.27e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-2)" "unprognostic (1.47e-2)" "unprognostic (1.35e-1)" "unprognostic (1.22e-4)" 4.9 6.0 1.0 10.4 0.7 0.0 2.9 0.3 0.7 16.2 23.3 0.0 13.0 2.0 24.6 8.1 28.1 7.8 6.8 16.0 0.7 3.6 1.8 1.3 51.9 1.6 3.6 0.5 33.3 3.1 0.3 1.1 8.1 2.6 18.4 6.1 14.0 4.9 11.3 3.7 1.5 6.2 10.5 4.3 5.5 6.4 6.9 0.1 0.5 1.3 4.9 0.2 9.7 7.6 0.0 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.5 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.0 0.7 0.3 0.7 0.7 3.6 3.6 0.5 2.6 0.1 0.0 1.4 0.0 0.1 0.2 11.4 15.4 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 2.0 0.7 0.0 0.0 0.0 0.0 11.0 0.1 16.1 0.0 0.2 0.0 0.0 16.0 0.0 1.6 93.5 0.0 5.0 0.0 0.0 5.2 0.2 0.0 150.3 0.3 1.6 148.8 0.9 0.5 0.1 1.0 0.0 0.0 0.0 0.3 SDR16C5 "EPHD-2, RDH-E2, RDHE2" ENSG00000170786 "Short chain dehydrogenase/reductase family 16C member 5" Q8N3Y7 8 56300010-56320776 "Enzymes, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 44.7;Alveolar cells type 2: 125.1;Basal keratinocytes: 45.3;Ciliated cells: 48.2;Pancreatic endocrine cells: 58.7;Suprabasal keratinocytes: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 36 "memory B-cell: 9.1;naive B-cell: 2.5" "Lineage enriched" "Detected in single" 56 "B-cells: 9.1" "Group enriched" "Detected in some" 4 "CAPAN-2: 18.0;HaCaT: 9.0;hTCEpi: 14.9;OE19: 21.3;T-47d: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025224 Enhanced NA NA "HPA025224: AB_1856163" "unprognostic (1.66e-1)" "unprognostic (8.88e-2)" "unprognostic (9.46e-2)" "unprognostic (4.18e-4)" "unprognostic (8.83e-3)" "prognostic favorable (7.88e-4)" "unprognostic (1.66e-1)" "unprognostic (2.51e-1)" "unprognostic (2.42e-1)" "unprognostic (1.78e-3)" "unprognostic (2.39e-1)" "unprognostic (2.48e-5)" "unprognostic (2.55e-1)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" 0.3 0.2 2.0 2.0 1.9 0.0 7.4 0.9 6.2 8.1 5.9 0.2 0.0 1.7 0.2 0.0 27.5 0.2 1.5 0.2 0.6 1.2 0.2 0.2 34.0 0.3 1.4 2.9 0.2 0.3 0.0 0.5 0.0 10.6 0.3 3.0 0.2 9.2 0.0 0.3 35.9 16.9 0.2 0.4 0.2 12.9 0.5 0.2 0.0 0.2 25.8 21.1 1.0 11.5 9.1 0.0 0.0 0.0 0.0 0.1 0.1 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 9.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 21.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 1.9 0.9 6.2 0.6 1.2 1.4 2.9 10.6 0.2 44.7 125.1 0.0 5.5 45.3 0.2 0.1 10.2 48.2 36.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.1 0.0 1.2 0.0 1.5 5.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 3.3 1.0 7.1 9.9 58.7 3.2 0.0 0.0 1.4 0.0 0.3 0.2 4.1 63.1 0.0 0.0 4.5 19.5 SFTA2 SFTPG ENSG00000196260 "Surfactant associated 2" Q6UW10 6 30931353-30955636 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lung: 104.5" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 497.3;Alveolar cells type 2: 624.9;Cholangiocytes: 170.7;Club cells: 204.8" "Cancer enhanced" "Detected in many" "lung cancer: 121.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 11 "B-cells: 1.7;T-cells: 1.7" "Group enriched" "Detected in some" 5 "CACO-2: 13.8;CAPAN-2: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (5.82e-2)" "unprognostic (1.16e-1)" "unprognostic (7.20e-3)" "unprognostic (6.64e-2)" "unprognostic (3.12e-1)" "unprognostic (1.34e-1)" "unprognostic (6.37e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (1.16e-1)" "unprognostic (3.96e-4)" "unprognostic (8.84e-2)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" "unprognostic (7.95e-2)" 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.1 1.2 0.1 0.1 0.5 0.0 0.2 0.1 13.6 1.4 6.3 0.2 0.1 0.0 1.6 0.1 104.5 0.1 0.1 0.1 0.3 1.1 0.4 0.1 0.6 0.2 0.2 0.0 0.1 1.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 2.0 1.3 0.1 0.1 1.0 0.4 0.3 0.1 5.4 1.7 0.1 0.1 0.0 0.0 1.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 7.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 1.5 0.5 0.1 1.7 1.3 1.7 0.1 0.0 0.0 0.0 0.4 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 497.3 624.9 0.0 0.1 0.1 0.4 0.0 170.7 14.7 204.8 50.6 0.0 0.0 3.3 18.0 2.9 0.7 0.0 0.0 32.4 0.0 0.2 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.3 0.2 0.0 0.0 0.0 1.1 57.0 0.0 0.4 0.3 0.0 0.0 0.0 6.2 0.9 0.0 0.0 0.0 0.0 1.3 SFTA3 "NANCI, SFTPH" ENSG00000229415 "Surfactant associated 3" P0C7M3 14 36473288-36513829 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "lung: 45.2;thyroid gland: 55.4" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 321.6;Alveolar cells type 2: 451.3;Club cells: 171.8" "Group enriched" "Detected in some" 238 "lung cancer: 18.4;thyroid cancer: 52.8" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 173 "SCLC-21H: 21.5" "Secreted in other tissues" NA NA "prognostic favorable (8.29e-4)" "unprognostic (3.95e-1)" "unprognostic (3.21e-3)" 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.1 321.6 451.3 0.0 0.0 0.0 0.0 0.0 0.0 53.5 171.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 0.0 0.0 0.0 0.0 SFTPA1 "COLEC4, SFTP1, SP-A, SP-A1" ENSG00000122852 "Surfactant protein A1" Q8IWL2 10 79610939-79615455 "Disease related genes, Predicted secreted proteins" "Gaseous exchange" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "lung: 411.8" "Cell type enriched" "Detected in some" 12 "Alveolar cells type 2: 12618.9" "Cancer enriched" "Detected in some" 25 "lung cancer: 706.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 63 "plasmacytoid DC: 6.2" "Lineage enriched" "Detected in single" 63 "dendritic cells: 6.2" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 30.8" "CAB016793, HPA042638, HPA045752, HPA049368" Supported "Secreted in other tissues" NA NA "CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731" "unprognostic (5.83e-4)" "unprognostic (1.17e-1)" "unprognostic (3.38e-2)" "unprognostic (4.24e-1)" "unprognostic (3.47e-2)" "unprognostic (9.09e-2)" 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 411.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1077.9 12618.9 0.0 0.0 0.0 0.0 0.0 0.0 156.6 337.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 418.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SFTPA2 "COLEC5, SP-A2" ENSG00000185303 "Surfactant protein A2" Q8IWL1 10 79555852-79560402 "Disease related genes, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 225 "lung: 501.0" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 2: 14379.1" "Cancer enriched" "Detected in many" 21 "lung cancer: 863.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 2.2" "Group enriched" "Detected in some" 21 "BEWO: 6.5;NB-4: 6.8;RPMI-8226: 21.7;U-2197: 13.1" "CAB002439, HPA042638, HPA045752, HPA049368" Enhanced "Secreted in other tissues" NA NA "CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" "unprognostic (4.99e-2)" "unprognostic (4.38e-2)" "unprognostic (4.29e-2)" "unprognostic (1.05e-1)" "unprognostic (5.78e-2)" "unprognostic (5.08e-1)" "unprognostic (4.94e-2)" "unprognostic (1.68e-3)" "unprognostic (3.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" "unprognostic (4.69e-3)" 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 501.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.1 0.4 0.3 0.1 0.0 0.2 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.8 0.4 0.0 0.0 0.2 0.0 21.7 0.0 0.3 0.2 0.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.2 13.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1479.9 14379.1 0.0 0.0 0.0 0.0 0.0 0.0 248.9 606.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.7 0.0 0.0 1.0 397.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 SFTPB "SFTP3, SP-B" ENSG00000168878 "Surfactant protein B" P07988 2 85657314-85668741 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "lung: 757.8" "Group enriched" "Detected in some" 18 "Alveolar cells type 1: 3391.6;Alveolar cells type 2: 11695.8;Club cells: 3546.5" "Group enriched" "Detected in many" 149 "lung cancer: 1306.7;thyroid cancer: 270.2" "Region enriched" "Detected in single" 17 "pons and medulla: 2.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.9;NB-4: 5.6;U-2197: 11.5;U-266/70: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002440, HPA034820, HPA062148" Enhanced "Secreted in other tissues" NA NA 71000000 "CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697" "unprognostic (6.46e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.71e-6)" "unprognostic (2.25e-3)" "unprognostic (4.57e-3)" "unprognostic (8.57e-3)" "unprognostic (6.45e-3)" "unprognostic (1.13e-1)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (2.99e-6)" "unprognostic (2.37e-1)" "unprognostic (1.09e-1)" "unprognostic (7.90e-2)" "unprognostic (4.38e-2)" 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 757.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 1.1 1.4 2.6 4.1 0.8 1.5 1.2 0.2 0.4 0.4 0.8 0.5 0.9 4.9 0.4 0.3 0.1 0.1 0.5 1.1 0.2 0.4 0.1 0.5 3.3 0.4 0.1 0.1 0.6 0.4 0.5 1.1 0.4 0.1 0.2 2.4 0.0 0.5 0.3 0.2 0.9 0.0 0.7 0.4 0.8 0.2 0.5 1.8 5.6 2.7 0.8 0.7 2.1 0.4 0.5 0.3 0.5 0.7 0.5 0.1 0.8 0.3 0.6 0.6 0.5 0.1 0.3 1.1 11.5 0.2 4.2 0.9 0.3 1.0 0.8 0.2 0.9 2.5 0.8 0.9 4.1 0.7 1.0 1.0 0.8 1.4 1.1 1.4 0.8 2.6 0.8 2.5 0.7 1.5 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 3391.6 11695.8 0.0 0.1 0.0 0.0 0.4 0.0 341.3 3546.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 241.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 SFTPC "BRICD6, PSP-C, SFTP2, SMDP2, SP-C" ENSG00000168484 "Surfactant protein C" P11686 8 22156913-22164479 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 718 "lung: 664.5" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 2: 80228.9" "Cancer enriched" "Detected in some" 218 "lung cancer: 226.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.4;NB-4: 10.7;SCLC-21H: 4.6;U-2197: 22.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA010928 Enhanced "Secreted in other tissues" NA NA "HPA010928: AB_1857425" "unprognostic (1.84e-1)" "unprognostic (1.96e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.97e-1)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (1.32e-2)" 0.1 0.8 0.2 0.3 0.5 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.3 0.1 0.1 0.1 664.5 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.7 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.6 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 0.3 0.1 0.4 0.1 0.9 0.1 7929.7 80228.9 0.0 0.0 1.5 0.0 0.3 0.0 623.7 2602.4 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 909.1 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 SFTPD "COLEC7, SFTP4, SP-D" ENSG00000133661 "Surfactant protein D" P35247 10 79937740-79982614 "Predicted secreted proteins" "Gaseous exchange, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lung: 127.0" "Group enriched" "Detected in many" 14 "Alveolar cells type 1: 408.0;Alveolar cells type 2: 1544.2" "Cancer enriched" "Detected in many" 16 "lung cancer: 106.4" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 11 "intermediate monocyte: 6.4;non-classical monocyte: 21.6" "Lineage enriched" "Detected in many" 17 "monocytes: 21.6" "Cell line enhanced" "Detected in some" "BEWO: 3.3;HaCaT: 2.4;HMC-1: 2.7;hTCEpi: 7.6;MCF7: 3.4;U-2197: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB004578, HPA044582, HPA056768" Enhanced "Secreted in other tissues" NA NA 5500000 "CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232" "unprognostic (3.81e-5)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (1.41e-2)" "unprognostic (4.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.66e-3)" "unprognostic (6.83e-2)" "unprognostic (3.85e-1)" "unprognostic (2.23e-1)" "unprognostic (5.29e-2)" "unprognostic (2.57e-1)" "unprognostic (4.70e-2)" "unprognostic (2.57e-2)" "unprognostic (2.38e-1)" "unprognostic (1.45e-1)" "unprognostic (8.86e-2)" 0.3 0.3 0.6 0.3 1.1 3.9 0.3 0.3 0.6 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.5 0.3 0.3 127.0 0.3 0.3 0.3 0.3 0.9 0.3 0.7 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 1.6 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 1.2 0.4 0.3 0.3 0.3 0.0 1.2 0.4 21.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.2 0.8 0.0 2.4 0.3 0.1 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.2 2.7 0.0 7.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 3.4 0.1 1.8 0.8 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.7 0.8 0.1 0.6 0.0 0.4 1.0 0.7 1.5 0.0 0.2 2.6 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 6.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.5 0.6 1.1 0.3 0.6 0.5 0.5 0.3 0.3 0.3 0.3 408.0 1544.2 0.0 0.8 0.8 1.8 0.5 0.0 17.4 68.2 5.2 0.0 0.0 1.7 1.0 5.2 0.3 0.0 0.0 5.2 2.3 1.9 0.8 18.6 0.8 0.1 0.0 0.0 0.0 0.0 8.9 1.1 1.4 0.0 0.0 0.0 2.3 2.0 0.0 0.4 0.2 0.3 0.0 0.2 0.4 0.1 1.6 0.1 0.0 0.0 0.3 SLC11A1 "LSH, NRAMP, NRAMP1" ENSG00000018280 "Solute carrier family 11 member 1" P49279 2 218382029-218396894 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.6;lymphoid tissue: 23.8" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9" "Cell line enhanced" "Detected in some" "HEL: 3.8;HMC-1: 3.7;NB-4: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA029590, HPA050378, HPA068540" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA029590: AB_10794613, HPA050378: , HPA068540: " "unprognostic (2.64e-1)" "unprognostic (3.05e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-2)" "unprognostic (1.99e-2)" "unprognostic (3.83e-2)" "unprognostic (1.04e-3)" "unprognostic (2.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (7.29e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.58e-8)" "unprognostic (9.55e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-2)" "unprognostic (1.08e-2)" 13.5 4.7 4.3 14.9 13.3 11.6 2.6 0.6 9.3 1.7 1.8 4.6 0.0 1.3 1.3 2.1 1.4 4.1 3.0 6.5 15.0 2.6 2.1 3.2 37.6 19.9 17.1 0.7 2.4 3.3 1.2 1.9 6.2 11.3 1.7 1.0 1.7 2.0 1.2 2.0 1.0 1.2 4.6 18.1 23.8 1.7 2.4 10.3 0.0 1.8 0.2 1.0 7.1 1.3 0.4 2.4 6.0 7.9 0.2 0.4 2.6 0.3 0.7 0.0 0.4 0.1 0.1 0.9 0.0 0.0 0.1 0.2 1.0 2.1 0.2 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.7 0.1 3.8 0.6 0.7 0.1 0.0 3.7 0.3 0.1 0.0 0.2 0.3 0.0 1.2 1.0 0.7 0.1 1.3 0.2 3.1 0.0 0.6 0.2 0.2 0.6 0.4 0.1 0.3 0.8 0.2 0.5 0.4 0.4 0.2 0.3 1.1 0.3 0.7 0.4 0.2 0.0 0.3 0.3 0.7 0.2 0.4 0.4 0.3 7.9 0.6 0.4 5.8 0.3 0.1 0.2 0.2 2.4 0.4 0.4 0.3 6.0 0.2 7.0 0.2 0.2 2.6 4.3 13.3 0.6 9.3 15.0 2.6 17.1 0.7 11.3 10.3 20.8 52.4 3.0 3.9 0.8 3.6 6.3 5.1 17.4 22.7 8.7 0.0 1.6 8.3 0.8 1.2 4.7 1.2 0.0 1.8 7.2 2.4 5.7 24.3 4.7 110.2 1.6 1.2 8.6 163.4 0.4 2.0 201.4 1.7 1.0 4.0 7.6 0.6 0.9 0.7 6.8 3.0 19.4 5.0 0.5 1.7 0.9 6.8 1.7 2.2 2.7 SLC22A31 ENSG00000259803 "Solute carrier family 22 member 31" 16 89195761-89201664 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 21 "brain: 39.3;lung: 50.7;pancreas: 69.7" "Cell type enriched" "Detected in some" 6 "Alveolar cells type 2: 129.3" "Group enriched" "Detected in many" 9 "liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4" "Region enriched" "Detected in some" 23 "cerebellum: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 23.7;Hep G2: 19.0;NB-4: 9.7;RPMI-8226: 11.4;THP-1: 6.2" NA NA "unprognostic (2.71e-3)" "unprognostic (2.53e-1)" "unprognostic (5.02e-3)" "unprognostic (6.82e-2)" "unprognostic (8.20e-2)" "unprognostic (1.95e-1)" "unprognostic (3.00e-2)" "unprognostic (1.93e-2)" "unprognostic (2.12e-1)" "unprognostic (2.67e-1)" "unprognostic (8.98e-2)" "unprognostic (1.09e-1)" "unprognostic (8.26e-4)" "unprognostic (2.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.72e-3)" "unprognostic (1.89e-1)" 0.1 0.3 0.0 0.3 0.4 1.1 0.1 39.3 0.1 0.3 0.5 0.0 0.0 0.6 0.2 0.5 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.3 50.7 2.5 0.0 0.0 0.7 69.7 0.1 0.0 0.1 1.7 0.2 0.1 0.4 0.7 0.2 0.1 0.3 0.3 0.1 0.3 1.0 0.5 1.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.0 1.1 0.0 0.0 23.7 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.0 9.7 0.6 0.2 2.4 0.0 2.6 11.4 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.1 0.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 39.3 0.1 0.1 0.0 0.0 0.0 1.7 0.0 6.0 129.3 0.0 0.0 0.0 0.0 0.4 0.0 4.0 14.8 0.0 0.0 0.0 0.0 0.1 20.8 0.0 0.0 0.0 4.2 0.1 0.0 0.2 8.1 0.2 0.6 0.0 0.0 0.6 0.3 23.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 2.8 0.1 0.0 0.0 0.0 0.0 SLC34A2 NAPI-3B ENSG00000157765 "Solute carrier family 34 member 2" O95436 4 25648011-25678748 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lung: 259.9;seminal vesicle: 69.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 585.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 81 "BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037989, HPA066474" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA037989: AB_10670536, HPA066474: " "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.38e-1)" "unprognostic (4.25e-2)" "unprognostic (7.33e-2)" "unprognostic (9.83e-2)" "unprognostic (2.37e-2)" "unprognostic (6.60e-3)" "unprognostic (6.27e-2)" "unprognostic (1.89e-2)" "unprognostic (5.77e-2)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (3.25e-1)" "unprognostic (6.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.93e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 3.2 0.2 0.1 13.0 0.1 0.0 24.7 2.9 6.9 2.1 0.5 13.0 3.4 0.1 0.1 0.1 10.8 0.5 259.9 0.0 0.1 0.0 2.9 4.4 0.0 0.6 2.6 0.8 0.3 0.0 1.6 27.4 69.1 0.1 0.7 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.4 27.9 0.1 1.9 0.0 0.1 0.4 0.2 1.9 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.9 0.5 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.4 0.3 0.2 1.5 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.0 443.7 1050.6 0.0 0.1 0.0 0.0 0.6 40.8 125.8 178.6 19.2 0.0 1.6 5.0 57.7 3.5 0.0 0.0 0.0 7.1 0.0 0.0 3.5 26.7 0.0 0.2 0.0 0.0 0.0 0.0 14.0 1.1 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 2.9 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 SLC39A8 BIGM103 ENSG00000138821 "Solute carrier family 39 member 8" Q9C0K1 4 102251041-102431258 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 67.3;salivary gland: 54.6" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 723.6;Alveolar cells type 2: 227.4;Extravillous trophoblasts: 184.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 45.5;HL-60: 33.1;Karpas-707: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038832, HPA038833" Approved NA NA "HPA038832: AB_2676226, HPA038833: AB_10670910" "prognostic favorable (6.69e-4)" "unprognostic (1.29e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (6.50e-2)" "unprognostic (9.59e-2)" "unprognostic (6.07e-2)" "unprognostic (2.74e-1)" "unprognostic (1.20e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-3)" "unprognostic (2.78e-2)" "prognostic favorable (6.34e-6)" "unprognostic (3.25e-1)" "unprognostic (6.54e-2)" "unprognostic (6.40e-2)" "unprognostic (7.13e-3)" 22.0 2.0 3.7 11.4 5.5 10.3 6.1 2.8 4.3 31.4 18.1 2.2 1.1 2.1 3.9 7.3 1.7 7.2 2.6 17.8 4.3 3.5 6.2 18.4 67.3 8.6 5.1 1.6 5.4 42.1 25.7 6.7 44.8 5.9 5.7 14.9 4.3 54.6 2.3 1.8 5.1 3.4 3.0 8.8 6.5 2.5 2.3 3.2 7.5 4.9 2.3 5.6 5.8 6.0 3.1 2.7 1.0 1.5 11.5 10.5 3.4 5.5 5.5 1.2 0.0 4.6 10.6 2.9 0.6 45.5 1.7 2.7 0.2 20.6 5.4 6.0 0.1 5.7 0.4 3.8 1.2 1.0 9.3 11.3 14.1 11.6 0.1 1.8 33.1 4.8 5.6 1.4 0.8 2.6 4.5 0.6 13.4 14.1 49.4 8.8 3.7 11.9 15.5 3.7 7.5 5.4 3.0 0.0 17.6 9.6 2.1 1.6 4.0 15.5 0.2 1.5 1.1 3.8 12.4 3.1 5.5 2.1 11.2 8.7 22.1 9.2 25.6 9.1 21.7 5.0 0.0 1.5 1.0 5.6 1.0 9.8 1.3 10.5 9.0 2.7 3.1 7.9 5.4 0.1 11.5 0.3 1.0 3.9 3.4 3.7 5.5 2.8 4.3 4.3 3.5 5.1 1.6 5.9 3.2 723.6 227.4 10.4 9.5 10.4 0.8 22.6 7.6 1.4 27.3 5.2 3.9 12.1 10.0 1.9 0.3 8.0 3.3 23.3 28.2 184.5 25.7 10.8 3.5 22.1 43.3 3.2 23.1 6.7 29.8 0.4 1.1 25.3 27.0 16.2 72.2 4.5 16.3 7.0 1.1 8.1 1.2 6.5 14.6 2.7 5.9 6.0 50.7 13.8 56.9 6.8 SLC6A14 ENSG00000268104 "Solute carrier family 6 member 14" Q9UN76 X 116436622-116461458 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 3.8;Hep G2: 8.2;OE19: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA003193 Uncertain Approved Vesicles NA NA Vesicles "HPA003193: AB_2190122" "unprognostic (3.06e-2)" "unprognostic (3.55e-2)" "unprognostic (8.49e-2)" "unprognostic (1.00e-3)" "unprognostic (1.30e-3)" "unprognostic (1.49e-2)" "unprognostic (7.41e-3)" "unprognostic (3.67e-3)" "unprognostic (2.66e-1)" "unprognostic (1.83e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 5.9 0.0 0.0 6.3 0.8 0.0 11.8 0.4 0.1 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.2 0.5 0.3 0.0 26.3 5.8 0.0 1.1 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 23.5 1.2 1.0 1.0 0.4 0.2 1.1 0.4 0.3 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 3.8 8.2 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.2 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.0 1.4 0.5 0.0 0.0 0.1 0.0 1.1 0.4 0.5 0.4 0.1 0.3 0.4 0.2 0.2 0.1 0.4 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.0 20.8 100.3 0.0 0.1 0.1 0.0 0.2 0.0 10.7 33.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.2 0.0 28.5 0.0 0.0 5.2 3.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.1 0.0 101.5 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.0 3.2 SLC6A4 "5-HTT, HTT, OCD1, SERT1" ENSG00000108576 "Solute carrier family 6 member 4" P31645 17 30194319-30236002 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.0;lung: 50.5" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 90.5;Syncytiotrophoblasts: 89.0" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enriched" "Detected in single" 36 "pons and medulla: 11.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 5.5;Hep G2: 14.7" "Region enriched" "Detected in some" 5 "midbrain: 69.9" "Low region specificity" "Detected in all" "HPA054723, HPA071354, HPA074728" Supported Supported Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA054723: , HPA071354: , HPA074728: AB_2686708" "unprognostic (7.45e-2)" "unprognostic (7.13e-2)" "unprognostic (2.26e-1)" "unprognostic (3.72e-4)" "unprognostic (2.07e-1)" "unprognostic (8.42e-3)" "unprognostic (2.73e-2)" "unprognostic (3.39e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-3)" "unprognostic (2.70e-3)" "unprognostic (1.16e-1)" "unprognostic (8.78e-2)" "unprognostic (4.98e-2)" "unprognostic (1.76e-1)" "unprognostic (4.05e-2)" "unprognostic (7.18e-2)" 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.1 6.3 0.1 0.3 1.6 0.9 0.1 0.7 0.1 0.1 0.3 0.1 50.5 0.1 0.1 0.1 0.1 0.6 0.0 0.1 11.3 11.2 0.1 0.0 0.2 0.7 0.1 0.1 0.4 25.0 0.4 0.1 0.1 0.5 0.3 0.1 0.1 0.2 0.1 0.3 0.1 0.3 0.0 0.1 1.0 0.2 0.4 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 14.7 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.0 1.0 0.0 0.7 0.8 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.0 0.4 0.2 0.1 0.0 2.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 11.2 0.1 14.9 5.3 0.0 0.4 0.1 0.2 0.8 0.0 1.4 3.4 1.8 0.0 90.5 0.0 0.0 2.3 0.5 1.0 0.0 0.0 7.0 1.6 0.3 2.3 0.0 8.4 0.0 0.0 2.5 0.6 1.0 0.3 0.4 0.0 0.0 0.0 0.5 0.5 0.0 0.4 0.3 0.9 0.0 1.4 0.0 0.4 0.3 89.0 0.0 0.0 0.3 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702228-66782848 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.1" "Cell type enriched" "Detected in many" 6 "Ito cells: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 21.2;HaCaT: 12.6;HeLa: 17.4;U-2197: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: AB_2684637" "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favorable (5.45e-5)" 9.8 1.9 2.5 3.1 4.6 0.6 5.1 0.8 2.8 6.3 4.7 2.6 2.1 3.8 5.2 1.9 3.1 4.4 11.6 21.6 3.0 2.0 6.1 6.2 37.1 1.2 3.6 2.3 5.1 3.1 2.3 2.8 13.8 4.5 9.7 2.5 18.5 1.6 22.1 1.8 1.6 3.8 3.1 2.9 3.2 8.0 1.7 2.0 0.0 16.7 0.6 0.8 6.8 7.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.9 7.0 1.1 2.4 4.3 1.1 6.7 4.9 0.1 0.8 0.0 1.4 3.1 0.5 21.2 4.2 0.6 12.6 1.5 0.0 0.1 1.5 5.8 10.9 17.4 1.1 0.5 0.0 0.8 1.4 0.0 0.0 0.0 2.4 0.9 3.6 0.9 0.7 0.3 1.3 0.1 3.0 2.1 7.1 2.6 0.0 1.3 1.5 2.4 5.5 2.6 1.1 2.7 3.0 0.5 4.3 1.0 2.0 4.2 3.1 4.0 12.3 0.9 0.4 1.2 0.2 2.2 3.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 4.6 0.8 2.8 3.0 2.0 3.6 2.3 4.5 2.0 11.9 5.9 1.4 1.0 0.7 0.0 4.5 5.1 0.0 4.5 1.8 2.0 0.5 3.3 4.3 2.8 19.4 2.8 0.0 5.0 0.7 4.3 1.5 4.6 2.8 1.7 0.0 0.0 107.4 9.5 1.0 2.6 0.8 0.0 1.0 2.0 11.1 5.6 0.0 7.8 1.5 0.3 0.0 1.0 0.2 0.6 0.1 0.7 0.5 5.3 0.3 SNTN "FLJ44379, S100AL" ENSG00000188817 "Sentan, cilia apical structure protein" A6NMZ2 3 63652668-63679020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5" "Cell type enriched" "Detected in some" 13 "Ciliated cells: 823.1" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "OE19: 3.1;RH-30: 2.4;SH-SY5Y: 3.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA043322, HPA058399" Enhanced NA NA "HPA043322: AB_10793945, HPA058399: AB_2683705" "unprognostic (9.70e-3)" "unprognostic (3.67e-1)" "unprognostic (4.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.34e-3)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (8.43e-3)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 1.1 26.6 0.0 73.9 0.0 0.0 0.6 0.3 0.0 0.0 29.5 0.0 0.0 0.0 18.5 0.1 0.0 1.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 5.8 0.0 0.1 0.0 0.0 0.9 0.4 1.6 0.2 0.4 0.5 0.1 0.3 0.2 0.6 0.8 0.1 1.4 0.5 0.0 0.0 0.0 0.3 0.2 0.8 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.5 0.0 0.0 0.2 0.4 0.2 3.1 0.0 0.3 2.4 0.2 0.1 0.3 0.3 3.4 0.1 0.3 0.0 0.6 0.1 0.3 0.0 0.6 0.6 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.6 1.6 0.2 0.2 0.3 0.2 0.3 0.1 0.2 0.3 0.0 0.9 0.5 0.4 1.1 0.4 0.2 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.6 0.0 3.0 3.4 0.0 0.0 0.0 0.0 0.2 0.0 823.1 64.8 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 SOX7 ENSG00000171056 "SRY-box 7" Q9BT81 8 10723768-10730512 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.2" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 57.2;Basal keratinocytes: 54.4;Endothelial cells: 70.1;Ito cells: 42.4;Suprabasal keratinocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 9.4;hTCEpi: 17.4;HUVEC TERT2: 20.3;TIME: 5.4" "Low region specificity" "Detected in many" HPA009065 Approved Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (1.21e-1)" "unprognostic (1.08e-1)" "unprognostic (1.15e-3)" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.74e-2)" "unprognostic (7.26e-2)" "unprognostic (7.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.71e-3)" "unprognostic (2.45e-3)" "unprognostic (2.38e-1)" "unprognostic (5.41e-3)" "unprognostic (4.84e-3)" 17.4 1.8 3.5 3.4 3.3 0.7 7.0 1.7 4.2 16.0 3.4 2.1 1.0 0.8 7.1 6.8 19.7 3.0 6.1 12.5 2.6 2.2 3.0 7.4 37.2 2.9 2.6 1.5 2.6 4.5 2.7 4.2 26.4 3.6 5.8 2.2 7.6 7.1 5.0 12.5 11.7 2.1 4.2 3.0 2.2 2.2 1.9 3.2 0.6 4.7 22.7 14.5 8.8 23.1 1.9 0.3 0.8 0.4 0.2 1.2 0.1 4.5 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.5 9.4 2.8 3.4 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.2 0.1 17.4 0.0 3.6 0.0 20.3 0.0 0.4 0.2 0.0 0.1 0.1 0.1 1.3 0.7 2.6 0.9 0.0 0.0 0.0 1.7 0.5 2.7 1.7 0.0 0.0 1.2 0.0 0.0 5.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.5 0.4 0.1 0.2 0.2 1.2 1.9 0.3 0.1 0.1 0.3 0.2 0.4 0.8 0.2 0.1 0.3 0.1 0.1 3.5 3.3 1.7 4.2 2.6 2.2 2.6 1.5 3.6 3.2 0.0 18.1 2.7 57.2 54.4 1.1 2.8 2.5 2.7 3.4 0.0 3.9 4.1 0.0 0.1 0.2 70.1 0.0 0.0 0.2 0.2 2.8 12.5 3.5 4.5 0.5 0.0 0.0 42.4 1.5 0.0 0.9 1.1 3.3 0.0 0.1 0.5 0.2 0.0 0.4 0.0 2.4 0.0 4.1 2.6 1.5 35.5 10.4 0.0 0.4 20.7 SPN "CD43, GPL115, LSN" ENSG00000197471 Sialophorin P16150 16 29662979-29670876 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 22.9;Erythroid cells: 23.3;granulocytes: 42.7;Hofbauer cells: 27.4;Kupffer cells: 21.5;Macrophages: 52.4;T-cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 52.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 56.1;HL-60: 49.8;HMC-1: 28.1;K-562: 17.4;MOLT-4: 19.3;REH: 17.4;THP-1: 27.0;U-937: 35.5" "CAB002666, HPA055244" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB002666: , HPA055244: AB_2682756" "prognostic favorable (1.40e-4)" "unprognostic (1.63e-3)" "unprognostic (3.14e-2)" "prognostic favorable (3.08e-5)" "unprognostic (2.68e-2)" "unprognostic (2.49e-3)" "unprognostic (4.02e-2)" "unprognostic (4.17e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.70e-1)" "unprognostic (4.67e-2)" "unprognostic (2.68e-1)" "unprognostic (2.61e-2)" "unprognostic (4.52e-2)" "unprognostic (4.14e-2)" "unprognostic (5.85e-2)" "unprognostic (4.72e-2)" 5.7 1.0 1.2 12.9 2.7 33.1 1.6 0.7 1.5 1.3 2.8 2.6 0.0 2.3 1.5 0.6 1.9 1.7 2.8 3.9 1.2 1.4 1.8 1.9 25.0 18.3 3.7 0.2 1.0 1.6 0.2 1.0 0.8 2.3 1.6 2.6 1.6 5.0 0.6 0.8 1.6 6.8 1.0 4.6 15.9 2.0 0.6 1.9 79.7 1.6 1.7 17.4 2.6 1.4 1.0 8.8 3.5 52.1 17.5 26.5 10.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.1 0.0 0.4 0.0 49.8 28.1 0.0 0.0 0.0 0.0 0.0 0.0 10.9 17.4 13.7 0.1 0.0 19.3 12.5 0.0 0.0 0.0 17.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 7.3 0.0 35.5 0.0 2.4 5.5 3.5 26.5 24.3 14.5 1.0 10.7 18.1 8.8 0.3 7.6 13.2 0.9 17.5 52.1 7.0 9.1 10.7 1.2 2.7 0.7 1.5 1.2 1.4 3.7 0.2 2.3 1.9 8.9 22.9 9.3 0.5 1.9 0.6 5.1 0.0 2.7 4.5 1.8 0.0 0.2 0.0 0.0 0.0 0.7 0.0 23.3 0.0 0.3 2.6 0.4 42.7 0.9 27.4 1.6 0.0 4.3 21.5 0.0 0.0 52.4 1.7 1.8 0.0 0.4 0.0 0.0 0.0 0.3 1.9 0.0 1.7 0.2 0.6 1.8 0.2 85.3 0.0 0.7 SPOCK2 "KIAA0275, testican-2" ENSG00000107742 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2" Q92563 10 72059035-72089032 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.1;brain: 70.7;lung: 52.1" "Group enriched" "Detected in many" 9 "Alveolar cells type 1: 268.0;Bipolar cells: 102.9;T-cells: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 27.5;MAIT T-cell: 47.1;memory CD4 T-cell: 27.7;memory CD8 T-cell: 21.9;naive CD4 T-cell: 21.5;naive CD8 T-cell: 21.2;T-reg: 37.5" "Lineage enriched" "Detected in many" 8 "T-cells: 47.1" "Group enriched" "Detected in some" 7 "Hep G2: 25.4;SCLC-21H: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044605 Enhanced "Secreted to blood" NA NA 42000 "HPA044605: AB_10965991" "prognostic favorable (4.05e-4)" "unprognostic (3.11e-3)" "unprognostic (2.92e-2)" "unprognostic (2.29e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.18e-2)" "unprognostic (9.04e-2)" "prognostic favorable (4.72e-4)" "prognostic unfavorable (7.19e-4)" "unprognostic (4.53e-3)" "unprognostic (2.29e-1)" "unprognostic (1.46e-3)" "unprognostic (5.59e-2)" "unprognostic (5.49e-2)" "unprognostic (3.19e-3)" "unprognostic (2.24e-2)" 4.2 29.8 31.9 24.9 47.8 27.9 2.0 70.7 63.2 2.5 4.2 9.8 0.0 6.2 2.5 2.7 2.8 4.7 9.9 4.7 27.5 49.5 18.8 2.5 52.1 36.4 36.0 32.1 3.7 1.5 1.7 12.8 2.9 47.9 3.0 4.1 5.4 2.8 4.5 3.6 1.9 9.3 3.4 22.3 16.9 8.3 13.6 9.2 43.4 3.3 0.6 27.0 8.0 1.4 5.6 0.7 2.9 0.2 2.8 47.1 10.3 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.4 0.1 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.1 0.6 25.4 0.9 0.2 0.6 0.1 0.2 0.0 0.0 0.1 0.0 1.4 0.0 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 36.2 2.2 0.0 0.8 0.2 0.2 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.4 0.8 3.8 0.1 0.0 0.1 0.0 0.1 0.0 27.5 0.2 47.1 5.6 27.7 21.9 0.0 4.5 21.5 21.2 2.9 2.8 0.0 0.7 37.5 10.3 31.9 47.8 70.7 42.0 27.5 49.5 36.0 32.1 47.9 9.2 268.0 14.3 16.4 0.2 3.4 102.9 2.5 0.0 2.7 5.7 14.0 5.9 0.1 0.0 0.4 6.3 9.0 0.7 0.0 0.7 0.0 2.4 0.4 3.5 0.0 0.2 3.2 4.7 6.7 2.6 8.2 4.9 2.0 5.0 0.0 0.3 3.8 0.0 0.0 5.6 0.0 12.4 0.0 4.2 3.6 0.6 3.9 0.3 96.9 0.0 0.3 ST8SIA6 SIAT8F ENSG00000148488 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6" P61647 10 17318383-17454330 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.5" "Group enriched" "Detected in some" 7 "Endothelial cells: 8.7;granulocytes: 10.3;Ito cells: 15.4;Melanocytes: 8.5" "Cancer enhanced" "Detected in some" "breast cancer: 5.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "HMC-1: 108.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011635, HPA072708" Uncertain Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA011635: AB_2194921, HPA072708: " "unprognostic (4.86e-3)" "unprognostic (7.01e-2)" "unprognostic (5.85e-3)" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.11e-2)" "unprognostic (6.81e-2)" "unprognostic (2.32e-1)" "unprognostic (3.23e-2)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.43e-1)" "unprognostic (2.22e-1)" "unprognostic (1.07e-3)" 1.8 0.9 3.1 1.0 5.0 4.0 14.4 2.5 3.4 1.1 1.7 3.3 0.4 1.0 1.6 10.4 2.4 1.3 1.9 9.1 3.7 4.4 2.5 2.4 17.5 0.8 8.8 1.7 1.1 0.5 0.3 1.3 3.5 5.5 4.3 1.8 13.7 1.9 0.6 2.0 2.8 1.3 1.3 4.3 1.5 1.0 1.2 2.5 0.0 1.8 0.5 2.0 1.1 3.9 0.9 0.7 3.8 1.4 2.1 5.6 0.9 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 13.3 0.0 0.1 0.0 0.0 108.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.5 0.1 0.9 1.3 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.4 1.3 2.5 0.4 0.5 0.3 1.2 1.4 0.7 0.9 1.0 1.7 2.9 2.1 0.7 0.6 5.6 0.9 3.1 5.0 2.5 3.4 3.7 4.4 8.8 1.7 5.5 2.5 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.7 0.0 0.0 0.0 0.0 0.2 1.6 10.3 0.0 0.1 0.0 0.0 15.4 0.8 0.4 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.0 0.0 0.0 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38991066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2" "Cell type enriched" "Detected in some" 24 "Ciliated cells: 133.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "AF22: 19.0" "Region enriched" "Detected in some" 6 "olfactory region: 29.0" "Low region specificity" "Detected in all" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA012892: AB_1857610, HPA071011: AB_2732169" "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favorable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.1 0.1 2.9 0.1 3.8 0.1 0.2 0.0 0.2 1.7 0.2 6.6 0.0 0.2 1.1 8.1 0.1 31.7 0.1 0.1 4.4 4.1 0.1 0.1 9.2 0.1 0.0 0.0 7.6 0.1 0.1 0.0 0.3 9.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.6 2.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.8 0.0 0.2 4.4 4.1 0.0 0.0 9.7 2.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 133.8 5.7 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 SUSD2 "BK65A6.2, FLJ22778" ENSG00000099994 "Sushi domain containing 2" Q9UGT4 22 24181259-24189110 "Predicted membrane proteins" Receptor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 100.1" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 232.3;Alveolar cells type 2: 121.0" "Cancer enhanced" "Detected in all" "testis cancer: 64.5" "Region enhanced" "Detected in many" "pons and medulla: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "SK-BR-3: 138.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA004117 Enhanced Approved "Plasma membrane" NA NA 3600000 "Plasma membrane" "HPA004117: AB_1857674" "unprognostic (5.24e-3)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-2)" "unprognostic (5.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.89e-2)" "unprognostic (5.87e-2)" "unprognostic (1.20e-2)" "unprognostic (9.74e-3)" "unprognostic (8.97e-2)" "prognostic unfavorable (3.29e-5)" "unprognostic (2.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.88e-2)" "unprognostic (3.33e-3)" 6.0 4.2 0.3 1.4 0.9 0.5 11.3 3.8 1.4 10.5 10.5 2.5 1.3 7.8 7.1 8.3 2.8 6.9 5.3 10.8 0.6 2.9 19.5 1.2 100.1 1.4 0.6 2.6 2.6 2.4 1.3 3.6 3.5 9.6 2.8 1.0 2.2 7.9 4.0 3.0 11.8 32.4 2.4 3.0 1.6 2.5 1.9 0.7 0.1 12.7 5.9 1.5 2.3 4.7 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.7 1.5 0.0 0.0 3.0 3.9 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.2 0.0 0.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.1 0.1 138.9 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.8 1.4 0.6 2.9 0.6 2.6 9.6 0.7 232.3 121.0 0.0 0.2 0.2 0.0 2.8 0.0 5.3 33.0 1.8 0.0 14.1 5.0 0.0 0.0 0.3 1.6 0.0 0.0 0.4 3.5 0.8 3.5 0.0 0.9 0.0 1.7 4.3 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 24.9 0.0 0.0 15.1 0.9 0.9 2.4 22.1 0.0 0.0 0.5 TBX4 ENSG00000121075 "T-box 4" P57082 17 61452404-61485110 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6" "Group enriched" "Detected in some" 7 "Early spermatids: 5.7;Late spermatids: 11.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 5.4;Hep G2: 2.2;OE19: 2.2;THP-1: 10.7" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "basal ganglia: 1.6" "CAB032413, HPA044457" Uncertain Approved Vesicles NA NA Vesicles "CAB032413: AB_2200705, HPA044457: AB_2678948" "unprognostic (1.03e-2)" "unprognostic (2.05e-2)" "unprognostic (1.43e-1)" "unprognostic (1.63e-3)" "unprognostic (6.07e-2)" "unprognostic (3.80e-2)" "unprognostic (1.25e-2)" "unprognostic (4.14e-2)" "unprognostic (7.77e-3)" "unprognostic (7.41e-2)" "unprognostic (6.83e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-8)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-2)" 0.5 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.0 0.6 15.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 26.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 18.6 4.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.1 5.4 0.5 0.4 0.5 1.9 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 2.2 0.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.2 0.1 0.0 0.2 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.5 0.2 0.0 10.7 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TBX5 HOS ENSG00000089225 "T-box 5" Q99593 12 114353931-114408442 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 44.5;lung: 14.0;placenta: 19.7" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 62.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hippocampal formation: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 13.1;BJ hTERT+: 29.2;BJ hTERT+ SV40 Large T+: 6.8;BJ hTERT+ SV40 Large T+ RasG12V: 8.3;HAP1: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008786, HPA064683" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008786: AB_10601720, HPA064683: AB_2685320" "unprognostic (3.09e-2)" "unprognostic (1.53e-1)" "unprognostic (3.79e-2)" "unprognostic (2.75e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-7)" "unprognostic (2.29e-2)" "unprognostic (1.68e-2)" "unprognostic (7.34e-2)" "unprognostic (4.38e-3)" 2.2 0.1 0.1 0.0 0.1 0.0 3.8 0.8 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 6.4 0.1 0.0 44.5 2.2 0.1 0.1 0.1 14.0 1.6 0.1 0.1 0.1 0.1 0.0 0.1 19.7 0.5 5.4 0.0 1.4 0.1 0.0 0.1 0.5 0.1 6.6 0.2 0.1 0.1 0.1 0.0 0.0 1.0 0.0 0.0 6.5 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.1 29.2 6.8 8.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 11.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.2 2.2 0.1 0.1 0.1 0.5 0.0 0.0 1.1 0.0 0.0 0.1 3.6 62.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 TCF21 "bHLHa23, POD1" ENSG00000118526 "Transcription factor 21" O43680 6 133889138-133895553 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lung: 74.4;ovary: 61.6" "Group enriched" "Detected in some" 5 "Leydig cells: 94.6;Peritubular cells: 110.0;Sertoli cells: 116.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HHSteC: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA013189 Uncertain NA NA "HPA013189: AB_10601215" "unprognostic (2.43e-2)" "unprognostic (8.45e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "unprognostic (4.78e-5)" "unprognostic (2.58e-2)" "unprognostic (6.66e-2)" "unprognostic (9.74e-2)" "unprognostic (2.88e-2)" "unprognostic (2.91e-3)" "unprognostic (2.01e-2)" "unprognostic (8.48e-2)" "unprognostic (5.37e-2)" "unprognostic (2.95e-1)" 4.7 2.2 0.2 11.6 0.5 0.0 0.4 0.2 0.2 12.7 16.8 0.4 9.6 5.2 12.9 9.6 19.1 2.2 14.6 13.2 0.2 0.2 17.0 4.1 74.4 1.0 0.2 0.0 61.6 1.9 0.0 2.4 48.4 1.2 57.8 5.3 0.0 0.2 16.0 0.8 0.3 13.9 21.1 0.2 52.2 5.7 5.9 0.0 0.0 0.5 0.0 0.0 19.6 24.6 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.0 1.2 0.0 3.0 0.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.2 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 19.5 0.3 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 94.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.0 0.0 0.0 116.4 1.7 0.2 0.4 0.0 4.8 0.0 0.0 0.4 TMEM100 "FLJ10970, FLJ37856" ENSG00000166292 "Transmembrane protein 100" Q9NV29 17 55719627-55732121 "Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 52.8;lung: 99.5" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 20.4;Leydig cells: 37.7;Peritubular cells: 49.5;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 18.1;ASC TERT1: 12.3;HHSteC: 28.0;HSkMC: 12.9;U-87 MG: 8.5;WM-115: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055936 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA055936: AB_2682975" "unprognostic (1.35e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (4.02e-2)" "unprognostic (6.78e-3)" "unprognostic (3.07e-1)" "prognostic favorable (2.67e-5)" "unprognostic (5.74e-2)" "unprognostic (1.87e-2)" "unprognostic (4.66e-1)" "unprognostic (1.89e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.91e-3)" "unprognostic (1.12e-1)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" 24.7 2.0 3.4 1.5 3.9 0.0 52.8 0.7 5.3 5.1 10.5 0.7 8.8 2.7 1.6 16.7 4.6 3.6 4.8 5.8 1.6 2.8 1.2 5.8 99.5 1.5 3.4 0.6 10.1 1.9 0.0 3.3 23.5 2.6 7.4 5.1 2.6 2.2 11.7 7.0 1.3 6.6 5.2 1.4 2.3 10.7 3.9 0.6 0.5 3.8 3.7 1.3 5.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 18.1 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 28.0 0.0 0.0 12.9 0.0 0.9 0.1 0.1 0.0 0.2 0.5 0.1 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 1.2 2.4 0.0 0.5 0.0 0.1 8.5 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.9 0.7 1.7 1.6 2.8 3.4 0.6 2.6 0.6 0.0 5.1 0.0 0.3 2.3 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 14.1 0.0 0.0 0.0 0.0 20.4 0.1 1.1 13.9 0.1 0.0 0.0 7.4 0.0 0.0 37.7 0.6 6.8 0.0 0.0 0.0 0.2 0.0 49.5 0.5 0.0 32.3 12.2 0.0 0.0 2.3 0.1 0.0 0.0 0.1 TMEM212 FLJ23172 ENSG00000186329 "Transmembrane protein 212" A6NML5 3 171843349-171938715 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.2;lung: 10.0;ovary: 12.8" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 22.8;Ciliated cells: 167.3;Club cells: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045736 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA045736: AB_2679436" "unprognostic (3.39e-2)" "unprognostic (1.78e-2)" "unprognostic (3.05e-1)" "unprognostic (5.54e-2)" "unprognostic (3.06e-1)" "unprognostic (2.87e-1)" 0.4 0.4 0.5 0.6 0.8 2.2 0.4 0.4 0.5 1.6 0.8 0.9 0.4 0.2 1.3 2.5 0.8 19.2 0.4 0.4 0.6 0.7 0.4 3.3 10.0 0.6 0.4 0.4 12.8 0.4 0.0 0.4 0.4 0.7 0.4 0.8 0.4 0.4 2.1 1.1 1.5 0.5 0.4 0.4 0.4 0.4 1.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 4.1 3.2 6.3 2.1 3.8 2.7 0.5 4.1 2.5 2.8 3.1 0.8 0.4 5.5 3.0 0.9 1.2 1.2 2.0 3.3 5.4 3.6 1.4 3.1 2.9 1.7 1.3 2.6 7.1 2.8 6.4 6.5 2.7 0.5 3.7 5.4 1.1 1.5 1.4 1.2 1.8 1.3 3.4 4.4 8.6 0.9 2.7 3.2 4.1 4.9 2.1 2.7 2.7 4.4 4.5 1.1 3.2 3.4 3.3 4.1 3.1 2.3 3.3 3.6 3.3 6.6 4.6 5.0 7.2 3.2 5.1 4.0 3.6 2.3 3.4 2.4 6.3 2.1 1.8 2.7 1.8 2.1 1.9 2.0 1.8 1.1 4.1 2.3 2.5 5.0 3.8 2.0 3.2 1.3 0.5 0.5 0.8 0.4 0.4 0.6 0.7 0.4 0.4 0.7 0.4 32.8 22.8 0.0 0.0 0.0 0.0 0.0 0.0 167.3 46.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 TMSB15A "TMSL8, TMSNB" ENSG00000158164 "Thymosin beta 15a" P0CG34 X 102513676-102516784 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 16.1;prostate: 17.3" "Cell type enhanced" "Detected in some" 17 "Glandular cells: 17.5;Sertoli cells: 6.5;Spermatogonia: 22.8" "Cancer enhanced" "Detected in many" "prostate cancer: 56.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 11 "NK-cell: 2.5;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 11 "dendritic cells: 1.1;NK-cells: 2.5" "Cell line enhanced" "Detected in many" "AF22: 101.2;NTERA-2: 26.1;RH-30: 46.0;SH-SY5Y: 26.3" NA NA "unprognostic (5.33e-3)" "unprognostic (3.09e-2)" "unprognostic (1.70e-2)" "unprognostic (5.82e-3)" "unprognostic (1.34e-1)" "unprognostic (4.03e-2)" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (6.88e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-3)" "unprognostic (2.96e-4)" "unprognostic (2.14e-1)" "unprognostic (7.83e-2)" "unprognostic (2.07e-1)" 1.6 1.0 1.9 1.0 2.2 0.7 5.1 3.4 2.6 4.9 0.8 0.7 2.7 0.3 5.4 1.3 0.9 1.4 1.5 2.2 1.9 1.4 2.7 0.2 16.1 3.8 1.6 0.7 6.1 0.8 0.0 1.0 1.8 1.9 17.3 1.0 0.7 4.0 1.6 1.2 0.5 0.7 2.3 1.7 0.6 0.5 4.7 1.8 7.8 6.1 0.9 2.6 0.9 6.0 0.1 1.1 0.0 0.0 2.5 0.1 1.1 0.0 0.0 101.2 18.9 0.4 0.0 0.0 2.1 0.1 0.3 0.8 0.0 0.1 0.0 0.2 0.3 5.0 0.0 19.0 0.1 0.2 0.0 0.9 1.7 0.3 0.0 0.0 0.0 1.8 0.2 0.0 0.2 0.0 2.5 1.1 0.9 0.1 0.0 7.0 0.0 18.9 0.0 26.1 0.0 0.2 0.0 46.0 0.0 2.0 0.0 17.3 26.3 2.4 0.1 0.0 4.0 0.2 0.5 0.4 0.0 11.4 0.2 1.7 2.1 0.3 0.0 1.2 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 1.1 0.0 1.1 1.9 2.2 3.4 2.2 1.9 1.4 1.6 0.7 1.9 1.8 0.0 0.0 0.0 0.6 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.8 1.3 17.5 0.0 0.0 0.4 0.0 0.0 1.8 0.3 0.0 0.3 0.0 1.7 0.0 0.5 0.4 0.0 0.0 2.5 0.2 0.0 6.5 4.1 1.1 22.8 0.0 0.2 0.5 0.6 1.0 TNFRSF6B "DcR3, M68, TR6" ENSG00000243509 "TNF receptor superfamily member 6b" O95407 20 63696651-63698684 "Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.4;lymphoid tissue: 56.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 17.4" "Lineage enriched" "Detected in single" 18 "dendritic cells: 17.4" "Group enriched" "Detected in some" 4 "HBEC3-KT: 11.7;RPTEC TERT1: 46.0;TIME: 28.5" "Not detected" "Not detected" HPA047154 Approved "Secreted to blood" NA NA 406000 "HPA047154: AB_2679959" 11.8 2.0 10.0 39.2 17.6 2.5 7.0 5.4 8.1 4.5 6.0 2.1 0.0 2.0 3.0 2.0 6.6 2.5 3.6 2.0 11.6 6.6 4.4 2.5 39.4 9.8 5.9 0.0 3.6 2.2 2.0 4.2 2.1 23.6 2.7 2.3 0.0 2.9 2.0 10.0 4.8 3.8 4.6 13.0 56.3 10.0 2.1 5.3 2.7 6.5 3.3 12.1 11.6 2.3 0.0 17.4 0.0 0.9 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 4.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 28.5 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.9 17.4 0.0 0.1 10.0 17.6 5.4 8.1 11.6 6.6 5.9 0.0 23.6 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNIP3 "ABIN-3, FLJ21162, LIND" ENSG00000050730 "TNFAIP3 interacting protein 3" Q96KP6 4 121131408-121227466 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 9.2;lung: 8.5;lymphoid tissue: 15.4" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 23.7;Early spermatids: 11.2;Late spermatids: 32.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 9.2" "Lineage enriched" "Detected in single" 12 "T-cells: 9.2" "Cell line enhanced" "Detected in some" "HDLM-2: 5.7;hTEC/SVTERT24-B: 6.6;U-138 MG: 25.4;U-266/70: 7.2;U-266/84: 7.1;U-87 MG: 5.2" "Low region specificity" "Detected in many" HPA043063 Uncertain NA NA "HPA043063: AB_10793989" "unprognostic (2.89e-3)" "unprognostic (2.60e-1)" "unprognostic (5.23e-3)" "unprognostic (8.75e-5)" "unprognostic (9.62e-3)" "unprognostic (2.14e-2)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (2.80e-1)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.35e-2)" "unprognostic (2.84e-7)" "unprognostic (3.35e-2)" "unprognostic (6.51e-2)" "unprognostic (3.51e-1)" "unprognostic (8.78e-2)" 2.2 0.3 1.0 9.8 0.2 1.3 0.3 0.3 0.7 2.0 1.3 0.2 0.2 0.6 0.2 0.2 1.8 0.4 1.5 0.4 0.4 0.6 0.3 0.7 8.5 3.5 0.7 0.2 0.2 0.2 0.0 0.2 0.2 0.5 0.9 0.4 0.2 0.8 0.2 0.4 0.3 1.2 0.5 0.3 2.8 0.8 1.4 0.2 15.4 0.4 3.6 6.3 1.3 0.4 0.2 0.1 0.7 0.2 0.1 9.2 0.8 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.3 0.4 0.1 0.1 0.9 0.1 0.1 0.1 2.2 3.7 0.0 0.0 0.5 0.8 5.7 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 6.6 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.1 25.4 0.5 2.0 0.1 7.2 7.1 0.2 5.2 0.2 0.8 0.7 0.2 0.0 4.0 0.0 2.7 0.1 1.8 9.2 0.0 0.2 0.8 4.4 0.6 0.1 0.2 0.1 1.1 0.8 1.0 0.2 0.3 0.7 0.4 0.6 0.7 0.2 0.5 0.2 3.0 23.7 0.5 0.0 0.1 0.0 0.4 0.0 0.0 2.3 0.0 5.9 0.0 0.0 0.1 11.2 0.7 0.0 0.0 1.0 0.0 0.2 0.1 6.9 0.0 0.4 0.0 0.0 0.0 1.2 32.4 0.3 5.2 0.0 0.0 0.0 0.1 0.4 1.1 0.0 0.0 1.1 0.0 0.0 0.5 0.4 0.4 0.0 6.7 0.0 0.1 TOGARAM2 "Crescerin-2, FAM179A, FLJ43249, LOC165186" ENSG00000189350 "TOG array regulator of axonemal microtubules 2" Q6ZUX3 2 28956611-29061373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 56.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.7" "Lineage enriched" "Detected in single" 5 "T-cells: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 3.8;NB-4: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA037561, HPA037562, HPA075216" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: " "unprognostic (8.35e-5)" "unprognostic (2.85e-3)" "unprognostic (1.41e-1)" "unprognostic (7.01e-3)" "unprognostic (6.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.11e-1)" "unprognostic (2.53e-3)" "unprognostic (3.93e-1)" "unprognostic (6.83e-2)" "unprognostic (2.32e-3)" "unprognostic (5.92e-2)" "unprognostic (3.94e-11)" "unprognostic (3.75e-2)" "unprognostic (4.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.81e-3)" 0.3 2.3 3.0 1.7 8.4 2.6 0.4 3.4 1.7 0.6 0.6 7.1 0.0 0.8 1.1 14.4 0.7 15.7 0.5 2.6 3.3 3.9 0.3 0.5 14.2 1.1 2.1 2.0 4.5 0.8 0.1 6.1 0.6 15.3 0.5 0.4 0.1 0.5 0.1 1.7 0.6 0.7 0.8 2.5 2.2 1.5 3.2 6.1 0.0 0.3 0.3 1.3 0.4 0.3 0.3 0.3 0.6 0.3 0.6 3.7 1.0 0.2 0.2 0.3 0.2 0.3 0.0 0.7 0.1 2.3 0.7 2.2 0.4 0.3 0.3 0.3 0.0 0.3 0.9 0.4 0.0 0.7 0.4 1.4 0.2 2.0 0.5 0.9 2.0 3.8 0.2 0.3 0.0 0.0 0.8 0.3 2.7 0.3 1.0 0.8 0.2 0.8 3.6 2.7 1.2 0.7 0.1 0.7 1.5 1.1 0.3 2.6 1.8 0.1 0.1 0.1 0.4 0.4 0.2 0.2 0.2 0.5 0.2 0.3 0.5 0.5 0.2 1.7 1.3 0.1 0.5 0.3 0.3 3.7 0.1 2.0 0.2 0.6 2.9 0.1 0.3 0.4 1.0 0.6 0.6 0.2 0.3 1.5 1.0 3.0 8.4 3.4 1.2 3.3 3.9 2.1 2.0 15.3 6.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 56.2 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TREM1 "CD354, TREM-1" ENSG00000124731 "Triggering receptor expressed on myeloid cells 1" Q9NP99 6 41267926-41286719 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 96.9;bone marrow: 38.5;lung: 34.2" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 31.6;Hofbauer cells: 25.6;Kupffer cells: 32.3;Macrophages: 79.4" "Cancer enhanced" "Detected in many" "lung cancer: 9.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 96.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 96.9" "Group enriched" "Detected in some" 5 "SuSa: 6.5;U-87 MG: 23.8" "HPA005563, HPA053612" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA005563: AB_1858259, HPA053612: " "unprognostic (6.41e-2)" "unprognostic (1.47e-3)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (6.07e-3)" "unprognostic (2.97e-2)" "unprognostic (5.73e-5)" "unprognostic (1.29e-1)" "unprognostic (1.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.24e-3)" "unprognostic (7.65e-2)" "unprognostic (3.18e-7)" "unprognostic (6.32e-3)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (7.26e-2)" 10.2 0.6 0.7 21.1 1.5 38.5 1.0 0.6 2.1 0.7 0.9 0.7 0.5 0.1 1.0 1.5 0.6 4.2 5.1 3.7 1.2 0.9 1.1 3.7 34.2 8.0 2.7 0.1 2.1 1.8 0.2 2.7 31.2 2.3 0.9 0.0 2.5 1.3 0.1 2.4 0.4 1.1 3.8 3.9 12.1 1.0 2.6 0.6 0.3 2.2 1.9 1.0 3.9 0.7 0.2 5.0 96.9 12.8 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 6.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 1.5 0.0 0.0 12.8 0.3 0.0 3.1 0.0 0.0 0.0 0.0 5.0 0.2 0.0 0.0 96.9 0.0 1.4 0.1 0.0 4.1 0.7 1.5 0.6 2.1 1.2 0.9 2.7 0.1 2.3 0.6 6.0 31.6 2.7 0.1 0.3 0.0 0.3 2.5 13.4 19.4 0.0 0.0 0.3 0.0 0.3 10.6 0.5 0.0 0.0 0.2 0.9 0.7 0.1 5.8 0.2 25.6 0.0 0.0 1.3 32.3 13.1 0.0 79.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 12.2 0.0 0.0 0.0 TREM2 "TREM-2, Trem2a, Trem2b, Trem2c" ENSG00000095970 "Triggering receptor expressed on myeloid cells 2" Q9NZC2 6 41158506-41163186 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.6;brain: 34.8;lung: 24.6" "Cell type enriched" "Detected in some" 12 "Hofbauer cells: 939.0" "Cancer enhanced" "Detected in all" "glioma: 93.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 1.3" "Group enriched" "Detected in some" 4 "hTCEpi: 37.4;THP-1: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010917, HPA012571" Approved "Intracellular and membrane" NA NA 19000 "HPA010917: AB_1080365, HPA012571: AB_1858260" "unprognostic (3.89e-1)" "unprognostic (4.44e-3)" "unprognostic (2.77e-2)" "unprognostic (1.80e-2)" "unprognostic (1.29e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (4.83e-2)" "unprognostic (1.07e-1)" "unprognostic (8.57e-3)" "unprognostic (1.33e-1)" "unprognostic (2.09e-1)" "unprognostic (3.58e-3)" "unprognostic (8.04e-2)" "unprognostic (1.04e-2)" "unprognostic (3.16e-3)" "unprognostic (1.85e-2)" 35.6 11.8 10.1 3.0 13.4 0.3 8.6 1.6 21.7 5.9 2.9 24.1 0.0 0.9 1.5 2.1 0.6 6.5 8.4 1.7 10.4 9.5 1.0 2.1 24.6 1.7 21.7 5.2 2.7 2.5 2.7 2.9 8.8 13.4 1.8 3.9 2.1 4.4 3.0 0.8 0.4 1.2 3.8 34.8 0.5 2.2 0.8 12.9 0.0 1.6 0.8 0.5 4.2 0.5 0.5 4.9 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.6 37.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 10.1 13.4 1.6 8.3 10.4 9.5 21.7 5.2 13.4 12.9 6.0 9.8 0.0 0.0 0.7 0.1 0.2 2.5 2.7 12.5 0.0 0.0 4.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.8 0.4 0.0 2.3 0.0 939.0 0.0 0.0 3.1 28.7 0.4 0.6 78.3 0.0 13.6 0.0 0.4 0.0 0.0 0.0 0.0 0.6 6.5 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 TREML4 TLT4 ENSG00000188056 "Triggering receptor expressed on myeloid cells like 4" Q6UXN2 6 41228324-41238882 "Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 5.4;neutrophil: 10.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.3" "Cell line enriched" "Detected in some" 4 "HEL: 4.6" HPA065044 Uncertain "Secreted - unknown location" NA NA "HPA065044: AB_2685411" "unprognostic (1.49e-1)" "unprognostic (1.51e-1)" "unprognostic (5.58e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (9.50e-3)" "unprognostic (1.18e-4)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (5.26e-2)" "unprognostic (1.21e-2)" 0.3 0.1 0.1 1.2 0.3 3.1 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.6 0.3 0.2 0.1 0.2 0.1 0.2 3.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.4 9.5 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 1.3 0.9 10.3 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.4 0.0 0.5 0.0 0.1 0.0 0.0 0.5 1.3 0.0 0.0 10.3 0.0 0.4 0.9 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM71 "LIN-41, LIN41" ENSG00000206557 "Tripartite motif containing 71" Q2Q1W2 3 32818018-32897826 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Ubl conjugation pathway" "Developmental protein, RNA-binding, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 6.5;testis: 11.1" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 8.9;Extravillous trophoblasts: 13.2;Spermatogonia: 12.6" "Cancer enriched" "Detected in some" 28 "testis cancer: 28.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.9;BEWO: 36.1;Hep G2: 23.3;NTERA-2: 31.9;SuSa: 30.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA038141, HPA038142" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" "HPA038141: AB_2675857, HPA038142: AB_10697240" "unprognostic (2.93e-2)" "unprognostic (4.29e-3)" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (2.58e-2)" "unprognostic (3.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.25e-1)" "unprognostic (3.16e-2)" "unprognostic (3.04e-1)" "unprognostic (1.11e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-6)" "unprognostic (3.92e-2)" "unprognostic (9.27e-2)" "unprognostic (8.17e-2)" "unprognostic (4.65e-2)" 0.1 0.0 0.7 0.1 1.9 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.7 0.7 2.2 0.0 6.5 0.0 0.2 0.0 0.1 0.0 0.0 0.5 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 11.9 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.6 0.0 23.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.2 2.5 31.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.0 0.5 2.7 0.7 0.2 0.0 1.9 0.0 8.9 2.6 0.0 0.0 0.0 0.4 2.8 0.0 1.4 3.4 0.0 0.0 3.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.9 0.4 0.0 0.0 0.3 12.6 0.0 3.3 0.0 0.0 0.0 TRPC6 "FSGS2, TRP6" ENSG00000137672 "Transient receptor potential cation channel subfamily C member 6" Q9Y210 11 101451564-101872562 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 35.3;placenta: 20.6" "Cell type enhanced" "Detected in some" 16 "Club cells: 19.4;Leydig cells: 5.8;Smooth muscle cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 4.7;ASC diff: 8.8;BJ hTERT+: 4.7;HEL: 4.4;RPTEC TERT1: 21.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6" HPA045098 Approved NA NA 140000 "HPA045098: AB_10959600" "unprognostic (1.45e-1)" "unprognostic (4.21e-1)" "unprognostic (2.43e-1)" "unprognostic (8.71e-5)" "unprognostic (1.86e-1)" "unprognostic (1.36e-2)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (5.47e-4)" "unprognostic (1.99e-3)" "unprognostic (4.88e-2)" "unprognostic (7.16e-2)" "unprognostic (1.32e-2)" 6.0 0.5 1.5 0.6 2.4 0.1 9.7 0.8 2.0 7.6 3.9 1.1 7.5 1.1 6.6 7.0 10.8 5.3 3.2 1.1 2.0 1.5 1.6 0.4 35.3 0.9 2.2 3.4 2.2 1.0 1.0 0.6 20.6 2.9 2.3 1.6 0.3 3.3 7.2 0.8 3.0 1.9 3.9 0.7 2.0 1.5 1.0 0.1 0.1 9.6 2.7 1.1 1.6 3.8 0.0 1.0 5.5 0.5 0.0 0.0 0.3 0.0 4.7 0.2 0.0 8.8 2.2 0.0 3.0 4.7 0.7 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.3 1.5 2.4 0.8 2.0 2.0 1.5 2.2 3.4 2.9 0.1 0.0 1.6 0.0 1.7 2.1 0.8 0.4 0.0 1.4 19.4 3.5 0.0 0.9 0.0 0.0 0.6 0.8 0.0 0.0 0.2 0.0 1.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.8 2.6 1.7 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 9.8 0.0 0.0 3.0 0.3 0.0 0.0 1.0 TSPAN19 ENSG00000231738 "Tetraspanin 19" P0C672 12 85014311-85036277 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lung: 9.7;pituitary gland: 20.0" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 360.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.4;SK-BR-3: 4.3" "Low region specificity" "Detected in all" HPA057066 Uncertain NA NA "HPA057066: AB_2683325" "unprognostic (1.94e-1)" "unprognostic (9.81e-4)" "unprognostic (8.57e-2)" "unprognostic (8.37e-2)" "unprognostic (2.33e-1)" "unprognostic (6.57e-2)" "unprognostic (2.26e-3)" "unprognostic (9.52e-2)" "unprognostic (5.09e-3)" "unprognostic (2.22e-1)" "unprognostic (3.78e-2)" 0.4 0.8 1.5 0.5 1.9 2.3 0.2 1.0 2.6 0.5 0.4 1.4 0.0 1.1 0.5 2.5 0.8 1.8 0.8 0.4 3.2 4.4 0.7 0.1 9.7 0.5 2.3 4.4 0.4 1.6 0.4 20.0 0.5 4.9 1.0 0.2 2.4 0.8 0.0 1.6 4.5 0.6 0.0 1.6 0.5 0.5 8.4 1.4 0.0 4.1 1.3 0.2 0.5 0.2 1.8 0.9 5.4 1.0 0.8 1.1 0.0 0.9 0.0 1.6 0.5 0.9 1.4 1.8 0.9 0.1 0.0 0.5 0.8 0.0 1.0 0.1 0.0 1.1 0.3 0.2 0.3 0.0 0.8 1.6 0.0 0.5 0.7 2.1 1.5 1.7 1.0 1.1 0.9 0.6 3.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 1.4 0.2 0.0 0.0 0.3 6.4 2.7 0.0 4.3 0.9 0.7 1.0 0.3 1.2 3.0 0.9 1.3 0.8 3.8 0.0 0.5 3.3 0.0 1.4 1.1 1.0 1.1 1.0 0.7 0.7 0.9 0.8 0.5 0.1 1.8 1.1 1.0 5.4 0.8 0.4 0.9 0.3 0.0 1.5 1.9 1.0 2.6 3.2 4.4 2.3 4.4 4.9 1.4 3.0 1.3 0.0 0.0 0.1 2.4 0.8 0.0 360.0 34.2 0.0 7.9 0.0 0.0 0.0 46.9 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.4 0.0 7.9 6.5 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149964007-149973710 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.9;lung: 9.7;testis: 10.5" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 13.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 23.1;JURKAT: 17.8" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: AB_2686332" "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.7 0.6 2.0 0.4 0.6 0.5 0.5 13.9 1.5 0.4 0.7 0.2 0.0 0.4 0.5 0.5 0.8 0.9 0.5 1.2 1.5 0.3 1.2 0.9 9.7 0.2 0.3 0.0 1.2 0.4 0.6 0.6 1.3 1.0 0.8 0.4 0.5 1.0 0.2 1.6 0.6 0.3 0.3 1.2 0.3 0.9 10.5 0.2 0.2 3.8 0.6 0.5 0.7 4.9 0.7 0.1 0.9 1.8 0.3 3.5 0.3 2.7 1.3 2.6 1.4 2.6 7.7 2.7 3.6 1.1 1.6 2.8 1.8 3.1 2.7 2.9 12.4 6.6 2.6 23.1 4.5 4.3 12.0 3.8 0.2 0.9 0.0 13.6 0.1 1.0 8.4 5.6 11.4 3.0 1.3 2.3 17.8 2.2 0.0 4.0 3.2 2.8 0.0 0.9 1.7 4.2 1.2 2.4 0.3 4.9 2.0 0.9 0.3 5.3 3.3 0.8 1.6 2.6 5.3 1.9 1.3 2.3 5.1 3.2 0.4 0.4 2.5 7.9 4.0 3.3 0.1 0.2 0.1 2.4 1.3 3.5 0.7 1.2 2.8 0.1 0.2 0.7 1.2 0.9 0.3 1.8 0.0 1.9 0.3 2.0 0.6 13.9 1.5 1.5 0.3 0.3 0.0 1.0 0.2 6.0 2.1 0.0 0.4 0.1 0.0 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.5 0.0 0.0 0.0 0.1 UPK3B "FLJ32198, MGC10902, p35, UPIIIb" ENSG00000243566 "Uroplakin 3B" Q9BT76 7 76510428-76516521 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 1: 113.2" "Group enriched" "Detected in many" 12 "ovarian cancer: 64.6;urothelial cancer: 78.4" "Region enriched" "Detected in single" 58 "pons and medulla: 5.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "A549: 7.8;CAPAN-2: 28.5;HaCaT: 5.8;RT4: 19.5;T-47d: 16.2" HPA010506 Approved NA NA "HPA010506: AB_1080479" "unprognostic (8.33e-2)" "unprognostic (1.30e-1)" "unprognostic (3.62e-3)" "unprognostic (2.26e-3)" "unprognostic (7.87e-2)" "unprognostic (8.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.63e-1)" "unprognostic (4.03e-1)" "unprognostic (5.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.06e-2)" "unprognostic (8.37e-9)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-1)" "unprognostic (6.34e-2)" 28.5 0.3 0.0 7.1 0.0 0.4 0.3 0.0 0.3 1.5 6.9 0.1 0.0 0.3 0.8 7.9 40.2 2.8 3.0 9.4 0.0 0.0 0.3 0.4 34.1 0.4 0.0 0.0 13.2 0.3 0.3 0.1 0.3 5.8 1.4 0.3 0.8 1.4 0.3 0.4 1.1 0.5 1.5 0.2 0.4 0.6 6.1 0.0 0.2 0.3 6.1 25.0 20.5 2.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.6 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.5 0.0 0.2 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.2 2.3 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 113.2 3.5 0.0 0.2 1.4 0.0 0.3 2.5 4.0 9.1 3.5 3.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 1.1 0.0 0.1 1.6 0.0 0.6 0.0 0.0 11.2 0.9 3.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 2.5 0.1 0.0 0.1 2.5 VEGFD "FIGF, VEGF-D" ENSG00000165197 "Vascular endothelial growth factor D" O43915 X 15345591-15384376 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.0" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.2;Club cells: 1.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;ASC TERT1: 6.0;EFO-21: 2.7;HSkMC: 6.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA027342 Uncertain "Secreted to blood" NA NA 592000 340000 "HPA027342: AB_1848597" "unprognostic (5.90e-2)" "unprognostic (9.79e-3)" "unprognostic (1.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-2)" "unprognostic (2.07e-1)" "unprognostic (6.06e-3)" "unprognostic (5.57e-2)" "unprognostic (2.24e-3)" "unprognostic (2.65e-2)" "unprognostic (1.59e-5)" "unprognostic (3.08e-2)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (1.75e-2)" 9.5 7.4 0.6 1.8 1.0 0.1 19.5 1.1 0.7 10.5 7.6 0.2 4.1 1.1 10.1 12.9 15.4 2.7 3.5 27.8 0.6 1.1 1.0 1.3 39.0 0.7 0.8 0.2 7.3 2.6 0.2 4.4 0.2 0.8 22.2 1.9 0.2 1.5 1.8 12.0 0.5 4.3 9.8 0.6 2.3 3.4 14.9 0.1 0.0 2.0 17.5 1.2 12.3 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 1.8 7.3 6.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 2.7 0.0 0.8 0.5 0.5 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.4 0.0 0.8 6.1 0.7 0.0 0.0 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.5 0.6 0.4 0.3 0.1 0.6 1.4 0.0 0.7 0.3 0.0 0.1 0.3 0.3 0.4 1.2 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 1.1 0.7 0.6 1.1 0.8 0.2 0.8 0.1 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favorable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.3 0.0 2.5 9.4 0.0 11.0 24.5 3.3 4.8 0.3 1.7 0.0 4.3 11.8 0.5 0.0 0.1 0.2 18.3 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 14.0 2.8 26.3 65.1 0.0 0.6 0.0 8.9 0.2 0.0 0.0 1.7 0.5 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 0.0 18.9 0.0 38.7 13.1 0.4 4.5 15.1 0.0 0.0 0.0 10.5 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 247.1 124.4 0.0 0.2 1.5 0.0 0.3 12.7 14.7 26.1 29.6 2.0 1.6 39.7 5.5 67.1 0.0 0.0 0.0 8.7 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 63.8 1.4 0.4 27.0 1.0 0.2 0.8 2.0 2.8 0.4 24.1 0.3 0.0 0.0 0.3 0.6 0.4 0.0 0.0 0.6 0.1 VIPR1 "HVR1, RDC1, VPAC1, VPAC1R" ENSG00000114812 "Vasoactive intestinal peptide receptor 1" P32241 3 42489299-42537573 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 83.1" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 40.7;Mucus-secreting cells: 38.5;Paneth cells: 92.0;Sertoli cells: 32.3" "Cancer enhanced" "Detected in many" "prostate cancer: 10.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.2;intermediate monocyte: 2.6;MAIT T-cell: 1.9;memory CD4 T-cell: 4.8;memory CD8 T-cell: 1.9;myeloid DC: 3.9;naive CD4 T-cell: 5.5;naive CD8 T-cell: 1.7;non-classical monocyte: 2.3" "Group enriched" "Detected in many" 32 "dendritic cells: 3.9;monocytes: 3.2;T-cells: 5.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 27.3;OE19: 15.9;RT4: 19.5;SK-BR-3: 11.1;WM-115: 35.4" "Group enriched" "Detected in many" 5 "amygdala: 6.5;basal ganglia: 4.1;cerebral cortex: 9.2;hippocampal formation: 8.5" "Low region specificity" "Detected in all" HPA026777 Approved NA NA "HPA026777: AB_10604003" "unprognostic (9.02e-2)" "unprognostic (9.34e-3)" "unprognostic (3.70e-1)" "unprognostic (1.57e-1)" "unprognostic (1.28e-1)" "unprognostic (1.47e-2)" "unprognostic (8.89e-4)" "unprognostic (4.00e-3)" "unprognostic (1.03e-1)" "unprognostic (2.95e-2)" "unprognostic (1.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-3)" "unprognostic (7.70e-2)" "unprognostic (1.69e-1)" "unprognostic (1.03e-2)" "unprognostic (1.05e-2)" 8.1 1.8 5.6 6.4 11.8 1.3 7.4 10.2 13.8 2.0 17.7 0.6 27.8 22.0 0.9 4.6 2.7 1.0 10.6 3.1 2.9 1.2 1.4 15.4 83.1 5.1 1.3 8.4 0.5 1.4 2.9 1.2 1.9 1.9 13.0 18.1 2.2 9.7 29.0 0.8 12.2 25.9 1.3 0.9 2.7 3.7 0.9 1.3 0.0 7.2 3.2 3.1 6.0 2.4 0.1 3.9 0.1 3.2 0.0 5.5 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.9 27.3 0.1 1.3 0.0 0.0 1.1 0.0 0.7 0.0 0.0 2.1 1.6 0.8 0.0 0.1 0.0 0.2 0.0 1.7 0.1 0.5 0.0 0.3 0.2 0.0 0.0 0.0 2.2 0.0 0.1 1.7 15.9 0.1 0.2 0.0 1.2 0.0 19.5 0.6 0.0 0.0 11.1 0.0 3.3 6.8 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.4 0.0 3.2 0.0 0.4 2.6 1.9 0.1 4.8 1.9 3.9 0.0 5.5 1.7 0.1 0.0 2.3 0.0 0.7 1.3 5.6 11.8 10.2 13.8 2.9 1.2 1.3 8.4 1.9 1.3 3.0 5.9 2.0 4.2 6.8 0.1 1.2 5.1 1.4 2.3 1.8 7.9 0.0 0.0 0.4 0.7 1.4 40.7 0.0 0.8 0.3 0.4 9.6 0.0 0.0 0.6 0.0 4.6 14.7 8.9 0.4 0.0 2.4 0.0 0.0 38.5 1.2 0.8 92.0 0.0 0.0 5.1 32.3 2.2 0.0 0.0 6.8 0.2 1.3 22.9 3.2 VNN2 "FOAP-4, GPI-80" ENSG00000112303 "Vanin 2" O95498 6 132743870-132763459 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 85.2;lung: 36.4;lymphoid tissue: 43.6" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Ductal cells: 36.1;Kupffer cells: 27.8;Macrophages: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 8 "neutrophil: 85.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 85.2" "Cell line enriched" "Detected in some" 8 "Daudi: 35.7" "Not detected" "Not detected" NA NA 270000 "unprognostic (2.13e-1)" "unprognostic (1.15e-1)" "unprognostic (9.60e-3)" "unprognostic (5.71e-2)" "unprognostic (2.14e-1)" "unprognostic (5.61e-3)" "unprognostic (1.98e-3)" "unprognostic (4.38e-1)" "unprognostic (3.07e-1)" "unprognostic (3.46e-1)" "unprognostic (2.84e-1)" "unprognostic (8.30e-2)" "prognostic unfavorable (2.72e-7)" "unprognostic (1.62e-1)" "unprognostic (8.17e-2)" "unprognostic (2.01e-1)" "unprognostic (5.45e-2)" 10.1 1.4 1.1 9.5 1.1 10.8 1.4 1.4 1.4 1.8 1.9 0.8 0.0 0.7 0.9 3.1 2.1 4.3 10.2 10.5 1.1 1.1 2.8 5.6 36.4 39.8 3.8 0.3 2.1 2.4 0.0 1.2 8.6 1.5 2.4 0.9 1.8 1.3 0.2 1.0 0.7 3.6 2.4 2.2 43.6 2.8 3.6 0.6 3.4 1.4 0.7 17.7 7.3 10.9 6.4 2.2 85.2 10.9 5.8 6.7 5.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.7 0.0 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.9 0.0 0.0 1.5 10.9 0.0 4.2 2.4 1.7 6.4 1.4 4.9 2.2 5.5 4.5 6.7 85.2 5.8 1.5 0.4 0.9 5.7 1.1 1.1 1.4 1.4 1.1 1.1 3.8 0.3 1.5 0.6 0.0 10.7 0.0 0.0 0.0 0.0 1.2 2.5 17.4 3.4 0.0 0.0 0.6 0.0 36.1 0.0 0.0 0.0 0.0 0.3 0.1 0.5 5.6 4.7 0.0 11.3 0.0 0.0 4.3 27.8 0.0 0.0 17.1 0.0 1.8 0.0 0.0 4.0 0.0 0.0 0.3 0.0 6.5 0.5 0.0 0.0 0.0 1.1 6.1 0.0 8.4 WIF1 ENSG00000156076 "WNT inhibitory factor 1" Q9Y5W5 12 65050626-65121566 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;lung: 67.7;retina: 29.6" "Cell type enriched" "Detected in many" 15 "Muller glia cells: 2337.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 16.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.4;LHCN-M2: 2.5;NTERA-2: 7.0;SCLC-21H: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (5.96e-3)" "unprognostic (2.00e-1)" "unprognostic (4.29e-3)" "unprognostic (3.26e-3)" "unprognostic (9.66e-2)" "unprognostic (1.91e-1)" "unprognostic (1.26e-2)" "unprognostic (7.94e-2)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (3.17e-1)" "unprognostic (2.30e-5)" "unprognostic (3.02e-1)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (7.24e-3)" 0.9 2.4 23.3 0.8 35.2 0.6 14.2 1.6 20.6 1.6 0.8 1.0 1.9 0.6 5.5 14.5 3.4 1.5 0.6 0.7 10.4 3.9 1.0 0.6 67.7 0.7 1.4 8.2 0.8 0.8 0.6 21.4 0.6 0.4 9.5 0.8 29.6 24.8 2.3 0.6 4.2 1.8 1.2 0.7 0.7 0.9 1.0 3.5 0.0 0.6 3.6 0.6 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.5 0.1 0.0 0.9 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 35.2 1.6 20.6 10.4 3.9 1.4 8.2 0.4 3.5 32.8 159.2 0.0 31.4 11.2 20.4 1.1 0.0 62.9 48.9 1.8 7.9 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 1.9 16.0 7.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 3.1 21.9 0.0 0.0 2337.6 0.0 0.0 0.4 0.8 66.4 0.0 3.6 0.5 0.2 9.3 0.0 0.0 0.0 0.5 WNT2 "INT1L1, IRP" ENSG00000105989 "Wnt family member 2" P09544 7 117276631-117323289 "Cancer-related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 10.4;lung: 10.9;placenta: 40.9" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 24.8;Fibroblasts: 9.4;Hofbauer cells: 6.8;Ito cells: 11.1;Late spermatids: 7.0;Syncytiotrophoblasts: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 21.6" "Region enhanced" "Detected in many" "basal ganglia: 12.6" "Low region specificity" "Detected in all" HPA020920 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA020920: AB_1858850" "unprognostic (1.90e-1)" "unprognostic (6.97e-2)" "unprognostic (2.88e-2)" "unprognostic (4.11e-3)" "unprognostic (9.14e-2)" "unprognostic (2.47e-1)" "unprognostic (2.54e-2)" "unprognostic (2.75e-1)" "unprognostic (2.74e-1)" "unprognostic (5.70e-2)" "unprognostic (1.36e-2)" "unprognostic (1.41e-1)" "unprognostic (3.43e-1)" "unprognostic (4.05e-2)" "unprognostic (2.50e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-1)" 1.8 0.0 0.2 0.1 1.1 0.0 1.4 0.3 2.3 3.0 0.2 0.4 0.4 0.0 10.4 2.7 0.4 1.0 0.2 0.7 0.9 0.9 0.3 0.8 10.9 0.0 0.1 0.5 0.8 0.1 0.0 0.2 40.9 0.5 7.6 0.0 0.9 0.1 0.5 0.0 1.1 0.2 1.2 0.2 1.5 0.1 0.7 0.0 0.0 0.2 0.0 0.1 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 2.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.3 2.3 0.9 0.9 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.0 24.8 0.4 0.0 0.0 0.0 2.9 9.4 0.2 0.0 0.0 6.8 0.0 0.0 11.1 1.0 7.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 1.6 0.1 2.4 7.6 0.0 0.0 0.1 WNT3A ENSG00000154342 "Wnt family member 3A" P56704 1 228007051-228061260 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lung: 7.4;placenta: 19.9" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 11.9;Basal glandular cells: 2.4;Basal keratinocytes: 3.1;Syncytiotrophoblasts: 2.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HEK 293: 2.8;U-2 OS: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA066281 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA066281: AB_2685647" "unprognostic (9.84e-3)" "prognostic favorable (6.11e-5)" "unprognostic (2.40e-1)" "unprognostic (3.37e-1)" "unprognostic (7.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.96e-1)" "unprognostic (4.22e-2)" "unprognostic (4.12e-2)" "unprognostic (2.16e-1)" "unprognostic (4.80e-3)" "unprognostic (1.99e-1)" "unprognostic (7.26e-2)" "unprognostic (5.43e-3)" "unprognostic (1.54e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.6 0.1 0.1 0.1 0.0 0.1 0.1 2.0 0.2 0.1 0.1 0.1 0.0 0.2 0.1 7.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 19.9 0.1 2.4 0.0 0.1 1.7 0.1 0.1 3.0 0.1 0.1 0.6 0.1 0.0 1.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 11.9 0.0 0.0 2.4 3.1 0.0 1.4 0.0 0.0 1.2 1.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.9 2.4 0.0 0.0 0.5